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DankwoorD
Het begon allemaal bijna tien jaar geleden, met de keuze om biochemie en biotechnologie 
te gaan  studeren aan de KU Leuven. Een logische keuze: ik vond zowel biologie als chemie 
boeiend en leuk. Biochemie is gelukkig zoveel meer dan een som van de delen: een wereld 
van genen, cellen en pathways ging voor mij open. En wanneer het thuisfront vroeg wat 
ik daar dan later zou mee gaan doen, antwoordde ik stellig: forensisch onderzoeker. 
Hoewel dit me nog altijd boeit, ben ik vandaag blij dat het anders is gelopen.   
Dit werk is het resultaat van vier en een half jaar hard werk, met ontelbare ups en downs,  bloed, 
zweet en tranen. Maar het was bovenal een periode waarin ik me volop kon wijden aan iets wat 
me boeit, met ontelbare leuke momenten, toffe ontmoetingen en leerrijke samenwerkingen. 
Zonder de hulp van een heleboel mensen stond ik hier vandaag niet en ik wil van 
de gelegenheid gebruik maken om jullie te bedanken. Allereerst wil ik Jos en Sarah 
bedanken. Bedankt om voor jullie te mogen werken, me zoveel te leren en voor alle 
kansen die jullie me boden. Jos, bedankt voor je aanstekelijk enthousiasme voor 
onderzoek en om me de vrijheid te geven om mijn wilde plannen waar te maken. Je hebt 
een onschatbare rol gespeeld in het aanwakkeren van mijn passie voor wetenschap.    
Sarah, ik wil je graag bedanken voor al je tijd en werk die je in mijn project hebt gestoken. Ik 
weet dat ik zeker niet altijd de makkelijkste was, maar jouw aanmoedigingen en opmerkingen 
hebben me gedreven om telkens het onderste uit de kan te halen. Ik kan alleen maar hopen dat 
ik het onderzoek dat jij startte waardig heb voortgezet. Bedankt voor alles.     
Ik had het geluk om nog een derde promotor te hebben: Joris, een welgemeende 
merci! Het is uiteindelijk geen gistonderzoek geworden, maar ik weet dat 
ik altijd op je steun en hulp kan rekenen. Ik ben ongelooflijk trots op wat 
ik heb mogen realiseren voor o.a. iGEM en BioSCENTer.     
In deze reeks van mensen die van cruciaal belang geweest zijn voor mijn doctoraat, wil ik ook 
zeker Sigrid aanhalen. Sigrid, ik kijk ongelooflijk op naar jou en je werk. Je onuitputtelijke 
energie en daadkracht zijn een blijvende bron van inspiratie voor me. Ik hoop dat we ook na 
dit avontuur contact blijven houden. 
Ik wil ook graag mijn voorzitter en de jury bedanken voor de interesse waarmee ze mijn werk 
gelezen hebben. Prof. Kris Laukens, bedankt voor de tips over de systematische assays, ze 
hebben me zeker geholpen om het één en ander in perspectief te plaatsen en beter te funderen. 
Prof. Dominique Schols, dank u wel voor uw enthousiasme en voor de tips ivm het pili werk. 
Prof. Bert Sels, wie had kunnen denken dat dit werk organosynthetische capaciteiten bezat? 
Ik alvast niet, bedankt om me dit te doen inzien. Last but not least, Prof. Willem M. de Vos, 
bedankt om in mijn jury te zetelen. Uw kennis over microbiologie lijkt onmetelijk te zijn, 
mijn hoofd tolt er soms een beetje van. Maar ik heb nog nooit van iemand zoveel bijgeleerd 
op zo’n korte termijn, het is dan ook een ware eer en genoegen om onder uw begeleiding aan 
een nieuw avontuur in Wageningen te beginnen. Bedankt voor uw kritische noten bij mijn 
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resultaten, de goede samenwerking, interessante discussies en de leuke mini sightseeing ritjes 
in Wageningen en Helsinki. 
Glycobiologie is een relatief nieuw onderzoeksveld. Ik wil graag IWT Vlaanderen bedanken 
om potentieel te zien in dit project en dit financieel te ondersteunen. Zonder de steun van de 
Projectfinanciering (PF3M100234) had ik dit werk niet kunnen uitvoeren. Hier wil ik ook 
zeker Prof. Jan Balzarini, tevens assessor van mijn project, bedanken. De financiële steun van 
ASL, FWO en UAntwerpen hielp me bovendien om de halve aardbol af te reizen om bij te 
leren over glycobiologie. 
Inzichten verkrijgen in bacteriële glycoconjugaten vergt een multidisciplinaire aanpak en ik 
heb tijdens dit doctoraat de hulp gekregen van fantastische mensen. Prof. Kathleen Marchal 
and Dr. Aminael Sanchez-Rodriguez, thank you very much for the collaboration on the in 
silico approach, I simply could not have done this without you and the results have really 
helped me throughout this work. Prof. Els Van Damme zonder uw lectines had dit werk er 
een pak magerder uit gezien. Prof. Ruddy Wattiez and Dr. Baptiste Leroy, I’m really happy 
that I could count on you for all the mass spectrometry. Baptiste, merci beaucoup pour la 
collaboration agréable! Also a large thanks to the laboratory of Prof. de Vos at UHelsinki. 
Especially to François Douillard and Pia Rasinkangas for the nice brainstorms and fruitful 
collaboration on the SpaCBA pili glycosylation and SecX story. I also want to thank Marcel 
Messing at the Haartman Institute for his help during my first stay in Finland. Prof. Paul 
Proost, bedankt om alle Edman-degradaties uit te voeren. Prof. Theo Geijtenbeek en Nienke 
van Teijlingen, ik wil jullie enorm hard bedanken voor de fijne en leerrijke tijd die ik mocht 
doorbrengen in jullie groep. Prof. Manfred Wuhrer en Kathrin Stavenhagen, I learnt some 
valuable lessons on glycan mass spectrometry and want to thank you for the nice brainstorms. 
Intussen is het CMPG al sinds 2008 een plek waar ik met veel plezier kom werken. Bedankt aan 
alle collega’s van alle groepen voor de fijne momenten, closing times, laboweekends… Ook alle 
sportactiviteiten (frisbee, lopen, badminton, zwemmen, squashen) zorgden voor onvergetelijke 
momenten. Nooit had ik bij aanvang van mijn doctoraat durven denken dat ik nu zelfs zou genieten 
van 10 km te lopen. Bedankt iedereen voor de fijne jaren en alle mooie herinneringen.   
Het CMPG zou het CMPG niet zijn zonder Anita, JosD en André. Jullie leiden alles in goede 
banen en ik denk dat we allemaal niet genoeg beseffen hoe jullie ervoor zorgen dat wij zonder 
zorgen aan wetenschap kunnen doen. Merci!
Het werk in dit boekje was niet tot stand kunnen komen zonder de hulp van Geert en 
Tine. Ik waardeer jullie hulp enorm en wil jullie beiden van harte danken voor alles wat 
ik van jullie mocht bijleren. Jullie waren van onschatbare waarde voor dit werk. Bedankt 
om altijd te willen antwoorden op mijn soms ‘blonde’ vragen en te willen inspringen 
wanneer ik iets te veel hooi op mijn vork nam.       
I want to thank all current and former members of the Probio group for all the scientific and 
less scientific moments we shared over the years. Mariya, thanks for all your tips and all the 
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fun moments we shared. Elke, het was echt leuk om met je samen te werken en om je er bij 
te hebben in Londen en Groningen. Cynthia, as your Rubia, I want to thank you for all the 
fun and nice talks. Elke, Mariya, Tine, Cynthia, Marijke and your husbandies (to be), thank 
you so much for making our India trip unforgettable! Shweta, thanks for being there, the talks 
inbetween work, the India trip, the friendship, our trips to NY and Seattle, London and Cork. 
Thanks for having us at your wedding. We will see each other soon in India or Belgium! 
That’s a promise. Ingmar, bedankt om mijn thesisbegeleider te zijn en de samenwerking voor 
de Kinderuniversiteitsessies. Op mijn beurt mocht ik ook drie thesisstudenten begeleiden: 
bedankt voor al jullie hulp en jullie interesse in mijn onderzoek. Ik wil vooral Anneleen 
bedanken om me zo goed en enthousiast te helpen bij alle experimenten en in te springen 
wanneer ik op buitenlandse stage was. 
Marijke, ook ik vind het moeilijk om onze tijd in enkel zinnen samen te vatten. We hebben 
zoveel momenten, frustraties, tripjes en triomfen gedeeld, waar moet ik beginnen? Bedankt 
voor alle congrestripjes en alle momenten voor en na de congressen met de shoppingtrips, 
wijnbarretjes, etentjes, Madrileense jogging, sightseeing… Zonder jou waren deze vier jaren 
lang niet zo leuk geweest. Bedankt voor onze vriendschap en de ontelbare mooie herinneringen.
Geen Probio zonder Salmo: bedankt David, Ami en Kai voor alle hulp, tips en antwoorden op 
mijn vragen. Een oprechte dank u wel aan alle vroegere en huidige leden van S&P voor de 
leuke sfeer. Een speciale dank aan Ansie, Seppe, Akanksha, Hans, Sandra, Stijn en Elke. Het 
CMPG is echter meer dan S&P alleen. Maarten, bedankt om ons op te vangen in je éénmanslab, 
alle nuttige discussies en alle leuke momenten daar in ons lab beneden. Pietje, merci om mijn 
bureaupartner te zijn in het ‘kiekenkot’, je luisterend oor en alle steun, zeker toen ik de tweede 
keer naar het IWT moest. Merci! Mikey/Kim, dank je om er te zijn en te luisteren, de sportieve 
momenten, de nuttige discussies en de terrasjes. Veerle, bedankt voor alle leuke gesprekken 
en de fijne trip naar Rome. Dank je ook Bram, Annelies, Maarten, Natalie en Toon! 
Tijdens mijn doctoraat kreeg ik ook de kans om me toe te leggen op wat minder wetenschappelijk 
getinte nevenprojecten. Sofie Boons, ik ben nog altijd heel trots op ons project. Ik heb 
ongelooflijk veel bijgeleerd en heb heel hard genoten van onze samenwerking. Wie weet doen 
we ooit nog eens iets samen? Ook een dank u wel aan Karen Verschooren om me mee te trekken 
in het ‘Alter Nature’ avontuur! Het was een leuke en verrijkende uitdaging voor me.  
Cheryl, thanks for getting me involved in DLI. I was not able to contribute as much as I would 
have wanted to, but I’m still a heavy supporter of your dream and our cause.
Zonder mijn vrienden waren het maar saaie jaren geweest. Bedankt allemaal om 
er altijd te zijn voor mij en alle onvergetelijke momenten.     
Lies, Sven, Isabelle, Jeroen, Jelle en Greet, zonder jullie was mijn tijd in Leuven niet 
half zo plezant geweest. Bedankt voor alle etentjes, tripjes in binnen- en buitenland en 
terrasjes. Bedankt voor alles.         
Nico, bedankt om er altijd voor me te zijn, voor Thailand, Amsterdam en onze Amerika roadtrip 
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door Amerika. Samen met Michiel, Jinne en Lorin zorgde je voor de nodige ontspannende 
feestjes, pokeravonden en etentjes. Merci mannen!       
Annelies, je kent me waarschijnlijk al het langst van iedereen. Ik vind het geweldig 
dat we er altijd zijn voor mekaar, zelfs al is dat fysiek niet zo. Bedankt voor alle 
telefoontjes, reisjes, etentjes, cocktails en shoppingsprees!      
Pieter, merci om me te blijven motiveren om te lopen en voor alle avonden dat we welkom 
waren bij jou thuis. Maar vooral, dit doctoraat en mijn papers hadden er niet half zo 
mooi uitgezien zonder jouw Photoshop kunsten. Bedankt dat ik altijd op je mag rekenen, 
dat je altijd paraat staat met tips en tricks en om mijn privéleraar ‘grafiek’ te zijn.   
Eline, het is heel nipt geweest, maar ik ben dan toch nog eerder Dr. geworden dan jij. 
Merci voor alle cocktails, onze mislukte Parijs trip, wandelingen in de sneeuw (ik beloof 
dat ik zal proberen Kerst terug te leren appreciëren) en zoveel meer.     
Wouter, Jef, Bieke, Samme, Ilse en Christiaan: merci voor alle Extravanganza-
uitjes! De momenten met onze hele bende zijn altijd chaotisch, maar o zo leuk! Ik kijk 
al uit naar onze volgende avonturen!        
(Anne)Lies, we zien elkaar niet veel, maar je weet wat onze vriendschap voor me betekent. 
Ik zou graag ook mijn familie en schoonfamilie bedanken. Bedankt voor jullie interesse in 
wat ik uitspookte hier in Leuven. Opa, Jan en tante Isabelle, bedankt om er altijd te zijn voor 
mij. Oma, pepe André, meme Paula en nonkel Roger, ik vind het ongelooflijk spijtig dat jullie 
er niet bij kunnen zijn, maar ik weet dat jullie trots zijn op jullie Hanneke. Ik mis jullie nog 
elke dag. Papa en mama, zonder jullie stond ik vandaag niet waar ik nu sta. Jullie hebben me 
gesteund en gepusht om het beste uit mezelf te halen. Ik hoop dat ik jullie trots heb kunnen 
maken. 
Lim, voor ik je kende was alles heel zwart-wit, jij bracht grijs in mijn leven. Jij bent het 
allerbelangrijkste in mijn leven en ik ben TedxFlanders nog elke dag dankbaar dat we elkaar 
daar hebben mogen ontmoeten. Ik kan niet wachten om te beginnen aan onze avonturen samen 
en bedank je om me te steunen bij al mijn wilde plannen. Samen kunnen we alles aan. Bedankt 
dat ik je maske mag zijn, om er altijd te zijn, om me altijd te steunen. Ik hou van je.
Doctoreren, wat een ervaring. Ik heb ongelooflijk veel bijgeleerd en hard genoten van elk 
moment. Bedankt aan iedereen die er voor me was, me geholpen heeft en bijgedragen heeft 
aan al die leuke herinneringen. Bedankt ook aan iedereen die ik ben vergeten op te noemen of 
niet expliciet vermeld heb. 
Op naar nieuwe avonturen…
          Hanne
- Playing it safe always ends in disaster -
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abstract
Humans live in close contact with a huge amount of bacteria, i.e. the microbiota, of which 
the gut microbiota is the best documented. The better we get to know this bacterial load, the 
more imbalances of the microbiota are linked to a plethora of diseases. Probiotics, defined as 
‘live microorganisms which, when administered in adequate amounts, confer a health benefit 
to the host’ can be used to prevent and influence such dysbiosis states. An underpinned use 
of probiotics requires a detailed understanding of the molecules underlying the specific 
interaction between these bacteria and their host. An important model probiotic strain and 
well-documented microbiota isolate is Lactobacillus rhamnosus GG, of which the clinical 
potential has already been widely studied and several key modulators of its probiotic function 
are known. 
In this PhD work, we focus on an intriguing class of bacterial molecules, namely glycoproteins. 
In 2008, the first indications were found that the secreted Msp1 protein, a cell wall hydrolase 
and probiotic effector of L. rhamnosus GG, is glycosylated. These findings were confirmed by 
complementary techniques such as lectin blotting (i.e. (glyco)proteins specifically interacting 
with sugar moieties), specific glycostaining and mass spectrometry, and the first report on 
an L. rhamnosus GG glycoprotein was then published in 2012. Subsequently, we wondered 
whether L. rhamnosus GG glycosylates more of its proteins and whether protein glycosylation 
plays a biochemical role, is involved in bacterial physiology and/or governs host-microbe 
interaction functions. Glycans on proteins, but also on various other glycoconjugates, are 
generally used by bacteria to shield of their immunogenic molecules from the host immune 
system, but they can sometimes also function to enhance interactions with it, e.g. by targeting 
specific immune lectin receptors. Bacteria are found to produce an enormous diversity of these 
glycans, resulting in strain-specific bacterial barcodes. Moreover, glycosylation of proteins 
can modulate the biochemical properties of these substrates, like their activity and stability. 
Taken together, the study of glycoproteins of a Gram-positive beneficial microbiota isolate is 
thus both of high interest for the field of probiotics and microbiota and the field of bacterial 
glycobiology. 
Glycosyltransferases (GTs) are the key enzymes of glycobiology, as they are involved in the 
build-up and attachment of glycans. Up till now, the exact factors that determine the substrate 
specificity of these enzymes remain to be elucidated, which often results in their flakey 
annotation in many bacterial genomes. Therefore, we designed an in silico workflow to screen 
bacterial genomes for genes encoding glycosyltransferases based on Hidden Markov Models 
typical for bacterial GTs (CAZy database and functionally characterized bacterial GTs). By 
relying on the functional network of the identified genes, we moreover could generate clues on 
their substrate specificity. Our results generated some interesting new insights and hypotheses, 
like the potential role of glycosylation in the regulation of the cell division machinery. 
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Since the experimental substantiation of the glycosylation of bacterial proteins is very 
challenging, several technical difficulties were encountered and tackled during this PhD work. 
An important experimental approach was the use of lectin blotting experiments to detect sugars 
on proteins. Although biotinylated lectin probes that can be detected with streptavidin form 
the common standard for these analyses, we observed that streptavidin interacts with various 
bacterial proteins binding endogenous biotin, rendering false positive results. By applying an 
alternative detection method, using digoxigenin, we could drastically reduce the detection of 
false positive putative glycoproteins. 
In addition, functional partition of the bacterial proteome in four experimental fractions, 
representing the cytosol, cell wall/membrane, cell wall-associated and secreted proteins, 
combined with 2D proteomics, lectin blotting and glycostaining, enabled us to map the 
putative glycoproteome of L. rhamnosus GG to different cellular locations. This resulted 
in the identification of 41 glycoproteins, of which most are involved in the carbohydrate 
metabolism.
To investigate the role of protein glycosylation on microbe-host interactions, we also 
studied the glycosylation status of the heterotrimeric SpaCBA pili, since these are key host 
interaction molecules of L. rhamnosus GG. Combining complementary techniques such as 
biochemical approaches with nanomechanical and immunological assays, we could show that 
these long flexible surface appendages are decorated with mannose and fucose. This unique 
multidisciplinary approach enabled not only the confirmation of the glycosylation of the 
SpaCBA pili, but also showed that the glycans present on the pili are key for the interaction 
between L. rhamnosus GG and the immune lectin receptor DC-SIGN present on dendritic 
cells. 
Taken together, in this PhD work the protein glycosylation potential of L. rhamnosus GG was 
studied both relying on systematic and dedicated approaches. Several technical breakthroughs 
were achieved by proposing new robust workflows and optimizing known protocols. Both 
systematic approaches (one in silico and one proteomic) generated important new insights and 
hypotheses on the role of bacterial protein glycosylation, like the potential role of glycosylation 
in the role of multiprotein complexes (e.g. the cell division machinery). In addition, the more 
dedicated multidisciplinary approach on the elucidation of the glycosylation of the adhesive 
heterotrimeric SpaCBA pili of L. rhamnosus GG revealed important insights in the possible 
functional interaction roles of bacterial glycoproteins. 
Conclusively, we believe that this work has enhanced both the knowledge on the importance 
of glycoproteins for the interaction of probiotics and members of the microbiota with the host 
and the knowledge on bacterial protein glycosylation in general. 
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samenvatting
De mens leeft in nauw contact met een enorme hoeveelheid bacteriën, met name de 
microbiota, waarvan de darmmicrobiota het best bestudeerd zijn. Hoe beter we deze bacteriën 
leren kennen, hoe duidelijker het wordt dat verstoringen van de microbiota kunnen leiden 
tot een rits aandoeningen. Probiotica, gedefinieerd als ‘micro-organismen, die wanneer ze 
in voldoende hoeveelheden worden toegediend, een gezondheidseffect kunnen hebben op de 
gastheer’, kunnen ingezet worden om deze dysbiose te voorkomen en te behandelen. Een 
onderbouwd gebruik van probiotica vereist een gedetailleerde kennis van de moleculen die aan 
de basis liggen van de specifieke interacties tussen de bacteriën en hun gastheer. Lactobacillus 
rhamnosus GG is een model organisme voor probiotica en werd oorspronkelijk geïsoleerd uit 
de microbiota. Het klinisch potentieel van deze bacterie is al uitgebreid bestudeerd en enkele 
belangrijke probiotische effectoren zijn al gekarakteriseerd.
In dit doctoraatsonderzoek focussen we op glycoproteïnen. In 2008 ontstonden de eerste 
vermoedens dat het gesecreteerde Msp1 proteïne, een celwandhydrolase en een probiotische 
effector van L. rhamnosus GG, geglycosyleerd is. De glycosylatie van Msp1 werd bevestigd 
met complementaire technieken zoals lectine blotting (dit zijn (glyco-)proteïnen die specifiek 
kunnen interageren met suikermonomeren), suikerkleuringen en massa spectrometrie. Die 
ontdekking deed ons o.a. afvragen of L. rhamnosus GG nog meer glycoproteïnen produceert 
en wat de functionele rol is van proteïnenglycosylatie. Dit laatste kan zowel gaan om de 
modulatie van de biochemische eigenschappen van het proteïne (bv. activiteit en stabiliteit), het 
beïnvloeden van de bacteriële fysiologie als het beïnvloeden van bacterie-gastheer interacties. 
Glycanen worden vaak door bacteriën gebruikt om immunogene moleculen af te schermen van 
het immuunsysteem van de gastheer of om net de interactie met de gastheer te bevorderen. Er 
is al aangetoond dat bacteriën een enorme diversiteit aan glycanen produceren, wat resulteert 
in een stam-specifieke barcode. Al deze factoren maken de studie van glycoproteïnen in een 
Gram-positieve gunstige stam waardevol, zowel voor het probiotica- en microbiota-onderzoek 
als in het kader van de verdere expansie van de bacteriële glycobiologie. 
Glycosyltransferases (GTs), betrokken bij de opbouw en aanhechting van glycanen, zijn 
de sleutelenzymen van de glycobiologie. De factoren die de substraatspecificiteit van deze 
enzymen bepalen zijn tot nu toe onbekend, wat vaak resulteert in onbetrouwbare gen annotaties. 
Daarom ontwierpen we een in silico methode om bacteriële genomen te screenen voor genen 
die coderen voor glycosyltransferases gebaseerd op Hidden Markov Modellen typisch voor 
bacteriële GTs (CAZy database en functioneel gekarakteriseerde bacteriële GTs). Door het 
functioneel netwerk van de geselecteerde genen te bestuderen, konden we bovendien een zicht 
krijgen op hun mogelijke substraatspecificiteit. Dit resulteerde in enkele interessante nieuwe 
inzichten en hypotheses, zoals over de potentiële rol van glycosylatie in de regulatie van de 
celdelingsmachinerie. 
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Glycobiologie is, gezien het posttranslationele karakter ervan, een uitdagend onderzoeksveld. 
Tijdens dit doctoraatsonderzoek moesten oplossingen gevonden worden voor verschillende 
technische uitdagingen. Een belangrijke experimentele techniek is het gebruik van lectine 
blotting om suikers te detecteren op proteïnen. Hoewel gebiotinyleerde lectine probes die 
gedetecteerd kunnen worden met streptavidine de algemene aanpak vormen voor deze 
analyses, resulteerde dit in vals-positieve resultaten, aangezien streptavidine ook interageerde 
met proteïnen die endogeen biotine binden. Een alternatieve methode, gebruikmakende van 
digoxigenin, reduceert deze vals-positieve waarnemingen drastisch. 
Bovendien konden we aan de hand van de functionele fractionatie van het bacteriële proteoom in 
vier fracties (cytosol, celwand/membraan, celwand geassocieerde en gesecreteerde proteïnen), 
gecombineerd met 2D proteomics, lectine blots en suikerkleuring, het glycoproteoom van L. 
rhamnosus GG in kaart brengen voor de verschillende fracties. Dit leidde tot de identificatie 
van 41 potentiële glycoproteïnen, waarvan de meeste een rol spelen in het suikermetabolisme.
Om de rol van proteïnenglycosylatie in bacterie-gastheer interacties te onderzoeken, bestudeerden 
we de glycosylatiestatus van de heterotrimere SpaCBA pili, aangezien dit belangrijke moleculen 
zijn voor de gastheerinteractie van L. rhamnosus GG. Een multidisciplinaire combinatie van 
biochemische, nanomechanische en immunologische technieken resulteerde in de detectie van 
mannose en fucose op deze SpaCBA pili. Bovendien konden we aantonen dat deze glycanen 
op de pili van belang zijn voor de interactie tussen L. rhamnosus GG en de immuun lectine 
receptor DC-SIGN, aanwezig op dendritische cellen. 
In dit doctoraatsonderzoek werd het glycosylatiepotentieel van L. rhamnosus GG met behulp 
van systematische en gedediceerde methodes bestudeerd. Daarbij werden verschillende 
doorbraken geboekt op technologisch vlak, zoals het aanreiken van robuuste methodologieën 
en de optimalisatie van bestaande protocols. De beide systematische studies (in silico analyse 
en proteoomstudie) genereerden belangrijke nieuwe inzichten in de potentiële rol van 
glycosylatie van proteïnen in bacteriën. Bovendien toonde multidisciplinair onderzoek aan 
dat de SpaCBA pili van L. rhamnosus GG geglycosyleerd zijn, een belangrijk nieuw inzicht 
wat betreft de mogelijke functionele rol van bacteriële glycoproteïnen.
We kunnen stellen dat dit werk zowel de kennis van het belang van glycoproteïnen in probiotica 
en microbiota-gastheer interacties heeft verruimd, evenals de kennis over glycosylatie van 
bacteriële proteïnen in het algemeen. 
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1.1 backgrounD
1.1.1   Human after aLL? - microbiota anD probiotics 
In this age we can start to ask ourselves how human we really are… The cells of our body 
are namely 10-fold outnumbered by the bacterial load we carry (1014). These bacteria occur 
in different niches in and on the body, like the skin, oral cavity, the nasopharynx, vagina, and 
their most important niche, the gastrointestinal tract (GIT) (The Human Microbiome Project 
Consortium, 2012). Currently, this bacterial load we all carry is being mapped, which has yet 
lead to the identification of several gut enterotypes (Arumugam et al., 2011), although the exact 
number and functional importance of these enterotypes is still debated on and continuously 
fine-tuned (Claes et al., 2014). 
The microbiota and the host interact in general in a mutually beneficial way. The commensal 
bacteria in the gut for instance aid in the digestion of nutrients, protect against infections, 
promote angiogenesis and balance the immune system (Belkaid & Hand, 2014; Gareau et al., 
2010). The microbiota thus plays an important role in host health. An imbalanced microbiota, 
or dysbiosis, is increasingly linked to several diseases, both gastrointestinal (e.g. inflammatory 
bowel diseases) and systemic (e.g. diabetes, obesitas) disorders, although the exact nature of 
this relation needs to be further determined (Belkaid & Hand, 2014; Cani & Delzenne, 2009; 
Tillisch, 2014).
This link between dysbiosis of the microbiota and diseases, lead to a peak in the interest 
in research on probiotics. Probiotics are ‘live microorganisms that, when administered in 
adequate amounts, confer a health benefit on the host’ (FAO/WHO, 2001). Rationale is to 
use microorganisms to modulate the microbiota in order to prevent and treat diseases linked 
to dysbiosis of the microbiota. Most probiotic strains are lactobacilli and bifidobacteria, 
i.e. endogenous members of a healthy microbiota, but also other strains are described, like 
Escherichia coli Nissle 1917 and the yeast Saccharomyces boulardii. Growing numbers of 
clinical trials support the view that certain bacterial strains or mixtures of strains can indeed 
influence the host health. But, not all results of intervention studies are evenly positive and 
the outcome of probiotic treatments in different pathologies is very difficult to predict (Segers 
& Lebeer, 2014). 
In our groups, research is focused on probiotic effectors, mostly present on the bacterial 
surface or secreted by the bacteria, to get a better understanding of the molecules modulating 
the interaction with the host (Lebeer et al., 2008). We believe that a thorough molecular 
knowledge of the microbiota-host interaction is needed to enable a more substantiated usage 
of probiotics to prevent and treat diseases linked to dysbiosis.  
1.1.2   LactobaciLLus rhamnosus gg: microbiota isoLate anD moDeL probiotic
In the labs of Prof. J. Vanderleyden (KU Leuven) and Prof. S. Lebeer (UAntwerpen), the 
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molecules on the cell surface and secreted by Lactobacillus rhamnosus GG (ATCC 53103) are 
being investigated. This strain has been widely studied in clinical and intervention studies and 
is considered to be a model probiotic (Segers & Lebeer, 2014).
L. rhamnosus GG was originally isolated from a healthy microbiota by Gorbach and Goldin 
(hence the GG). L. rhamnosus GG was already proven to be efficient to prevent and treat 
a plethora of disorders like diarrhea (e.g. travellers diarrhea), atopic diseases (e.g. atopic 
dermatitis) and caries (Doron et al., 2005; Segers & Lebeer, 2014). However, the exact nature 
of the molecular interactions underlying its probiotic function remains to be fully understood.
Several key molecules present on the cell surface and secreted by L. rhamnosus GG have been 
studied in our labs to elucidate their structure and role in the interaction with the environment 
and host. The cell wall consists of a thick peptidoglycan layer, on which the SpaCBA pili 
(Kankainen et al., 2009; Lebeer et al., 2012a; Reunanen et al., 2012), exopolysaccharides 
(Francius et al., 2008; Lebeer et al., 2011; Lebeer et al., 2009) and specific (glyco)proteins are 
anchored. There are also lipoteichoic acids present, which are embedded in the cell membrane 
(Claes et al., 2010; Perea Velez et al., 2007). L. rhamnosus GG also produces two major 
secreted proteins, Msp1 and Msp2 (Claes et al., 2012; Lebeer et al., 2012b). In this PhD 
thesis, the focus lays on the glycoconjugates present on the cell wall of L. rhamnosus GG and 
more in particular on the glycoproteins produced by this strain. 
1.2 scope
In 2012 our groups published the first report that the probiotic effector protein Msp1 of L. 
rhamnosus GG is glycosylated (Lebeer et al., 2012b). This formed the onset of the present 
PhD work, in which we aimed to explore the full protein glycosylation potential of this model 
probiotic strain. 
Bacterial glycoproteins are widely explored in Gram-negative pathogens, but knowledge on 
their occurrence and role in Gram-positive beneficial bacteria is still scarce (Tytgat & Lebeer, 
2014). Nevertheless, some important general trends strengthen the belief that glycoproteins 
and glycoconjugates in general are key molecules both modulating bacteria-host interactions 
and having special biochemical properties. These are thus important targets to study both 
in Gram-negatives and –positives and both in pathogens and beneficial species. Studies in 
pathogens have already shown that bacteria glycosylate immunogenic molecules to either 
enhance interaction or either to render them ‘stealth’ from the immune system. Moreover, 
bacteria were found to produce an overwhelming diversity of glycans, making them ideal 
candidates to establish these very specific interactions with their environment. And a last 
important finding, already well-substantiated for glycoproteins, is that the glycosylation of 
substrates modulates the biochemical parameters of these proteins, by influencing features 
like their activity and stability (Tytgat & Lebeer, 2014). 
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Taken these intriguing potential roles of glycoproteins together, it is key to elucidate the 
occurrence and role of these structures in beneficial bacteria. L. rhamnosus GG, being 
a microbiota isolate and a model probiotic strain, is an ideal organism to focus on, as it 
glycosylates one of its probiotic effectors, Msp1 (Lebeer et al., 2012b). Studying the 
glycosylation potential of this strain would thus not only push the field of microbiota-host 
interactions further, but would also widen the knowledge on bacterial glycosylation processes 
in beneficial, Gram-positive species. 
1.3 experimentaL cHaLLenges in bacteriaL gLycoprotein anaLysis
In this work we will focus on gaining insights in the protein glycosylation potential of 
L. rhamnosus GG. In order to do so, a complementary set of tools is needed, as the non-
template driven character, the enormous diversity of glycosylation processes in bacteria and 
the only fragmentary documentation of protein glycosylation processes in bacteria make this 
a particularly challenging field to study. Advances in (protein) glycobiology thus require 
a multidisciplinary approach and the combination of various systematic and dedicated 
approaches. This is exemplified in this work in which experimental and in silico analyses were 
combined. In this first chapter, we aim to briefly situate the current and future methodological 
possibilities, techniques and strategies to unravel the protein glycosylation potential and 
function in bacteria.
First, a few (mainly predictive) analyses can be done at the DNA level, both at the gene 
and genome level. Bioinformatics tools can offer valuable insights into the glycosylation 
potential of a strain, by predicting glycan-processing enzymes. Of special interest are the 
glycosyltransferases (GTs), which are the key enzymes of glycosylation (Lairson et al., 
2008). The identification of these enzymes offers important leads for further analyses. But, 
as we illustrate in chapter 3, also other information can be inferred from these predictions: 
for instance, their genomic localization can generate clues on the nature of the glycosylation 
mechanism they are involved (Sanchez-Rodriguez et al., 2014). As we elaborate in more 
detail in chapter 2, the biosynthesis of glycoconjugates occurs via two main mechanisms: en 
bloc and sequential biosynthesis of glycoconjugates. The former is often characterized by a 
clustering of the genes for all involved enzymes, transporters and regulators in a dedicated 
operon, whilst the enzymes of the latter mechanism are rather scattered throughout the 
genome (Tytgat & Lebeer, 2014). This moreover renders insights in the potential underlying 
evolutionary processes. 
The conservation amongst glycosyltransferase structures enables their classification into 
glycosyltransferase families, like in the Carbohydrate Active enZymes database (CAZy, 
www.cazy.org). This can be further exploited using bioinformatics tools, based on the use of 
Hidden Markov Models (HMM) representing these CAZy families, to mine genomes for genes 
encoding glycosyltransferases. Such a strategy has been exemplified in the model organism 
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of prokaryotic glycosylation, Campylobacter jejuni (Kay et al., 2010) and for Arabidopsis 
plants (Hansen et al., 2010; Hansen et al., 2009). The power of in silico methods is uncannily, 
but these methods do come with some important caveats and limitations. Machine-learning 
techniques and other in silico tools are based on the extrapolation of current knowledge, which 
may stand in the way of new discoveries. This is of special importance in the still rather young 
field of glycobiology, where lots remains to be discovered. Also, the non-template driven 
character of this field might call for more specialized strategies, as bioinformatics tools often 
cannot make decisions on the importance of different kinds of input. 
The identification of genes putatively encoding glycosyltransferases can also offer leads on 
the genes of interest to study via mutagenesis approaches. This enables the construction and 
study of knockout or overexpression mutants, which can provide clues on the functional role 
of the enzymes or entire pathway (for instance for operons involved in en bloc biosynthesis) 
and ideally on the substrate (e.g. by investigating which glycoconjugates are modulated in 
these mutants). Since standard bacterial cloning hosts such as Escherichia coli appear not to 
glycosylate proteins (Messner, 2004), an interesting approach to validate the link between a 
glycosyltransferase enzyme and its protein substrate is their heterologous expression in such 
a non-glycosylating host. This as was first illustrated in the benchmarking paper of Wacker et 
al., who transferred the N-protein glycosylation system of Campylobacter jejuni into E. coli 
(Wacker et al., 2002), which is especially relevant for Gram-negative bacteria. The analysis 
of GTs via mutagenesis comes with some important caveats: GTs might be essential for a 
bacterium, manipulation of a GT can affect the fitness of a cell drastically, not all bacteria can 
be manipulated genetically and the role of a mutated GT might be compensated by another GT 
(cf. chapter 2).
Once the genomic potential for glycosylation, i.e. a compendium of glycosyltransferases, is 
known, it also will be interesting to study the actual expression of these enzymes and proteins 
associated to glycosylation processes (e.g. transporters). Transcriptome analyses, like RNA-
seq and microarrays are powerful tools to achieve this. Transcriptome data was therefore also 
implemented in the in silico method we designed in chapter 3: the STRING database is used 
there to provide information on the interaction partners of the predicted GTs of L. rhamnosus 
GG (Sanchez-Rodriguez et al., 2014). This STRING database gathers all information on 
predicted and proven interactions between proteins, including all available microarray data 
(von Mering et al., 2005). Moreover, the conditions in which certain enzymes, like GTs, are 
expressed can be monitored by differential transcriptomics. To the best of our knowledge, this 
approach has not yet been widely applied in the field of bacterial glycoprotein research, but 
might provide interesting clues to further elucidate the glycosylation potential of a bacterium. 
Although DNA- and RNA-research can provide valuable information, proteomics and 
glycoproteomics are the methods of choice if one wants to investigate the glycoprotein 
repertoire directly. The two most commonly used techniques of proteomic analyses, i.e. 
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SDS-PAGE and Western blot, are also important workhorses in glycoproteome screenings. 
In chapter 2, an overview is given of the current knowledge on bacterial glycoconjugates 
illustrating the widespread use of SDS-PAGE and Western blot related techniques to study the 
glycosylation of proteins. An overview of many studies relying on these techniques is given 
in chapter 2, where all known glycoproteins relevant to human health are discussed (Tytgat & 
Lebeer, 2014). 
Periodic Acid Schiff staining (PAS) of proteins separated by SDS-PAGE is an almost ancient 
but still commonly used method both in pro- and eukaryotes. This approach is the method of 
choice to visualize all glycoproteins in a sample (Fairbanks et al., 1971). The application of 
periodate oxidizes the glycol groups resulting in aldehyde formation. These aldehydes then 
can react with fuchsin to generate a pink coloring reaction. Drawbacks of this method are the 
low sensitivity (1 μg of glycoprotein) and false positives that can occur if the protein contains 
a lot of aromatic amino acids. To tackle the first issue, a commercial version of the PAS stain 
was marketed, in which the fuchsin was replaced by a fluorescent dye. The detection limit of 
this Pro-Q® Emerald dye (Life Technologies) is as little as 4 ng of glycoprotein (Hart et al., 
2003).
Another important method to screen for glycoproteins after SDS-PAGE separation and blotting 
of protein samples, is the probing of Western blots with lectins. Lectins are (glyco)proteins 
that specifically recognize a sugar monomer in a specific configuration and conformation 
(Van Damme et al., 2011). This implicates that different lectins recognizing the same sugar 
monomer (e.g. GNA and HHA which both bind mannose), still will render different results 
when applied to the same sample. Lectins are often applied to generate clues on the sugar 
monomers present in a particular sample, but can thus also render false negative results, if 
a certain sugar monomer is not accessible in the right configuration or conformation. False 
positive results are also possible, as illustrated further in chapter 4, in which we report on some 
necessary tweaks to the design of a lectin experiment to prevent false positive reactions. These 
adaptations include the careful selection of the blocking agent and detection method (Tytgat 
et al., 2014). Lectins can also be used to generate functional clues on the role of glycans by 
the construction and screening of lectin microarrays. This technique was first described by the 
groups of Angeloni and co-workers (Angeloni et al., 2005) and by Hsu et al. who evaluated 
the potential of the technique to follow the glycome dynamically (Hsu et al., 2006). 
Lectins can be further exploited to purify glycoproteins and glycopeptides, a method, which 
was for instance applied earlier in our lab to purify the Msp1 glycoprotein (Lebeer et al., 
2012). Other purification techniques are HPLC (High-Performance Liquid Chromatography) 
techniques like HILIC (Hydrophilic Interaction Liquid Chromatography) and RP-HPLC 
(Reversed Phase-HPLC). These purification techniques are combined with mass spectrometry 
strategies to identify glycoproteins, investigate glycopeptides and determine the structure of 
the attached glycan, as was done for instance in C. jejuni (Ding et al., 2009). A good overview 
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of this field is given in: (Hitchen & Dell, 2006; Marino et al., 2010; Schiel, 2012). The 
elucidation of glycan structures often relies on the release of the glycans from the peptide. 
To do so, both chemical and enzymatic techniques can be used. Chemical deglycosylation 
techniques, like the application of trifluoromethane sulfonic acid (Raju & Davidson, 1994) 
are often harsh, degrading both the protein and glycan, but they have the advantage that they 
can remove almost any glycan (both O- and N-linked) from any protein. Most enzymes used 
(e.g. PNGase F) only recognize eukaryotic glycoproteins or N-linked glycans (Marino et al., 
2010), whilst the latter form of glycosylation is thought to be scarce in bacteria (Tytgat & 
Lebeer, 2014). To elucidate the 3D structure of a glycan or glycoprotein in detail, one can rely 
on NRM and X-ray crystallography (Kay et al., 2010; Marino et al., 2010). 
At the moment information on the functional role of bacterial glycoproteins is still extremely 
scarce, explaining the lack of standard methods to investigate the functional role of protein 
glycosylation in a high-throughput manner. Nevertheless, as we illustrate in chapter 6, these 
studies ideally require the purification of intact glycoproteins and the availability of knockout 
or overexpression mutants affecting the glycosylation of the target protein (or chemically/
enzymatically altered glycoproteins). Moreover, there is a need for validated and standardized 
phenotypic and biochemical assays to investigate the functional role of the glycan present 
on a certain protein. But some work already has been performed, mainly on the biochemical 
impact of glycans on their substrate, as illustrated for many in chapter 2, where the glycans 
for instance protect the protein from degradation by proteases (Tytgat & Lebeer, 2014). 
In our lab it was already shown that the Msp1 glycoprotein is more stable compared to its 
less glycosylated close homologue Msp2 (Lebeer et al., 2012). And in the closely related L. 
plantarum WCFS1 strain glycosylation modulates the activity of the Acm2 enzyme, which is 
homologous to Msp1 (Fredriksen et al., 2012). 
We can conclude that the glycomics toolbox consists out of a variety of techniques, often 
requiring, especially in the case of MS-strategies, the expertise of a specialized group. For an 
extensive overview of all currently used techniques in glycosciences, the reader is referred to 
the following review: (Solis et al., 2015). 
1.4 a guiDe tHrougH tHe cHapters
This PhD manuscript is a compilation of three peer-reviewed articles, a submitted manuscript 
and a manuscript in preparation. In this outline (chapter 1) on overview of these papers is 
given and how they fit in the general scope of this PhD, namely the elucidation of the protein 
glycosylation potential of the model probiotic L. rhamnosus GG. 
To initiate this work, a thorough and comprehensive literature study of the current knowledge 
on bacterial glycoconjugates was carried out. Strikingly, only a few common general pathways 
are used by bacteria to synthesize the plethora of glycoconjugates they express. In this work 
we only focus on the important lessons that can be learnt from bacterial glycoprotein research 
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(chapter 2). For the extended work covering all existing glycoconjugates, the reader is referred 
to the complete version of the review (Tytgat & Lebeer, 2014). 
Chapter 3 is dedicated to the mining of the genome of L. rhamnosus GG for genes encoding 
glycosyltransferases, the key enzymes of glycosylation processes. This bioinformatics approach 
was used to generate clues on interesting genes to focus on during later stages of this work 
by e.g. the construction of deletion mutants lacking glycosyltransferases. As glycosylation 
is a non-template driven process, the link between these enzymes and their substrates is still 
enigmatic. In this work we relied on a network-based in silico approach to elucidate potential 
targets of these glycosyltransferases. Moreover we present some interesting new hypotheses 
on various roles for glycosylation in bacteria (Sanchez-Rodriguez et al., 2014). 
Since the experimental substantiation of the bacterial protein glycosylation is very challenging, 
several technical difficulties were encountered and tackled during this PhD work. An important 
glycobiology approach is the use of lectin blotting experiments to detect sugars on proteins. 
Although biotinylated lectin probes that can be detected with streptavidin form the common 
standard for these analyses, we observed that streptavidin interacts with various bacterial 
proteins binding endogenous biotin, rendering false positive results. In chapter 4, we describe 
that by applying an alternative detection method, using digoxigenin, we could drastically 
reduce the detection of false positive putative glycoproteins (Tytgat et al., 2014). Other 
optimizations of techniques are mentioned in chapter 5.  
The optimization of techniques (cf. chapter 4) enabled the systematic study of the glycoproteome 
of L. rhamnosus GG after fractionation in different cellular fractions (cytosol, cell wall/
membrane, cell wall-associated and secreted proteins), combined with 2D proteomics, lectin 
blotting and glycostaining. Chapter 5 reports on the design of a specific workflow to do so, 
which resulted in the identification of 40 new glycoproteins in L. rhamnosus GG, next to the 
confirmation of Msp1 glycosylation. Among the glycosylated hits several enzymes of the 
carbohydrate metabolism were found, together with transport- and protein metabolism related 
proteins. Our results give rise to new hypotheses on general trends that may occur across 
species, as our results substantiate data gathered in other species.
In chapter 6 a more dedicated approach was used to study the glycosylation of the adhesive 
SpaCBA pili of L. rhamnosus GG. Molecular biology techniques were combined with 
mechanical and immunological approaches to illustrate the glycosylation statues of these pili. 
Moreover, this multidisciplinary approach enabled us to prove that the glycans are important 
for the interaction between these pili, and thus L. rhamnosus GG, and dendritic cells via the 
immune lectin receptor DC-SIGN. 
Chapter 7 gives a comprehensive overview the most intriguing results and breakthroughs of 
this PhD work and their potential importance for the field of microbiota and probiotics on the 
one side and the field of bacterial glycobiology on the other side.
on
e.
9
two.
the sweet tooth of 
bacteria:
common themes in 
bacterial 
glycoconjugates
everything you (n)ever wanted to know on 
bacterial glycoconjugates
two.
the sweet tooth of 
bacteria:
common themes in 
bacterial 
glycoconjugates
everything you (n)ever wanted to know on 
bacterial glycoconjugates
12
th
e 
sw
ee
t t
oo
th
 o
f b
ac
te
ria
An extended version of this chapter was published:
Tytgat H.L.P., Lebeer S. (2014). The sweet tooth of bacteria: common themes in 
bacterial glycoconjugates. MMBR, 78(3), 372-417.
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abstract
Humans have been increasingly recognized as being superorganisms, living in close contact 
with a microbiota on all their mucosal surfaces. Yet, most studies on the human microbiota 
focus on gaining comprehensive insights on the composition of the microbiota in different 
health conditions (e.g. enterotypes), while there is also a need for detailed knowledge on the 
different molecules that mediate interactions with the host. Glycoconjugates are an interesting 
class of molecules for detailed studies as they form a strain-specific barcode on the surface of 
bacteria, mediating specific interactions with the host. 
Strikingly, most glycoconjugates are synthesized by similar biosynthesis mechanisms. 
Bacteria can produce their major glycoconjugates using a sequential or an en bloc mechanism, 
with both mechanistic options coexisting in many species for different macromolecules. In 
this chapter, these common themes are conceptualized and illustrated for all major classes of 
known bacterial glycoconjugates, with a special focus on the rather recently emerged field 
of glycosylated proteins. We describe the biosynthesis and importance of glycoconjugates in 
both pathogenic and beneficial bacteria and both in Gram-positives and –negatives. The focus 
lies on microorganisms important for human physiology. In addition, the potential of a better 
knowledge of bacterial glycoconjugates in the emerging field of glycoengineering and other 
perspectives are discussed.
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2.1 introDuction to bacteriaL gLycobioLogy
Pathogenic and beneficial members of the microbiota establish an intimate interaction with 
the host mucosa in order to manipulate the host metabolism and immune system (Lebeer 
et al., 2010). Key to a better understanding of these interactions are molecules present on 
the bacterial cell surface and secreted in the environment. Often, these key molecules are 
glycoconjugates such as glycoproteins, exopolysaccharides (EPS), capsular polysaccharides 
(CPS), lipopolysaccharides (LPS), lipooligosaccharides (LOS), lipoglycans, peptidoglycan 
(PG), glycosylated teichoic acids (TA) and other glycosylated secondary cell wall polymers. 
The glycans present on these molecules show an enormous diversity in monosaccharide 
building blocks, anomeric configuration, conformation and stereochemistry (Marino et al., 
2010), which largely exceeds the eukaryotic glycoconjugate repertoire. The resulting diversity 
is uncannily: two glucose residues can already be joined together in thirty different ways 
(Laine, 1994). Bacteria are also able to produce ‘exotic’ rare sugars like bacillosamine, 
present on glycoproteins of Campylobacter jejuni (Young et al., 2002), in contrast to the 
ten monosaccharides that are typically detected in mammalians (Marino et al., 2010). The 
prominent location of bacterial glycoconjugates on the cell wall and their enormous diversity 
suggest that they form a unique barcode on bacterial cell surfaces. This makes them ideal 
candidates to establish specific and ‘tight’ interactions with host cells and abiotic surfaces, 
ranging from adhesion to immunomodulation (Kay et al., 2010). Of particular interest are 
various lectin immune receptors with different specificity displayed by host cells to scan these 
bacterial barcodes and induce specific responses (Rabinovich et al., 2012). This is crucial in 
view of the abundance, importance and niche-specificity of the microbiota and pathogenic 
infections. Most studies of the microbiota focus on mapping the microbiota and microbiome in 
different health conditions (Qin et al., 2010; Qin et al., 2012; The Human Microbiome Project 
Consortium, 2012), with the work on enterotypes as one of the most widely discussed findings 
of this research (Arumugam et al., 2011). These general studies need to be complemented with 
dedicated studies on the bacterial mediators of specific interactions, such as glycoconjugates 
to generate a comprehensive view of our bacterial friends and foes. Currently, the studies of 
glycoconjugates in pathogens outnumber those in beneficial bacteria largely. Especially for 
glycoproteins, the discrepancy is apparent. Moreover, the field of (bacterial) glycobiology is 
enigmatic: understanding the ties between glycan structures and their biological function is 
hampered by the non-template nature of glycan biosynthesis and the resulting heterogeneity. 
In addition, their enormous diversity and versatility makes their study quite challenging (Zaia, 
2011). Considering the large amount of energy cells dedicate to the build-up of glycans, their 
functional importance - from an evolutionary perspective - should be high. Also, a better 
fundamental knowledge on bacterial glycomes can open up new horizons in the discovery 
of new drugs, bioactive compounds and vaccines. A combination of existing and new 
emerging technologies is rapidly advancing the field of glycobiology. This chapter aims at 
giving an overview of the current knowledge on bacterial glycoconjugates and focuses on the 
tw
o.
15
commonalities of their biosynthesis mechanisms both in Gram-positive and –negative species, 
and functions in bacteria-host interactions both in pathogens and beneficial bacteria.
2.2 generaL tHemes in gLycoconjugate biosyntHesis
Strikingly, bacteria appear to use only two main pathways to synthesize a plethora of 
glycoconjugates. The two main modular mechanisms used for glycoconjugate biosynthesis 
are the sequential and en bloc mechanism. This chapter conceptualizes and illustrates these 
two biosynthesis mechanisms. The commonality of these mechanisms is also illustrated by 
the promiscuity of some glycosyltransferases (GTs), which are able to glycosylate different 
substrates in some bacterial species. For instance, in several pathogens, GTs are active both in 
LPS/LOS and glycoprotein biosynthesis pathways (Bernatchez et al., 2005; Hug & Feldman, 
2011). More specific examples of these commonalities will be discussed later.  
2.2.1   gLycosyLtransferases, tHe key enzymes of gLycosyLation
Glycoconjugates do not fit into a linear understanding of the flow of biological information, 
as the glycome is not a template-driven process such as DNA, RNA and protein biosynthesis. 
In contrast, the glycan structures that are present on glycoconjugates are primarily determined 
by the complement of glycan-modifying enzymes present in an organism (Zaia, 2011). GTs, 
glycoside hydrolases or glycosidases, transporters, flippases, polymerases and other enzymes 
are all required to synthesize and metabolize the glycome of an organism. The crucial enzymes 
in the build-up of glycans are the GTs, which is underlined by their presence in the genome: 
GTs and glycosidases are believed to constitute 1 to 3% of the gene products of bacterial, 
eukaryotic and archaeal organisms (Davies et al., 2005). This percentage lies higher in plants 
and bacterial members of the microbiota like Bacteroides and Bifidobacterium, which suggests 
an important role of glycans in interaction with the human host (Davies et al., 2005; Xu et 
al., 2007). Parasitic and symbiotic life forms, on the other hand, generally contain fewer 
glycosylation enzymes (Davies et al., 2005). It remains to be seen if this figure needs to be 
updated as the fields of (meta)genomics and glycomics further evolve. 
GTs (EC 2.4.x.y.) strictu sensu catalyze the formation of glycosidic bonds between a sugar 
moiety from an activated donor molecule and a specific substrate molecule. GTs can use a 
range of donor molecules, both nucleotide and non-nucleotide ones, and can target a wide 
diversity of substrates, like saccharides, proteins, nucleic acids, lipids and small molecules 
(Lairson et al., 2008). Chemically, these enzymes catalyze the transfer of a glycosyl group 
to a nucleophilic group, usually an alcohol. The net result of this reaction is an O-, N-, S- or 
C-glycosylated acceptor molecule (Lairson et al., 2008). The glycosidic bond is established by 
retainment (e.g. UDP-glucose turns into an α-glucoside) or inversion of the stereochemistry of 
the anomeric carbon of the donor sugar monomer (which results in an β-glucoside for UDP-
glucose). These two stereochemical outcomes of reactions catalyzed by GTs, is also used as a 
means to classify these enzymes.
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Inverting GTs use a direct displacement SN2-like reaction to catalyze the formation of the 
glycosidic bond (Murray et al., 1996). The result is a net inversion of the stereochemistry 
of the anomeric reaction center of the donor substrate. Most of the inverting GTs require a 
divalent cation, typically Mg2+ or Mn2+, which plays the role of an acid catalyst, coordinated 
by the non-stringent D-X-D motif, although metal-independent GTs are also reported (Lairson 
et al., 2008; Ramakrishnan et al., 2004). For instance, SpsA, a GT involved in the biosynthesis 
of the spore coat of Bacillus subtilis, was one of the first characterized bacterial inverting GTs 
(Charnock & Davies, 1999a; Charnock & Davies, 1999b). 
The catalytic mechanism used by retaining GTs is still debated and two hypothetical 
mechanisms are described in literature. Both can require a divalent cation coordinated by 
D-X-D for their catalytic activity. The first mechanism was extrapolated from knowledge 
on retaining glycosidases (cf. the elucidation of the inverting GT mechanism), which means 
that retaining GTs would use a double displacement mechanism with a short-lived glycosyl-
enzyme intermediate (Zechel & Withers, 2000). However, despite numerous efforts, no such 
glycosyl-enzyme intermediate could be trapped (Lairson et al., 2004). The second proposed 
mechanism suggests a direct attack of the acceptor, by a SNi-like or ‘internal return’ mechanism 
(Jakeman, 2011). This hypothesis originated from research on the crystal structure of the LOS 
galactosyltransferase LgtC of Neisseria meningitidis (Persson et al., 2001). Recently, this 
SNi-like mechanism was further supported by mechanistic evidence, which makes this latter 
mechanism more plausible (Lee et al., 2011). 
GTs can also be classified according to the donor substrates they recognize. GTs that use sugar 
mono- or diphosphonucleotides (e.g. UPD-Glc, GDP-Man) are termed Leloir GTs, in honor of 
Nobel prize winner Leloir who performed groundbreaking work on sugar nucleotides (Cabib 
& Leloir, 1954). GTs utilizing non-nucleotide donors, like polyprenol pyrophosphate and 
sugar-1-phosphate, are then called non-Leloir GTs (Lairson et al., 2008). 
The biochemical characterization of GTs has proven to be hard, as the first reports on the 
X-ray crystal structures of GTs only started to emerge in the late 1990s (Unligil & Rini, 2000). 
Although the similarities between glycosidases and GTs are quite high, GTs appear to only 
exhibit a narrow spectrum of folds. The Leloir enzymes can be split in two large families 
based on their common 3D-fold: the GT-A en GT-B fold (Lairson et al., 2008). More recently, 
a third fold category was discriminated, the GT-C fold (Roychoudhury & Pohl, 2010). An 
important caveat hereby is that not all enzymes that represent a GT-A or GT-B fold are GTs. 
Also, non-Leloir GTs possess non-GT-A and non-GT-B folds. An example of such GTs is the 
transglycosylase, PBP2, of Staphylococcus aureus involved in peptidoglycan biosynthesis, 
which has a bacteriophage-lysozyme-like fold (Lovering et al., 2007).
As GTs are a very diverse group of enzymes and they can recognize a range of donor and 
acceptor molecules, a classification was proposed by the group of Henrissat based on the amino 
acid sequence of GTs, analogous to the classification of glycoside hydrolases (Campbell et 
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al., 1997). These constantly updated GT families can be consulted online in the Carbohydrate-
Active enZymes (CAZy) database (www.cazy.org) (Cantarel et al., 2009). Using algorithmic 
methods to subdivide protein sequences in distinct families, GTs are currently classified in 95 
families (March 2014). Each GT family contains enzymes related by sequence and 3D-fold. As 
the mechanism of catalysis, and additionally their inverting or retaining character, is (largely) 
conserved within each family, this classification can be used to predict the mode of action of 
newly predicted GTs. Nevertheless, this does not mean that all enzymes of a family recognize 
the same donor and/or acceptor: polyspecificity is common among GT families (Coutinho et 
al., 2003). One should be prudent with the overinterpretation of predictions purely based on 
the classification of a GT in a certain family (Davies & Sinnott, 2008). 
A few ‘special classes of GTs’ deserve some extra focus, i.e. the transglycosylases of 
peptidoglycan (PG) biosynthesis pathways, synthases catalyzing EPS/CPS formation and 
enzymes of the en bloc glycosylation pathway, such as priming GTs, polymerases and 
oligosaccharyltransferases (OSTs). 
Transglycosylases are GTs involved in the polymerization of carbohydrate chains to PG. 
These enzymes follow the same mechanism as retaining glycoside hydrolases and their 
action can be described by a nucleophilic substitution reaction, resulting in inversion of the 
configuration (Welzel, 2005). Transglycosylases use lipid II as an acceptor and add these new 
PG subunits processively to the non-reducing end of the growing chain, which is the donor 
(Barrett et al., 2007; Perlstein et al., 2007; Yuan et al., 2007). Transglycosylases are classified 
in CAZy family 51 and have a lysozyme-like fold (Lovering et al., 2007). These enzymes 
occur as monofunctional or bifunctional enzymes, the latter combine their GT action with a 
transpeptidase domain (van Heijenoort, 2001).  
Synthases are multifunctional processive GTs that catalyze the initiation, polymerization and 
transport of usually rather simple glycans. These enzymes are involved in the biosynthesis of 
e.g. the type 3 CPS of Streptococcus pneumoniae and EPS structures like alginate, cellulose and 
hyaluronan (Whitney & Howell, 2013; Yother, 2011). In Salmonella enterica serovar Borreze 
O:54, a synthase is responsible for O antigen biosynthesis (Keenleyside & Whitfield, 1996). 
Synthases are relatively small integral membrane proteins, consisting of 4 transmembrane 
domains and a large cytoplasmic loop. This loop harbors the catalytical residues and a Q-X-
X-R-W motif involved in the processivity of the enzyme by retaining the growing polymer in 
the enzyme (Saxena et al., 2001; Weigel et al., 1997). The synthase of S. pneumoniae loosely 
associates with the growing glycan chain in the beginning, but interacts more tightly after 
synthesis of a short oligosaccharide to ensure processive elongation (Forsee et al., 2009). 
Priming GTs are implicated in the en bloc biosynthesis of glycoconjugates like EPS, CPS, LPS 
O antigen and glycoproteins. These are special GTs, as they do not catalyze the formation of 
a glycosidic bond. Priming GTs are linked to the membrane and are involved in the transfer of 
a phosphorylated sugar monomer from an activated nucleotide to an undecaprenyl phosphate 
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(UndP) carrier, on which the glycan is then further assembled. These enzymes, also known as 
initiating GTs, catalyze the formation of an energy-rich phosphate bond (Bugg & Brandish, 
1994; Lehrer et al., 2007; Price & Momany, 2005; Wang et al., 1996). This UndP-linked sugar 
monomer forms the substrate for the successive action of GTs that build up the glycan further 
(cf. infra). 
OSTs transfer an oligosaccharide en bloc from the lipid carrier to the acceptor substrate, a protein 
(Musumeci et al., 2014; Wacker et al., 2002). The currently best-studied and characterized 
OST is the PglB OST of Campylobacter sp. (Ihssen et al., 2012; Kowarik et al., 2006b; Lizak 
et al., 2011b; Wacker et al., 2006; Wacker et al., 2002). This OST is strikingly similar to the 
central catalytic STT3 enzyme of the eukaryotic multicomponent OST counterpart (Knauer 
& Lehle, 1999b). Bacterial OSTs, like PlgB, however, are monosubunit enzymes (Feldman et 
al., 2005). PglB is involved as N-OST in the N-glycosylation of proteins in Campylobacter sp. 
and the factors determining its catalytic mechanism and specificity are extensively studied. 
The catalysis of the oligosaccharide transfer could be linked to the presence of an N-acetyl 
group in position 2 of the sugar directly linked to the UndP carrier. This C-2 acetamido group 
at the reducing end sugar is necessary for recognition and /or catalysis either as a partner 
in forming critical hydrogen bonds with the OST or as a stabilisator of the transition state 
(Wacker et al., 2006). The PglB enzyme was shown to recognize a D/E-Y-N-X-S/T (Y, X 
cannot be a P) motif located in flexible loops of folded proteins, which is an extension of the 
eukaryotic N-glycosylation motif (N-X-S/T) (Kowarik et al., 2006a; Kowarik et al., 2006b; 
Schwarz et al., 2011b). More specifically, D-Q-N-A-T was identified as being the optimal 
consensus sequence for C. jejuni (Chen et al., 2007a; Kowarik et al., 2006b). 
In the biosynthesis of polysaccharides (EPS, CPS, LPS O antigen), the OST is replaced by 
a polymerase (Drummelsmith & Whitfield, 1999; Whitfield, 2006). Several oligosaccharide 
building blocks are, in the case of polysaccharide biosynthesis, linked together to form the 
glycan. This reaction is catalyzed by a ‘Wzy’ polymerase (Drummelsmith & Whitfield, 1999; 
Whitfield, 1995; Whitfield, 2006; Whitfield & Paiment, 2003; Whitfield & Roberts, 1999). 
In most cases, the factors determining the specificity of GTs remain elusive and it is difficult 
to predict merely based on sequence analysis in which glycoconjugate biosynthesis they are 
involved. Thus, a crucial area for further research in bacterial glycobiology is the search 
for factors or motifs determining the substrate specificity of GTs, both in the GTs and in 
the substrates. This would significantly improve the annotation of GTs and glycoconjugate 
biosynthesis clusters and would also be highly relevant for the ongoing bacterial genome 
and metagenome projects. A complicating aspect is, however, that some GTs, and especially 
several OSTs, show promiscuity towards different substrates. PglB of C. jejuni for instance 
can both transfer O antigen polysaccharides and N-glycosylate proteins (Feldman et al., 
2005). Another example is the O-OST of N. meningitidis, PglL, which can interfere with PG 
biosynthesis and even act as a Leloir GT by transferring monosaccharides (Faridmoayer et al., 
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2008; Faridmoayer et al., 2007; Musumeci et al., 2013). 
2.2.2   Sequential glycosylation
Sequential glycosylation (Fig.2.1) in bacteria is the most basic form of glycosylation: GTs 
transfer the sugar moieties directly to the substrate and build up the glycan. Sequential 
glycosylation has been documented both in Gram-positive and –negative species (cf. infra). 
Essentially, GTs use nucleotide-activated sugars as donors to transfer sugar moieties to their 
substrate in the cytoplasm. This can occur directly, like in the case of protein glycosylation 
or glycosylation of TAs. Or, in the case of CPS and LPS O antigen biosynthesis, the glycan 
is synthesized whilst associated to the membrane (e.g. via diacylglycerol or UndP in rare 
cases). Once synthesized, the glycoconjugates are transported through the inner membrane 
(Gram-negative species) or cytoplasmic membrane (Gram-positives). Some peculiar GTs, i.e. 
synthases, are multifunctional and are both responsible for the biosynthesis and the transport 
of the glycan (cf. earlier) (Fig.2.1).
Figure 2.1 – The sequential mechanism of bacterial glycoconjugate biosynthesis
In this rather intuitive way of glycosylation, GTs transfer the sugar moieties from nucleotide-activated sugar donors 
directly to their substrate. This substrate can be a glycoprotein or a growing polysaccharide chain linked to the 
membrane. Once the glycoconjugate is fully synthesized, a transporter transfers the structure to the periplasm 
(Gram-negative species) or to the other side of the cytoplasmic membrane (Gram-positive species). In some cases, 
the GT also is responsible for the transport of the glycan across the membrane.
The glycans synthesized by this pathway are usually rather simple, meaning consisting of a 
single or only a few different sugar building blocks. In many cases, several GTs work in 
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concert, often even processively, i.e. without release of intermediate glycan products. Good 
illustrations of the sequential glycosylation mechanism are the ABC-transporter dependent 
pathway of CPS (e.g. E. coli group 2 and 3 capsules (Corbett & Roberts, 2008)) and LPS O 
antigen biosynthesis (e.g. E. coli 08 and 09a (Whitfield, 1995)). Also bacteria using a synthase 
for their CPS (e.g. type 3 CPS of S. pneumoniae (Dillard et al., 1995)), EPS (e.g. alginate 
produced by P. aeruginosa sp. (Rehm & Valla, 1997)) or LPS O antigen biosynthesis (e.g. in 
S. enterica serovar Borreze O:54 (Keenleyside & Whitfield, 1996)), follow the here-described 
sequential glycosylation mechanism. Substitution of proteins with simple glycans (both N- 
and O-linked), like flagellar glycosylation in several pathogenic species, also illustrates the 
sequential mechanism neatly (Grass et al., 2003; Logan, 2006). Furthermore, TA glycosylation 
in Firmicutes is thought to occur via the direct attachment of sugars to the backbone (Allison et 
al., 2011). The widespread nature of sequential glycosylation in bacteria is illustrated further 
in detail, where several type examples of bacterial glycoconjugate biosynthesis are discussed.
2.2.3   En bLoc gLycosyLation of gLycoconjugates
Figure 2.2 – The en bloc mechanism of bacterial glycoconjugate biosynthesis
In the en bloc mechanism, in addition to standard Leloir GTs, peculiar GTs come into play, i.e. the priming GT and 
OST (glycoproteins) or polymerase (polysaccharides). The priming GT forms an energy-rich bond between a sugar-
phosphate moiety and the UndP carrier. Several GTs then consecutively glycosylate the lipid carrier further, till the 
full glycan (in the case of glycoproteins) or the building block (polysaccharides) is synthesized. A transporter (e.g. a 
flippase) then transfers the glycans to the other side of the inner membrane (Gram-negative species) or cytoplasmic 
membrane (Gram-positives). Glycosylated proteins are formed through the action of an OST, which transfers the 
glycan to the protein. In the case of polysaccharides, like EPS, CPS and the O antigen of LPS, the building blocks are 
assembled by a polymerase.
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The second important modular mechanism involved in the build-up of glycoconjugates is the 
en bloc mechanism (Fig.2.2). This mechanism is essentially dedicated to the biosynthesis 
of more complex glycoconjugates. En bloc biosynthesis of glycans starts in the cytoplasm, 
where a membrane-anchored priming GT utilizes a nucleotide-activated sugar residue to add 
a first glycan subunit via an energy-rich pyrophosphate bond to a recyclable lipid carrier 
(i.e. UndP) (Bugg & Brandish, 1994; Meier-Dieter et al., 1992; Price & Momany, 2005; 
Valvano, 2008). The glycan is then further assembled by the successive and concerted action 
of GTs that use nucleotide-activated sugar residues as donors. Once a building block of the 
glycan is fully synthesized, the lipid-linked oligosaccharide is flipped or transported across 
the inner membrane (Gram-negative species) or the cytoplasmic membrane (Gram-positive 
bacteria) (Bugg & Brandish, 1994). Here, a polymerase links several building blocks and 
forms a repetitive glycan polymer, which leads to the production of EPS, CPS and O antigen 
LPS structures (Whitfield, 1995; Whitfield & Roberts, 1999). The flippase is commonly 
denominated as Wzx and the polymerase as Wzy (Wzy dependent pathway) (Whitfield, 
2006; Whitfield & Paiment, 2003). In the case of glycoprotein biosynthesis, the polymerase 
is ‘substituted’ by an OST (cf. supra), which transfers and ligates the glycan to a protein 
substrate in an en bloc manner (Kowarik et al., 2006a; Wacker et al., 2002). This mechanism 
has up till now only been reported in the O- and N-linked glycosylation of Gram-negative 
species, with N-protein glycosylation in C. jejuni being a type example (Nothaft & Szymanski, 
2010; Szymanski et al., 2003a) (Fig.2.2). The en bloc mechanism and detailed illustrations of 
bacteria using this pathway to synthesize their glycoconjugates are further discussed below.
2.3 bacteriaL gLycoconjugates
Bacterial glycoconjugates display an enormous structural diversity. Bacteria can produce 
a variety of both intracellular and extracellular polysaccharides (Fig.2.3). The major 
glycoconjugates of the glycome of Gram-negative bacteria encompass PG, EPS, CPS, LPS, 
LOS, glycoproteins (both O- and N-linked) and intracellular storage polysaccharides. Gram-
positives lack LPS and LOS, but can have lipoglycans and glycosylated TAs.
Intracellular polysaccharides are used as an energy reserve, like the well-known storage 
polysaccharide glycogen. An overview on the knowledge on glycogen and other bacterial 
intracellular storage polysaccharides is beyond the scope of this chapter and the reader is 
referred to existing reviews (Wang & Wise, 2011; Wilson et al., 2010). 
For a detailed overview of the current knowledge on the biosynthesis mehanisms of PG, EPS, 
CPS, LPS, LOS, lipoglycan and teichoic acid the reader is referred to the original manuscript 
as published in MMBR (Tytgat & Lebeer, 2014). In this work the main focus lies on the 
current knowledge on protein glycosylation.
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Figure 2.3 – Bacterial glycoconjugates
Bacteria synthesize a plethora of glycoconjugates. Characteristic for Gram-negative species are LPS and LOS 
structures, while several Gram-positives are known to glycosylate their TAs (WTA and LTA). Both Gram-negative and 
-positive species can produce glycosylated flagella, pili or fimbriae, CPS, EPS and glycoproteins. The cell walls of both 
Gram-negative and –positive species also harbor a PG layer, which serves as a scaffold for the anchorage of other 
molecules. The round dots represent proteins, while the triangles are ribitol- or glycerolphosphate moieties.
2.4 protein gLycosyLation
In 1999, Apweiller et al. estimated based on analysis of the SWISS-PROT database, that about 
half of proteins in nature is glycosylated (Apweiler et al., 1999). Albeit their existence in 
prokaryotic species was refuted for a long time, glycoproteins were first discovered in Archaea 
in 1976 (Mescher & Strominger, 1976) and the occurrence of protein glycosylation in Bacteria 
is already well documented since the first reports in Clostridium bacteria that were published 
in 1975 (Sleytr, 1975; Sleytr & Thorne, 1976). The fact that bacterial protein glycosylation 
was discovered ‘quite late’ can be linked to the absence of glycoproteins in the most frequently 
used laboratory strains of E. coli and Salmonella sp. (Messner, 2004). Glycosylated bacterial 
proteins have mainly been characterized in pathogens and include surface layer proteins, 
pilins, flagellins and enzymes. Recent studies also report the occurrence of glycoproteins in 
beneficial bacteria like the gut symbiont Bacteroides fragilis (Fletcher et al., 2011; Fletcher 
et al., 2009) and Lactobacillus species (Fredriksen et al., 2012; Konstantinov et al., 2008; 
Lebeer et al., 2012b). 
The glycosylation of proteins can occur via the linkage of glycans to the hydroxyl group 
of a serine or threonine residue and in some cases tyrosine residues, commonly referred to 
as O-glycosylation or the glycan can be linked to an asparagine residue, which results in 
an N-glycosylated protein. Occasionally, such as for the glycocin F protein of L. plantarum 
KW30, glycosylation is linked to a cysteine, resulting in S-glycosylation (Stepper et al., 2011; 
Venugopal et al., 2011). Protein glycosylation processes can also be distinguished based on 
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the mechanism used to transfer glycans to the protein substrate, i.e. in a sequential or en bloc 
manner. Sequentially glycosylated substrates are directly targeted by GTs transferring sugar 
moieties (Fig.2.1). Often, these systems are dedicated, meaning that the genes encoding the 
protein substrate and the GT, as well as the necessary transporters, are clustered. If the glycan 
structure is fully synthesized on a lipid carrier (UndP carrier) prior to collective ligation on 
the substrate, this is called en bloc biosynthesis (Fig.2.2). 
Protein en bloc glycosylation in prokaryotes resembles the eukaryotic N-glycosylation processes 
partially. In eukaryotes, protein glycosylation occurs in the lumen of the endoplasmic reticulum 
(ER), whilst in prokaryotes, which do not have organelles, the sugar nucleotide precursors are 
synthesized in the cytoplasm. The biosynthesis of the glycan then occurs in close proximity 
of the cell membrane, as priming GTs are membrane-bound enzymes. After biosynthesis, the 
glycan is flipped across the cell membrane. In Gram-negative species the transfer of the glycan 
to the substrate takes place in the periplasm. Whether Gram-positives also have a periplasm is 
still debated, but several studies point towards the presence of a small periplasm between the 
cell membrane and PG-layer (Matias & Beveridge, 2005; Matias & Beveridge, 2006; Takade 
et al., 1988; Umeda et al., 1992). Both eu- and prokaryotes utilize lipid carriers to assemble 
the glycans: dolichol pyrophosphate in eukaryotic species and UndP in bacteria (Jones et 
al., 2009). The en bloc glycosylation of proteins is catalyzed by an OST, which is typically 
a multimeric protein containing up to eight transmembrane subunits in eukaryotes, whilst 
bacterial OSTs appear to be monomeric proteins (Feldman et al., 2005). In eukaryotes, en bloc 
N-glycosylation occurs prior to folding, when the substrates are still flexible (Kowarik et al., 
2006a). In contrast, data from C. jejuni suggests that en bloc glycosylation of proteins occurs 
on flexible, surface-exposed parts of folded proteins (Kowarik et al., 2006a). In addition, 
eukaryotes perform a quality control of the N-glycoproteins, while the glycans are generally 
also further modified or trimmed in the ER and Golgi apparatus. Quality control and trimming 
of glycans has –to the best of our knowledge- not (yet) been reported in bacteria. 
Eu- and prokaryotes both can perform en bloc N-glycosylation and sequential O-glycosylation 
of proteins. However, in prokaryotes, sequential N-glycosylation and en bloc O-glycosylation 
have also been reported (Aebi et al., 2010; Dell et al., 2010; Larkin & Imperiali, 2011; 
Weerapana & Imperiali, 2006), highlighting that the glycosylation possibilities in prokaryotes 
appear to be larger. Current knowledge seems to indicate that N-glycosylation of proteins occurs 
almost exclusively in Gram-negative species, namely in epsilon and a few delta proteobacteria 
(Dell et al., 2010). Only one report has been published on a potentially N-glycosylated protein 
in Gram-positive bacteria, more in particular on the Platelet Aggregation-Associated Protein 
of S. sanguis (Erickson & Herzberg, 1993). Taken together, O-glycosylation is a widespread 
phenomenon in bacteria, whilst N-glycosylation of proteins seems to be more restricted. 
Glycosylation of proteins in bacteria has been shown to modulate the physicochemical 
properties of their substrates. Glycan modifications of proteins can protect them against 
proteolysis (e.g. AIDA-I of E. coli 2787 (Charbonneau et al., 2007)), confer extra stability (e.g. 
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C. jejuni proteins (Alemka et al., 2013)), enhance the activity (e.g. gingipains of P. gingivalis 
(Vanterpool et al., 2005a)) and change the surface properties (e.g. pili of P. aeruginosa 1244 
(Smedley et al., 2005)). In addition, glycoproteins play a role in interactions between bacteria 
and their surroundings. Often, glycoproteins are important virulence factors and antigens, 
involved in adhesion events (e.g. AIDA-I of E. coli 2787 (Benz & Schmidt, 2001)), immune 
modulation (e.g. Apa glycoprotein of M. tuberculosis (Horn et al., 1999; Romain et al., 1999)) 
and evasion (e.g. the pili of N. meningitdis (Faridmoayer et al., 2008; Hamadeh et al., 1995; 
Marceau et al., 1998)). Protein glycosylation is often also heterogeneous and dynamic: one 
protein can carry more than 1 type of glycans and glycans can be incomplete or modified. In 
Clostridium botulinum this heterogeneity can manifest itself even between flagella of different 
isolates (Twine et al., 2008), which points towards a role for glycoproteins as a strain-specific 
barcode. 
Genome sequencing of the food-borne intestinal pathogen Campylobacter jejuni revealed an 
unexpected capacity for this organism to produce a wide variety of glycoconjugates, including 
PG, LOS, CPS and N- and O-linked sugars (Guerry & Szymanski, 2008; Gundogdu et al., 
2007; Parkhill et al., 2000). Glycobiologists started to focus their efforts on C. jejuni as a 
toolbox to unravel the mechanisms of protein glycosylation. Gradually, C. jejuni became 
a model organism of protein glycosylation, as it can both N- and O-glycosylate proteins by 
en bloc and sequential transfer resp. Especially the enzymes for protein N-glycosylation, 
clustered in the pgl locus, show remarkably high conservation (Nothaft & Szymanski, 2010; 
Szymanski & Wren, 2005), and can even be functionally transferred into Escherichia coli 
(Wacker et al., 2002), which was one of the early milestones of glycoengineering. In contrast, 
O-glycosylation genes are less conserved and phase variable (Karlyshev et al., 2002; van 
Alphen et al., 2008). 
2.4.1   En bLoc n-gLycosyLation of proteins
N-protein glycosylation has been described only in a few species, and its occurrence in 
bacteria is believed to be rare. En bloc N-glycosylation has until now mainly been studied 
in detail in Campylobacter sp. (Nothaft & Szymanski, 2010), while H. influenzae and A. 
pleuropneumoniae harbor a sequential N-glycosylation mechanism (Grass et al., 2010; 
Schwarz et al., 2011a). Recently, genomic analysis revealed the presence of an en bloc 
N-glycosylation mechanism in some Helicobacter sp. (Loman et al., 2009). N-glycosylation 
has been suggested in Chlamydia trachomatis, but information on the underlying mechanisms 
is lacking (Swanson & Kuo, 1991a; Swanson & Kuo, 1991b). For a long time, it was also 
believed that Borrelia burgdorferi, the cause of Lyme disease, produced four N-glycoproteins 
(FlaA, FlaB, OspA, OspB) (Ge et al., 1998; Sambri et al., 1992). A later report by Sterba and 
co-workers refutes these findings and attribute the positive glycosylation signals to tightly 
bound culture medium glycoproteins (Sterba et al., 2008). This illustrates how important it is 
to document the occurrence of glycoproteins in bacteria by at least complementary methods.
tw
o.
25
C. jejuni, a gastrointestinal pathogen to humans and commensal in avian colons, produces 
a wide variety of N-glycosylated proteins. First evidence on the existence of an N-protein 
glycosylation gene cluster came from the identification of LPS-like biosynthetic enzymes in 
C. jejuni 81-176. The glycans produced by the gene products of this locus, named the pgl locus 
(16 kb), seem to be immunodominant as their absence has been shown to result in reduced 
reactivity with antisera and a loss of immunogenicity (Szymanski et al., 1999). One of the 
first characterized glycoproteins of C. jejuni is PEB3 (CJ0289c), an important antigen of C. 
jejuni (Pei et al., 1991), which is glycosylated with a heptasaccharide of 1406 Da, that reacts 
with Soybean lectin (SBA) (Linton et al., 2002; Young et al., 2002). An asparagine residue 
of PEB3 was shown to be modified with one monomer of the special sugar D-Bacillosamine 
(Bac; 2,4-diacetamido-2,4,6-trideoxyhexose), five D-GalNAc residues and a D-Glc branch 
(Young et al., 2002). The en bloc nature of the process was confirmed by mutational analysis 
of the pgl locus, as interference at any stage of the oligosaccharide subunit assembly resulted 
in a total loss of glycoconjugate formation (Kelly et al., 2006). The only feature that seemed to 
be dispensable is the addition of the glucose branch of the heptasaccharide (Kelly et al., 2006). 
Gradually, more evidence emerged on the presence of other N-glycoproteins in C. jejuni strains 
(mostly in the 81-176 and NCTC 11168), confirming the general nature of the N-glycosylation 
process, i.e. targeting a range of proteins (Ding et al., 2009; Kakuda & DiRita, 2006; Linton 
et al., 2002; Rangarajan et al., 2007; Scott et al., 2009; Scott et al., 2011b; Wyszynska et al., 
2008; Young et al., 2002). In total over 60 glycoproteins are already identified in C. jejuni sp. 
(Ding et al., 2009; Guerry & Szymanski, 2008; Scott et al., 2011b; Young et al., 2002). 
The conserved pgl locus comprises all enzymes necessary for the N-glycosylation of proteins. 
Its role was confirmed by the functional transfer of the locus and the AcrA (CJ0367c) 
periplasmic glycoprotein into E. coli, which resulted in the production of glycosylated AcrA 
proteins (Wacker et al., 2002). The pgl cluster was also extensively studied in vitro, which 
-complementary to mutant analysis- enabled the characterization of all enzymes individually 
(Glover et al., 2005a). 
PglF (CJ1120c) is a C6 dehydratase, which together with the UDP-4-keto-6-deoxy-GlcNAc 
C4-aminotransferase PglE (CJ1121c) (Vijayakumar et al., 2006) is involved in the biosynthesis 
of the Bac moiety (Schoenhofen et al., 2006c). PglD, an acetyltransferase modifying the UDP-
4-aminosugar, is coupled to the reactions catalyzed by PglF and PglE (Olivier et al., 2006). 
Mutation of this enzyme resulted in monoacetylated Bac, which can still be transferred in 
mutant strains (Ding et al., 2009). A complementing enzyme was also found in the C. jejuni 
genome (Kelly et al., 2006). Later, PglD was found to be a multifaceted acetyltransferase as 
it can both target intermediates of O- and N-glycosylation processes (Demendi & Creuzenet, 
2009) (Fig.2.4A.). 
The priming GT or Bac 1-phosphorytransferase, PlgC, an integral membrane protein, then adds 
Bac to the lipid carrier (UndP). Its reaction is coupled to the action of the consecutive GTs 
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PglA, PglJ, PglH and PglI (Glover et al., 2006). PglA adds an α(1-3) linked GalNAc to Bac 
and this disaccharide serves as a substrate for the action of PglH, PglI and PglJ (Fig.2.4A.). 
These latter GTs add the other four GalNAcs in an α(1-4) manner (the first GalNAc is added 
by PglJ, the latter three by PglH) and a branching β(1-3) Glc (PglI) to the structure (Glover et 
al., 2005a; Kelly et al., 2006; Szymanski et al., 2003b; Young et al., 2002). PglH was found 
to have polymerase activity, as it can transfer three GalNAc residues consecutively (Glover 
et al., 2005a). This processive polymerase only harbors a single active site and product 
inhibition seems to limit the sequential GT reactions carried out by PglH to three. Regulation 
of this enzyme occurs thus via a ‘counting mechanism’ of product accumulation and inhibition 
(Troutman & Imperiali, 2009). 
The protein encoded by CJ1130c (wlaB) transfers the resulting lipid-linked heptasaccharide 
from the cytoplasm to the periplasm and was renamed PglK. PglK is an ABC transporter 
using the hydrolysis of ATP as an energy source to flip the glycans (Alaimo et al., 2006) 
(Fig.2.4A.). Strikingly, expression of the pgl locus in E. coli revealed the presence of two 
distinct interchangeable mechanisms to flip the lipid-linked oligosaccharides across the 
membrane: one using PglK and the other one using the Wzx flippase of the LOS pathway. 
Moreover, PglK could even complement a defect in Wzx, albeit the two enzymes show very 
little similarity, which suggest a relaxed specificity of these enzymes (Alaimo et al., 2006). 
In H. pylori a homologue of PglK, WzK, was identified as a flippase involved in O antigen 
biosynthesis (Hug et al., 2010). 
An OST termed PglB (CJ1126c) finally transfers the oligosaccharide from the lipid carrier 
to the substrate protein (Linton et al., 2002; Young et al., 2002) (see earlier) (Fig.2.4A.). 
Structurally, the enzyme contains 11 transmembrane segments and two relative large 
periplasmic regions apart from the periplasmic C-terminal domain (Li et al., 2010). PglB 
contains a strictly conserved W-W-D-Y-G motif, required for its activity in vivo (Ihssen et al., 
2012; Wacker et al., 2002). Several X-X-D domains were also found: two in the C-terminal, 
one in the first periplasmic region and three more in the periplasm. These domains are typical 
for GT activity and are thought to be involved in catalysis (see before). 
The PglB OST recognizes a motif in the acceptor substrate, similar to the eukaryotic N-X-
S/T sequence (Glover et al., 2005b). Work by Kowarik and co-workers further extended the 
consensus sequence of PglB to D/E-Y-N-X-S/T, with Y and X being any amino acid except 
for proline (Kowarik et al., 2006b). They also showed the requirement of a negatively charged 
side chain at the -2 position of the glycoproteins. Chen and co-workers (Chen et al., 2007a) 
took these findings a step further and assessed variable amino acids at the Y and X position 
of the glycan sequon for their impact on glycosylation efficiency. The Y amino acid of the 
sequence is preferably a glutamine, asparagine or large hydrophobic moiety, while for the 
one on the X-position there is a preference for negatively charged amino acids, like lysine, 
arginine, alanine and serine. This resulted in the postulation of D-Q-N-A-T as the optimal 
tw
o.
27
acceptor sequence (Chen et al., 2007a). The lipid-linked oligosaccharides also need to be 
transferred to the periplasm where PglB is active (Linton et al., 2005; Nita-Lazar et al., 2005). 
In contrast to eukaryotic OSTs, PglB catalyzes with a high efficiency the glycosylation of 
folded bacterial substrates, but the glycosylation sites of bacterial proteins are predominantly 
present in the flexible, surface-exposed parts of folded protein (Kowarik et al., 2006a). The 
acceptor region appears to partially adopt an unstable α-helix conformation and form random 
coils (Slynko et al., 2009). These findings were confirmed experimentally via the crystal study 
of the PEB3 glycosylated adhesin (Rangarajan et al., 2007). Three key glycosylated residues 
are well exposed at the surface, which makes them accessible to PglB even in the folded state 
of the protein. In this way, PglB can target the glycosylation sites without the need for local 
protein structure rearrangements (Rangarajan et al., 2007). 
Research on the specificity of PglB, PglC and PglJ towards the polyisoprenol diphosphate 
carriers on which the oligosaccharide is built, revealed the preference towards cis double 
bond geometry and α-unsaturation, while the precise length of the polyisoprene is less critical 
(Chen et al., 2007b). Li et al. later confirmed this relative relaxed specificity towards the lipid 
carriers (Li et al., 2010). Moreover, PglB recognizes an acetamido group at the C-2 position 
of the sugar directly linked to the UndPP carrier (Wacker et al., 2006). Bac, GlcNAc, GalNAc 
and FucNAc all have a C-2 acetamido group, which can partially explain the promiscuity of 
PglB (the enzyme can even transfer monosaccharides) towards the sugars it transfers (Li et 
al., 2010; Wacker et al., 2006).
Studies on the functional importance of N-glycans present on the proteins of C. jejuni are 
still rather scarce. These glycans seem to modulate the functions of several specific proteins, 
which are not the same for all proteins. Impaired glycosylation of the VirB10 glycoprotein, 
a type IV secretion system glycosylated at two sites, for instance, resulted in reduced natural 
transformation (Larsen et al., 2004). Mutations affecting the pgl locus resulted in altered 
phenotypes, such as decreased adhesion, invasion efficiency in vitro and abolishment of 
mouse and chicken colonization in vivo (Karlyshev et al., 2004; Szymanski et al., 2002; 
Vijayakumar et al., 2006; Young et al., 2002). The glycans were also hypothized to play a role 
in immune evasion by masking primary amino acid sequences, based on studies with human 
antisera (Szymanski et al., 1999). Moreover, the terminal GalNAc residues of the N-linked 
heptasaccharides were shown to interact with the human C-type Macrophage Galactose Lectin 
(MGL) receptor present on human dendritic cells and distinct macrophage subsets, thereby 
modulating immune responses (van Sorge et al., 2009). A mutant in the pgl locus also resulted 
in enhanced expression of the pro-inflammatory cytokine IL-6, again implicating a shielding 
role of the glycans (van Sorge et al., 2009). 
In addition to a role in host interaction, recent work by Alemka et al. underlines the importance 
of N-glycosylation for bacterial fitness, as mutation of pglB resulted in a reduced growth in 
medium supplemented with chicken cecal content (Alemka et al., 2013). This result could be 
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linked to the presence of proteases in this medium as inhibition of the serine and metalloproteases 
resulted in restored viability and a partial rescue of bacteria growth. This further adds support 
for a role of N-glycans in protection against proteolysis of surface proteins. 
A similar en bloc N-glycosylation system has been discovered in Helicobacter canadensis 
based on genome analysis (Loman et al., 2009). Further genome analysis showed the presence 
of PglB orthologues in H. canadensis, H. pullorum and H. winghamensis (Jervis et al., 2010). 
H. pullorum has two orthologues of pglB, pglB1 and pglB2, which are unrelated and not 
located in a large locus involved in protein glycosylation, although the colocalisation of pglD, 
pglE and pglF orthologues in a small separate cluster was reported. The PglB1 enzyme can 
transfer the C. jejuni heptasaccharide in E. coli, but results only in the modification of two 
sites of the CJ0114 protein instead of the four that are modified by PglB of C. jejuni. This 
indicates the OST character of this enzyme and the distinct specificity compared to PglB from 
C. jejuni. PglB2 seems to be essential, as no knockout can be made in this gene (Jervis et 
al., 2010). The character, activity and functionality of this glycosylation system remain to be 
further investigated. At the moment it seems, in contrast to the findings in C. jejuni, that the 
N-glycosylation of proteins is not a genus-wide feature of Helicobacter (Jervis et al., 2010). 
The only report on a glycoprotein in Helicobacter sp. is on the glycosylation of RecA in H. 
pylori. Based on mutational analyses of recA and eno (an enolase homologue), glycosylation 
was claimed to be required for the full functionality of RecA in response to DNA damage 
(Fischer & Haas, 2004). However, glycosylation of RecA needs to be further substantiated, 
especially also in other bacterial species, given its universal role.
2.4.2   sequentiaL n-gLycosyLation of proteins
In H. influenzae, a distinct mechanism of N-glycosylation was reported, in which the 
glycosylation occurs in a sequential way (Fig.2.4B.). The high molecular weight HMW1 
adhesin, which is loosely associated with the bacterial surface and involved in the attachment 
of the pathogen to human epithelial cells, is decorated with galactose, glucose and mannose 
residues (Grass et al., 2003). The glycan is believed to account for 5% of the total mass 
of HMW1 and is attached in the cytoplasm (Grass et al., 2003). 31 sites of the protein are 
modified with mono- or dihexoses (total of 47 hexoses), all harboring the N-X-S/T sequence, 
except one, which is glycosylated at an N-V-E sequon (Gross et al., 2008). 
HMW1 is associated with two accessory proteins of which HMW1B is involved in the 
translocation of HMW1 from the periplasm to the cell surface and HMW1C was found to be 
required for HMW1 glycosylation (Grass et al., 2003). The HMW1C protein shows homology 
to GTs and can transfer glucose and galactose residues to HMW1. In addition, the GT can 
also generate hexose-hexose bonds, which suggests that this multifunctional GT belongs to 
a new family of bacterial GTs (Grass et al., 2010; Gross et al., 2008). HMW1C transfers 
glucose residues to all N-glycosylation sites, while it can transfer galactose to only a subset 
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of the glucosylated N-residues. How the HMW1C GT makes the distinction between both 
types remains to be elucidated (Grass et al., 2010). The biosynthesis of the UDP-glucose 
precursors that are linked to HMW1 requires an enzyme of the LOS pathway, namely the 
phosphoglucomutase PgmB (Grass et al., 2003). Glycosylation of the HMW1 adhesin was 
shown to play a role in the tethering of the adhesin to the surface and stability of the protein, 
as glycosylation defects result in an HMW1 adhesin that is prematurely degraded and released 
from the surface (Grass et al., 2003).
A homologue of the HMW1C GT of H. influenzae was found by the group of M. Aebi in 
Actinobacillus pleuropneumoniae. This inverting cytoplasmic N-glycosyltransferase, termed 
NGT, targets the N-X-S/T consensus sequence and modifies this sequon with Gal and Glc 
residues. Elongation of the Glc residue can be performed by an α 1,6-glucosyltransferase 
(Schwarz et al., 2011a). The relaxed specificity of the NGT enzyme was illustrated by the 
reconstruction of this glycosylation pathway in E. coli. This general glycosylation system 
seems to have a preference for autotransporter adhesins, but can also glycosylate heterologous 
proteins (Naegeli et al., 2014).
In Chlamydia trachomatis, causing chlamydia in humans, three N-glycosylated proteins were 
reported. The analyses all date from the early 90s and rely on the use of lectins, glycosidases 
and blocking experiments. The 18 kDa and 32 kDa lectin binding proteins of the L2 serovar 
were found to be glycosylated and the glycans were suggested to be of importance for the 
interaction with HeLa cells (Swanson & Kuo, 1991a; Swanson & Kuo, 1994a). The best-
documented glycoprotein is the Major Outer Membrane Protein (MOMP), which constitutes 
up to 60% of the chlamydial protein envelope. MOMP harbors the N-X-S/T sequence and its 
N-glycans mediate the attachment and infectivity of C. thrachomatis with HeLa cells (Kuo et 
al., 1996; Swanson & Kuo, 1991b; Swanson & Kuo, 1994b). This glycan is a high mannose 
type oligosaccharide of 8-9 mannose residues. The presence of other sugar monomers, like 
GlcNAc, was also suggested (Kuo et al., 1996). These findings remain, however, to be further 
substantiated to ascertain that the results are not origination from cross-contamination with 
human serum.
2.4.3   DeDicateD o-gLycosyLation of proteins: fLageLLa
C. jejuni has bipolar flagella involved in the colonization of mucus (Black et al., 1988; Logan 
et al., 1989). The structural proteins, FlaA and FlaB, of C. jejuni flagella are decorated with 
glycans. In C. jejuni 81-176, up to 19 sites of a surface-exposed region of FlaA are glycosylated 
(Thibault et al., 2001). This implicates the requirement of surface accessible S and T residues 
for the attachment of glycans (Thibault et al., 2001). The glycan modifying FlaA in many 
C. jejuni strains, like 81-176, is pseudaminic acid (Pse), a 9-carbon sugar similar to sialic 
acid, or derivatives thereof (Guerry et al., 2006). The flagellin structural protein FlaA of 
the related Campylobacter coli VC167 strain was found to be glycosylated on 16 sites, both 
with Pse and legionaminic acid (Leg) or its derivatives, which is a C-9 sugar related to sialic 
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acid like Pse (Logan et al., 2002; McNally et al., 2007). Whether a Campylobacter strain 
produces Pse, Leg or both and which derivatives it produces, is strain-specific and determined 
by the heterogeneous O-glycosylation loci they harbor. Flagellin glycosylation is a factor 
determining variety between strains and their serospecificity (Doig et al., 1996; Logan et al., 
2009). FlaB is thought to be glycosylated similarly to FlaA in several C. jejuni strains (Logan, 
2006).
The genetic locus responsible for the glycosylation of flagella in C. jejuni NCTC 11168 
comprises nearly 50 genes and encompasses the genes involved in Pse biosynthesis, Maf 
(Motility accessory factor) genes, genes encoding the structural subunits FlaA and FlaB and 
lots of genes with unknown function (Gundogdu et al., 2007; Parkhill et al., 2000). Of note, the 
related strain C. jejuni 81-176 has only half the amount of genes, namely 24 genes, involved 
in flagellar O-glycosylation (Guerry et al., 2006). 
Genes orthologous to sialic acid biosynthesis genes regulate Pse biosynthesis (neuA2, neuB3, 
neuB2, neuC2, neuA3) (Chou et al., 2005; Schoenhofen et al., 2006c). Leg biosynthesis is 
carried out by 11 ptm genes and uses particular GDP-linked sugar residues (Schoenhofen et 
al., 2009). The maf genes (maf1 – maf7) are members of the 1318 motility accessory factor 
family of flagellin-associated proteins and some (the identical maf1 and maf4 genes) harbor 
polymorphic G tracts, which enable motility variation by slipped-strand mispair (Karlyshev 
et al., 2002; van Alphen et al., 2008). The maf5 gene is involved in flagella formation and 
is therefore invariant (Karlyshev et al., 2002). Another four paralogous genes are members 
of the 617 gene family and contain intragenic single nucleotidic repeats, which are prone to 
phase variability. The exact role of the genes of both the Cj1318/maf and 617 gene family (i.e. 
families of highly homologous genes in the O-glycosylation cluster) remains to be elucidated 
(Szymanski & Wren, 2005). Strikingly, to none of the 50 genes of the O-glycosylation cluster, 
a GT activity is yet attributed. Up till now –to the best of our knowledge- no reports on the 
characterization of one or more O-GTs in C. jejuni strains were published. Recently, our 
group designed an in silico strategy to predict/annotate genes encoding GTs more accurately 
in bacterial species (Sanchez-Rodriguez et al., 2014). This study could identify four candidate 
genes involved in O-protein glycosylation in C. jejuni NCTC 11168, namely Cj1328, Cj1329, 
Cj1331 and Cj1333. Further experimental validation of these targets is needed to confirm that 
these are truly flagellar GTs.
The genetic variation displayed by the presence of both gene families (617 and Cj1318/maf) 
results in an alteration in the behavior of C. jejuni strains. For example, phase variation of 
the maf4 gene of C. jejuni strain 108 results in an altered glycosylation of the flagella and 
agglutination behavior (van Alphen et al., 2008). Other genes, like Cj1295 of C. jejuni NCTC 
11168, also contain single nucleotide repeats and homopolymeric tracts, which can result in 
considerable structural changes in the flagellar glycoproteins (Hitchen et al., 2010).
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Figure 2.4 – Protein glycosylation
Fig. 2.4A. En bloc N-protein glycosylation in the model organism C. jejuni. The type example of en bloc protein 
glycosylation is the general N-protein glycosylation system of C. jejuni. Prior to the start of the glycosylation process, 
UDP-GlcNAC is modified to diNAcBac by the action of PglF, PglE and PglD. The priming GT PglC transfers this sugar 
moiety to and UndP carrier, followed by the successive actions of the PglA, J and H GTs adding GalNAc and Glc 
residues. Once finished, the glycan moiety is transferred across the inner membrane by the PglK flippase. Finally, the 
PglB OST then N-glycosylates the protein (Nothaft & Szymanski, 2010; Szymanski et al., 2003a; Szymanski & Wren, 
2005) (and the references mentioned in the text). Fig. 2.4B. The peculiar sequential N-protein glycosylation system 
of H. influenzae. In H. influenzae the glycan moieties are directly attached to serines and threonines in the protein 
by HMW1C. Transportation across the inner membrane relies on the Sec pathway, followed by further export to the 
cell surface by HMW1B (Grass et al., 2003; Grass et al., 2010; Gross et al., 2008). Fig. 2.4C. Sequential O-protein 
glycosylation of pili, flagella and other proteins (illustrated for Fap1 of S. parasanguinis). The glycosylation of the 
Fap1 fimbrial protein of S. parasanguinis remains to be fully elucidated. It is currently known that the first step of the 
glycosylation process is catalyzed by a heterodimer of Gtf1 and Gtf2, whilst Gtf3 regulates the latter glycosylation 
steps. Especially the glycoprotein secretion mechanism is of note here, as it involves a SecA2-SecY2 heterodimer. The 
SecY2 forms a translocation channel, with SecA2 being an accessory protein. Gap1 and Gap3 are crucial accessory 
proteins for fimbrial biogenesis (Bu et al., 2008; Chen et al., 2004; Peng et al., 2008a; Peng et al., 2008b; Stephenson 
et al., 2002; Wu et al., 1998; Wu & Wu, 2011; Zhou & Wu, 2009; Zhou et al., 2010). Fig. 2.4D. The general en bloc 
protein glycosylation system of Neisseria sp. In Neisseria sp. the PglD, C and B or B2 enzymes modify a nucleotide-
activated GlcNAc residue. The action of PglB results in the formation of DATDH, PglB2 in GATDH. These enzymes are 
also the priming GTs, adding these sugar residues to an UndP carrier. The successive action of PglA and PglE results 
in the addition of two Gal residues. The glycan is then transferred to the periplasm by a PglF flippase and ligated to 
the protein by the PglL/PglO OST (Borud et al., 2010; Borud et al., 2011; Faridmoayer et al., 2008; Faridmoayer et 
al., 2007; Hartley et al., 2011).
In C. jejuni 81-176, glycosylation was shown to be required for flagellar filament assembly 
as the glycans mediate interactions between subunits within the filament (Ewing et al., 2009). 
The flagellar glycans of the 81-176 strain also can establish interactions between different 
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filaments and modulate autoagglutination events (Ewing et al., 2009; Guerry et al., 2006). 
Differences in glycan modifications on flagella impact the formation of microcolonies on 
intestinal epithelial cells in vitro, which is critical for the virulence of the strains (Golden & 
Acheson, 2002). In C. jejuni NCTC 11168 flagellar glycosylation with Leg residues results in a 
change of the surface charge, important for the colonization of the colon of chickens (Howard 
et al., 2009). Of note, the flagellar glycans of C. jejuni NCTC 11168 are not implicated in 
the evasion of recognition of C. jejuni flagella by TLR-5 (de Zoete et al., 2010). Mutation of 
genes involved in flagellar glycosylation results in a loss of motility in C. jejuni and C. coli 
strains (Goon et al., 2003; Guerry et al., 1996; Logan, 2006). 
H. pylori, a species closely related to C. jejuni, also produces complex polar flagella consisting 
of two structural glycosylated proteins, FlaA and FlaB. Both flagellins are modified with Pse: 
FlaA on seven sites and FlaB on ten sites (Josenhans et al., 1999; Schirm et al., 2003). The 
glycosylation sites lie in the central core region of the flagellin monomers, which are surface 
exposed in the filament (Schirm et al., 2003). In contrast to the remarkable heterogeneity 
of flagellin glycosylation in C. jejuni strains, the heterogeneity of isoforms and glycoforms 
is low in Helicobacter species. For instance, no derivatives of Pse are reported. The sheath 
surrounding the flagellar filaments of Helicobacter pylori probably negates the need for this 
variation (Schirm et al., 2003). This results in an analogous, but simpler glycosylation region 
compared to C. jejuni. This explains the large number of functional studies of enzymes involved 
in Pse biosynthesis in H. pylori, which facilitated the elucidation of the C. jejuni mechanism 
(Schirm et al., 2005; Schoenhofen et al., 2006a; Schoenhofen et al., 2006b; Schoenhofen et 
al., 2006c). The enzyme encoded by HP_0840 (PseB) was characterized as a bifunctional C6-
dehydratase/C5-epimerase (Creuzenet et al., 2000; Schoenhofen et al., 2006c). The HP_0366 
gene codes for the flagellar aminotransferase PseC (Schoenhofen et al., 2006a; Schoenhofen 
et al., 2006c). Further elucidation of Pse biosynthesis in H. pylori revealed the function of the 
other enzymes involved: HP_0326A or PseF is the CMP-Pse synthetase, HP_0326B or PseG 
the nucleotidase, PseH encoded by HP_0327 is an N-acetyltransferase and the HP_0178 gene 
codes for the Pse synthase (PseI) (Schoenhofen et al., 2006b). It was also shown in vitro that 
the modification of UDP-GlcNAc to form CMP linked Pse occurred in one step combining 
these six enzymes (Schoenhofen et al., 2006b). The enzyme encoded by HP_0114 is central 
to flagellar assembly, either via transfer of Pse to the flagellin monomer or via its function in 
later steps of flagellar assembly (Schirm et al., 2003). The modification of FlaA with glycans 
at seven sites was proven to be a general feature of H. pylori strains (Schirm et al., 2005). 
Glycosylation of H. pylori flagellin is crucial for the filament assembly and bacterial motility, 
as mutants in the glycosylation region resulted in the absence of functional flagella (Asakura 
et al., 2010; Josenhans et al., 2002; Schirm et al., 2003). Flagellin is thought to be only 
glycosylated upon secretion (Josenhans et al., 2002). Study of a hypermotile mutant of H. pylori 
G27 resulted in the identification of HP_0518 as an enzyme involved in the deglycosylation 
of FlaA (Asakura et al., 2010). This mutant had an increased glycosylation of FlaA, which 
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points towards a link between its glycosylation state and the pathogenicity of H. pylori: as this 
mutant can interact better with host cells and causes accelerated host cell responses, which is 
of course detrimental for a pathogen (Asakura et al., 2010). This also points out the need for a 
strict regulation of glycosylation. Recent papers report on the presence of other glycoproteins, 
of which many are cytoplasmic, in H. pylori strains besides the well known flagellar ones 
(Champasa et al., 2013; Hopf et al., 2011). An MS screening of enriched azide labeled proteins 
of H. pylori 26695 resulted in the identification of 125 candidate O-linked glycoproteins 
serving diverse functions and located in different fractions of the cell (Champasa et al., 2013). 
In P. aeruginosa, two major serogroups (a and b) are discriminated, based on the expression 
of the flagellin structural protein, FliC. Totten and Lory reported an important discrepancy in 
molecular weight for FliC of P. aeruginosa type a strain PAK (52 kDa instead of the calculated 
45 kDa) (Totten & Lory, 1990). Eight years later this molecular weight shift was attributed 
to the glycosylation of type a flagellin (Brimer & Montie, 1998). Genome comparison of the 
type a strain PAK and type b strain PAO1 revealed a flagellin glycosylation island of 14 genes 
(orfA-orfN) present in the PAK strain, organized in several operons (Arora et al., 2001). In the 
type b strain PAO1, this glycosylation island is replaced by three genes of unknown function 
and a putative GT. This putative GT shows low homology to the orfN gene present in PAK, 
which was recognized as a putative flagellin-GT (Dasgupta et al., 2003). Further research on 
the glycosylation island in type a strains revealed a high polymorphism for this cluster. Many 
strains encode a shorter version of the island, in which orfD, E and H are polymorphic and the 
orfI, J, K, L, M genes can be absent (Arora et al., 2004). 
P. aeruginosa type a flagellins were shown to be modified at two sites (T189 and S260) 
on each monomer and produce unique glycan structures. The PAK flagellin is glycosylated 
with a heterogeneous O-linked glycan which can comprise up to 11 monosaccharides, linked 
to the protein backbone via a rhamnose residue. Flagellin of another strain, JJ692, has less 
complex modifications: single rhamnose subunits are linked to each site. In the PAK strain, 
a long glycosylation island is involved in the glycosylation of the PAK flagellin, encoding 
the OrfA enzyme responsible for the attachment of the heterogeneous glycan and the OrfN 
rhamnosyltransferase. In contrast, the JJ692 strain harbors a truncated glycosylation island, 
similar in length to the shorter glycosylation islands found in other Pseudomonas strains. 
Nevertheless, these other strains can show more extensive glycosylation of flagellin compared 
to the single glycan substitution in JJ692. Like in C. jejuni flagellar glycosylation, genetic 
variation of the glycosylation island can result in altered glycosylation profiles (Schirm et al., 
2004a). 
It was believed for a long time that b type flagella were non-glycosylated, until it was reported 
that the short genomic island (4 genes) of PAO1 modifies S191 and S195 with a simple glycan 
of 700 Da. This glycan was identified as a deoxyhexose with a unique modification of 209 Da, 
which harbors a phosphate moiety. In contrast to a type flagellar glycosylation, polymorphism 
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of the glycosylation island is low, which results in less heterogeneous flagellar glycosylation 
(Verma et al., 2006).
In contrast to the observations made in C. jejuni, the function of flagellin glycosylation seems 
to be not involved in flagellar motility or filament assembly in Pseudomonas (Schirm et al., 
2004a). Also, the flagellar glycans are not the epitope recognized by the human anti-type a 
flagellin monoclonal antibody (Brimer & Montie, 1998). Nevertheless, flagellar glycosylation 
was shown to be involved in virulence of Pseudomonas in a burn wound model (Arora et al., 
2005) and triggering of the inflammatory response, as was shown by the comparison of IL-8 
production by A549 cells triggered by (un)glycosylated flagellin (Verma et al., 2005). The 
exact in vivo role of flagellar glycosylation in Pseudomonas strains remains unclear.  
The first Gram-positive organism in which flagellar glycosylation was reported, is Listeria 
monocytogenes (Schirm et al., 2004b). The elucidation of flagellin glycosylation in L. 
monocytogenes resulted from earlier reports on the discrepancy in molecular weight of its 
flagellin, FlaA, which suggested a posttranslational modification (Dons et al., 1992; Peel 
et al., 1988). In 2004, the flagellins of the listerial serotypes 1/2a, 1/2b, 1/2c and 4b were 
shown to be β-O-glycosylated. Up to six sites of the central surface exposed region of the 
flagellin monomer are glycosylated (Schirm et al., 2004b). The enzyme encoded by Lmo0688 
(GmaR) was later identified as a bifunctional GT protein that transcriptionally regulates the 
expression of its enzymatic substrate as it harbors both β-O-GlcNAc-transferase activity 
and is an anti-repressor of the MogR repressor, which represses flagellar production in a 
temperature dependent manner. As Listeria sp. only express their flagella at low temperature, 
their expression is repressed at 37°C (human body temperature) to evade recognition by the 
immune system (Shen & Higgins, 2006). Based on mutational analyses of the GmaR GT, 
flagellar glycosylation in Listeria is believed to be unnecessary for the secretion, stability 
and motility of the flagella, nor for adhesion and biofilm formation (Lemon et al., 2007; Shen 
& Higgins, 2006). Further research will have to shed light on the functional importance of 
flagellar glycosylation in this species.  
Clostridium species are Gram-positive pathogens targeting the GIT and it is speculated that 
their glycosylated flagella might help them to establish an interaction with the host (Twine et 
al., 2009), although this remains to be documented. The first reports of flagellin glycosylation 
in Clostridium sp. were published on C. tyrobutyricum and C. acetobuytlicum ATCC824 
(Arnold et al., 1998; Bedouet et al., 1998; Lyristis et al., 2000). C. botulinum was the first 
human pathogenic Clostridium species in which O-glycosylation of flagellin was studied. The 
genomes of these species harbor genes homologous to Leg biosynthetic genes of C. coli. The 
flagella are O-glycosylated with a new derivative of Leg on up to seven sites per monomer. 
Among C. botulinum isolates, a range of glycan structures could be found (Twine et al., 
2008). Strains targeting infants appear to be glycosylated with Leg derivatives, whilst other 
strains that have no link to infections are generally decorated with hexuronic derivatives. 
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This suggests a possible link between flagellin glycosylation and the pathogenic potential of 
Clostridium isolates.
The peritrichous flagella of C. difficile strains and isolates, well-known GIT pathogens, are 
modified with O-linked HexNAc residues. This modification seems to be conserved amongst 
most strains. In C. difficile 630, up to seven sites of the flagellin (FliC) are modified with 
a HexNAc residue on which a methylated aspartic acid is linked via a phosphate bond. C. 
difficile clinical isolates have more heterogeneous glycans consisting of a maximum of five 
monosaccharides, again starting with a HexNAc residue. In C. difficile 630, the GT CD0240 
was further studied: inactivation of this gene led to a non-motile phenotype, which could 
only produce a limited amount of unglycosylated FliC. This finding illustrated the need for 
glycosylation of flagellin in the assembly and motility of flagella (Twine et al., 2009). 
The bacterial agent causing syphilis, Treponoma pallidum, expresses flagella composed of 
core proteins, FlaB, and sheath proteins, FlaA. It was shown that the core protein, FlaB, is 
glycosylated (Wyss, 1998). The nature of its flagellar glycosylation has yet to be further 
investigated, but a role for FlaB glycosylation was speculated in the regulation of the assembly 
of FlaA on the core flagellin and in the transport and stability of flagellar components. 
Taken together, flagellar glycosylation has been reported in many species. In species harboring 
simple flagella, like Pseudomonas, glycosylation appears a non-essential feature, while 
glycosylation appears to be essential for the assembly and motility of complex flagella, such 
as in Campylobacter, Helicobacter, Clostridium species. This latter fact seems to be typical 
for strains colonizing the human GIT. Nevertheless, more studies are needed to understand the 
functional importance of flagellin glycosylation. 
2.4.4   DeDicateD o-gLycosyLation of proteins: piLi
Similar to glycosylated flagella, bacterial pili are often glycosylated. Some bacteria use a 
general system to do so, targeting both pili and other proteins (i.e. general O-glycosylation, 
see further), others harbor a mechanism dedicated to pili glycosylation. 
We described earlier the glycosylation of flagella in certain Pseudomonas strains, while other 
strains express type IV pili and some decorate these pilins with glycans. The best-studied 
glycosylated pilins are from P. aeruginosa 1244. Each PilA subunit of the pilus fiber is 
decorated with a single trisaccharide (Castric et al., 2001). The glycan is evenly distributed 
over de fiber surface, at the seam between two adjacent pilins (Smedley et al., 2005). The 
trisaccharide consists of 5-N-β-OHC47NfmPse, xylose and FucNAc (Castric et al., 2001) 
linked to the C-terminal serine 148 (DiGiandomenico et al., 2002). This S148 lies adjacent 
to a disulfide loop, which is an important B-cell epitope (Comer et al., 2002). The terminal 
character of the pilin glycosylation is quite unusual, as proteins are mostly glycosylated 
on their core. Further comparison with a non-glycosylating strain PA103 resulted in the 
identification of this terminal serine as the major pilin glycosylation recognition feature. The 
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compatibility of the surface also plays a role, as a positive charge of the adjacent disulfide 
loop appears to enable glycosylation and the terminal serine needs to be at a minimum distance 
from the pilin subunit, probably to avoid steric hindrance of the disulfide loop (Horzempa et 
al., 2006a). These findings suggest that glycosylation occurs after pilin folding, early in the 
pilus biogenesis. Further investigation of pili glycosylation specificity revealed that only the 
structure of the sugar at the reducing end of the trisaccharide (FucNAc) is of importance, 
suggesting that the structural aspects of the remaining sugars are unimportant (Horzempa et 
al., 2006b). 
The trisaccharide made of 5-N-β-OHC47NfmPse, xylose and FucNAc is similar to the O antigens 
of the LPS molecules of P.aeruginoa 1244, which suggests a common metabolic origin for 
both oligosaccharides. And indeed, a mutant affected in O antigen synthesis resulted both in 
the loss of O antigens and pilin glycosylation (DiGiandomenico et al., 2002). Heterologous 
expression of the O antigen producing machinery in E. coli further confirmed these findings. 
The fact that P. aeruginosa 1244 uses the same pathway to generate glycans for LPS formation 
and pilin glycosylation is probably an energy saving process. 
The structural pilA gene was found to be part of an operon also harboring pilO, which was 
shown to be required for pilin glycosylation (Castric, 1995). This O-OST has a sequence 
pattern that is also found in WaaL (LPS ligase). The two enzymes compete for the same 
substrate, namely lipid linked monomeric O antigens, so it is no surprise that they are part of 
the same Pfam Wzy_C family (Musumeci et al., 2014; Qutyan et al., 2007). Nevertheless, the 
active site of PilO differs from the other enzyme. The Wzy domain of PilO and C-terminal 
proximal hydrophilic portion of PilO are the regions linked to enzyme activity (Qutyan et al., 
2007). PilO has a relaxed glycan specificity towards short oligosaccharides, which prevents 
the addition of polysaccharides that would impede pilus assembly (Faridmoayer et al., 2007). 
The factors determining this remarkable preference for short oligosaccharides remain to be 
established. The only substrate specificity that could be found for PilO is the presence of a 
C-terminal serine or threonine residue, and the earlier mentioned minimum distance form the 
pilin surface and a compatible surface charge (Qutyan et al., 2010).  
PilO was shown to be the only pilin specific glycosylation factor (Castric, 1995; DiGiandomenico 
et al., 2002). Mutational analysis of PilO resulted in non-glycosylated pili, which had a normal 
appearance but had somewhat reduced twitching motility and were more sensitive to pili-
specific bacteriophages. Competition of this mutant with the wild type 1244 strain in a mouse 
model of acute pneumonia resulted in a greater survival for the strain carrying glycosylated 
pilins. This indicates that the glycosylation of the pilins is an important virulence factor that 
can interfere with infection establishment (Smedley et al., 2005). These findings were in 
concordance with earlier reports on the higher frequency of Group I Pseudomonas strains, such 
as 1244 and PAO1, in cystic fibrosis patients (Kus et al., 2004). There are in total five groups 
of Pseudomonas strains, which are defined based on the comparison of the DNA sequence 
tw
o.
37
comparison of the pilin clusters (Castric & Deal, 1994). The glycans on the pilin reduce the 
hydrophobicity of the pilin, which enables these strains to colonize other microenvironments 
(Smedley et al., 2005). 
Another P. aeruginosa strain harboring glycosylated pilins is the Pa5196 strain of Group IV, 
later glycosylated proteins were also found in strain PA7 (Kus et al., 2008; Voisin et al., 2007). 
These pilins are decorated with a peculiar homo-oligomer of α(1-5)linked D-arabinofuranoses. 
This uncommon sugar also occurs in lipoglycans of Mycobacteria. The D-arabinofuranose 
biosynthesis of Pa5196 is also highly homologous to M. tuberculosis (Harvey et al., 2011). 
The arabinofuranoses are present on several positions in the flexible central part of the protein 
(Voisin et al., 2007). The T glycosylation sites are modified with trisaccharides and additional 
mono- and disaccharides can be found on serine residues, which add up to about 16 arabinoses 
per pilin subunit. The TfpW enzyme was identified as the pilin arabinosyltranferase and is 
thus a potential O-OST (Kus et al., 2008), which points towards an en bloc glycosylation 
mechanism. The glycan substitutions are required for the efficient assembly of the pilus and 
more in particular to establish subunit-subunit interactions (Harvey et al., 2011). 
A peculiar case of glycosylation of pili (or fimbriae) can be found in Streptococcus 
parasanguinis FW213, where the fimbriae-associated protein, Fap1, which was later identified 
as the major constituent of its fimbriae, is O-glycosylated (Stephenson et al., 2002; Wu et al., 
1998) (Fig.2.4C.). The Fap1 protein is a high molecular weight, serine-rich repeat protein of 
200 kDa and is decorated with Rha, Glc, Gal, GlcNAc and GalNAc residues (Stephenson et al., 
2002). The fimbriae of S. parasanguinis are important for the adhesion to teeth and the sugar 
residues present on Fap1 mediate this process (Stephenson et al., 2002; Wu et al., 2007b). 
Glycosylation is essential for biofilm formation of S. parasanguinis (Wu et al., 2007b). The 
glycans on Fap1 also protect the protein from degradation and stabilize its conformation (Chen 
et al., 2004). 
Upstream of the fap1 gene, a biogenesis locus can be found comprising 3 orfs (gap1-3), 
genes coding for putative GTs (gtf1, gtf2, gly, nss, galT1 and galT2), a SecA2 and SecY2 
system (Zhou & Wu, 2009). This SecA2 system is an accessory secretion system (next to the 
canonical SecA pathway) and allows the transport of glycosylated proteins, as glycosylation 
of Fap1 occurs intracellularly (Chen et al., 2004). The SecY2 protein not only forms the 
translocation channel, but is also thought to play a role in the complete glycosylation of Fap1 
(Wu et al., 2007a). Also, the canonical SecA is thought to interact with the accessory SecA2 
pathway (Zhou et al., 2011). The gap3 (orf3) gene of the locus upstream form fap1 plays a role 
in the glycosylation of Fap1 by linking this to the secretion of the protein. Gap3 is therefore 
of importance for fimbrial assembly, adhesion and in vitro biofilm formation (Peng et al., 
2008a; Peng et al., 2008b). Gap1 also plays a role in the biogenesis of Fap1 and mediates 
glycosylation. To do this, the protein requires a conserved C-terminal 13 amino acid motif 
(Zhou et al., 2008). Taken together, Gap1 and Gap3 are accessory proteins interacting with 
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SecA2 and mediating Fap1 biogenesis in this manner (SecA2-Gap1-Gap3 complex) (Zhou et 
al., 2011) (Fig.2.4C.). 
The Gtf1 GT catalyzes the first step in Fap1 glycosylation and adds GlcNAc (Bu et al., 2008; 
Wu et al., 2007a; Zhou et al., 2008). Gtf1 interacts via its N-terminal domain (DUF1975) with 
Gtf2 and the formation of this heterodimer complex was proven to be required for optimal 
GlcNAc transferase activity (Bu et al., 2008; Wu & Wu, 2011; Wu et al., 2010) (Fig.2.4C.). 
Gtf2 acts thus as a molecular chaperone via the stabilization, subcellular localization and 
modulation of the activity of Gtf1 (Wu & Wu, 2011). 
The second step in Fap1 glycosylation is carried out by the product of the nss gene, which was 
renamed to Gtf3 (Zhou et al., 2010) (Fig.2.4C.). This Gtf3 forms a new subfamily of GTs and 
only shares homology to other Streptococcus sp. harboring similar glycosylated serine-rich 
proteins (Zhu et al., 2011). 
The here-described system will be discussed further in the section on O-glycosylation of 
proteins in bacteria, as the association of a high molecular weight serine-rich repeat adhesion 
with an accessory SecA2 locus and GTs is highly conserved in Streptococcal and Staphylococcal 
species (Zhou & Wu, 2009). 
In Streptococcus salivarius sp. K+ and K- strains can be distinguished, the former having long 
fibrils, the latter fimbriae. Antigen B and C, present on the fibrils of K+ cells are glycoproteins 
(Weerkamp et al., 1986) and the fimbriae of K- strains are assembled from glycoproteins that 
form a filamentous structure resistant to dissociation (Levesque et al., 2001). 
2.4.5 DeDicateD o-gLycosyLation of otHer proteins
The inability to glycosylate proteins of the most studied E. coli strains is widely recognized. E. 
coli is therefore extensively used as a vehicle for the heterologous expression of glycosylation 
systems to confirm their ability to produce glycosylated proteins and in glycoengineering. 
Nevertheless, some glycoproteins were reported in some, mainly pathogenic, E. coli strains. 
Already in 1968, an envelope specific glycoprotein was identified in E. coli strain B (Okuda & 
Weinbaum, 1968), followed in 1975 by the publication of the glycosylation of the conjugative 
F pili (Tomoeda et al., 1975). The EDP208 and ColB2 F pili of E. coli K12 were later further 
investigated, the former were found to be unglycosylated and the glycosylation status of the 
latter is still uncertain (Armstrong et al., 1981). Strikingly, these early reports of E. coli 
glycoproteins were not investigated further. In 2003, a Gp45 membrane glycoprotein was 
identified in E. coli PCRO 1687 containing mannose, glucose, galactose and GalNAc residues 
(Kumar et al., 2003). 
Better characterized are the self-associating autotransporters of E. coli, which are glycoproteins. 
Three autotransporters were identified in different strains: AIDA-I (Adhesin Involved 
in Diffuse Adhesion), TibA and Ag43. All are important virulence factors modified with 
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heptose residues that are added by a single heptosyltransferase. These GTs are believed to be 
functionally interchangeable between strains as they have similar specificities (Charbonneau 
et al., 2007; Moormann et al., 2002; Sherlock et al., 2006).
In the enterotoxigenic E. coli (ETEC) strain H10407, a glycosylated TibA outer membrane 
protein was identified (Elsinghorst & Weitz, 1994; Lindenthal & Elsinghorst, 1999). Immediately 
upstream of the tibA gene, a tibC gene was identified, coding for a heptosyltransferase 
(Lindenthal & Elsinghorst, 1999). The TibA protein is decorated with single, surface exposed 
heptose residues, which is of importance for the binding of ETEC H10407 to HCT8 cells, a 
human ileocecal epithelial cell line in a specific and saturable manner. This suggests that TibA 
is an important factor in ETEC pathogenesis, involved in adhesion and invasion (Lindenthal 
& Elsinghorst, 2001). TibC homologues were found in several ETEC strains, but not in all 
(Moormann et al., 2002). In the same ETEC H10407 strain, an adhesin important for binding 
to intestinal epithelial cells, EtpA was also found to be glycosylated by an adjacent enzyme 
(EtpC). Both genes, together with an etpB gene encoding a transporter, are part of the same 
locus (Fleckenstein et al., 2006). 
The AIDA-I adhesin was identified in the diarrhoeagenic E. coli 2787 clinical isolate and its 
glycosylation was found to be essential for the adhesion to human intestinal cells (Benz & 
Schmidt, 2001). The main role of AIDA-I glycosylation is thought to lie in the stabilization of 
the protein at the cell surface, offering protection against the action of the numerous proteases 
present in the gut (Charbonneau et al., 2007). Like in TibA glycosylation, the heptoses are 
added to AIDA-I by a heptosyltransferase, Aah (encoded by aidA), immediately upstream 
from the AIDA-I gene. AIDA-I is modified with up to 19 heptose residues, which come from 
ADP-glycero-manno-heptose precursors from the LPS pathway of E. coli (Benz & Schmidt, 
2001). Glycosylation was found to occur at the extracellular domain, which is a β-helix and 
harbors imperfect repeats of 19 amino acids. Further investigation of Aah specificity, indicates 
that this enzyme rather recognizes a structural motif of β-helices, than a specific sequence 
(Charbonneau et al., 2012). Deletion of Aah resulted in a loss of adhesion, but retention of the 
biofilm formation and autoaggregation capacity. 
The functional relation between TibC and Aah was further investigated, and indeed recombinant 
TibC can substitute for AIDA-I glycosylation (Moormann et al., 2002). Furthermore, AIDA-I 
specific antibodies can also recognize TibA. This strong homology suggests that Aah and 
TibC are members of a novel class of heptosyltransferases, which transfer heptose residues to 
multiple sites on the protein backbone (Moormann et al., 2002). 
A third autotransporter is the Ag43 protein, which is widespread in entero- and uropathogenic 
E. coli strains, like UTI536. Ag43 is also modified with heptoses (18 glycosylation sites 
could be identified), but in contrast to TibC and Aah, no specific GT could be identified 
upstream from the flu gene (Knudsen et al., 2008; Sherlock et al., 2006). The homology with 
TibA and AIDA-I is high, as Aah and TibC can glycosylate Ag43. Glycosylation was found 
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to be important for the affinity of Ag43 for human cells (Sherlock et al., 2006). The glycans 
also increased the stability of Ag43 against chemical and thermal denaturation and increase 
refolding kinetics (Knudsen et al., 2008). 
Several researchers report on the occurrence of glycoproteins in the periodontal pathogen 
Porphyromonas gingivalis. In the W50 strain, two proteases, RgpA and RgpB, are glycosylated 
(Curtis et al., 1999). These proteases are called Arg-gingipains and are extracellular cysteine 
proteases, degrading molecules like collagen, fibrin and fibronectin. RgpA occurs in three 
different forms: the heterodimer HRgpA containing an α-catalytic and β-adhesin domain, 
monomeric RgpA and membrane type mt-RgpA, both harboring only the α-catalytic domain. 
2% of the molecular weight of the heterodimer could be attributed to glycosylation, whilst this 
is 14% in monomeric RgpA and even 30% in mt-RgpA. These percentages are similar for the 
monomeric RgpB, which can occur in a monomeric soluble form or as membrane-associated 
RgpB (Curtis et al., 1999; Rangarajan et al., 2005). The glycan is linked to the catalytic 
domain and cross-reacts with antibodies directed against Porphyromonas LPS. This indicated 
that there are similarities between the glycans present on the Rgp proteins and LPS structures 
(Slaney et al., 2002). Later, a similarity with special anionic cell surface polysaccharides 
(APS) was also reported (Paramonov et al., 2005). In sera of adult patients the glycans of 
RgpA are recognized as being immunogenic, while deglycosylation of the proteins abolishes 
this recognition (Slaney et al., 2002). Glycosylation of the proteins also seems to modulate 
their stability, as the less glycosylated HRgpA has a lower half time compared to RgpA 
(Curtis et al., 1999). Aberrant glycosylation had also dramatic effects on the stability of RgpA 
(Rangarajan et al., 2005). RgpB was found to have an effect on monomeric RgpA maturation 
(Aduse-Opoku et al., 1998). This is thought to occur via the activation of the glycosylating 
enzyme or via the induction of oligosaccharide extension (oligosaccharides of RgpA are 
consist of 7 to 35 sugar monomers) (Rangarajan et al., 2005). The secretion, processing, 
anchorage and/or activity of the gingipains are modulated by the activity of the vimA and vimE 
gene products, in which VimE is needed to establish proper glycan biogenesis, but is not a GT 
(Vanterpool et al., 2005b). Downstream of vimE, a vimF gene encodes a putative GT, which 
alters the glycosylation, anchorage and activity of the gingipains (Vanterpool et al., 2005a). 
The details of this mechanism remain to be studied further. 
Another glycoprotein reported in P. gingivalis is the highly conserved outer membrane protein 
OMP85 of which the glycosylation was shown to influence biofilm formation (Nakao et al., 
2008). The minor fimbriae of 67 kDa (encoded by the mfa1 gene) were also shown to be 
glycosylated and target DC-SIGN (Zeituni et al., 2010). Via this binding, P. gingivalis can 
bind and invade DCs and elicits an immunosuppressive response. A last reported glycoprotein 
is the hemin binding protein 35, HBP35 (40 kDa), an outer membrane protein involved in 
haem utilization. Like the arginine gingipains, this HbP35 is secreted by the Por secretion 
system (Shoji et al., 2011).  
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Aggregatibacter actinomycetemcomitans serotype b strain VT1169, an oropharyngeal pathogen 
glycosylates a nonfimbrial extracellular matrix adhesion, EmaA. This protein trimerizes to 
form antenna-like structures that can bind collagen. EmaA is modified with the O PS moiety 
of LPS containing fucose, rhamnose and GalNAc (Tang & Mintz, 2010; Tang et al., 2007). 
Strikingly, the O PS is attached in the periplasm to the protein via the activity of the O Antigen 
ligase WaaL (Tang & Mintz, 2010; Tang et al., 2012). The glycan was proven to be crucial 
for collagen binding and the protection of EmaA against proteolytic degradation (Tang et 
al., 2012). Earlier, the potential glycosylation of the Flp fimbriae was reported (Inoue et al., 
2000). 
Two O-glycoproteins were reported in the bacterium causing ehrlichiosis, Ehrlichia chaffeensis: 
P120 and P156 (McBride et al., 2003; McBride et al., 2000). P120 is an immunodominant and 
surface exposed protein modified with glucose, galactose and xylose residues, attached to its 
Serine rich tandem repeat units (McBride et al., 2000). 
Similar to the earlier described Fap1 glycosylation in Streptococcus parasanguinis, other 
Streptococcus sp. and Staphylococcus sp. O-glycosylate their major serine rich repeat adhesin 
via accessory GTs and secretion also occurs via an accessory SecA2 system (Zhou & Wu, 
2009). 
Streptococcus gordonii M99 glycosylates GspB (280 kDa), a serine rich repeat protein 
(SRR1 and SRR2) important for the adhesion to human platelets (Bensing & Sullam, 2002). 
Glycosylation occurs prior to export and 70 to 100 monosaccharides are added, probably 
sequentially, to several sites on a GspB protein (10% of its MW), of which Glc and GlcNAc 
residues are the most predominantly (Bensing et al., 2004a). Similarly to Fap1 (Fig.2.4C.), 
a SecY2A2 locus can be found in the adjacent to the gspB gene, comprising accessory 
proteins (Asp1-5), SecY2, SecA2, genes involved in GspB glycosylation (gtf, orf4, gly, nss) 
(Takamatsu et al., 2004a; Takamatsu et al., 2004b). The large glycoprotein is transported by 
the SecA2-SecY2 accessory system (Bensing & Sullam, 2002). Unglycosylated GspB can also 
be transported by the canonical Sec system (Bensing et al., 2005). Feltcher and Braunstein 
recently reviewed the accessory SecA2 system (Feltcher & Braunstein, 2012).
The accessory proteins are involved in the mediation of GspB secretion (Takamatsu et al., 
2004b). Asp2 and 3 bind the serine rich repeats of GspB and are chaperones of the early 
phases of GspB transport (prior to full glycosylation) (Yen et al., 2011). Findings suggest 
that Asp2 is a bifunctional protein, which modulates, next to the transport, also the deposition 
of GlcNAc on the serine-rich repeats of GspB (Seepersaud et al., 2012). Asp4 and Asp5 are 
functional homologues of the canonical SecA pathway proteins SecE and SecG (Takamatsu 
et al., 2005b). Gtf and the protein encoded by orf4 are required for the glycosylation and 
translation or stability of GspB and were renamed respectively to GtfA and GtfB (Takamatsu et 
al., 2004a). These are homologous to the Gtf1 and Gtf2 initiating enzymes of S. parasanguinis 
and are most probably performing the same role in GspB glycosylation (Takamatsu et al., 
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2004a; Wu & Wu, 2011). Gly adds the terminal sugars to GspB and its N-terminal domain 
shares homology to known GTs. Nss is thought to be involved in the biosynthesis of UDP-
sugar precursors (Takamatsu et al., 2004a; Takamatsu et al., 2004b).
The DL1 strain of S. gordonii also expresses a serine-rich sialic acid binding adhesin (like 
GspB), termed Hsa (Bensing et al., 2004b; Takahashi et al., 2004). Both Hsa and GspB bind 
sialic moieties on the platelet membrane protein Ibα, the low molecular weight mucin MG2 
and agglutinin present in saliva (Takamatsu et al., 2005a), showing that glycoproteins can also 
have lectin activity themselves. 
In S. sanguis, adhesion to platelets is also mediated by a serine-rich protein, SrpA, homologous 
to Hsa and GspB from S. gordonii (Plummer et al., 2005). Other reported glycoproteins in 
this S. sanguis strain include a fibrillar glycoprotein in strain 12 (Morris et al., 1987) and 
a Platelet Aggregation-Associated Protein (PAAP), which is thought to be N-glycosylated 
with rhamnose residues (Erickson & Herzberg, 1993). This would be the first example of 
N-glycosylation in Gram-positive species, although more experiments are needed to confirm 
the N-glycosylation status of this protein.
A homologue of the Gtf1-Gtf2 system of S. parasanguinis and S. gordonii is also present in S. 
pneumoniae and glycosylates the Pneumococcal serine-rich repeat protein, PsrP (Shivshankar 
et al., 2009; Wu et al., 2010). This protein also has serine-rich repeat domains and is 
accompanied by the typical SecY2A2 locus (Shivshankar et al., 2009).
A last well-studied example of a serine-rich glycosylated adhesin and its accessory locus 
can be found in S. agalactiae NEM316 (i.e. Group B Streptococcus, GBS), where the Srr1 is 
glycosylated with GlcNAc and sialic acid residues prior to transport (Mistou et al., 2009). GtfA 
and/or GtfB are essential for the production of glycosylated Srr1, whilst the other accessory 
GTs are thought to play a role in the adaptation of GBS in vivo (Mistou et al., 2009). 
The described conserved mechanism of the glycosylation and transport of serine-rich repeat 
adhesins is also conserved in Staphylococcus aureus strains. In S. aureus ISP479C the SraP 
platelet binding virulence factor is glycosylated (Siboo et al., 2005). An accessory SecA2 
locus can be found, but Asp4, Asp5, Gly and Nss are missing. SecY2, SecA2 and Asp1-3 are 
involved in the surface expression of SraP and the GTs GtfA and B modulate its glycosylation 
(Siboo et al., 2008). Of 21 investigated isolates by Siboo and co-workers, 85% were shown to 
express SraP (Siboo et al., 2005). 
The 60kDa immunodominant glycoprotein IDG-60 of S. mutans is modified with sialic acid, 
Man, Gal and GalNAc residues. This glycoprotein is essential for the maintenance of the cell 
wall integrity and cell shape, and thus for bacterial survival in stress conditions (Chia et al., 
2001).
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Streptococcus faecium ATCC 9790 expresses a glycoenzyme that has autolytic 
N-acetylmuramoylhydrolase activity and is decorated with O-linked mono- and oligomers of 
glucose (Kawamura & Shockman, 1983). Also in L. rhamnosus GG, Lactobacillus plantarum 
WCFS1 and Lactococcus lactis MG1363, the glycosylation of a PG hydrolase was reported 
(Fredriksen et al., 2012; Huard et al., 2003; Lebeer et al., 2012b). In L. buchneri strains 
CD034 and NRRL, the glucosylation of putative glycosylhydrolases was reported recently 
(resp. LbGH25B and LbGH25N) (Anzengruber et al., 2013). 
The Msp1 (p75) protein of L. rhamnosus GG is O-glycosylated with ConA-reactive sugars 
(Lebeer et al., 2012b). Its glycosylation was shown to have an impact on the stability of 
this PG hydrolase and protect against proteases. However, glycosylation was not essential 
for the PG hydrolyzing activity and Akt signaling capacity of Msp1 (Lebeer et al., 2012b). 
Acm2, the major autolysin of L. plantarum WCFS-1, is intracellularly glycosylated on its 
N-terminal AST domain, a domain that is rich in A, S and T residues (Fredriksen et al., 2012). 
Glycosylation was recently shown to be an autoregulating factor of the enzyme and have a 
negative impact on its N-acetylglucosaminidase activity. 21 mono GlcNAc substitutions were 
found in the AST domain of Acm2, which help to stabilize the enzyme against proteases 
(Fredriksen et al., 2012; Rolain et al., 2013). A broader screening of the glycoproteome of 
L. plantarum WCFS1 revealed 10 novel glycoproteins: 5 that have an intracellular nature, 2 
extracellular PG hydrolases and one mucus-biding protein. Most glycoproteins are modified 
with 1 HexNAc residue, but in some cases hexose moieties were detected (Fredriksen et al., 
2013). Based on the homology with the Gtf1 GT of Fap1 of S. parasanguinis (cf. earlier), the 
GtfA and GtfB GTs responsible for the O-glycosylation of Acm2 were recently elucidated 
(Lee et al., 2014). Taken together, these findings might point towards a general mechanism of 
glycosylation in this species, but this remains to be further substantiated. 
2.4.6   generaL o-gLycosyLation systems
A few bacterial species contain a glycosylation system that targets a diverse set of proteins, 
often also pili and adhesins. In such ‘general systems’, the genes encoding the proteins 
substrates are not clustered with the genes encoding the GTs and transport functions, in 
contrast to dedicated glycosylation systems. 
2.4.6.1   generaL o-gLycosyLation of neisseriaL proteins
The best-studied general O-glycosylation mechanisms are found in Neisseria gonorrhoeae or 
gonococcus and in N. meningitidis, also known as meningococcus (Fig.2.4D.). Both species 
are important Gram-negative human pathogens, the former causing gonnorhea, the latter 
meningitis. 
Already in 1977, the first report on gonococcal pili glycosylation (strain P9) was published 
(Robertson et al., 1977). Dedicated research on the glycosylation of meningo- and gonococcal 
pili only emerged in the early 1990s (Jennings et al., 1998; Marceau et al., 1998; Marceau & 
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Nassif, 1999; Stimson et al., 1995; Virji, 1997; Virji et al., 1996) and has remained a hot topic 
in bacterial glycosylation with the discovery of the general character of the glycosylation 
machinery in 2009 (Vik et al., 2009). 
N. gonorrhoeae strain MS II cells are covered with type IV pili and the S63 residue of this pilin 
subunit (PilE) is modified with a covalently bound O-linked GlcNAc-α(1-3)Gal dimer (Parge 
et al., 1995). The formation of the glycosidic bond between Gal and GlcNAc is catalyzed 
by a pilin galactosyltransferase, PgtA. In more than half of clinical N. gonorrhoeae isolates 
tested by Banerjee and co-workers (40 out of 70), this gene contains a poly G-tract, which 
renders PgtA prone to phase variation (Banerjee et al., 2002). Remarkably, the poly G-tract 
is present in all clinical isolates of patients with disseminated gonococcal infection (24 out of 
24 isolates tested). The phase variation of PgtA is thought to be involved in the conversion 
of uncomplicated gonorrhea to a disseminated gonococcal infection, suggesting a clear link 
between PgtA and the glycosylated pili of N. gonorrhoeae as virulence factors (Banerjee 
et al., 2002). The phase variation of gonococcal pili glycosylation appears to enhance the 
immune evasion properties of the pilin glycans and thus the survival of N. gonorrhoeae in 
human blood (Ghosh et al., 2004; Parge et al., 1995). 
In another N. gonorrhoeae strain, i.e. N400, pilin is glycosylated on S63 with a hexose linked 
to a proximal 2,4-diacetamido-2,4,6-trideoxyhexose (HexDATDH) (Hegge et al., 2004), 
with DATDH being diNAcBac (di-N-acylated-bacillosamine) (Hartley et al., 2011). Other 
glycoforms like DATDH, HexHexDATDH and O-acylated forms of the DATDH linked to 
hexoses are also found, which rounds up to a total of five different glycoforms in this N400 
strain. The glycan is transferred en bloc to its substrate after assemblage on a lipid carrier 
(Aas et al., 2007) (Fig.2.4D.). Glycan biosynthesis is distantly related to the N-glycosylation 
pathway of C. jejuni (Hartley et al., 2011). DATDH is the product of the priming GT, PglB, 
a bifunctional acetyltransferase and phosphoglycosyltransferase, mainly characterized in 
N. meningitidis strains (Power et al., 2000). PlgB is in some strains and isolates replaced 
by PglB2, resulting in GATDH (2-acetamido-4-glyceramido-2,4,6-trideoxyhexose) sugar 
moieties (Kahler et al., 2001). PglC was identified as a transaminase, PglD as a dehydratase, 
PlgF as a flippase and PgtA was renamed to PglA. PglA is a GT that transfers the hexose 
moiety, i.e. galactose to DATDH. PglE is a GT involved in the transfer of the second hexose 
residue to HexDATDH. Both PglA and PglE are prone to phase variation, which results in 
the mono-, di- and trisaccharide glycoforms. Moreover PglE shows promiscuity towards Hex 
and HexNAc residues. The OST PglO shows a relaxed specificity towards mono-, di- and 
trisaccharides and mutation of this enzyme has been shown to result in the absence of glycan 
modifications (Aas et al., 2007). The glycan can be O-acetylated by the activity of the PglI 
acyltransferase enzyme, which uses AcetylCoA as a donor (Aas et al., 2007). Of interest, 
many N. gonorrhoeae and meningitidis strains were found to harbor another GT, PglH, which 
has a similar function to PglA. As this would result in a metabolic conflict with PglA, a 
conserved deletion inactivates PglH in most strains. This results in reduced glycan diversity 
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as the action of PglH results in unique disaccharide products modified with glucose residues 
instead of galactose (Borud et al., 2011; Johannessen et al., 2012). Taken together, PglD, 
C and B synthesize the UDP-sugars and PglB, A, E and H form the core locus of glycan 
assembly, whilst the PglO OST transfers the finished glycan en bloc to the substrate (Borud et 
al., 2011; Hartley et al., 2011) (Fig.2.4D.). 
N. gonorrhoeae strains can thus modulate their glycan diversity to enhance their virulence by 
the expression of a range of glycoforms resulting from their ability to express mono-, di- and 
trisaccharides, use both GATDH (PglB2) and DATDH (PglB), potentially acetylate (PglI) the 
sugars and the exploitation of PlgH and the phase variability of PglA and PglE (Hartley et al., 
2011). 
In 2009, the en bloc glycosylation mechanism of gonococcol pilins was shown to be a general 
system targeting -in addition to pili- also several membrane associated proteins (Vik et al., 
2009). 11 glycoproteins were identified, sharing a S-A-P-A motif that was not sufficient, nor 
necessary for glycosylation. The glycoproteins include the disulfide oxidoreductase DsbA, 
various proteins involved in electron transport systems and redox components and proteins 
involved in solute uptake. These findings implicate the promiscuous character of PglO having 
various substrates (Vik et al., 2009). In 2012, another six new glycoproteins were reported, 
with PilQ, a secretin critical for the ability of pili to reach the cell surface, as most important 
example (Anonsen et al., 2012b; Collins et al., 2001). 
The PilE pilin was not only shown to be glycosylated, but it is also modified with phosphocholine 
and phophoetanolamine residues on Ser 68 (Hegge et al., 2004). The clustering of both 
modifications on pilin peptides results in a dynamic interplay, and even a direct substrate 
competition between phosphoform modifications and O-linked glycans (Anonsen et al., 
2012a). 
Functionally, the glycan chain length modulates differential effects on gonococcal growth, 
while glycoform variation affects the intrinsic processes of pilus dynamics and interactions 
between subunits (Vik et al., 2012). Also the glycosylation of pilin has been linked to 
the activation of Complement Receptor 3 (CR3) of primary cervical epithelial cells by N. 
gonorrhoeae 1291 (Jennings et al., 2011) and adhesion of N. gonorrhoeae F62 (Gubish et al., 
1982). Neisseria strains typically also produce truncated soluble pilins, so-called S-pilins, of 
unknown function (Marceau & Nassif, 1999). These S-pilins were found to be more abundant 
in gonococcal strains and glycosylation of the Ser 63 residue further increased, but was not 
necessary for, the S-pilin production. These findings are in contrast to these in N. meningitidis, 
where glycosylation of Ser 63 is crucial for the production of S-pilins. S-pilin production is 
thus divergent in both species (Marceau & Nassif, 1999). 
The general O-glycosylation mechanism of N. meningitidis is also well studied and similar 
to the one in N. gonorrhoeae. In 2009, Ku and co-workers could demonstrate that the pilin 
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glycosylation mechanism of N. meningitidis is also a general system (Fig.2.4D.), with the 
discovery of the C-terminal glycosylation of the nitrite reductase, AniA, in the C311 strain 
(Ku et al., 2009). 
Pilin glycosylation in N. meningitidis was first noted by the discrepancy in molecular weight of 
the pilins of N. meningitidis strains C311 and MC58 (Virji et al., 1993). Further investigation 
of the PilE pilin of the C311 strain revealed an O-linked trisaccharide consisting of a terminal 
β(1-4)-linked diGal covalently linked in an α(1-3) manner to a DATDH sugar which is directly 
attached to the pilin (Stimson et al., 1995; Virji et al., 1996), likely on the S63 residue (Marceau 
et al., 1998). Class I N. meningitidis strains show O-glycosylation of S63 with the Gal α(1-3)
GlcNAc disaccharide and are highly similar to some gonococcal glycosylated pili (Marceau 
et al., 1998; Marceau & Nassif, 1999). Pili glycosylation is variable between meningococcal 
strains and isolates, but most have covalently linked galactose residues modifying their pili 
(Virji et al., 1999). 
In N. meningitidis strain MC58, PglA was identified as the pilin specific galactosyltransferase 
responsible for the formation of the α(1-3) linkage between galactose and DATDH (Jennings 
et al., 1998). PglA also shows substrate flexibility towards both Gal α(1-3) DATDH (C311 
N. meningitidis strain) and GalGlcNAc (N. gonorrhoeae and e.g. 8013SB N. meningitidis 
strain) (Warren et al., 2004). Mutation of PglA had no effect on pilus-mediated adhesion to 
human epithelial and endothelial cells. This enzyme has a homopolymeric G tract and is thus 
phase variable (Jennings et al., 1998). PglA of N. gonorrhoeae and N. meningitidis catalyze 
similar linkages using distinct substrates and are highly homologous (96% sequence identity). 
The N. gonorrhoeae enzyme can be constitutively expressed or show phase variability in 
some cases, the meningococcal enzyme in contrast is always phase variable (Banerjee et al., 
2002). As mentioned earlier, also N. meningitidis strains can express PglH, a GT of which the 
activity results in unique glycans, but which is inactive in most strains (Borud et al., 2011; 
Johannessen et al., 2012). 
PglE was identified in the C311 strain as a galactosyltransferase, catalyzing the transfer of the 
terminal galactose. The gene encoding this enzyme has up to 24 copies of a heptant repeat, 
which results in a phase variation between di- and trisaccharide structures. The number of 
heptant repeats varies between different strains (Power et al., 2003). 
Also in C311, the clustered PglB, C and D enzymes were identified as being involved in the 
biosynthesis of DATDH, with PglB being the GT that transfers the sugar from the activated 
nucleotide directly to the lipid carrier. PglB was found to be bifunctional as it also acetylates 
the C2 or C4 of the diacetamido sugar. The PglC aminotransferase transaminates C2 or C4 
and PglD is a dehydratase acting on C2, C4 or C6 (Power et al., 2000). PglB, C, D and A 
are present in all Neisseria species, which suggests a common pili glycosylation mechanism 
(Jennings et al., 1998; Power et al., 2000). PglI was also found to play a role in DATDH 
biosynthesis and shows homology to acetylases (Warren et al., 2004).  
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After assembly of the glycan on the lipid carrier, the UndP-linked trisaccharide intermediate 
is transferred by the PglF flippase to a position where the glycan can be transferred to the 
pilin subunit prior to pilin polymerization (Kahler et al., 2001; Power et al., 2006). More in 
particular, the pyrophosphate linker between the glycan and the carrier needs to be adjacent to 
the OST (Faridmoayer et al., 2008). The PglF enzyme is similar to the WaaL enzyme involved 
in E. coli O antigen biosynthesis (Power et al., 2006). The involvement of a lipid-linked 
oligosaccharide intermediate in the glycosylation process was confirmed by mutants having 
a blockage in the pilin glycosylation pathway: these mutations also interfered with capsular 
transport and assembly (Kahler et al., 2001). 
After translocation of the lipid-linked oligosaccharide in the periplasm, the PglL OST transfers 
the glycan to the substrate (Fig.2.4D.). Expression of PglL, pilin and diverse UndP-linked 
glycans of the MC58 strain in E. coli resulted in glycosylated pilins, which proved the relaxed 
specificity of PglL and its capability to transfer diverse oligo- and polysaccharides. The only 
requirement seems to be the translocation of the saccharides into the periplasm (Faridmoayer 
et al., 2007). PglL shows 95% identity to the gonococcoal OST PglL (Faridmoayer et al., 
2007) and is also similar to the O antigen ligase of E. coli (Power et al., 2006). As mentioned 
earlier, these O-OSTs represent a novel family of which the members share a homologous 
domain of 30 amino acids, which is also present in the WaaL LPS enzyme (Faridmoayer et 
al., 2007). 
The promiscuity of PglL was further tested and resulted in the finding that PglL can transfer 
virtually any glycan from an UndP carrier to pilin both in E. coli and Salmonella (Faridmoayer 
et al., 2008). PglL could even interfere with peptidoglycan biosynthesis (Faridmoayer et al., 
2008). It was thought that the substrate specificity of PglL primarily lies in the lipid carrier. 
More in particular PglL recognizes the C1 and O1 of the monosaccharide at the reducing end 
of the glycan, the pyrophosphate linker and the first few carbon atoms of the lipid carrier 
(Faridmoayer et al., 2008). Later studies showed that the catalytic efficiency of PglL is linked 
to the length and conformation of the acyl chain of the glycan donor. PglL can even act as 
a Leloir enzyme and transfer sugar moieties directly from activated nucleotide donors. This 
means that the lipid carriers influence glycosylation, but are not essential for the PglL function 
(Musumeci et al., 2013). Taken together, this proves the extreme promiscuity of PglL, which 
opens new avenues in glycoengineering.
Nearly half of the clinical isolates have an insertion in the pglBCD operon, more particular in 
pglB, which results in a different glycosylation of the pili (Power et al., 2003). This insertion 
results in a different form of PglB, called PglB2, which encodes a glyceramidotransferase 
(Chamot-Rooke et al., 2007). PglB2 has a functional distinct C-terminal, resulting in a different 
modification of the acetamido sugar (Kahler et al., 2001). The net result is a GATDH sugar 
instead of DATDH (Chamot-Rooke et al., 2007). Moreover, PglB2 can be expressed by two 
different alleles, which results in extra glycan diversity (Viburiene et al., 2013).
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Like in N. gonorrhoeae, the glycosylation of pilin is susceptible to variation, both by the gene 
complement expressed by strains and by the phase variability of the genes present (Power et 
al., 2003). For example, PglE and F are present in all strains studied, in contrast to PglG, H 
and B2, which are not present in C311, but are expressed in a large number of clinical isolates. 
Moreover PglG, H and B2 are potentially phase variable (Johannessen et al., 2012; Power et 
al., 2003; Viburiene et al., 2013). Together with the extreme promiscuity of the PglL OST, 
this results in an enormous glycan repertoire, which infers an evolutionary advantage to N. 
meningitidis (Borud et al., 2010; Faridmoayer et al., 2008). In analogy to N. gonorrhoeae, it 
was hypothesized that this glycan modification serves as a cloak for host immune responses 
(Faridmoayer et al., 2008; Hamadeh et al., 1995; Marceau et al., 1998). This is illustrated by 
the binding of anti-Gal antibodies to the pilin of N. meningitidis, which results in the blockage 
of complement-mediated lysis of the cells (Hamadeh et al., 1995). The diversification of the 
glycans present in N. meningitidis challenges the selection by the innate and adaptive immune 
system of the host (Borud et al., 2010). The pili of N. meningitidis are structurally variable 
and involved in adhesion processes (Virji, 1997; Virji et al., 1993). Nevertheless, glycan 
modification of the pili appears to play no major role in piliation and adhesion, but facilitates 
the solubility of pilin monomers (Marceau et al., 1998; Power et al., 2003). 
2.4.6.2   General protein O-glycosylation in Bacteroidetes
Another important example of general O-glycosylation of proteins in bacteria can be found in 
the order of the Bacteroidales, where these systems were found across the whole Bacteroidetes 
phylum (Coyne et al., 2013), Flavobacterium meningosepticum (Plummer et al., 1995) and 
Tannerella forsythia (Posch et al., 2011).
B. fragilis is a common inhabitant of the human colon (10-20% of the colon microbiota) 
and uses a mammalian-like pathway to decorate numerous surface capsular polysaccharides 
and glycoproteins with L-fucose (Coyne et al., 2005; Fletcher et al., 2009). Fucose is an 
abundant surface modification of intestinal epithelial cells and the coordinated expression of 
similar surface molecules by the colonic symbiont and its host, i.e. molecular mimicry, result 
in a competitive colonization advantage for the B. fragilis symbiont (Coyne et al., 2005). 
It was found that microorganisms, and B. fragilis in particular, even stimulate the terminal 
fucosylation of glycoproteins and –lipids of intestinal epithelial cells (Bry et al., 1996). B. 
fragilis strain 9343 can cleave these L-fucose residues to internalize them and use as an energy 
source. More strikingly this strain can convert these exogenously acquired sugars to GDP-L-
fucose to incorporate in its own surface capsular polysaccharide structures and glycoproteins 
(Coyne et al., 2005).   
In 2009, a general O-glycosylation system in B. fragilis 9343 was characterized, glycosylating 
proteins with roles in chaperone requiring processes (BF0994 and BF0447), protein-protein 
interactions (BF2334 and BF2494), peptide degradation (BF0935 and BF3918) and surface 
lipoproteins (BF0522 and BF3567). The eight identified glycoproteins were all present in 
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the periplasm or outer membrane and shared a common three residue motif, which was later 
identified as D-(S/T)-(M/I/A/L/T/V). The residues are thought to be involved both in catalysis 
of O-glycosylation and recognition (Fletcher et al., 2011; Fletcher et al., 2009). Engineering 
of this motif in naturally unglycosylated proteins resulted in site-specific glycosylation, which 
proves the glycoengineering potential of this strain (Fletcher et al., 2011). 
An in silico screening of the proteome of B. fragilis based on the presence of this glycosylation 
motif and the fact that a signal peptidase I or II cleavage site or transmembrane spanning 
domain should be present (periplasmic and outer membrane localization of eight earlier 
confirmed glycoproteins), predicted 1021 candidate glycoproteins. Twelve of these were 
confirmed experimentally and four of them were predicted to localize at the inner membrane. 
Remarkably, four of the confirmed glycoproteins have roles in cell division and chromosomal 
segregation (BF0066, BF0252, BF0289 and BF0586), of which two are encoded by essential 
genes (FtsI, BF0252 and FtsQ, BF0259) (Fletcher et al., 2011). This may point towards a 
role for protein glycosylation in divisome regulation, which is in accordance with predicted 
glycoproteins in L. rhamnosus GG and C. jejuni (Sanchez-Rodriguez et al., 2014). Later, the 
number of essential candidate glycoproteins was augmented to 43 (Coyne et al., 2013). 
The confirmation of the glycosylation status of all 12 extracytoplasmic potential glycoproteins 
carrying the glycosylation motif may implicate the presence of hundreds of extracytoplasmic 
glycoproteins, which would account for more than half of the total proteins present in the 
extracytoplasmic fraction, i.e. 365 out of 762 proteins (Fletcher et al., 2011).  
The glycan added to the proteins is an oligosaccharide of nine units, which contains a fucose 
and is attached via a hexose (e.g. mannose) to the protein substrate (Posch et al., 2013). 
Further investigation of the glycan revealed the presence of a core and outer glycan, which 
are independently built. The genetic region (lfg gene locus, see below) encoding proteins 
involved in the biosynthesis of the outer glycan is conserved within a species, but divergent 
between species, whilst the genetic region for the core glycan is more conserved among 
species (core glycan is absent in an gmD-fclΔfkp) (Coyne et al., 2013). The enzymes (GTs 
and Wzx flippase) responsible for the en bloc glycosylation of proteins are clustered in the 
lfg gene locus. Strikingly, albeit the high homology between O-OSTs, no OST could yet be 
uncovered (Fletcher et al., 2009). The transcription of this locus is linked to metG (encoding 
a methyionyl-tRNA synthetase) transcription, which links protein synthesis and glycosylation 
(Coyne et al., 2013). 
This general en bloc O-glycosylation system is central to the physiology of Bacteroides 
as a substantial amount of proteins in diverse locations and with a range of biochemical 
functions were found to be glycosylated. Moreover, no unglycoyslated forms of these proteins 
could be recovered. Glycosylation seems to be vital for protein synthesis and deletion of the 
glycosylation machinery was shown to result in a strain deficient in growth and unable to 
competitively colonize the GIT (Coyne et al., 2013; Fletcher et al., 2009). It is likely that this 
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machinery confers a competitive colonization advantage to these species (Coyne et al., 2005; 
Fletcher et al., 2011). Functionally, the glycosylation of proteins is thought to confer labels 
for binding and recognition and improve the stability, solubility and resistance of proteins 
against proteases (Fletcher et al., 2009). 
The glycosylation machinery is conserved among Bacteroides species (Fletcher et al., 2009) and 
even phylum-wide: the four diverse classes of Bacteroidetes also harbor the O-glycosylation 
machinery, i.e. Bacteroidia (B. fragilis), Flavobacteria (F. meningosepticum), Sphingobacteria 
and Cytophaga (T. forsythia) (Coyne et al., 2013; Plummer et al., 1995; Posch et al., 2013). 
This points towards the early emergence of the general O-glycosylation system in evolution, 
before the divergence of the four Bacteroidetes classes. It is believed that the mechanism 
is maintained in view of its physiological importance to the diverse species of the phylum 
(Coyne et al., 2013).
Both B. fragilis and T. forsythia use an identical glycosylation motif, which allows the 
heterologous expression of glycoproteins of one species in the other (Posch et al., 2013). T. 
forsythia is a periodontal pathogen covered with an S-layer built up by two glycoproteins that 
show no homology to other known S-layer (glyco)proteins: TfsA and TfsB (Lee et al., 2006). 
Later also other glycoproteins like the BspA surface antigen were discovered (Posch et al., 
2011; Veith et al., 2009). The oligosaccharide modifying the glycoproteins of T. forsythia 
contains mannose, L-fucose and Pse residues and is the result of genes encoded by an 6-8 
kb conserved locus (TF2049-TF2055) (Posch et al., 2011). The S-layer of T. forsythia was 
identified as an important virulence factor as this helps the pathogen to evade recognition by 
the innate immune system of the host (Sekot et al., 2011; Settem et al., 2013).  
The three amino acid glycosylation motif was also conserved in Flavobacterium 
meningosepticum, where several secreted proteins were found to be glycosylated at a D-S or 
D-T-T motif with a peculiar seven-residue oligosaccharide (Plummer et al., 1995; Reinhold 
et al., 1995).
2.4.6.3   FrancisELLa tuLarEnsis
F. tularensis is a pathogen causing tularemia, a severe potentially fatal zoonotic disease 
and is therefore classified as a potential bioterroristic agent. The bacteria expresses type IV 
pilin, PilA, which appears to be glycosylated based on aberrant migration on SDS-PAGE 
(Forslund et al., 2006). Expression of PilA in N. gonorrhoeae resulted in glycosylated pilins 
(Salomonsson et al., 2009). Later research confirmed pilin modification with a pentasaccharide 
consisting of hexoses and acylated hexoses. Glycoforms of the pentasaccharide were also 
found carrying unusual moieties linked to the distal sugar via a phosphate bridge (Egge-
Jacobsen et al., 2011). Apart from the pilin, other proteins linked to virulence were also found 
to be glycosylated. Balonova and co-workers used a combination of techniques (Periodic 
Acid Schiff base stain, lectin blots and lectin affinity chromatography) to identify 15 new 
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candidate glycoproteins, including proteins involved in cell division (FtsZ or FTSH_1830), a 
thioredoxin family protein DsbA (FTH_1071), OmpA family protein FTH_0323 and several 
chaperones (GroEL or FTH_1651 and DnaK or FTH_1167) (Balonova et al., 2010). Of note, 
many of these proteins were also identified by Janovska et al. (Janovska et al., 2007) as 
immunoreactive antigens in the live vaccine strain LVS of F. tularensis subsp. holarctica 
reacting with human tularemic sera. Interestingly, the glycosylated lipoproteins FTH_1071 
and FTH_0414 were also previously found to interact with TLR-2/TLR-1 heterodimers of 
HeLa cell lines, resulting in the induction of a proinflammatory response (Thakran et al., 
2008). Since interaction with these TLRs is generally mediated via acylation, glycosylation is 
thought to play a modulatory role, such as shown by Sieling et al. (Sieling et al., 2008). They 
demonstrated that glycosylation of the mycobacterial lipoglycoprotein LprG is required for 
the stimulation of innate immune responses via activation of MHC class II-restricted T-cells. 
The DsbA protein (FTH_1071), an essential virulence factor of Francisella, is modified 
with a hexasaccharide, which seems to be non-essential for the virulence in vivo in a murine 
model for tularemia (Thomas et al., 2011). Another important immunoreactive virulence 
factor encoded by FTH_0069 is glycosylated with the same hexasaccharide as DsbA and 
PilA. This oligosaccharide consists of two hexoses, 3 N-acetylhexosamines and an unknown 
monosaccharide containing a phosphate group (Balonova et al., 2012).   
A gene cluster (FTT0789-FTT0800) was identified in the FSC200 strain, which contains three 
GT homologues, a GalE homologue (FTT0791), a transporter and three hypothetical proteins 
(Thomas et al., 2011). This cluster plays a role in glycan biosynthesis and the FTT0791 and 
FTT0798 gene products are implicated in DsbA glycosylation, with FTT0791 being the GalE 
homologue and thus a putative UDP-Gal-4-epimerase (Thomas et al., 2011). 
The OST involved in the en bloc glycosylation of the protein substrates was also identified: 
PglA encoded by FTT0905 in FSC200. The expression of PglA is modulated by MglA, a 
virulence regulator, also required for pilus expression (Egge-Jacobsen et al., 2011; Zogaj et 
al., 2008). PglA is conserved in Francisella sp. and expression of PglA and PilA in E. coli 
proved to be sufficient for pilin glycosylation (Egge-Jacobsen et al., 2011). Homologues of 
PilA and PglA are found in all strains of the Francisella genus and the glycosylation machinery 
seems to be a general feature of these strains (Egge-Jacobsen et al., 2011). 
2.4.6.4   acinEtobactEr baumanii
Only very recently, a general O-linked protein glycosylation system was discovered in the 
‘superbug’ Acinetobacter baumanii, known as a causing agent of nosocomial infections. In 
A. baumanii ATCC 17978, seven glycoproteins were identified, including the OmpA protein 
A1S_1193, each modified with a branched pentasaccharide of GalNAc, Glc, Gal, GlcNAc and 
a triacetylated glucuronic acid (Iwashkiw et al., 2012b). 
52
th
e 
sw
ee
t t
oo
th
 o
f b
ac
te
ria
Strikingly, a common pathway synthesizes this pentasaccharide and the capsular 
polysaccharides. PglC (A1S_0061), the priming GT, initiates the production of the 
pentasaccharide via the transfer of a GlcNAc residue to the lipid carrier. Further assembly is 
carried out by four GTs encoded by A1S_0058, A1S_3482, A1S_0059 and A1S_0060. Once 
this oligosaccharide is finished, Wzx (A1S_0056) flips the structure to the periplasm. This 
pentasaccharide modifies glycoproteins and also serves as a building block for the capsular 
polysaccharides. The pathways diverge in the periplasm: glycoproteins are further processed 
by the PglL OST and capsular polysaccharides are polymerized by Wzy (A1S_3483) (Lees-
Miller et al., 2013). The PglL OST involved in the biosynthesis of the glycans is encoded by 
A1S_3176, and shows homology to the other O-OSTs (Iwashkiw et al., 2012b). Furthermore, 
the maximum glycan modification found on glycoproteins is a decasaccharide, suggesting the 
inability of PglL to access polymerized glycans and use these as a substrate (Lees-Miller et 
al., 2013). 
Abolishment of the glycosylation machinery in A. baumanii ATCC 17978 resulted in 
diminished biofilm formation, reduced virulence in two infection models (Dictyostelium 
discoideum and larvae of Galleria mellonella) and a reduced in vivo fitness in a mouse model 
of peritoneal sepsis (Iwashkiw et al., 2012b; Lees-Miller et al., 2013). Both glycoproteins 
and capsular polysaccharides are an important virulence factor of A. baumanii for infection of 
animal models. 
Despite the genome plasticity of A. baumanii strains, the O-glycosylation machinery is present 
in all clinical isolates and all sequenced genomes. This indicates a strong evolutionary pressure 
to maintain this feature (Iwashkiw et al., 2012b).
2.4.6.5   pecuLiar gLycoproteins in actinomycEtEs
A peculiar general O-glycosylation mechanism is found in Actinomycetes sp., of which M. 
tuberculosis, M. leprae and M. bovis are important human pathogens. These species decorate 
their proteins with mannose residues following an evolutionary conserved mechanism similar 
to eukaryotic O-mannosylation processes (VanderVen et al., 2005). The identification of 
glycoproteins in these actinomycetes was mainly based on their reaction with the ConA 
lectin, which specifically binds to mannose residues (Dobos et al., 1995; Espitia & Mancilla, 
1989; Garbe et al., 1993). Most of the identified glycoproteins are also acylated. Already 
in 1989, Espitia and co-workers identified a glycoprotein of 38 kDa and a doublet of 50-55 
kDa in Mycobacterium tuberculosis H37Rv (Espitia & Mancilla, 1989). The glycosylation 
of the doublet was later confirmed by digestion of the glycans with the α-mannosidase from 
jack bean (Espitia et al., 1995). The 38kDa glycoprotein is involved in a phosphate specific 
transport system and is better known as PstS1 or PhoS1 (Rv0934) (Herrmann et al., 2000; 
Torres et al., 2001).
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A 19 kDa major membrane lipoprotein, and known virulence factor, LpqH (Rv3763), was 
also found to be ConA-reactive (Garbe et al., 1993; Herrmann et al., 2000) and its glycan 
substitutions seem to regulate the cleavage of a proteolytically sensitive linker region 
(Herrmann et al., 1996). The glycan confers thus resistance to proteases to LpqH and doing 
so retains the protein on the cell. Cleavage of the linker by contrast results in a non-acylated 
secreted antigen (Herrmann et al., 1996). LpqH is a major adhesin and TLR-2 agonist and 
was found to bind to mannose receptors of THP-1 monocytes. Doing so, LpqH was shown 
to promote the phagocytosis of mycobacteria (Diaz-Silvestre et al., 2005). Another adhesin, 
HBHA, or the Heparin-binding hemagglutinin, is also glycosylated and the glycan residues are 
thought to protect the lysine-rich C-terminal of the protein against proteolytic attack (Menozzi 
et al., 1998). 
Apa (MPT32), encoded by Rv1860, is a ConA-reactive glycoprotein of 45 kDa rich in proline. 
4% of its molecular weight can be attributed to the presence of glycan moieties (Dobos et 
al., 1995). Further research showed the presence of 5 glycopeptides in which a T residue is 
modified with a mannose, α(1-2) linked mannobiose or α(1-2) linked mannotriose (Dobos et 
al., 1996). The most common glycoforms are modified with 6, 7 or 8 mannose residues, Apa 
proteins modified with 3, 4 or 5 mannoses are also found, but glycoforms harboring 0, 1, 2 or 
9 mannoses are seldom (Romain et al., 1999). 
Recombinant expression of Apa in M. smegmatis and a non-glycosylating E. coli host resulted 
in a decreased capacity to stimulate T-lymphocyte responses in Guinea pigs (Horn et al., 
1999). Moreover, deglycosylation of Apa generally decreased the capacity of the protein to 
elicit cellular immune responses in vivo and in vitro. Deglycosylated Apa is 10-fold less active 
in delayed type hypersensitivity reactions in immunized Guinea pigs and 30-fold less active 
in the stimulation of T-lymphocytes in vivo (Romain et al., 1999). These studies indicate 
mannose as an essential component of Apa as an antigen and in the modulation of T-cell 
dependent immune responses (Horn et al., 1999; Romain et al., 1999). Lara et al. showed 
that tuberculosis patients carry antibodies that mainly react against the carbohydrate part of 
Apa (Lara et al., 2004). M. tuberculosis targets the Pulmonary Surfactant Protein A (PSP-A) 
C-type lectin of the innate immune system mainly via its lipoglycans, but the Apa antigenic 
glycoprotein was also suggested to aid in the attachment to this receptor (Ragas et al., 2007). 
Most of the here-mentioned glycoproteins are T-cell antigens, but the SodC superoxide 
dismutase (Rv0432), a B-cell antigen, was also found to be glycosylated at six residues in its 
N-terminal. Strikingly, apart from glycans attached to threonine residues, also glycosylated 
serine residues were identified, which represents the first evidence of serine linked 
O-glycosylation in Mycobacterium sp. (Sartain & Belisle, 2009). 
In view of the evolutionary relatedness to O-mannosylation in yeast, mechanistic studies 
on O-protein glycosylation in M. tuberculosis were done and resulted in the identification 
of an O-mannosyltransferase encoded by Rv1002c, which initiates protein mannosylation 
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(VanderVen et al., 2005). This enzyme is a membrane protein and Sec translocation of the 
protein is required for its mannosylation, which also implicates the need for a lipid carrier for 
the glycan residues (VanderVen et al., 2005). The Rv1002c enzyme is crucial to the virulence 
of M. tuberculosis as mutation of the enzyme, and the subsequent loss of mannoproteins, 
severly impairs in vitro growth and attenuates the virulence of M. tuberculosis (Liu et al., 
2013). 
In the closely related strain M. bovis, a pathogen mainly targeting oxes, but also humans, some 
glycosylated antigens were identified (Fifis et al., 1991). The MPB83 antigen is the best-
characterized one up till now and is modified at two threonine sites with mannose and α(1-3) 
mannobiose. This is peculiar, as the MPT32 mannose residues of M. tuberculosis are α(1-2) 
linked (Michell et al., 2003).
In M. leprae, no protein glycosylation mechanism has been described yet, but the LprG 
lipoprotein was found to be glycosylated and activates TLR-2 via its carbohydrate moiety. 
Moreover the glycan is required for the inhibition of IFNγ induced MHC class II T-cell 
activation and antigen representation by monocytes to T-cells by TLR-2 dependent mechanisms. 
A homologue of LprG is also present in M. tuberculosis (Rv1411c) and in the genome of M. 
leprae a homologue of Rv1002c was found (Sieling et al., 2008). 
2.4.6.6   inDications of generaL o-gLycosyLation systems in otHer species
A conceptual study by Gebhart and co-workers revealed the presence of O-OSTs in Vibrio 
cholera N16961 (VC0393) and Burkholderia thailandensis E264 (BTH_I0650) (Gebhart et 
al., 2012). To the best of our knowledge- no glycoproteins are yet reported in V. cholera, 
but it was shown that it harbors the potential to express a glycosylation system in its genome 
(Gebhart et al., 2012). It remains to be established if this is functional in a native background.
In Burkholderia thailandensis and B. mallei species, flagellar O-glycosylation was reported 
earlier. In B. peudomallei, a gene of the LPS O antigen cluster (rmlB) was found to be involved 
in flagellar glycosylation (Scott et al., 2011a). Recently, it was hypothesized that the BimA 
autotransporter of B. mallei might be glycosylated by BimC (Schell et al., 2007). Taken 
together, Burkholderia species possess the genomic content to carry out protein glycosylation, 
but the nature of this system remains to be elucidated. 
It is also not inconceivable that more general protein glycosylation systems yet have to be 
identified. The above described dedicated systems targeting flagella, pili and other proteins 
could target more proteins, since the elucidation of the general O-glycosylation system of 
Neisseria sp. was also initiated by the discovery of glycosylated pili (cf. supra). The discovery 
of multiple glycoproteins in L. plantarum is an example of a bacterium in which a general 
mechanism is very likely to be found (see earlier). Moreover, the protein glycosylation 
potential of a range of bacteria has not yet been studied.
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2.4.7   s-gLycosyLation of proteins
The modification of cysteine residues with glycans occurs regularly in eukaryotes. This 
phenomenon was only recently reported in a bacterium. Lactobacillus plantarum KW30 
produces a bacteriocin, glycocin F, which is glycosylated on a serine with a GlcNAc residue 
and also on a cysteine residue with a HexNAc (Stepper et al., 2011; Venugopal et al., 2011). 
The serine-linked glycosylation was found to be essential for the bacteriostatic activity of the 
bacteriocin, whilst the cysteine-linked glycan enhances bacteriostasis. The glycans are also 
believed to protect this glycocin from proteolysis. The plantaricin ASM1 of L. plantarum 
A-1 and lantibiotic sublancin 168 of B. subtilis 168 are also believed to be (S-) glycosylated 
(Stepper et al., 2011; Venugopal et al., 2011). 
2.4.8   s-Layer proteins
S-layer proteins form the outermost cell envelope of some bacterial species. These crystalline 
layers are built up of identical protein or glycoprotein subunits. The lattice-like S-layers are 
formed by an entropy-driven self-assembly process of their substituent (glyco)proteins. The 
mono- or multilayered S-layers confer an evolutionary advantage to the cells, but are not 
essential for their survival (Messner, 1997). Their self-assembling capacities make them 
interesting candidates to study in the field of biomimetics and glycoengineering of therapeutic 
targets (e.g. vaccine design, drug targeting and diagnostics) (Steiner et al., 2008). The research 
field dedicated to these intriguing molecules is called ‘nanoglycobiology’ (Messner et al., 
2008). 
It was long believed that only Gram-positive species could produce S-layers, but the 
first Gram-negative S-layer was discovered in 2006 in Tannerella forsythia (Lee et 
al., 2006). S-layers are common in Bacillaceae, like Clostridium sp. and Bacillus sp., 
with Bacillus stearothermophilus being a model organism (Messner et al., 2008). Many 
lactobacilli also produce this crystalline layer (Avall-Jaaskelainen & Palva, 2005). 
S-layers have been excellently reviewed (Messner, 1997; Messner et al., 2008; Schaffer & 
Messner, 2004), and we only provide a short overview of the current knowledge on their 
structure and biosynthesis mechanism in relation to their glycosylation. 
Glycans on S-layer glycoproteins can be linear or branched long homo- or heteropolysaccharides 
composed of identical repeating units. In the bacteria studied to date, these oligosaccharides 
are O-linked to a serine or threonine, albeit also linkages to tyrosine residues are found. 
Commonly, one glycan is found per protein, which accounts for 1 to 10% of the molecular 
weight of the S-layer proteins. 50 to 150 sugar monomers (hexoses, amino sugars, exotic 
sugars…) can be found in 15-50 repeating units of 2-6 sugars. 
S-layer glycans resemble O antigen carrying LPS molecules, as they consist of a tripartite 
structure in which the glycan chain of a variable number of repeating units (cf. O antigen) is 
linked via a variable core oligosaccharide to the S-layer protein backbone (versus lipid A in 
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LPS). The oligosaccharide is strain-specific, whilst the core is less variable. In some cases the 
core oligosaccharide is missing and the sugar is directly attached to the protein. The linkage 
sugar, i.e. the first repeating unit, can have an inverted anomeric configuration, in which case 
it is called a pseudocore. A non-carbohydrate constituent, like an O-methyl group, can cap 
the terminal sugar of the oligosaccharide. This constituent potentially serves as a termination 
signal, analogous to LPS biosynthesis. The proteins are water insoluble and have multiple 
domains: the cell wall targeting region (anchoring in the PG) and the self-assembly domain 
(Messner et al., 2008). 
Nucleotide-activated sugars are used in the biosynthesis of S-layer glycoproteins and assembly 
of the oligosaccharide requires an UndP carrier. Genes involved in S-layer glycosylation are 
in some species clustered in a ‘S-layer glycosylation cluster’ (slg), as dedicated systems. This 
cluster harbors a priming GT, transporter, polymerase and OST, thus analogous to en bloc 
N-glycosylation. Some clusters contain a flippase, which would point towards a mechanism 
resembling the Wzy dependent O antigen biosynthesis. 
2.5 commonaLities in gLycoconjugate biosyntHesis
The plethora of glycoconjugates produced by bacteria is, as elaborated extensively earlier, 
synthesized by only a limited amount of biosynthesis pathways. These pathways share 
important general themes, like homologous proteins, which point towards an evolutionary 
connectivity in glycoconjugate biosynthesis strategies. Several organisms even modify several 
of their glycoconjugates with the same glycans or have enzymes that are active in more than 
one biosynthesis pathway. 
2.5.1   generaL tHemes in gLycoconjugate biosyntHesis patHways
The two most obvious general themes in glycoconjugate biosynthesis pathways have been 
conceptualized already earlier: the sequential (Fig.2.1) and en bloc pathway (Fig.2.2). Both 
were extensively illustrated using examples of several bacterial glycoconjugates (cf. Fig.2.4 
and the extendend version of this chapter (Tytgat & Lebeer, 2014)). Here we zoom in on the 
common denominators of both biosynthesis pathways.
2.5.1.1   tHe LipiD carrier
The biosynthesis of almost all glycoconjugates requires the involvement of a lipid carrier 
on which the glycan moiety is built prior to its transport to its substrate. In most cases, this 
lipid carrier is an UndP carrier: O antigen of LPS, CPS, EPS, TA, PG and en bloc protein 
glycosylation (Bugg & Brandish, 1994). Even Mycobacteria sp. that have a modified PG layer 
(arabinogalactan) use a modified version of the UndP carrier for the assembly of their PG, 
being decaprenol phosphate (Wolucka et al., 1994). However, some sequential glycoconjugate 
biosynthesis pathways use membrane lipids such as diacylglycerol and phosphatidylinositol 
as carrier (e.g. CPS biosynthesis in E. coli K1) (Corbett & Roberts, 2008) and in the case of 
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some membrane spanning synthases, no lipid carrier is needed (e.g. alginate biosynthesis) 
(Rehm & Valla, 1997; Whitney & Howell, 2013).
A priming GT transfers the first sugar moiety to the lipid carrier and catalyzes the formation 
of a high-energy pyrophosphate bond. This resulting undecaprenyl pyrophosphate (UndPP) 
lipid carrier serves as a scaffold for the further synthesis of the glycan. The lipid-linked 
oligosaccharide is then transported over the membrane, the phosphate-sugar bond is cleaved 
and the oligosaccharide is transferred to its substrate. The lipid carrier is then recycled to 
the cytoplasmic face of the membrane (Bugg & Brandish, 1994). A phosphatase (e.g. Wzb) 
removes the remaining extra phosphate after the transfer of the glycan (Valvano, 2008; 
Wugeditsch et al., 2001). The recycling of the UndP lipid carrier is essential for the viability 
of bacterial cells, because of its key role in PG biosynthesis (van Heijenoort, 2001).
As stated before, the factors determining the substrate (acceptor) and donor specificity of 
GTs remain largely unclear, but it is believed that priming GTs and OSTs recognize the lipid 
carriers (e.g. length, saturation…) (Hug & Feldman, 2011). An important exception is the 
PglL OST of Neisseria, which is known for its extreme promiscuity in view of lipid-linked 
oligosaccharides used (Faridmoayer et al., 2008). 
2.5.1.2   priming or initiating gts
The activated lipid linked sugar monomer resulting from the action of the priming GT forms 
the acceptor for the action of other GTs that assemble the glycan further (Price & Momany, 
2005). 
As illustrated in the discussion of the biosynthesis of LPS structures (cf. (Tytgat & Lebeer, 
2014)), there are currently two families of priming GTs characterized. The first family is the 
polyprenyl-P N-acetylhexosamine-1-P transferase family (PNPT), of which the E. coli WecA 
enzyme is a type example (Al-Dabbagh et al., 2008; Lehrer et al., 2007; Meier-Dieter et al., 
1992; Price & Momany, 2005). The second family is the family of polyprenyl-P hexose-1-P 
transferases (PHPT) and its best-studied member is the WbaP priming GT of S. enterica 
serovar Typhimurium (Jiang et al., 1991; Wang et al., 1996). These families are evolutionary 
unrelated and have a different topology and primary sequence. The PNPT family is, besides 
in LPS O antigen biosynthesis, often implicated in TA (e.g. TagO of B. subtilis (Soldo et al., 
2002)), PG (e.g. MraY (Ikeda et al., 1991)) and glycoprotein (e.g. WbpL of P. aeruginosa 
(Rocchetta et al., 1998)) biosynthesis. The PHPT family can initiate O antigen LPS (e.g. 
S. enterica) and EPS/CPS biosynthesis (e.g. various E.coli strains), but also glycoprotein 
biosynthesis (e.g. Neisseria sp.) (Power et al., 2000). 
2.5.1.3   transport of tHe LipiD-LinkeD oLigosaccHariDe across tHe membrane
There are two main strategies used to transfer lipid-linked glycans across the membrane: 
flippases and ABC transporters. Both were discussed in detail in the extended version of 
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this chapter (Tytgat & Lebeer, 2014) for EPS/CPS and LPS O antigen biosynthesis, but are 
also involved in the biosynthesis of other glycoconjugates, like PG, TAs and glycoproteins 
(Fig.2.4A. and Fig.2.4D.). 
The Wzx flippase system generally transfers short, complex and often branched oligosaccharides 
and exhibits low substrate specificity (Feldman et al., 1999). ABC transporters are involved 
in the translocation of longer glycan chains (Cuthbertson et al., 2005). The first system is 
believed to recognize the first sugar linked to the lipid carrier (Marolda et al., 2004), while 
ABC transporters recognize the stop elongation signal, like glycan caps or terminal methylation 
(Cuthbertson et al., 2007; Cuthbertson et al., 2005). The ABC transporters can consist of a 
single polypeptide chain (e.g. PglK of C. jejuni) or several polypeptide chains (e.g. Wzt and 
Wzm of E. coli) (Alaimo et al., 2006). 
2.5.1.4   gLycan Ligation to tHe substrate
In the end, the glycan has to be conjugated to its substrate, being lipid A-core polysaccharide 
(O antigen), polysaccharide (EPS/CPS, O antigen) or protein (glycoprotein). Strikingly, these 
reactions are often catalyzed by evolutionary connected enzymes, all harboring a Wzy_C 
domain (Musumeci et al., 2014). These include WaaL O antigen ligases and O-OSTs involved 
in protein glycosylation. N-OSTs, like the PglB N-OST of C. jejuni, seem to be unrelated 
and of a different evolutionary origin (cf. earlier) (Hug & Feldman, 2011). These enzymes 
remove the glycan from its lipid carrier by cleaving the phosphate-sugar bond and form a new 
linkage with the substrate (Musumeci et al., 2014; Qutyan et al., 2007; Raetz & Whitfield, 
2002). Nevertheless, it is currently very difficult to predict the substrate specificity, i.e. the 
glycoconjugates biosynthesis pathways in which these enzymes are involved merely from 
sequence information. This often results in miss annotations in full genome sequences (e.g. 
the annotation of GTs implicated in LPS biosynthesis in Gram-positive species) and thus 
probably also in metagenomic analyses. 
2.5.1.5   common tHemes faciLitate new Discoveries
The fact that almost all biosynthesis pathways use homologous carriers, enzymes and 
transporters reflect the importance of the maintenance of these pathways from an evolutionary 
perspective. There is also an evolutionary connection to the eukaryotic glycobiosynthesis 
pathways, but an in-depth comparison of prokaryotic and eukaryotic glycosylation is beyond 
the scope of this work, as this is the topic of a previous review (Dell et al., 2010).
There are still many species of which the glycosylation potential has to be unraveled. New 
emerging techniques in MS (Ding et al., 2009; Scott et al., 2011b; Wuhrer et al., 2009), NMR 
(Slynko et al., 2009), analytical glycoscience (Balonova et al., 2009), single molecule force 
spectroscopy (Francius et al., 2008), shotgun glycomics (Song et al., 2011) and in silico 
glycobiology (Fletcher et al., 2011), boost the further in-depth study of new and already 
known glycoconjugates (Reid et al., 2010). The already known common themes can facilitate 
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these studies and make it also easier to spot important exceptions and evidence which is still 
lacking. An example is found in B. fragilis, where a Wzx transporter was identified, but to the 
best of our knowledge, up till now, no OST (Fletcher et al., 2009). 
2.5.2   overLap in gLycoconjugate biosyntHesis patHways
In several species the commonalities between the biosynthesis pathways of their glycoconjugates 
are even more elaborated. Several species use the same oligosaccharides to build up their LPS 
and glycoprotein structures. Other species harbor pathways encompassing shared enzymes. The 
most common overlapping glycoconjugate biosynthesis mechanisms are the polysaccharide 
(CPS, LPS, LOS) and glycoprotein biosynthesis pathways. There are two main trends, the first 
one being the attachment of the same glycan moieties to both glycoconjugates, the other being 
the competition for sugar precursors. 
The first phenomenon, i.e. double usage of the same glycan, and thus biosynthesis pathway, 
to modify different glycoconjugates, is already illustrated in several species. A. baumanii 
has only one priming GT, PglC, to initiate CPS and O-glycoprotein biosynthesis (Lees-
Miller et al., 2013). This results in the attachment of pentasaccharide CPS building blocks 
to glycoproteins (max. two linked subunits). A single locus thus is responsible for the 
production of both glycoconjugates (Cuccui & Wren, 2013; Lees-Miller et al., 2013). In C. 
jejuni NCTC 11168, both CPS and LOS consist of heptoses, which require the activity of 
the same GmhB phosphatase (Guerry & Szymanski, 2008; Karlyshev et al., 2005). The same 
glycan is also incorporated in the CPS and LPS glycans of E. coli O9a:K30 (Drummelsmith 
& Whitfield, 1999). But most examples of shared glycans are found between overlapping 
LPS and glycoprotein biosynthesis pathways. In P. aeruginosa 1244, the pili are glycosylated 
with the same building blocks as used for LPS O antigen biosynthesis (Castric et al., 2001; 
DiGiandomenico et al., 2002). Both pathways are distinguished later by the difference in 
specificity and active site of the competing enzymes Wzy, WaaL and PilO (Horzempa et 
al., 2006b). The EmaA adhesin of A. actinomycetemcomitans is modified with O antigen 
sugars and is a substrate of the WaaL enzyme (Tang & Mintz, 2010; Tang et al., 2007; Tang 
et al., 2012). The same is true in B. pseudomallei, where the glycan attached to the RgpA 
glycoprotein is similar to the anionic polysaccharides (Curtis et al., 1999; Paramonov et al., 
2005). In E. coli 2787 the Aah GT uses heptose residues from the LPS core to glycosylate the 
AIDA-I adhesin (Benz & Schmidt, 2001).
As mentioned, a second trend is the competition for nucleotide activated sugar precursors 
between different glycoconjugate biosynthesis pathways. In P. aeruginosa strain PAO1, the 
LPS and glycoprotein biosynthesis pathways both use the TDP-L-Rha precursor (Lindhout 
et al., 2009). This is also the case in C. jejuni NCTC 11168, where the same Gne epimerase 
(CJ1131c) is involved in the production of Gal and/or GalNAc precursors, which are present 
on its N-glycoproteins, LOS and CPS structures (Bernatchez et al., 2005; Guerry & Szymanski, 
2008). Glycosylation of the HMW1 adhesin of H. influenzae requires UDP-glucose and thus 
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the phosphoglucomutase PgmB, an enzyme also important in LOS biosynthesis (Grass et 
al., 2003). The same precursor is used in B. pseudomallei in LPS biosynthesis and flagellin 
glycosylation. The RmlB enzyme of the LPS O antigen cluster synthesizes this nucleotide 
activated sugar precursor (Scott et al., 2011a).
These overlapping enzymes and pathways are particular intriguing, as they render the bacteria 
with several advantages, but also disadvantages. As mentioned earlier, the production of 
glycoconjugates is an energy-costly process for bacteria. Commonalities in glycosylation 
pathways reduce the arsenal of precursors and enzymes needed and are thus energy saving. 
Bacteria also need a way to discriminate between these bifurcated biosynthesis pathways and 
have evolved several solutions to do so: they can express only a subset of the glycoconjugate 
repertoire (cf. H. pylori (Hug et al., 2010)), use downstream enzymes with different specificities 
(cf. P. aeruginosa (Qutyan et al., 2010)), have both pathways competing (e.g. same precursors 
for LOS, CPS and N-glycoprotein biosynthesis in C. jejuni (Bernatchez et al., 2005)) and their 
expression can be dependent on environmental stimuli (cf. expression of colonic acid in E. 
coli (Whitfield & Roberts, 1999)). 
Common glycans can serve as a cloak to shield immunogenic molecules from the host immune 
system (cf. P. gingivalis (Slaney et al., 2002)). Some species exploit this by covering their 
surface with glycans resembling host sugars (e.g. fucose, sialic acid…). This strategy is used 
by commensals, like B. fragilis that harbors a surface fucosylation pathway to modify its 
CPS and O-glycoproteins (Coyne et al., 2005), but also pathogens like H. pylori use this to 
prolong their presence in the host (Hug et al., 2010). But the addition of similar antigenic 
glycans to more structures can also have a major disadvantage: it can enhance the recognition 
by the immune system. In P. aeruginosa 1244, for instance, O antigen subuntis are also added 
to the pilin, enlarging the pool of antigens and activating the cross reaction of antibodies 
(DiGiandomenico et al., 2002). 
2.5.3   bifunctionaL anD promiscuous gts
Another common theme in glycoconjugate biosynthesis is the involvement of bifunctional and 
promiscuous GTs in several bacteria. Bifunctional GTs combine the catalysis of the formation 
of a glycosidic linkage with another catalytic role. Classic examples are the bifunctional PBPs 
used in PG biosynthesis, which have both a transglycosylase and –transpeptidase domain 
(van Heijenoort, 2001). In L. monocytogenes the GmaR (Lmo0688) is a bifunctional GT, 
which also transcriptionally regulates the expression of flagellar expression (cf. supra) (Shen 
& Higgins, 2006). The PglB priming GT of N. gonorrhoeae and N. meningitidis is both an 
acetyltransferase and a phosphoglycosyltransferase (Power et al., 2000). But the unrefuted 
champions of multitasking are ofcourse the synthases, which initiate, elongate and transport 
glycans (Yother, 2011). 
Promiscuous enzymes can transfer a plethora of glycans and/or target several substrates. Most 
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promiscuous enzymes are OSTs, with PglL of N. meningitidis MC58 being an exponent of 
this as this OST can transfer virtually any glycan (Faridmoayer et al., 2008; Faridmoayer et 
al., 2007). The enzyme can even interfere with the PG machinery and transfer incomplete PG 
subunits (muramoyl-GlcNAc tetra- and tripeptide) to pilin (Faridmoayer et al., 2008). PglL 
can even act as a Leloir enzyme and transfer monosaccharides (Musumeci et al., 2013). The 
same phenomenon could also be linked to the PglB N-OST of C. jejuni, of which the only 
requirement is the presence of a C-2 acetamidogroup in the non-reducing sugar (Li et al., 
2010; Wacker et al., 2006). The PilO O-OST is also promiscuous, but to a lesser extent (cf. 
earlier) (Qutyan et al., 2007). An example of promiscuity of a non-GT is the fact that the 
PglK transporter of C. jejuni can complement a Wzx defect (Alaimo et al., 2006). Moreover, 
a homologue of PglK (WzK) was identified as the O antigen ligase in H. pylori (Hug et al., 
2010). 
2.6 concLusions
The field of bacterial glycosylation remains enigmatic, due to the complexity of the field. The 
here summarized current knowledge probably only scratches the surface of what there is to 
know on bacterial glycobiology. Bacterial glycoconjugates exhibit an enormous diversity, but 
their biosynthesis is also stooled on common themes and pathways. This common ground can 
enhance the study of the still unexplored glycosylation potential of several bacterial strains, 
but should be complemented with performant analytical methods, since sequence information 
does not adequately predicts the glycosylation potential. 
Albeit glycoconjugates like EPS, CPS and LPS are studied for years now, many aspects 
remain unknown. In addition, especially research concerning the functional importance of 
glycoconjugates such as glycoproteins has been lagging behind. Currently, the focus lies mainly 
on the elucidation of their role in virulence, pathogenesis and bacteria-host interactions in 
general. But their functional importance can even be more vibrant than currently appreciated. 
For instance, several groups report on the (potential) glycosylation of proteins involved in the 
multienzyme complexes of the cell wall biosynthesis and division machinery (Balonova et al., 
2010; Fletcher et al., 2009; Sanchez-Rodriguez et al., 2014). It is tempting to speculate that 
the yet unexplored glycosylation of major enzymes in these complexes could play a role in 
the regulation of their interaction and activity, but this remains to be elucidated. Only a few 
illustrations of the fascinating functional importance of bacterial protein glycosylation are the 
modulation of flagellin glycosylation in H. pylori to remain stealth from the immune system 
(Josenhans et al., 2002), the link between protein glycosylation, redox reactions and electron 
transport systems seen in Neisseria sp. (Ku et al., 2009; Vik et al., 2009) and the dynamic 
interplay between post-translational modifications in N. gonorrhoeae (Anonsen et al., 2012a).
Another important driver for the further expansion of the field of prokaryotic glycobiology 
is its glycoengineering potential. This technology is extremely interesting for industrial 
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applications like the amelioration of food quality by the engineering of EPS structures or 
the production of engineered glycoproteins, like vaccines and human therapeutic agents (e.g. 
insulin) (Campbell et al., 2007; Elliott et al., 2003; Farahmand et al., 2011; Ihssen et al., 2010; 
Iwashkiw et al., 2012a; Jain et al., 2003; Lindhout et al., 2011; Lizak et al., 2011a; Pandhal 
& Wright, 2010; Saxon & Bertozzi, 2001; Werner et al., 2007). A better knowledge of the 
glycosylation mechanisms in beneficial bacteria could cause a revolution in the biosynthesis 
of therapeutic molecules in prokaryotic vectors. 
The current knowledge on bacterial glycosylation probably only scratches the surface of what 
there is to know. But the already known facts show that a further elucidation of the enigmatic 
world of bacterial glycoconjugates is worth pursuing as this can render important insights in 
bacteria-host interactions and our understanding of bacterial life. Without doubt, the future of 
bacterial glycobiology looks promising and exciting.
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abstract
Bacterial interactions with the environment- and/or host largely depend on the bacterial 
glycome. The specificities of a bacterial glycome are mainly determined by GTs, the enzymes 
involved in transferring sugar moieties from an activated donor to a specific substrate. Of 
these GTs their coding regions, but mainly also their substrate specificity are still largely 
unannotated as most sequence-based annotation flows suffer from the lack of characterized 
sequence motifs that can aid in the prediction of the substrate specificity.
In this chapter, we developed an analysis flow that uses sequence-based strategies to predict 
novel GTs, but also exploits a network-based approach to infer the putative substrate classes 
of these predicted GTs. Our analysis flow was benchmarked with the well-documented GT-
repertoire of C. jejuni NCTC 11168 and applied to the probiotic model L. rhamnosus GG to 
expand our insights in the glycosylation potential of this bacterium. In L. rhamnosus GG we 
could predict 48 GTs of which eight were not previously reported. For at least 20 of these GTs 
a substrate relation was inferred.
We confirmed through experimental validation our prediction of WelI acting upstream of 
WelE in the biosynthesis of exopolysaccharides. We further hypothesize to have identified 
in L. rhamnosus GG the yet undiscovered genes involved in the biosynthesis of glucose-
rich glycans and novel GTs involved in the glycosylation of proteins. Interestingly, we also 
predict GTs with well-known functions in peptidoglycan synthesis to also play a role in protein 
glycosylation.
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3.1 backgrounD
The glycome, playing a crucial role in allowing bacteria to establish environment- and 
host-specific interactions (Kay et al., 2010; Upreti et al., 2003) consists of a wide variety 
of glycoconjugates, i.e. glycans being covalently linked to other macromolecules. In Gram-
negatives, these glycoconjugates occur mainly in the outer membrane as a thin layer of 
peptidoglycan (PG) and lipopolysaccharides (LPS) or lipo-oligosaccharides (LOS). Across the 
outer membrane, exopolysaccharides (EPS) or capsular polysaccharides (CPS), glycoproteins 
and glycolipids can further decorate the cell surface (Upreti et al., 2003). In Gram-positives, 
which in contrast to Gram-negatives lack an outer membrane, complex polymers such as 
teichoic acids in Firmicutes and lipoglycans in Actinobacteria strengthen a thick layer of PG. 
CPS or EPS are also often found as most external layer in Gram-positive bacteria. Bacteria can 
also produce intracellular glycoconjugates, such as glycosylated secondary metabolites and 
storage polysaccharides like glycogen (Upreti et al., 2003).
Glycosyltransferases (GTs), transferring sugar moieties from an activated donor to a specific 
substrate (Lairson et al., 2008), are key enzymes in the biosynthesis of glycoconjugates. 
Depending on their specificity, the substrates of GTs range from lipids, proteins, saccharides, 
nucleic acids to small molecules (Lairson et al., 2008). In bacteria, two different glycosylation 
mechanisms have been described: sequential glycosylation, in which either soluble or 
membrane-associated GTs transfer glycan monomers directly to the final substrate and en 
bloc glycosylation, in which the sugar moiety is first assembled and only then transferred 
to the final substrate by an specialized GT (oligosaccharyltransferase (OST) or polymerase) 
(Guerry & Szymanski, 2008; Hug & Feldman, 2011). The latter mechanism is by far the best 
documented, and is involved in the biosynthesis of heteropolymeric EPS/CPS, O antigens in 
LPS, and even PG biosynthesis, highlighting the commonalities in the biosynthesis of these 
glycoconjugates (Hug & Feldman, 2011). Apart from their general role in glycosylation, the 
specificities of most of the GTs and the cellular role of their end products are still largely 
unknown. In addition, most of the substrate specificities of GTs involved in LPS, PG and 
glycoproteins have been described in Gram-negatives (Lerouge & Vanderleyden, 2002; Typas 
et al., 2012), while glycosylation in Gram-positives is much less studied.
Whereas sequence-based predictions have shown useful to identify potential GTs (Egelund 
et al., 2004; Hansen et al., 2010; Hansen et al., 2009), predicting the specificity of those 
identified GTs is less trivial, definitely for prokaryotes for which no clear sequence motifs 
determining substrate specificity have been described (Weerapana & Imperiali, 2006). In 
addition, many GTs and OSTs show substrate promiscuity (Faridmoayer et al., 2008; Wacker 
et al., 2006), hampering the identification of clear substrate motifs.
To improve the annotation of GTs in prokaryotes, we developed an analysis flow that uses 
a sequence-based strategy to predict GTs and a network-based approach (Szklarczyk et al., 
2011) to identify links between these predicted GTs and other genes/proteins. Although such 
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links do not give insights into the precise biochemical mechanisms of a GT with its substrate, 
they aid in relating the GT to possible classes of molecules that could accept the sugar moieties 
from these GTs (referred to as substrate classes).
We tested our analysis flow on the genome of C. jejuni NCTC 11168, in which the important 
classes of glycoconjugates (N- and O-glycoproteins, PG, LOS, and CPS) are well characterized 
(Guerry & Szymanski, 2008).
Further applying our analysis flow on the probiotic bacterium Lactobacillus rhamnosus GG 
provided a comprehensive re-annotation of putative GTs in this species, the possible substrate 
classes of these GTs and their mode of action. These predictions are a very useful resource for 
experimentalists, predominantly because the study of (protein) glycosylation in lactobacilli 
and related organisms is not straightforward (Claes et al., 2012). Our predictions unveil 
putative novel mechanisms of (protein) glycosylation, involving the potential, promiscuous 
role of GTs with known function in PG biosynthesis.
3.2 metHoDs
3.2.1  bacteriaL proteomes
The proteomes and current genome annotations of Lactobacillus rhamnosus GG (NC_013198.1) 
and Campylobacter jejuni NCTC 11168 (NC_002163.1) were obtained from GenBank (http://
www.ncbi.nlm.nih.gov/genbank/).
3.2.2   HiDDen markov moDeL profiLe searcHes
Hidden Markov Models (HMMs) describing known GT signatures were collected from 
SUPERFAMILY (http://supfam.cs.bris.ac.uk/SUPERFAMILY/), CAZy (http://www.cazy.
org/) and Pfam (http://pfam.sanger.ac.uk/) and subdivided into three groups depending on 
their expected specificity for GTs (Table 3.1). For CAZy, a thorough search of this database 
was performed, and all the HMMs covering GT classes that had bacterial representatives were 
included in our analysis (see below).
The first and least specific group contains the HMM representing ‘Rossmann-fold domains’, 
which are known to resemble the GT-A and GT-B folds typical for GTs using sugar nucleotides 
as donor (Ha et al., 2001; Hansen et al., 2010; Lairson et al., 2008). A second group comprises 
the HMMs for ‘Sugar transferases’ and ‘UDP-Glycosyltransferases’ respectively, both HMMs 
of intermediate specificity covering a broad class of GTs (Egelund et al., 2004; Hansen et 
al., 2010). A last group combines a set of more GT-specific HMMs (10 in total), all of which 
are based on a small number of family-specific sequences (Baiet et al., 2011; Campbell et 
al., 1997; Di Guilmi et al., 2003; Knauer & Lehle, 1999a; Maldonado-Barragan et al., 2011; 
Mengin-Lecreulx et al., 1991; Provencher et al., 2003; Silberstein et al., 1995; Sun et al., 
2012; Yoshida et al., 1998). This group combines HMMs extracted from CAZy (Coutinho et 
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al., 2003), representative for enzymes that catalyze glycosidic bonds (strictu-sensu GTs) with 
HMMs extracted from Pfam (Finn et al., 2010) that are representative for non-Leloir GTs that 
use non-nucleotide sugar donors or oligo/polysaccharides. Enzymes involved in the transfer 
of the sugar moiety to the final substrate (such as OSTs and priming GTs) are examples of this 
latter class of non-Leloir GTs.
The collected HMMs were used to screen entire proteomes (C. jejuni NCTC 11168 and L. 
rhamnosus GG) with hmmsearch from the HMMER package version 2.2 (Finn et al., 2011). 
Hits were filtered using an E-value cut-off of 0.1.
Table 3.1 - Summary of the Hidden Markov Models (HMMs) used to screen for glycosyltransferases in the 
proteomes of Campylobacter jejuni NCTC 11168 and Lactobacillus rhamnosus GG
HMM   
group
Description Database Reference
I Rossmann-fold domains SUPERFAMILY Ha et al., 2001
Egelund et al., 2004
Lairson et al., 2008
Hansen et al., 2010
II Sugar transferase SUPERFAMILY Egelund et al., 2004
Hansen et al., 2010
UDP-Glycosyltransferase SUPERFAMILY Egelund et al., 2004
Hansen et al., 2010
III Transglycosylase (PF00912) Pfam/CAZy Di Guilmi et al., 2003
Glycosyltransferase WecB/TagA/CpsF 
(PF03808)
Pfam/CAZy Maldonado-Barragán et al., 
2011
Bacterial sugar transferase (PF02397) Pfam Yoshida et al., 1998
Provencher et al., 2003
Oligosaccharyltransferase STT3 subunit 
(PF02516)
Pfam/CAZy Baïet et al., 2011
DAD family (PF02109) Pfam Silberstein et al., 1995
OST3/OST6 family (PF04756) Pfam/CAZy Knauer et al., 1999
Glycosyltransferase family 25 (PF01755) Pfam/CAZy Campbell et al., 1997
Glycosyltransferase family 28 (PF04101) Pfam/CAZy Mengin-Lecreulx et al., 
1991
Glycosyltransferase family 9 (PF01075) Pfam/CAZy Kadrmas et al., 1998
HMM group: HMMs were grouped according to their expected specificity for glycosyltransferase activity in an 
increasing order. Description: description of the HMM. The Pfam model id is also provided. Database: source of the 
model. Reference: bibliographic citation supporting the inclusion of the corresponding HMM in the analysis.
3.2.3   protein foLD recognition
The profile based fold recognition method pGenTHREADER (Lobley et al., 2009), accessible 
via the PSIPRED server (http://bioinf.cs.ucl.ac.uk/psipred/) was used to detect known GT-A/
th
re
e.
71
GT-B folds in proteins predicted to be GTs by the HMM search. Each of the input sequences 
was aligned against a library of 3D folds based on CATH v3.3 (the Protein Structure Database, 
available at http://www.cathdb.info/) by pGenTHREADER. The library of 3D folds contains a 
total of 684 PDB structures of known GTs. Putative GTs were only retained if they predicted 
fold showed significant homology (net score > 46) to the one of a resolved 3D structure with 
known GT activity present in the library (refined set). We selected a cutoff > 46 on the net 
score of pGenTHREADER since any values higher than this threshold are categorized as 
HIGH to CERTIFIED confidence predictions (default conservative setting of the tool).
3.2.4   Detecting functionaL partners of gLycosyLtransferases
The STRING database (http://string-db.org/) was used as the source of functional networks 
(Szklarczyk et al., 2011; von Mering et al., 2005). We interrogated STRING using as queries 
our predicted GTs from both L. rhamnosus GG and C. jejuni NCTC 11168 to retrieve the 
network of functional partners associated to each query (query-based subnetwork). We only 
considered functional interactions with a score higher than 0.7, which is the default value 
in STRING for high confidence interactions. A total of 1112 functional interactions were 
retrieved for L. rhamnosus GG, supported by 2338 independent evidences distributed as 
follows: 1682 evidences based on the genomic context of the interacting partners (e.g. physical 
closeness, co-occurrence in closely related species, gene fusion events); 153 evidences based 
on the co-expression of the interacting partners; 28 evidences derived from high-throughput 
experiments (e.g. protein-protein interaction data); 465 evidences derived from the literature 
(text-mining). For C. jejuni NCTC 11168 a total of 1727 functional interactions were retrieved 
supported by 3190 independent evidences from the following data sources: 2520 evidences 
based on the genomic context of the interacting partners; 47 evidences based on co-expression; 
37 evidences from high-throughput experiments; 584 evidences derived from the literature.
Gene Ontology annotation files for L. rhamnosus GG and C. jejuni NCTC 11168 were obtained 
from http://www.ebi.ac.uk/GOA/proteomes.html. To calculate which functional GO classes 
were enriched amongst interacting partners of a certain GT, we used the hypergeometric test, 
corrected for multiple testing using False Discovery Rate (Storey & Tibshirani, 2003).
We then created ‘consensus networks’ that combine the local network neighborhood of all 
GTs, predicted to belong to the same specificity class and of which the local subnetworks 
are enriched in the same GO terms. GT-specific subnetworks were merged in a consensus 
network by retaining the edges from all the composing subnetworks that either reflect GT-GT 
interactions, interactions between a GT and one or more transmembrane proteins (membrane 
associations) or interactions between GTs and proteins with predicted glycosylation signals 
(predicted protein substrate relation).
3.2.5   Detection of putative protein gLycosyLation sites
Glycosylation sites were predicted in the proteomes of C. jejuni NCTC 11168 and L. 
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rhamnosus GG using the GlycoPP webserver (http://www.imtech.res.in/raghava/glycopp/), 
specially developed for the analysis of prokaryotic protein sequences. Predictions were made 
using the hybrid approaches: BPP + ASA (for N-glycosites predictions) and PPP + ASA (for 
O-glycosites prediction) as suggested by the developers. A SVM threshold of 0.5 was used to 
reduce the probability of false positive predictions.
3.2.6   preDiction of transmembrane HeLices
Transmembrane helices were predicted using the TMHMM server version 2.0 (http:// www.
cbs.dtu.dk/services/TMHMM/).
3.2.7   bencHmark
The available data on glycosylation in the paradigm organism C. jejuni NCTC 11168 was used 
for benchmarking purposes and helped us to fine-tune and evaluate our workflow. C. jejuni is 
considered as a model for bacterial glycosylation, since it can not only N- and O- glycosylate 
proteins by both sequential and en bloc transfer (Nothaft & Szymanski, 2010; Szymanski et 
al., 2003a), but also produces a wide variety of glycoconjugates, including PG, LOS and CPS. 
Because glycosylation is extensively studied in C. jejuni NCTC 11168 we used this model 
system to compile a literature benchmark dataset. We obtained information on 10 proteins 
with experimentally verified glycosyltransferase activity and known substrate specificity in 
C. jejuni (Cj1124c, Cj1125c, Cj1126c, Cj1127c, Cj1128c and Cj1129c involved in protein 
N-glycosylation and Cj1133, Cj1136, Cj1139c and Cj1148 involved in LOS biosynthesis). 
Proteins annotated in C. jejuni NCTC 11168 as GTs based on indirect evidence (e.g. through 
homology assignment) were omitted from the benchmark dataset.
3.2.8   reannotation of gts in c. jEjuni anD L. rhamnosus gg baseD on our preDictions anD 
Literature
For the GTs that were previously annotated with a GT-related function, a simplified annotation 
is proposed when the evidence on the exact GT activity is not available for L. rhamnosus GG 
(such as for LGG_00279, LGG_00280 and LGG_00281). In addition, gene names inferred from 
non-strong homology searches (i.e. BLASTn E-value > 0.01) were removed (e.g. LGG_00348). 
For GTs putatively involved in polysaccharide biosynthesis (LGG_00279-LGG_00283, see 
below), gene names were corrected in agreement with the correct gene nomenclature (Reeves 
et al., 1996).
3.2.9   experimentaL work
L. rhamnosus GG and its mutant derivatives were grown in MRS without agitation. 
A new ΔwelI::TcR gene deletion mutant, lacking the LGG_02047 gene, termed 
CMPG10811, was constructed as described earlier (Lebeer et al., 2012b), using 
the pro-7946 (5’-ATACTAGTTCTTATCATAGTTTCCAGACC-3’) and pro-7947 
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(5’-ATCCCGGGGTGGGGAACTTGCTG-3’) primers. As this is a gene deletion mutant in 
an operon, polar effects can not completely be ruled out. Total EPS determination, monomer 
analysis and adhesion assays were performed as previously described (Lebeer et al., 2009). 
Statistical analysis (One-way ANOVA) was performed using GraphPad Prism 6 on data 
corresponding to three technical repeats of three independent biological samples.
3.3 resuLts
3.3.1   annotating putative gLycosyLtransferases
To predict additional GTs, we used an HMM based screening (Figure 3.1A). To maximize 
the sensitivity of our screening, the heterogeneous functional family of GTs was represented 
by a collection of 12 different HMMs, each of which captures a different characteristic of 
known GTs (Table 3.1). These 12 HMMs were subdivided into three groups depending on 
their expected specificity for GTs, referred to as respectively I) ‘Rossmann-fold domains’, 
II) ‘Sugar transferase’ and ‘UDP-Glycosyltranferase’ and III) a set of nine more GT-specific 
HMMs.
As HMM-based screenings, definitely those performed with the least GT-specific HMMs, 
tend to also find many non-specific hits (false positives), predictions were further filtered 
using a protein fold recognition step: GTs predicted by the HMM profiling were only retained 
if they contained a three-dimensional fold with significant homology to folds present in 
experimentally confirmed GTs from any species (referred to as the refined set in Figure 3.1) 
(see Material and methods).
The results of the HMM based screening in both L. rhamnosus GG and C. jejuni NCTC 11168 
before and after filtering with the fold based predictions are shown in Figure 3.2, together with 
the most abundant GO categories present amongst the predicted GTs. Filtering successfully 
reduced potential false positive predictions, for instance, a large fraction of oxidoreductases 
(all binding the cofactor NAD) obtained by screening with the least specific ‘Rossmann-fold 
domain’ HMM were removed after the fold recognition based filtering (Figure 3.2A). The 
three predictions in C. jejuni (Additional file 1: Table S1) and the five in L. rhamnosus GG 
(Table 3.2) made by the ‘Rossmann-fold domain’ HMM and retained after the fold recognition 
could not be retrieved by any of the other HMM models, showing the added value of also 
using this least specific class of HMMs. Screening with the ‘Sugar transferases’ and “UDP-
glycosyltransferases’ HMMs in contrast resulted in predictions that were quite GT-specific, 
as indeed approximately 50% of the originally obtained predictions also contain a GT-like 
fold (Figure 3.2B and C). Fold-based filtering here removed mainly predicted DNA-binding 
proteins, as their mechanism of binding DNA is also based on recognizing the sugar moieties 
of the nucleotides. As expected, screening with the HMMs obtained from Pfam and CAZy 
resulted both in C. jejuni NCTC 11168 and L. rhamnosus GG in the highest fraction of hits 
that also displayed a GT-like fold (Figure 3.2D).
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Figure 3.1 – Glycosyltransferase annotation flow
A: Genome-wide annotation of glycosyltransferases (GTs). Glycosyltransferases are predicted by scanning the 
proteomes of the studied species for GT-specific signatures using Hidden Markov Models (HMM) from SUPERFAMILY, 
CAZy and Pfam. An additional fold recognition filtering step is applied to only retain those genes containing a 
three-dimensional fold (inferred by the PGenTHREADER algorithm) with significant homology to folds present in 
experimentally confirmed GTs (deposited in the SCOP database). B: Predicting GT substrate class and putative 
mode of action. The local network neighborhood of each query GT (black node) in a functional interaction network 
(STRING) is used to extract a GT-specific local subnetwork for each query GT. The local subnetwork of a GT comprises 
predicted functional partners (proteins being functionally related to the query GT). Based on the GO enrichment 
analysis of these genes in this local subnetwork, the substrate class of the query GT is derived. To gain information on 
the mode of glycosylation, the GT specific local subnetwork is further annotated with either membrane associations 
between a query GT and a predicted transmembrane protein (blue edge) and with relations indicative for protein 
glycosylation (yellow edge).
The performance of our GT prediction flow with and without the fold recognition filtering step 
was also evaluated in terms of the true-positive rate on the C. jejuni benchmark (containing 
10 proteins with experimentally validated GT activity in C. jejuni NCTC 11168, see Materials 
and methods). To obtain a full recall of 100% (that is retrieving all 10 positives), we had to 
make 184 predictions before the filtering. After the filtering the true positive rate increased 
from 10/184 to 10/44 (Additional file 1: Table S1). In addition to recovering all benchmark 
GTs (those indicated with experimental validation in Additional file 1: Table S1), most other 
predictions corresponded to previously made GT related annotations in C. jejuni NCTC 11168 
that were based on indirect evidence (e.g. through experimental validation in other closely 
related species), such as the loci comprising the GT genes responsible for the synthesis of LOS 
(CJ1133 – CJ1148) (Karlyshev et al., 2005), the GTs for N- (CJ1121c – CJ1129c) (Nothaft 
& Szymanski, 2010) and O-glycoprotein biosynthesis (CJ1311 – CJ1333) (Szymanski et al., 
2003a) and the CPS biosynthesis cluster (CJ1416c – CJ1442c) (Gundogdu et al., 2007; Linton 
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et al., 2001). In addition, we made a total of 17 new predictions for yet unannotated genes in 
C. jejuni NCTC 11168 (Additional file 1: Table S1). Finally, we also retrieved four potential 
false positives (Additional file 1: Table S1).
Figure 3.2 – Annotated glycosyltransferases
Results for the model system Campylobacter jejuni are shown on the left panel and for L. rhamnosus GG on the right 
panel. Putative GTs were predicted using an HMM based screening. A: results obtained with an HMM recognizing 
‘Rossmann-fold domains’, expected to be the HMM with the lowest specificity towards GTs (Table 1, class I). B: results 
obtained with a family of HMMs of intermediate specificity for GTs (Table 1, class II). C: results obtained with the class 
of HMMs, most specific for GTs (Table 1, class III). Pie charts indicate the extent to which different functional classes 
were enriched amongst the predictions obtained with the respective classes of HMMs. Slices indicated in red on the 
pie chart correspond to the functional classes of the predictions that were retained after the fold recognition filtering 
step. For each group of HMMs, the total number of predictions is denoted in black on top of every pie chart and the 
number of predictions retained after applying the fold recognition step is denoted in red.
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The good agreement between our predictions and known information on glycosylation in C. 
jejuni NCTC 11168 (Nothaft & Szymanski, 2010), suggests that also for L. rhamnosus GG, 
the predictions summarized in Table 3.2 reflect true GTs. In addition, Table 3.2 provides a 
curated annotation update of GTs in L. rhamnosus GG: besides adding novel predictions, we 
removed potential erroneous annotations that originated through homology-based associations 
(indicated by conservation in Additional file 1: Table S1) as especially for GTs it is difficult 
to extrapolate the functional annotation without further experimental evidence (e.g. for 
LGG_00279). For GTs putatively involved in polysaccharide biosynthesis (LGG_00279-
LGG_00283, see below), gene names were corrected in agreement with the conventional gene 
nomenclature (Reeves et al., 1996).
Of the total number of 48 final predictions in L. rhamnosus GG (Table 3.2), five correspond 
to the experimentally documented locus encoding the enzymes involved in the synthesis of 
the complex galactose-rich EPS of L. rhamnosus GG (Lebeer et al., 2011; Lebeer et al., 
2009). We also recovered the conserved cluster of GTs involved in the production of the 
intracellular storage glycogen-like polysaccharides (Kiel et al., 1994) and the GTs necessary 
for the biosynthesis of PG (Di Guilmi et al., 2003). In 33 cases, our predictions were consistent 
with previously annotated GTs (supported either by sequence conservation or by experimental 
evidence in related species). In five cases, indicated in Table 3.2 with a hash, our predictions 
are likely false positives. Eight of the 48 predicted GTs in L. rhamnosus GG were completely 
novel (indicated with a star in Table 3.2).
Among the novel predictions, two resulted from the screening with the ‘Rossmann-fold domain’ 
(class I) (LGG_01412 and LGG_00928, see Table 3.2). The other novel predictions LGG_01195 
(previously annotated as ‘ABC transporter’), LGG_00985 (previously annotated as ‘integral 
membrane protein’) and LGG_02347 (previously annotated as ‘hypothetical protein’ were 
all detected by screening with the dedicated HMMs of class III (Table 1), further confirming 
the added value of these HMMs to find additional GTs. The screening with the HMMs of 
class II predicted as potential GTs LGG_00283 (a yet unannotated protein), LGG_01991 and 
LGG_01992. Both latter enzymes exhibit a high similarity with experimentally validated GTs 
in E. coli of the UDP-glycosyltransferase/Glycogen phosphorylase superfamily (Kiel et al., 
1994), further suggesting their GT activity. However, they also show high sequence homology 
with UDP-N-acetylglucosamine 2-epimerases. This would be in agreement with the work of 
Campbell et al. (2000) showing that UDP-N-acetylglucosamine 2-epimerase has homology 
to phosphoglycosyl transferases and shares the same catalytic mechanism (Campbell et al., 
2000).
Despite the similar number of predicted GTs, the genomic organization of these predicted GTs 
is very different in C. jejuni NCTC 11168 and L. rhamnosus GG. In C. jejuni NCTC 11168, 
about 82% of the predicted GTs (corresponding to 36 GTs) are clustered into seven genomic 
regions, each of which contains at least two and on average five GTs that are physically 
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located next to each other. The remaining eight predicted C. jejuni NCTC 11168 GTs are 
scattered in the genome (i.e. with no other GT present immediately up- or downstream). For 
L. rhamnosus GG, a smaller fraction of the predicted GTs is organized in clusters: about 56% 
of the predicted GTs (corresponding to 28 GTs) are located in 9 clusters, that are on average 
slightly smaller (with a mean size of three GTs) than those found in C. jejuni NCTC 11168. 
The remaining 20 predicted GTs in L. rhamnosus GG are isolated in the genome. For both 
species, most of the well-studied experimentally verified GTs are localized in these clusters, 
e.g. in C. jejuni NCTC 11168 these clusters correspond to the genomic regions involved in the 
synthesis of LOS, CPS and N- and in O-protein glycosylation (Guerry & Szymanski, 2008), 
whereas in L. rhamnosus GG one of the predicted clusters correspond to the known region 
for galactose-rich EPS (Lebeer et al., 2011; Lebeer et al., 2009) and one to the cluster for the 
biosynthesis of intracellular storage glycogen-like polysaccharides (Kankainen et al., 2009; 
Kiel et al., 1994). The function of the remaining seven clusters in L. rhamnosus GG is yet 
unknown.
Compared to the ones organized in clusters in both genomes, most of the GTs found in isolation 
appear to be much less studied. A closer inspection of these isolated GTs showed that in L. 
rhamnosus GG (in 7 of the 20 cases (LGG_01057, LGG_01069, LGG_01147, LGG_01412, 
LGG_01487, LGG_01538, LGG_02004)), but not in C. jejuni NCTC 11168, these isolated 
GTs are flanked by DNA topoisomerases, tyrosine recombinases, Holliday junction-specific 
endonucleases, phage-related resolvases and transposases (according to the current genome 
annotation of L. rhamnosus GG (NC_013198.1)). In addition, overlaying our predictions 
with the results of a previous comparative analysis between L. rhamnosus GG and its close 
relative L. rhamnosus LC705 (Kankainen et al., 2009), indicates that many of the isolated GTs 
we identified are specific for L. rhamnosus GG (such as LGG_02004). These observations, 
together with the lower fraction of GTs occurring in large genomic clusters, indicates that in 
L. rhamnosus GG, much more than in C. jejuni NCTC 11168, the glycosylation potential has 
been shaped by horizontal gene transfer and intra-genomic rearrangements, similarly to what 
has been observed for GTs belonging to family 6 of GTs in bacteria and vertebrates (CAZy 
database) (Brew et al., 2010; Cantarel et al., 2009).
3.3.2   network-baseD strategy reLating gts to tHeir substrate cLasses
To relate the predicted GTs to their potential substrates, we exploit the ‘local neighborhood’ 
of these GTs in a functional network, hereby assuming that GTs should be connected to their 
substrates, either directly or indirectly, via other GTs or enzymes. For the network, we relied 
on STRING, of which the functional interactions are inferred from physical (genome-wide 
protein-protein interactions, literature) and functional data (genomic co-localization, co-
expression, co-occurrences, gene fusion-fission events) (Szklarczyk et al., 2011; von Mering 
et al., 2005). The local neighborhood of a predicted GT (or local subnetwork) is here defined 
as the nodes that directly connect to the predicted GT (the latter of which is also referred to as 
th
re
e.
81
the query GT) in the STRING network. We could derive 44 subnetworks for C. jejuni NCTC 
11168, and 48 for L. rhamnosus GG. For each GT-specific subnetwork, the GO categories that 
were most overrepresented amongst the members of the subnetwork were used to infer for the 
query GT of each subnetwork a putative substrate class. As such we could predict a substrate 
class for 30/44 GTs in C. jejuni NCTC 11168 and for 20/48 GTs in L. rhamnosus GG, which 
related to saccharides, PG, proteins and lipids (see Additional file 2: Table S2 for C. jejuni 
NCTC 11168 and Table 3.3 for L. rhamnosus GG).
The relation of the predicted GTs with their network neighbours was further specified using 
information on putative membrane associations or presence of glycosylation sites in the 
network members (Materials and methods): a query-GT being connected to a transmembrane 
protein is referred to as a ‘membrane association’ and is indicative for soluble GTs that exert 
their action by interacting with transmembrane proteins, e.g. a transporter of glycoconjugates 
(Charbonneau et al., 2012; Dell et al., 2010; Grass et al., 2010; Mohammadi et al., 2007; Wu 
& Wu, 2011). A query-GT being connected to proteins with putative glycosylation sites hints 
towards the glycosylation of those proteins by the query-GT (substrate relation).
To gain insight in the mutual interactions between GTs and of these GTs with other proteins 
involved in the same process, we created ‘consensus networks’ that combine the local network 
neighbourhood of all GTs, predicted to belong to the same specificity class and of which the 
local subnetworks are enriched in the same GO terms (Figure 3.3).
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Figure 3.3 - Consensus networks derived for each of the predicted substrate classes of putative GTs in L. 
rhamnosus GG.
Consensus networks show all GTs, having the same substrate class, together with their protein neighbors that are 
hypothesized to contribute to the same common glycosylation mechanism as the one the GTs are involved in. On 
the consensus networks, nodes are proteins than can either be GTs (green nodes), transmembrane proteins (orange 
nodes) or proteins containing glycosylation signals (violet nodes). Membrane associations established between GTs 
and transmembrane proteins are represented by blue edges while predicted substrate relations between GT and 
proteins containing glycosylation signals are represented by yellow edges. Black edges refer to interactions between 
predicted GTs. If the local network neighborhood of GTs (local subnetwork) belonging to the same substrate class 
shows enrichment in more than one GO category (e.g. both the GO terms of EPS and glycogen biosynthesis), the 
consensus network is shown for each of the enriched GO categories. A: consensus networks involving GTs, predicted 
to glycosylate saccharides. Note that here two independent consensus networks were derived corresponding to 
respectively extracellular and intracellular PS biosynthesis. B: consensus network involving GTs, predicted to 
glycosylate peptidoglycan (PG). C: consensus network involving GTs, predicted to glycosylate lipids. D: consensus 
networks involving GTs, predicted to glycosylate proteins. Three independent consensus networks were derived 
corresponding to respectively cell cycle regulation, protein translation and DNA metabolic processes. Our analysis 
suggests substrate promiscuity for MurG, PBP1A, PBP1B and PBPA, all of which were predicted to be involved in the 
glycosylation of both peptidoglycan and proteins.
3.3.3   inferreD substrate cLasses of preDicteD gts in tHe bencHmark
To assess the extent to which our network-based approach was able to correctly infer substrate 
classes, we used as benchmark again the 10 GTs in C. jejuni NCTC 11168 for which also the 
substrate specificity is known (see Material and methods). Our strategy was able to recover the 
known substrate class of all 10 GTs (sensitivity of 100%) on a total of 31 predicted substrate 
classes for GTs in C. jejuni (true positive rate of 10/31).
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3.3.4   inferreD substrate cLasses of preDicteD gts in L. rhamnosus gg
The 20 GTs in L. rhamnosus GG for which we could predict their putative substrate class are 
summarized in Table 3.3.
3.3.4.1   gts preDicteD to gLycosyLate saccHariDes
In L. rhamnosus GG, the substrate class saccharides (Figure 3.3A) comprises the largest 
number of GTs, which is to be expected as saccharides are the most common substrates 
for GTs. The group of GTs that could be related to saccharides comprises two consensus 
networks: the first consensus network consists of GTs that, according to their GO annotation 
are involved in the biosynthesis of extracellular polysaccharides (WclC, WclB, WelE, WelG, 
WelH, WelI, RmlA2, LGG_00295) (Lebeer et al., 2011; Lebeer et al., 2009). The topology of 
this consensus network is indicative for en bloc glycosylation (Guerry & Szymanski, 2008; 
Hug & Feldman, 2011) because it contains several interconnected soluble GTs, all linked to a 
membrane-bound priming GT together with Wzx flippases that transfer the subunits en bloc 
(see below).
This consensus network (Figure 3.3A) can be further subdivided into two cliques of 
interconnected GTs. The first clique (welI-welG-welH-rmlA1-rmlA2) contains genes involved 
in the synthesis of galactose-rich EPS, such as amongst others WelE (LGG_02043), the priming 
GT, with an experimentally verified substrate (Lebeer et al., 2009). From the previously 
annotated gene cluster for galactose-rich EPS (Lebeer et al., 2011; Lebeer et al., 2009), our 
analysis only missed welJ, annotated as alpha-1,3-galactosyltransferase (LGG_02048), as this 
gene was not predicted as a GT in our analysis. This gene does not appear to contain any 
signatures of the currently known HMMs for GTs and might represent a false negative of our 
analysis or an erroneous annotation in the current release of the L. rhamnosus GG genome 
NC_013198.1. This last hypothesis is supported by the small gene size of welJ, which would 
be atypical for a GT.
Regarding the second clique (wclC-LGG_00295-wclB), it contains genes for which the 
substrate specificity towards saccharides is known from homology-based extrapolation only. 
As we know from previous work that L. rhamnosus GG contains, besides its galactose-rich EPS 
also shorter, glucose-rich polysaccharides structures, we would hypothesize that this clique 
contains the missing genes for those glucose-rich polysaccharides structures (Francius et al., 
2008). The prediction of an independent Wzx flippase for each of the sets of interconnected 
GTs (cliques) (i.e. LGG_02049 for the galactose-rich clique and WclC and WclB for the clique 
putatively responsible for glucose-rich EPS synthesis), together with the known exquisite 
substrate specificity of Wzx flippases (Islam & Lam, 2013) further supports the hypothesis 
of each clique being responsible for the biosynthesis of another glycan type. Assuming that 
indeed the upper clique is involved in the synthesis of glucose-rich saccharide structures 
implies that the predicted link between WelE and this second clique (WclC, LGG_00295 
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and WclB) must be mere functional (i.e. not invoking a direct interaction), since knock-out 
experiments indicate that WelE is not the direct priming GT of the glucose-rich EPS structures 
(Lebeer et al., 2009).
The second consensus network (Figure 3.3A lower part, GlgA, GlgC, GlgD, GlgP, GalU) 
recapitulates all known members of the glycosylation system involved in glycogen synthesis 
except GlgB (LGG_02027), a conserved glycogen branching enzyme with transglycosylase 
activity, i.e. an enzyme that has both hydrolase and GT characteristics (Lim et al., 2003), 
which was not picked up by our HMM-based search step. From the predicted GTs in this 
network only GlgA, previously already known as a glycogen synthase, seems to be a genuine 
GT (Kiel et al., 1994; Wilson et al., 2010). For the other proteins GlgC, GlgD and GlgP, 
GalU -though related to glycan biosynthesis- enzyme activities other than GT activity have 
been documented (Ballicora et al., 2003). The consensus network of the glycogen enzymes is 
composed solely of soluble proteins, which is in agreement with the intracellular nature of the 
glycogen-like polysaccharides. The connectivity between only soluble GTs points towards a 
sequential glycosylation mechanism in which sugar monomers are directly transferred from 
activated sugar-nucleotide donors (probably produced by GalU) to the respective substrates.
3.3.4.2   gts preDicteD to gLycosyLate peptiDogLycans
Five GTs could be related to PG precursors (PBP1A, PBP1B, PBP2A, MurG and LGG_01538), 
an annotation that has previously been suggested based on sequence conservation of these 
GTs across species (Figure 3.3B). GO enrichment analysis of their functional subnetworks 
suggests, both in L. rhamnosus GG (Table 3.3) and C. jejuni NCTC 11168 (Additional file 
2: Table S2), a link between PG biosynthesis and a diverse set of processes, such as the 
regulation of cell shape, cell cycle and response to antibiotics, in agreement with the well-
known functions of PG. Compared to the genes involved in EPS biosynthesis, it is remarkable 
that the GT genes involved in PG biosynthesis and remodelling do not occur in genomic 
clusters. The diversity of the processes in which these PG GTs are involved, might imply their 
necessity to be expressed under different environmental stimuli, which in turn can explain 
their organization in individual transcriptional units rather than in operons.
The consensus network of this class of GTs (Figure 3.3B) shows that all of these GTs are 
predicted to have transmembrane domains except for the soluble protein encoded by murG. 
The network organization is consistent with the known two-stage mechanism of bacterial 
PG biosynthesis consisting of cytoplasmic glycosylation reactions mediated by soluble GTs, 
followed by membrane-bound transglycosylation activities (Peregrin-Alvarez et al., 2009; van 
Heijenoort, 2001).
3.3.4.3   gts preDicteD to gLycosyLate LipiDs
The group of GTs that could be related to lipids contains three predicted GTs (LGG_00998, 
LGG_00999, LGG_01057) (Figure 3.3C). For these three GTs, their respective functional 
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subnetworks showed enrichment for the terms ‘carbohydrate’ and ‘lipid metabolism’, 
suggesting that they are involved in the synthesis of lipoglycans present on the cell wall of the 
Gram-positive bacterium L. rhamnosus GG. This predicted role is more plausible than their 
homology based annotated role as ‘LPS biosynthesis glycosyltransferases’, as LPS molecules 
are absent in Gram-positives. The sparsity of the consensus network of these three GTs might 
be due to the incompleteness of the STRING network. So far, the existence of lipoglycans in 
L. rhamnosus GG has not yet been shown by biochemical studies.
3.3.4.4   gts preDicteD to gLycosyLate proteins
A final group of seven GTs could be related to protein substrates and contains both predicted 
transmembrane (PBP1A, PBP1B, PBP2A) and predicted soluble GTs (LGG_00825, 
LGG_00826, LGG_01147, MurG). The GTs in this class were classified as protein GTs 
because the putative protein substrates in their subnetworks carry glycosylation signals. The 
GTs fall apart in three consensus subnetworks related to respectively cell cycle regulation, 
protein translation and DNA metabolic processes (Figure 3.3D).
A first consensus network comprises three transmembrane GTs (PBP1A, PBP2A, PBP1B) and 
MurG all predicted to be involved in ‘cell cycle regulation’ (according to the GO enrichment 
analysis of their respective subnetworks). Their consensus network points towards a substrate 
relation between each of the four GTs MurG, PBP1A, PBP2A and PBP1B, and cell division 
proteins (between MurG, PBP1A, PBP2A and PBP1B and the cell division protein FtsI on 
the one hand and between PBP1A, LGG_01706 and LGG_00254 on the other hand). Two 
previous studies further support our predictions: in Bacteroides fragilis FtsI, and other cell 
cycle related proteins such as FtsX and FtsQ, have been shown to be glycosylated (Fletcher et 
al., 2011). In addition, a very recent study in L. plantarum WCFS1 (Fredriksen et al., 2013) 
provides experimental evidence for the glycosylation of the cell division proteins FtsY, FtsZ, 
and FtsK 1 (Fredriksen et al., 2013). Our results -on the other hand- indicate that the three 
transmembrane GTs and MurG, known to be involved in PG biosynthesis show substrate 
promiscuity and would also have relations with protein substrates in L. rhamnosus GG (Table 
3.3). A link between PG biosynthesis and protein glycosylation is not completely impossible 
given the fact that these predicted ‘promiscuous’ GTs co-occur with their predicted protein 
substrates including FtsI in cell division multienzyme complexes (Figure 3.4).
This link between PG biosynthesis and protein glycosylation is further supported by the fact 
that the other predicted protein substrate of PBP1A (the D-alanyl-D-alanine carboxypeptidase 
(LGG_00254)), is also known to be directly involved in PG biosynthesis by introducing 
interpeptide cross-links. Although not yet reported for D,D transpeptidases, other PG 
remodeling enzymes such as the PG hydrolases Msp1 in L. rhamnosus GG (Lebeer et al., 
2012b) and Acm2 in L. plantarum WCFS1 (Fredriksen et al., 2012) were recently shown to be 
glycosylated (Barinka et al., 2004).
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Schematic overview of the cell division machinery of L. rhamnosus GG. PBP1A, PBP1B, PBPB2A and MurG are 
predicted to be putative GTs. Our network-based analysis predicted PBP3, FtsI and PBP2B as putative substrates 
of the indicated GTs. The Msp1 cell wall hydrolase is the experimentally validated glycoprotein in L. rhamnosus GG 
(Lebeer et al., 2012b).
A second consensus cluster is composed of two soluble GTs predicted to be involved in 
‘protein translation’ (LGG_00825-LGG_00826). Both of these GTs were predicted to 
participate in the glycosylation of YkuJ, a protein co-translated with CcpC, a repressor of 
the tricarboxylic acid cycle in Bacillus subtillis (Figure 3.3C) (Commichau et al., 2006). 
LGG_00825 and LGG_00826 also exhibit a membrane association mediated by LGG_00751, 
annotated in L. rhamnosus GG as a hypothetical protein with a pfam09335 domain typical for 
SNARE associated Golgi proteins in eukaryotes. The membrane association of both GTs via 
a protein involved in translation, together with the fact that the subnetwork of LGG_00825 is 
enriched in the function ‘protein translation’ is consistent with the existence of an eukaryotic 
counterpart of sequential co-translational glycosylation in bacteria (Dell et al., 2010).
A last consensus network comprises only one GT, LGG_01147, predicted to be involved 
in ‘DNA metabolic processes’. LGG_01147 shows a substrate relation with LGG_01145, 
encoding a putative DNA entry nuclease, while establishing a membrane association mediated 
by LGG_01146 (Figure 3.3C). Little is known about these interacting partners, but nucleases 
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are often glycosylated in eukaryotes (Pimkin et al., 2006). Although not specifically related to 
nucleases, glycosylation of extracellular enzymes has been reported in prokaryotes (Brechtel et 
al., 1999; Fredriksen et al., 2012; Huang et al., 1988; Lebeer et al., 2012b; Olsen & Thomsen, 
1991) and is thought to promote their stability (Lebeer et al., 2012b). Whether this is also the 
case for LGG_01145 needs to be further substantiated.
3.3.5   experimentaL anaLysis of tHe gt network invoLveD in eps biosyntHesis
Figure 3.5 - Experimental validation of the EPS network hierarchy
A: Total cell wall polysaccharides were extracted from respectively L. rhamnosus GG wild type, a ΔwelE::TcR gene 
deletion mutant (CMPG5351) and ΔwelI::TcR gene deletion mutant (CMPG10811). The total amount of EPS was 
measured. Error bars indicate standard deviations (of three repeats). One-way ANOVA statistical analysis rendered 
a p-value smaller than 0.05 for the variation of EPS across strains. B: Sugar monomer composition. The data are 
expressed as relative amounts, taking the total amount of detected monomeric sugars as 100%. Error bars indicate 
standard deviations (of three repeats). One-way ANOVA analyses (performed independently on each of the three 
datasets) rendered significant p-values (<0.05) for the variation of each sugar monomer across strains. C: Adhesion 
capacity. The adhesion capacity of wild type and mutants to Caco-2 cells is compared. Error bars indicate standard 
deviations (of three repeats). A One-way ANOVA analysis rendered a significant p-value (<0.05) for the variation of 
the adhesion capacity of the strains.
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We experimentally validated the GT network hierarchy within the clique for galactose-rich 
EPS (Figure 3.3A) by constructing a gene deletion mutant in the welI gene and comparing its 
phenotype to the phenotypes of the wild type (WT) and the gene deletion mutant of the priming 
GT WelE. As phenotypes, we tested the amount and monomer composition of EPS, and the 
adhesion capacity to the intestinal epithelial cell line Caco-2 as an indirect measurement of the 
EPS level (Lebeer et al., 2009). According to our predictions, WelI would be one of the GTs 
that transfer sugar moieties to the sugar subunit initiated by the priming GT WelE. Based on 
these predictions, a gene deletion mutant of WelI would be expected to affect the amount of 
EPS, as in the absence of WelI less sugar moieties will be transferred to the subunit initiated 
by the WelE, but the effect of the WelI deletion on the phenotype should be less severe than 
the effect observed when deleting the priming GT WelE. A phenotype for the welI mutant 
intermediate between the WT and the welE gene deletion mutant is indeed observed for both 
assays confirming the predicted role of WelI upstream of WelE: the ΔwelI::TcR mutant displays 
a lower galactose-rich EPS content than the WT, but a higher content and more galactose than 
the gene deletion mutant of the priming GT WelE (Figure 3.5A and B). In agreement with 
EPS having a negative effect on adhesion, the adherence capacity is the highest for the welE 
mutant, intermediate for the welI mutant and lowest for the WT (Figure 3.5C).
3.4 Discussion
In this work we developed an analysis flow that uses sequence-based strategies to predict 
novel GTs, but also exploits a network-based approach to infer the substrate classes of these 
putative GTs. Using a broad definition of GT activity, including also HMMs for OSTs and 
other non-typical GTs, allowed covering a large part of the glycosylation potential. Applying 
our flow resulted in a careful revision of GTs in the current genome annotation of L. rhamnosus 
GG (NC_013198.1). We confirmed the identity of 33 GTs and predicted 8 novel ones. In 
contrast to what is observed in C. jejuni NCTC 11168, GTs appear to be much less clustered 
in genomic regions, but rather occur as isolated genes flanked by transposable elements. This 
points towards a key role of horizontal gene transfer in the acquisition of the glycosylation 
potential of L. rhamnosus GG.
Complementing the sequence-based with a network based-approach allowed us to also relate 
some of those GTs to their potential substrates. Most prior experimental studies focused on 
analyzing the specificity of GTs organized in clusters together with their auxiliary enzymes, 
as this allows for the straightforward extrapolation of known specificities of some members to 
all members in the cluster. By considering, next to the genomic organization, also links in a 
functional network, we could predict the substrate classes for the numerous, isolated GTs in L. 
rhamnosus GG. Exploiting membrane associations and substrate relations for the nodes in the 
GT-centered networks helped predicting the mutual relations between the GTs and between 
the GTs and their substrates.
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Our analysis contributed to the annotation of GTs in L. rhamnosus GG. For instance, we 
hypothesize that one of the genomic regions that was previously annotated to be involved in 
EPS biosynthesis in general would contain the missing genes involved in the biosynthesis of 
short glucose-rich polysaccharides that are known to decorate the surface of L. rhamnosus GG 
(Francius et al., 2008). In addition, we uncovered several novel interactions. For instance, for 
the isolated GTs known to be involved in PG biosynthesis (PBP1B, PBP2A, PBP1A and MurG), 
our network-based approach suggests an additional role in the glycosylation of proteins that 
are either involved in the biosynthesis of the PG (LGG_00254) or in cell division (LGG_01280 
or FtsI). Substrate promiscuity of GTs is not uncommon in bacteria as for instance in Gram-
negative pathogens, enzymes with relaxed specificity are shared between different processes, 
such as LPS and glycoprotein biosynthesis (Guerry & Szymanski, 2008; Karlyshev et al., 2005). 
Validating the activity of GTs that were predicted to glycosylate proteins- is cumbersome, as 
in vitro enzymatic assays do not represent the cellular conditions that are relevant for the 
assembly of these GTs in multienzyme membrane-associated complexes (Zapun et al., 2012). 
However, because PG biosynthesis is a process involving multienzyme complexes for which 
the assembly is tightly regulated (Zapun et al., 2012), it is not unlikely that also protein 
glycosylation would act as an additional regulatory layer in this structural complex formation. 
Provided our hypothesis on their substrate specificity towards both proteins and PG would 
be true, these promiscuous GTs (PBP1B, PBP2A, PBP1A and MurG) are unlikely to be the 
priming GTs of their putative protein substrates, given their well characterized specificities 
towards PG precursors in both Gram-positives and negatives (Sauvage et al., 2008). We 
hypothesize that the priming GTs predicted to be involved in protein glycosylation must be 
(Lactobacillus) species- or strain-specific rather than generally conserved in prokaryotes. 
This is supported by the observation that the best documented glycoprotein in L. rhamnosus 
GG, i.e. Msp1, another protein associated to the divisome (Lebeer et al., 2012b) (see Figure 
3.4), was no longer glycosylated after transfer to the Gram-negative E. coli (Claes et al., 2012) 
despite the fact that E. coli also has PBP1A, PBP1B, PBP2A and MurG homologs. In addition, 
the sugar monomers added on Msp1 (Lebeer et al., 2012b) and related PG hydrolases such as 
Acm2 (Rolain et al., 2013) show different sugar lectin specificities in L. rhamnosus, L. casei 
and L. plantarum.
3.5 concLusions
Our results show how combining sequence- and network-based computational predictions 
can unveil insights in the bacterial glycosylation potential, thereby providing novel links and 
interesting hypotheses for further investigation. 
Future experiments are needed to confirm the predicted GT activity of these proteins, 
both by knockout mutagenesis and biochemical analyses after recombinant expression and 
purification. During this PhD work eleven knockout mutants of the predicted GTs were already 
constructed, with a focus on the ones predicted to target proteins (cf. addendum). Preliminary 
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screening of these mutants did not result in a significant phenotype or the elucidation of their 
substrate. A more thorough (glyco)proteomic screening is needed, combined with biochemical 
assays underpinning the GT activity of these enzymes. Moreover, the known promiscuity and 
redundancy of GTs will require the construction of double and triple knockout mutants, which 
is currently ongoing. 
3.6 aDDitionaL fiLes
The additional files of this work can be consulted in the published paper of this chapter 
(Sanchez-Rodriguez et al., 2014), which is open access (http://www.biomedcentral.com/1471-
2164/15/349).
3.6.1   aDDitionaL fiLe 1: tabLe s1
List of glycosyltransferases predicted in the genome of C. jejuni NCTC 11168.
3.6.2   aDDitionaL fiLe 2: tabLe s2
Proposed substrate classes of glycosyltransferases in C. jejuni NCTC 11168.
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streptavidin-based protein detection. Microbial Biotechnology, 8, 164-168.
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summary
Biotinylation is widely used in DNA, RNA and protein probing assays as this molecule has 
generally no impact on the biological activity of its substrate. During the ‘high troughput’ 
streptavidin-based detection of glycoproteins in L. rhamnosus GG with biotinylated lectin 
probes, a strong positive band of approximately 125 kDa was observed, present in different 
cellular fractions. This potential glycoprotein reacted heavily with the Concanavalin A (ConA), 
a lectin that specifically binds glucose and mannose residues. Surprisingly, this protein of 125 
kDa could not be purified using a ConA affinity column. Edman degradation of the protein, 
isolated via cation and anion exchange chromatography, lead to the identification of the band 
as pyruvate carboxylase, an enzyme of 125 kDa, which binds biotin as a cofactor. Detection 
using only the streptavidin conjugate resulted in more false positive signals of proteins, also 
in extracellular fractions, indicating biotin-associated proteins. Indeed, biotin is a known 
cofactor of numerous carboxylases. 
The potential of false positive bands with biotinylated protein probes should thus be considered 
when using streptavidin-based detection, e.g. by developing a blot using only the streptavidin 
conjugate. To circumvent these false positives, alternative approaches like detection based on 
digoxigenin labeling can also be used.
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4.1 introDuction
Biotin is a small molecule, which is widely used in molecular biology as a result of its extremely 
high affinity for streptavidin binding (Kd = 10
-14 - 10-15M) (Green, 1975; Laitinen et al., 2006). 
The streptavidin-biotin interaction is one of the strongest non-covalent bonds known in nature, 
in strength almost matching covalent strength (Chaiet & Wolf, 1964; Laitinen et al., 2006). 
The rigid nature of the bond results in resistance of the complex against organic solvents, 
denaturants, detergents, proteolytic enzymes and extreme pH and temperature conditions. 
This is exploited in biological assays by coupling biotin to substrates like DNA, RNA and 
proteins, such as the sugar-binding lectins important in our study of bacterial glycoproteins. 
Detection and purification of these biotinylated substrates is then accomplished by application 
of a streptavidin conjugate tagged with an enzyme reporter (like alkaline phosphatase or horse 
radish peroxidase) or a fluorescent probe (Chapman-Smith & Cronan, 1999; Chevalier et al., 
1997). Another important advantage of this detection method is the low molecular weight of 
the biotin, which enables linkage to its substrate without affecting the substrate activity. To 
further limit effects on substrate activity, the biotin is mostly linked via an extending long 
linker (Chapman-Smith & Cronan, 1999; Chevalier et al., 1997). 
Biotin is an important cofactor of carboxylase enzymes in all domains of life. The biotin 
cofactor is involved in the transfer of carbon dioxide in oxidative metabolism reactions. Biotin 
is bound via a biotin carboxyl carrier protein, which can be part of a multidomain carboxylase 
or substitute a separate subunit of the carboxylase enzyme complex (Fugate & Jarrett, 2012; 
Tong, 2013; Wood & Barden, 1977). Some of these proteins can be moonlighting proteins, as 
described in yeast (Huberts et al., 2010).
Earlier reports already mentioned the presence of proteins binding biotin as a cofactor resulting 
from false positive reactions during gene probing in bacteria (Wang et al., 1993), and several 
reports have been published on the interference of endogenous biotin in eukaryotic assays 
(Chen et al., 2012; Horling et al., 2012; McKay et al., 2008). Nevertheless, many research 
groups still use biotinylated probes to detect specific DNA, RNA and protein structures. With 
the booming interest in glycobiology and bacterial glycoproteins, biotinylated lectins are now 
widely used to identify specific sugar residues (Coyne et al., 2005; Lebeer et al., 2012b; Lee 
et al., 2014; Wu et al., 2014). We report in this chapter on the occurrence of false positive 
hits due to endogenous biotin-binding proteins when biotinylated probes are used to probe 
(glyco)proteins.
As yet mentioned, an integral part of the experimental approach of this PhD research, is 
based on the detection of specific sugar modifications on proteins of L. rhamnosus GG 
using biotinylated lectins. Because we aimed here at an open approach to explore whether 
L. rhamnosus GG glycosylates other proteins than Msp1, it was important to investigate the 
robustness of the lectin-based screening approach. Intriguingly, an apparent strong positive 
protein band of approx. 125 kDa present in several proteome fractions could not be purified 
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using lectin affinity chromatography. The protein turned out to be LGG_01329, a pyruvate 
carboxylase, which harbors a domain that binds a biotin cofactor. This protein did not stain 
with the glycoprotein Periodic Acid Schiff (PAS) base staining method, and is thus not a 
glycoprotein. Probing the protein samples using only streptavidin, lead to the discovery of 
even more false positive hits. We therefore suggest the implementation of alternatives such as 
the digoxigenin detection method to circumvent these false hits. 
4.2 resuLts anD Discussion
4.2.1   Detection of an intruiging 125 kDa banD using biotinyLateD Lectins
As yet mentioned, the discovery of a glycosylated protein in L. rhamnosus GG (ATCC 53103) 
(Lebeer et al., 2012b) raised the question if this bacterium is able to produce more glycoproteins. 
Therefore a Western blot screening was designed in which an array of biotinylated lectins 
was used to sample the glycosylation state of the proteome of L. rhamnosus GG. Lectins 
are (glyco)proteins which, similar to the use of antibodies in Western blot development, can 
bind specific carbohydrate structures. Their binding affinity depends on the configuration 
and accessibility of the specific sugar(s) that are recognized by the lectins under study (Van 
Damme et al., 2011). 
We applied an array of biotinylated lectins with different specificities to Western blots of 
proteome samples of L. rhamnosus GG to screen for glycosylated proteins. We here depict 
the results (Fig. 4.1A) for Western blots of the extracellular proteome developed using 
Concanavalin A (ConA) (specific for glucose, terminal mannose) and a mix of lectins consisting 
out of ConA, the Galanthus nivalis lectin GNA (terminal mannose), the Hippeastrum hybrid 
HHA lectin (mannose), Wheat germ lectin (WGA) [N-acetylglucosamine, (GlcNAc)], the DSL 
isolated from Datura stramonium (GlcNAc), UDA originating from Urtica dioica (GlcNAc), 
Nictaba purified from Nicotiana tabacum leaves (GlcNAc), the Rhizoctonia solani lectin RSA 
[Galactose (Gal), N-acetylgalactosamine, (GalNAc)] and PNA purified from peanuts (Gal, 
GalNAc) lectins. Figure 4.1A shows the resulting lectin blots for the proteome of wild type 
L. rhamnosus GG and the ΔdltD::TcR mutant (CMPG5540) (Perea Velez et al., 2007). After 
incubation with the biotinylated lectins, the Western blots were probed with a streptavidin 
conjugate, which enabled the visual detection of bands (Fig. 4.1A). 
To our surprise, both wild type and the ΔdltD::TcR mutant samples showed a strong band at 
approximately 125 kDa (Fig. 4.1A). All repetitions of the assays using single biotinylated 
lectins or mixtures of lectins confirmed these findings (results not shown). The same 125 kDa 
band was also observed on Western blots of the proteomes of other mutants of L. rhamnosus 
GG as well as in the probing of other cellular proteomic fractions (results not shown).
102
en
do
ge
no
us
 b
io
tin
-b
in
di
ng
 p
ro
te
in
s
Figure 4.1 - Detection of glycoproteins on Western blot using biotinylated lectins and streptavidin results 
in false positive hits.
(A) Biotinylated lectin blots - The exoproteome of wild type L. rhamnosus GG and its ΔdltD::TcR mutant were 
subjected to SDS-PAGE on NuPAGE® Novex® 12% Bis-Tris gels (Life Technologies) and subsequently blotted to PVDF 
membranes (Life Technologies). The prestained KaleidoscopeTM ladder (Bio-Rad) was added as a molecular weight 
marker. The Western blots were developed using biotinylated probes, in this case lectins. In the left panel the Western 
blot was probed with biotinylated ConA, which specifically binds glucose and terminal mannose. Incubation with 
streptavidin conjugated to alkaline phosphatase (Roche) enabled the visual detection of positive bands using NBT 
and BCIP. In the right panel the blot was developed using the same principle, but initial probing was performed using 
a mix of biotinylated lectins: ConA (Glc, Man), GNA (Man), HHA (Man), WGA (GlcNAc), DSL (GlcNAc), UDA (GlcNAc), 
Nictaba (GlcNAc), RSA (Gal, GalNAc) and PNA (Gal, GalNAc). In both Western blots and for both strains a peculiarly 
strong band appeared at approximately 125 kDa. (B) Using a streptavidin conjugate to sample the proteome for 
false positive hits – The blotted exoproteome of L. rhamnosus GG and the ΔdltD::TcR mutant were probed directly 
with a streptavidin conjugate. This resulted in the appearance of several bands, among which the strong 125 kDa 
band. Based on this result, we suggest that the band is not caused by a glycoprotein, but is a false positive. (C) PAS 
glycostain does not react with the 125 kDa protein – An SDS-PAGE gel of the proteome of L. rhamnosus GG was 
poststained with Periodic Acid Schiff base stain (PAS, Pro-Q® Emerald 488 stain, Life Technologies), a method to 
specifically stain glycosylated proteins in a gel. At 125 kDa, no band could be detected, which further supports our 
hypothesis that the 125 kDa signal perceived on the lectin blots is the result of a false positive hit. 
4.2.2   purification of tHe 125 kDa protein
We set out to identify the protein eliciting this strong signal on all blots. Based on the positive 
signal of the protein with ConA, a ConA affinity chromatography approach (HiTrap ConA 
4B column, GE Healthcare) was initiated. However, despite of numerous efforts, we were 
unable to purify the protein in this set-up. Finally, a combination of cation (SP Sepharose 
HP, GE Healthcare) and anion exchange chromatography (Q Sepharose HP, GE Healthcare) 
resulted in the successful purification of the protein. Identification by Edman degradation on 
a Procise 491 cLC protein sequencer revealed that the LGG_01329, a pyruvate carboxylase 
is responsible for the positive bands on the lectin blots. The theoretical molecular weight 
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of 125028 Da for this protein corresponds to the apparent molecular weight observed on 
SDS-PAGE (results not shown) and on the lectin blots (Fig. 4.1A). The molecular weight of 
glycosylated proteins typically differs from the mass calculated from the deduced amino acid 
sequence of the protein, which forms a first indication that the protein encoded by LGG_01329 
is not glycosylated. This was confirmed with a gel stained with Periodic Acid Shiff base 
stain (PAS, Pro-Q® Emerald 488 stain, Life Technologies) a glycoprotein stain, on which 
the 125 kDa band is absent (Fig. 4.1B). Taken together with the fact that carboxylases bind 
endogenous biotin as a cofactor, we suggest that the LGG_01329 protein is a false positive hit 
resulting from the reaction of the endogenous biotin with the streptavidin detection method, 
even when the extracellular proteome is investigated. This also would explain why the 125 
kDa protein could not be purified using ConA affinity chromatography, despite of its strong 
positive reaction with biotinylated ConA on Western blot. 
4.2.3   confirmation tHat faLse positives are causeD by enDogenous biotin
Figure 4.2 - The digoxigenin – anti-digoxigenin detection as an alternative to avoid false positive hits 
caused by proteins binding endogenous biotin. 
(A) DIG-labeled lectin blots – The wild type exoproteome of L. rhamnosus GG was Western blotted and developed 
using a mix of DIG-labeled lectins: ConA (Glc, Man), GNA (Man), HHA (Man), WGA (GlcNAc), DSL (GlcNAc), UDA 
(GlcNAc), Nictaba (GlcNAc), RSA (Gal, GalNAc) and PNA (Gal, GalNAc). These lectins were labeled using digoxigenin-
3-O-methyl-ε-aminocaproix acid-N-hydroxysuccinimide ester (Roche). Anti-DIG Fab antibody fragments (Roche) 
were used to detect proteins that reacted positively with the lectin probes. Here we clearly see that the false positive 
band at 125 kDa is absent. (B) Negative control with anti-DIG – Direct application of the anti-DIG Fab antibody 
fragments (Roche) to the Western blotted proteome of L. rhamnosus GG results in a blot on which no bands can be 
perceived. This confirms that the DIG – anti-DIG detection method is a good alternative for the biotin-streptavidin 
system, without causing false positive hits.
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To further confirm our hypothesis that the false positive 125 kDa band resulted from the binding 
of endogenous biotin to the pyruvate carboxylase encoded by LGG_01329, we performed 
a Western blot on the extracellular proteome fraction in which we probed the blot with 
streptavidin alone. This means that we did not apply any primary biotinylated protein (in this 
case lectins), but merely developed the blot after incubation with streptavidin conjugate (Fig. 
4.1C). These results are depicted in figure 4.1C, in which a Western blot of the exoproteome 
of wild type L. rhamnosus GG and the ΔdltD::TcR mutant is shown, which was probed with 
streptavidin. One of the strongest signals on this blot could be found at 125 kDa (Fig. 4.1C) 
and represents the pyruvate carboxylase LGG_01329. 
The streptavidin blot also reveals several other bands, which represent other false positives. 
Indeed, several genes turn up when screening the genome of L. rhamnosus GG for proteins 
binding biotin or related to biotin metabolism (Gene database of NCBI). Examples are the 
AccC (LGG_02112) and AccB (LGG_02114) proteins encoding an Acetyl-CoA carboxylase 
biotin carboxylase and its biotin carboxyl carrier protein subunit, respectively. 
These findings implicate that the interpretation of ‘screening’ Western blots developed with 
biotinylated probes should be carried out with caution. We therefore suggest to always include 
a control Western blot only probed with streptavidin conjugate when using biotinylated probes 
(Fig. 4.1B). Complementary screening of the genome of the species under study can also 
reveal the presence of biotin-binding enzymes. 
To circumvent the occurrence of false positive bands completely, we suggest the digoxigenin – 
anti-digoxigenin (DIG – anti-DIG) detection method as a good alternative. As digoxigenin is a 
steroid only produced by Digitalis plants, interference of endogenous material in other species 
is not an issue (Chevalier et al., 1997) (cf. Fig. 4.2B, for a confirmation in L. rhamnosus GG). 
The DIG label is recognized by an anti-DIG antibody, which binds with a high specificity 
to the small steroid molecule (only 390 Da). In practical set-ups, only the Fab fragments of 
the anti-DIG antibody are used to avoid (albeit rare) cross reaction with structurally related 
steroids (Kessler, 1991). An N-hydroxysuccinimide ester derivative with an 6-aminocaproate 
spacer is commercially available to label probes with DIG. Results for the L. rhamnosus 
GG wild type exoproteome probed with a DIG-labeled lectin mix show less bands and most 
importantly, at 125 kDa no band is visible, which leads to the presumption that false positives 
hits are lacking (Fig. 4.2A). This hypothesis is confirmed by a Western blot developed using 
only the anti-DIG antibody (Fig. 4.2B).
Our findings are corroborated by earlier reports on false positive results caused by endogenous 
biotin in eukaryotes (Chen et al., 2012; Horling et al., 2012; McKay et al., 2008) and in the 
gene probing of Streptococcus mutans (Wang et al., 1993). Interestingly, recent work by Lee 
et al. on the glycoproteome of L. plantarum WCFS-1 reported a recurring band of approx. 125 
kDa on Western blots developed with the biotinylated WGA and the biotinylated lectins of 
Dolichos biflorus and Lens culinaris (Lee et al., 2014). Based on our results, we suggest that 
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this band could correspond to the pyruvate carboxylase Lp_2136 of 127 kDa.
4.3 concLusion
In this work we illustrated the occurrence of false positive results on Western blots developed 
with biotinylated probes. Biotin-binding proteins, such as carboxylases, which bind 
endogenous biotin as a cofactor, cause these false positives. These proteins also occur in 
extracellular fractions, possibly as moonlighting proteins. Based on the here-presented results 
we suggest that when using biotinylated probes, a control experiment only using a streptavidin 
probe should be included (Fig. 4.1C). A good alternative labeling method is DIG labeling and 
detection with anti-DIG Fab fragments.
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abstract
The human body hosts a complex bacterial community that plays a major role in human 
health. Recently, massive parallel sequencing studies have resulted in major breakthroughs 
in the understanding of the diversity of this microbiota, but these compositional studies 
now need to be complemented with functional omic approaches at DNA, RNA and protein 
level. Glycoproteins form an interesting class of macromolecules involved in bacteria-host 
interactions, but they are not yet widely explored in Gram-positive and beneficial species. 
Here, an integrated and widely applicable approach was followed to identify putative bacterial 
glycoproteins, combining proteome fractionation with 2D protein- and glycostained gels and 
lectin blots. This approach was validated for the model beneficial isolate of the microbiota 
Lactobacillus rhamnosus GG. The approach resulted in a list of putative glycosylated proteins 
receiving a ‘glycosylation score’. Ultimately, we could identify 41 unique glycosylated proteins 
in L. rhamnosus GG (6 top confidence, 10 high confidence and 25 putative hits, classification 
based on our glycosylation score). Most glycoproteins are associated with the cell wall and 
membrane but glycoproteins were also detected in the cytosol, a cellular location in which not 
many bacterial glycoproteins have been reported yet. Identified glycoproteins include proteins 
involved in transport, translation and sugar metabolism processes. Among them, we identified 
glyceraldehyde 3-phosphate dehydrogenase, GapA (LGG_00933), of which the glycosylation 
status was experimentally validated by a dedicated glycostaining.  
A robust screening resulted in a comprehensive mapping of glycoproteins in L. rhamnosus 
GG. Fractionation of the proteome enabled us moreover to predict the cellular locations of the 
glycoproteins. Our results reflect the glycosylation of sugar metabolism enzymes, transporters 
and other proteins crucial for cell physiology. We hypothesize that protein glycosylation can 
confer an extra level of regulation, for e.g. by the affecting enzyme functions. This is the first 
systematic study of the glycoproteome of a probiotic and beneficial gut isolate.
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5.1 introDuction
It is the era of the microbiome: a plethora of big data projects is mapping the bacterial load of 
eukaryotic species. The human intestine hosts a complex bacterial community important for 
human health and nutrition. Large sequencing studies have led to a better understanding of this 
bacterial community and have shown links between several dysbiosis states and susceptibility 
to diseases. Therefore, the exploration of ways to beneficially modulate this bacterial load 
to influence host health holds great promise for the treatment of dysbiosis-related diseases. 
An interesting strategy is the use of intrinsic members of the microbiota as probiotics. 
Probiotics are ‘live microorganisms which, when administered in adequate amounts, confer a 
health benefit on the host’ (FAO/WHO, 2001). Well-known probiotics are Lactobacillus sp., 
Bifidobacterium sp., beneficial strains of Escherichia coli and even Saccharomyces boulardii, 
although this yeast species does not seem to be an intrinsic member of the microbiota. To 
allow a targeted application of the best probiotic strains for specific dysbiosis conditions, 
in-depth knowledge of the nature of the (beneficial) bacteria-host interactions and the key 
molecules modulating these interactions is crucial. 
From the bacterial-side, the molecules in the secreted protein fraction and on the cell wall 
are interesting candidates to investigate as these molecules can directly mediate contacts 
with host cells. In this context, glycosylated proteins are intriguing molecules. Research on 
mainly pathogenic glycoproteins has uncovered an enormous diversity of glycans present on 
bacterial proteins. These unique glycans might form, together with other surface saccharides, 
a species-specific barcode on bacterial cell surfaces and are ideal candidates to establish 
specific interactions with the environment (Tytgat & Lebeer, 2014). Glycoproteins can for 
instance interact with specific immune lectin receptors as was shown for Campylobacter 
jejuni glycoproteins that interact with the Macrophage Galactose Lectin receptor (van 
Sorge et al., 2009). On the other hand, glycans on bacterial surfaces can also be used to 
shield immunogenic surface factors from detection by the host immune system. Moreover, 
the attachment of glycans to proteins can modulate the biochemical properties of proteins, 
enhancing their activity, specificity and stability (Tytgat & Lebeer, 2014). Taken together, 
this makes glycoproteins potentially important microbiota-host interactions factors. Indeed, in 
the major Gram-negative commensal Bacteroides fragilis, the general protein O-glycosylation 
system was shown to be essential for the competitive colonization of the mammalian intestine 
(Coyne et al., 2013; Fletcher et al., 2011; Fletcher et al., 2009), although specific interactions 
have not been mapped yet. Also in several Gram-positive Lactobacillus strains, glycoproteins 
have been fragmentarily reported (Anzengruber et al., 2013; Fredriksen et al., 2012; 
Fredriksen et al., 2013), but -to the best of our knowledge- the only Gram-positive beneficial 
isolate of the gut microbiota that has been reported to produce at least one glycosylated 
protein is L. rhamnosus GG (Lebeer et al., 2012b). To facilitate more systematic analyses of 
bacterial glycoproteomes, we report here on an extended and widely applicable analysis of 
the glycoproteome of this model microbiota isolate and documented probiotic strain (Doron 
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et al., 2005). This chapter complements our earlier work on the systematic screening of genes 
encoding glycosyltransferases in L. rhamnosus GG (Sanchez-Rodriguez et al., 2014).
In order to map the glycoproteome of the Gram-positive L. rhamnosus GG, the proteome was 
separated in four functional fractions: the secreted, cell wall associated, cell wall/membrane 
and cytosolic proteins. This protocol was designed as such to generate information on the 
localization of glycosylated proteins but also to improve detection of membrane and cell wall 
associated proteins among which most of the glycoproteins are expected. The subproteome 
fractions were subsequently analyzed using 2D electrophoresis and their glycosylation status 
was assessed using a combination of Periodic Acid Schiff glycostain (PAS) and lectin blotting 
with the Galanthus nivalis (GNA) lectin specific for mannose. After identification with mass 
spectrometry, the hits were evaluated using a ‘glycosylation score’ to assess their probability 
of being a genuine glycoprotein. Ultimately, this rendered a list of 41 putative glycoproteins. 
6 glycoproteins were identified with top confidence, 10 with high confidence and 25 as 
putatively glycosylated. The list was further challenged and compared to earlier results and 
to known glycoproteins in other species. This resulted in the further confirmation of the 
efficacy of our workflow. To confirm the overall robustness of the workflow, glyceraldehyde 
3-phosphate dehydrogenase (GapA, GAPDH), encoded by LGG_00933, was isolated from the 
four fractions and its glycosylation status was experimentally confirmed in all fractions by 
independent PAS staining experiments.
5.2 materiaL anD metHoDs
5.2.1   bacteriaL strains anD cuLture conDitions
L. rhamnosus GG was grown at 37°C in Lactobacilli AOAC medium (Difco) in non-shaking 
conditions.
5.2.2   gLycoproteome isoLation anD fractionation
L. rhamnosus GG was grown for 24 h in AOAC medium. The supernatant of the culture 
after centrifugation at 6000 g during 20 min resulted in the secreted proteins (i.e. fraction 
1, SP). This fraction was filtered to remove any remaining bacteria (0.45 μm) followed by 
precipitation with trichloroacetic acid (TCA, 20% final concentration). The precipitated 
proteins were washed twice with cold acetone (100%). The protein pellet was air-dried and 
resuspended in lysis buffer (2 M thiourea, 7 M urea, 4% CHAPS, 2% DTT).
The pellet of the overnight culture, containing L. rhamnosus GG, was washed twice with 
PBS. The cells were then incubated in a solution of 1.5 M LiCl in 10 mM Tris-HCl (pH 8) 
for 1 h at 4°C. Centrifugation (6000 g, 15 min) resulted in a second fraction, i.e. the cell 
wall-associated proteins (CWA), which was precipitated with TCA (Bauerl et al., 2010). The 
remaining pellet was dissolved in PBS and sonicated at an amplitude of 20% (2x2’) to ensure 
cell lysis (Branson sonifier). The lysate was cleared by centrifugation (several runs at 4000 g 
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to remove cell debris). Cytosolic proteins (fraction 3, Cyt) could be found in the supernatant 
after centrifugation (22 000 g, 20 min). The pellet was washed three times with cold Tris-HCl 
50 mM, pH 8, 500 mM NaCl. The resulting pellet was dissolved in PBS and contained the cell 
wall/membrane proteins (CWCM, 4th fraction). Similarly to the other fractions, both the Cyt 
and CWCM fractions were precipitated and dissolved in lysis buffer. 
5.2.3   2D geL eLectropHoresis
2D gel electrophoresis is a method to separate proteins in two dimensions according to their 
intrinsic isoelectric point (i.e. isoelectric focusing) and their molecular weight (SDS-PAGE). 
2D gel electrophoresis was performed as described earlier by Sonck et al. (Sonck et al., 2009). 
Briefly, Immobiline DryStrips (24 cm) with a 3-11 pH range (GE Healthcare) were rehydrated 
overnight in reswelling buffer (6 M urea, 2 M thiourea, 2% CHAPS, 0.4% DTT, 0.002% 
Bromophenol blue) containing 0.5% 3-11 IPG buffer (GE Healthcare). Prior to anodic cup 
sample loading on the DryStrips, 0.8% 3-11 IPG buffer (GE Healthcare) was added to the 
samples dissolved in lysis buffer (cf. supra). Isoelectric focusing of the samples on the 
Immobiline DryStrips was performed on a Multiphor II instrument (GE Healthcare). 
Prior to SDS-PAGE, the focused proteins were reduced using equilibration buffer (6 M urea, 
30% glycerol, 2% SDS, 0.002% bromophenol blue in Tris-HCl 1.5 M, pH 8.8, 1% DTT. 
The same procedure was repeated with equilibration buffer containing 4.5 % IAA. Second 
dimension separation (SDS-PAGE) was performed by application of the DryStrips with the 
isofocused samples on fresh 15% polyacrylamide gels (Amresco®), using the EttanDALTsix 
instrument (GE Healthcare). 
5.2.4   Detection of gLycosyLateD proteins
Glycosylated proteins were detected by PAS staining (Fairbanks et al., 1971). The 2D gels 
were fixed and stained with the Pro-Q® Emerald 488 Glycoprotein Gel Stain Kit (Molecular 
Probes®), a fluorescent and sensitive PAS stain (detection limit of 4 ng of glycoprotein) (Hart 
et al., 2003). After analysis of the PAS stained gels, the same gels were submerged overnight 
in Sypro® Ruby protein gel stain (Molecular Probes®). Scanning of the stained gels was 
performed on a Typhoon 9400 laser scanner (GE Healthcare). 
5.2.5   image anaLysis anD spot picking
Gel images were analyzed using ImageMaster software (GE Healthcare). The positive hits 
with PAS stain were matched to the Sypro® stained spots. The relative intensity and volume 
percentage on glyco- and protein stained gels were compared for each spot. More in particular, 
the intensity of the spots was recalculated relatively to the spot with the highest intensity, both 
for the PAS and Sypro® stained gels. The same was done for the volume percentage. Then the 
ratio was calculated of the relative intensity values (value Pro-Q® Emerald 488/value Sypro®) 
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and of the relative volume percentages. Spots that had a ratio higher than 1 were selected for 
further identification. In order not to miss any highly glycosylated spots, all hits with a relative 
intensity higher than 20% on the PAS stained gels were also picked for further identification. 
Spot picking was executed automatically with the Ettan SpotPicker (GE Healthcare). 
5.2.6   2D Lectin bLot
2D gels of the four fractions of the proteome of L. rhamnosus GG were transferred to PVDF 
membranes (Millipore) using a TE77 Semi-Dry transfer unit (GE Healthcare). These Western 
blots were probed with digoxigenin-labeled GNA, which specifically binds mannose residues 
(Tytgat et al., 2014). To reduce background, polyvinylalcohol was used as a blocking agent 
(Thompson et al., 2011). Spots reacting with the lectin were matched to the Sypro® stained 
gels and picked for identification.  
5.2.7   in-geL tryptic Digestion anD ms
Reactive spots were submitted to in-gel trypsin digestion. Spots were first washed twice in 50 
mM NH4HCO3 for 15 min followed by dehydration during 25 min in 50% (v/v) acetonitrile in 
50 mM NH4HCO3. 10 µL of 50mM NH4HCO3 containing 0.05 µg of trypsin was then added 
to the gel pieces and incubated on ice for 20 min. Trypsinolysis was carried on overnight at 
37°C and stopped by addition of 2 µL of 1% (v/v) formic acid. Tryptic peptides were analyzed 
using an LC-MS/MS workflow as already described (Mastroleo et al., 2009). Briefly, peptides 
were separated by Reverse Phase chromatography using a 40 min ACN gradient (4-45%) and 
analyzed on an HCTultra Ion Trap (Bruker) in MS/MS mode. MS spectra were acquired across 
the 300-1500 m/z mass range and the four ions with the highest intensity were selected for MS/
MS and excluded after one spectrum for 30 sec. Acquired data were analyzed with the Mascot 
search engine against the NCBI database (NCBInr_20130409) restricted to L. rhamnosus GG. 
5.2.8   Data anaLysis anD gLycosyLation score
Proteins were first filtered through the identification p value: only proteins with p <0.05 were 
selected. Peptides with a Mascot ion score lower than 30 were also discarded. Finally only 
proteins identified with at least 2 unique peptides were further analyzed. A glycosylation score 
was attributed to each identified protein as follows: 1 point was given to a protein identified 
as a top hit in a spot with no other putative glycoproteins present (a putative glycoprotein is a 
protein with a glycosylation score > 2, top hit protein is defined as the protein with the highest 
Mascot score for a spot); 2 points were given each time a protein was identified as the sole 
protein in a reactive spot; 3 points were attributed if the protein has been detected as a putative 
glycoprotein in the repetition of the experiment. 
5.2.9   purification of gapDH (Lgg_00933)
Protein fractions of L. rhamnosus GG were prepared as described above and GAPDH was 
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purified as described by Saad and co-workers (Saad et al., 2009). All fractions, except for 
the secreted proteins, were dissolved in NH4HCO3 25 mM pH 7.5, 5 mM EDTA, 1 mM PMSF 
(Buffer A) after TCA precipitation. The secreted protein fraction was concentrated and 
resuspended in buffer A using a tangential flow filtration system (KrosFlo, Spectrum Labs). 
All samples were dialyzed overnight (4°C) against buffer A. The dialyzed fractions were 
applied to a 5 mL Fast Flow Blue Sepharose CL 6B column (GE Healthcare) pre-equilibrated 
with buffer A at a flow rate of 2 mL/min. Elution was performed using a linear gradient of 0 
to 10 mM nicotine amide adenine dinucleotide (NAD) in buffer A, pH 8.5 (buffer B) (Saad et 
al., 2009). 
5.2.10   assessment of tHe gLycosyLation state of gapDH (Lgg_00933)
Glycosylation of GAPDH in the different proteome fractions of L. rhamnosus GG was tested 
using the Pro-Q® Emerald 488 Glycoprotein Gel Stain Kit (Molecular Probes®) on 1D gels, as 
described earlier (Lebeer et al., 2012b). Gels were imaged using a Typhoon 9400 laser scanner 
(GE Healthcare). Gels were post-stained with Sypro® to visualize the proteins. Confirmation 
that the bands corresponded to GAPDH was obtained by Western blots developed with GAPDH 
yeast antibody (Nordic Immunology). The high level of conservation among GAPDH proteins 
justified usage of this antibody in general and binding of this antibody to purified GAPDH of 
L. plantarum CMPG5300 ((Malik et al., 2014) & personal communication S. Malik) further 
confirmed this.
5.3 resuLts
5.3.1   Design of tHe workfLow
Our workflow to map the glycoproteome of a bacterium is depicted in figure 1. In short, the 
fractionated proteome was screened for glycosylation using a combination of 2D PAS gels and 
lectin probed 2D blots (Fig. 5.1).
As the proteome of bacteria is quite large (e.g. over 3000 proteins in L. rhamnosus GG 
(Kankainen et al., 2009)), 2D electrophoretic images can become (over)crowded with spots. 
In order to end up with interpretable gels and to generate clues on the cellular localization of 
glycosylated proteins, we designed a protocol to fractionate the proteome of L. rhamnosus GG 
in four subcellular fractions: cytosol (Cyt), cell wall/membrane (CWCM), cell wall-associated 
(CWA) and secreted protein (SP) fraction. After 2D electrophoresis, the gels were stained 
using PAS. This glycostain oxidizes the alcohol groups of the sugars, forming aldehydes that 
react with the Schiff base resulting in a color reaction (Fairbanks et al., 1971). The commercial 
version of this stain, the Pro-Q® Emerald 488 (Molecular Probes®) was applied, as this stain 
has a higher sensitivity (Hart et al., 2003). The same gels can then be post stained with non-
specific Sypro® Ruby protein stain to visualize all proteins. An example is represented for the 
cytosol in figure 5.2.
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Figure 5.1 – Overview of the workflow
The here-presented workflow relies on the combination of proteome fractionation and 2D screening for potential 
glycoproteins. The proteome was fractionated in such a way that it was subdivided in four fractions. Centrifugation 
of an overnight culture of L. rhamnosus GG separated the secreted proteins (SP) from the cells, which were subjected 
to LiCl treatment resulting in the cell wall-associated proteins (CWA). The final sonication and ultracentrifugation 
steps result in the proteins present in the cell wall/membrane (CWCM) and the cytosol (Cyt). 2D gel electrophoresis 
resulted in a distinct 2D pattern for each fraction (cf. Sypro® stained gel pictures). The 2D separated proteomes 
were subjected to both PAS staining and lectin probing with GNA, which specifically binds mannose residues. The 
combination of positive hits from both assays was identified via LC-MS/MS, which resulted in a list of candidate 
glycoproteins. This list was further refined by scoring all hits with a ‘glycosylation scoring’ which rendered a list 
of 41 glycosylated proteins in L. rhamnosus GG. The glycosylation scoring system enabled the classification of the 
glycosylated proteins in top confidence hits (6), high confidence ones (11) and putative glycosylated proteins (25). 
Additionally, the initial fractionation of the proteome resulted in clues on the localization of these glycoproteins. The 
full list of identified glycoproteins and all additional generated data can be consulted in table 5.1. 
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Figure 5.2 - Glycoproteins are ubiquitously present in the cytosolic fraction of the L. rhamnosus GG 
proteome
2D electrophoresis of the cytosolic fraction of the proteome of L. rhamnosus GG is shown. On these gels the proteins 
are first separated according to their isoelectric point in the first dimension, followed by molecular weight separation 
in the second dimension. The left panel shows the gel stained with the total protein Sypro® and thus depicts the 
cytosolic proteome. The same gel was screened for glycoproteins using the Pro-Q® Emerald 488 staining kit (PAS 
staining) (right panel). These gels illustrate the presence of glycoproteins in the cytosolic fraction of the proteome 
of L. rhamnosus GG. Similar gels were obtained for the other functional proteome fractions, i.e. secreted, cell wall/
membrane and cell wall-associated proteins (available on request). 
The robustness of the PAS screening was increased by the design of a set of rules to select 
PAS reactive spots for further identification by mass spectrometry. Abundantly present 
proteins might, for instance, cause an overinterpretation of the PAS signal of the spot. This 
problem was bypassed by calculating the ratio of the relative intensity and volume percentage 
of the glycostained versus the protein stained spot. These values are generated by the analysis 
software, and represent the intensity and distribution of this intensity relative to the area of the 
spot respectively. Only spots in which the ratio of the relative intensity or volume percentage 
was higher than 1, i.e. a significantly higher Pro-Q® Emerald 488 than Sypro® signal, were 
picked for further analysis. This list was further extended by addition of PAS stained spots 
with a relative intensity higher than 20%, to ensure not to miss heavily glycostained spots. 
This last step largely corroborated the earlier selected spots, but ensured the inclusion of spots 
that were heavily stained with both stains.
The same subproteome fractions were also subjected to lectin probing to complement the PAS 
screening. Lectins are known to bind glycans in a more selective manner, i.e. recognizing 
specific sugars in specific configurations and linkages, while the PAS staining method detects 
all glycoconjugates (Van Damme et al., 2011). The mannose specific lectin GNA was applied 
to the Western-blotted subproteome fractions. Mannose is a typical sugar incorporated in 
surface glycans by L. rhamnosus GG, i.e. the Msp1 glycoprotein and exopolysaccharides 
(Lebeer et al., 2012b; Lebeer et al., 2009). The lectin GNA was chosen over Concanavalin A 
(glucose and mannose specific), as GNA resulted in a lower background signal (results not 
shown). Positive spots were picked after matching them to Sypro® stained gels. Overall the 
GNA-reactive spots accorded well with the results of the PAS staining (results not shown). 
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5.3.2   functionaL proteome fractionation
Application of the workflow to L. rhamnosus GG cells resulted in 2D gels with distinct patterns 
for the four fractions, which illustrates the efficacy of the fractionation process (results shown 
for the cytosol in Fig. 5.2.). The numerous spots visualized on the PAS stained gel illustrate 
the presence of glycoproteins in this cellular fraction. In total, eight glycoproteins were 
found exclusively in the cytosol (Table 5.1 & Fig. 5.2.). Moreover, the occurrence of the 
specific glycoproteins in each fraction was reproducible. In table 5.1, an overview is given 
of all identified glycoproteins and a dot (l) indicates the occurrence of a glycoprotein in the 
same fraction in each repetition of the experiment. The actual robustness of the proteome 
fractionation is probably even higher, as only hits with a glycosylation score higher than 2 
were now included in the table. 
A nice illustration of the robustness of the fractionation process is the fact that all five transport-
related glycoproteins (Table 5.2) were identified in the cell wall/membrane fractions (Table 
5.1). Another example is the three closely related glycoproteins Msp1 (LGG_00324), Msp2 
(LGG_00031) and LGG_02016, being cell wall hydrolases. The function of Msp1 and Msp2 
as cell wall hydrolases has previously been validated experimentally (Claes et al., 2012), in 
agreement with their main occurrence on the cell surface and secreted protein fractions of 
the proteome. Also consistent with their cellular function is the occurrence of glycosylated 
proteins involved in carbohydrate metabolism, transcription, translation and stress response in 
the intracellular fraction of the proteome (Cyt) (Table 5.1 and 5.2).
Quite peculiar though is the presence of Eno (LGG_00936), GapA (LGG_00933), Pgk 
(LGG_00934) and Tig (LGG_01351) in the extracellular fractions (CWCM, CWA and SP). 
Although the main functions of these proteins reside in the cytosol, their surface localization 
was already reported earlier (Deepika et al., 2012; Saad et al., 2009). This ‘aberrant’ localization 
suggests a moonlighting role for these proteins (Deepika et al., 2012; Izquierdo et al., 2009; 
Jeffery, 2003; Sanchez et al., 2009a), which has already been documented in other species 
for the glycolytic enzymes Eno, GapA and Pgk (Castaldo et al., 2009; Granato et al., 1999; 
Henderson, 2014; Kinoshita et al., 2008a; Kinoshita et al., 2008b; Sanchez et al., 2009a).
In total we were able to identify 15 cytosolic putative glycoproteins, 28 glycoproteins in 
the CWCM fraction, 17 cell wall-associated proteins and 5 secreted ones (Table 5.1). 
Nevertheless, although we illustrated that these fractions are quite robust and confirm earlier 
protein localizations, we are aware that some leakiness of fractions cannot be ruled out. 
Implementation of controls is hard, as proteins that were once thought to be typical for the 
cytosol, are now also discovered in other fractions and appear to be moonlighting proteins.
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5.3.3   gLycoprotein iDentification
To circumvent the fact that most picked spots contain multiple proteins, a ‘glycosylation 
scoring’ system was implemented to identify genuinely glycosylated targets. Only proteins 
identified on the presence of at least two peptides were taken into account in our dataset. The 
‘glycosylation score’ was conceived as a cumulative index: the confidence of the glycosylation 
status of a protein increases when a) the candidate glycoprotein is detected in both repetitions 
of the experiment (3 points), b) a protein is identified alone in a PAS-/GNA-reactive spot 
(2 points) and c) a protein is a top hit (highest mascot score) in a reactive spot in which no 
other glycoproteins are present (1 point). Based on this score, the putative glycoproteins were 
divided in three categories: top confidence hits (>10), high confidence glycoproteins (>4) 
and putative glycosylated proteins (>2). Proteins with a lower score were discarded from the 
dataset. 
In total, our workflow (Fig. 1) resulted in the identification of one or more proteins in more 
than 230 PAS/lectin reactive spots through LC MS/MS (full datasets for each fraction are 
available as supplementary tables 1-8). The glycosylation score allowed filtering this dataset 
and selecting 41 glycosylated proteins in L. rhamnosus GG, which are presented in table 1. 
Among the six glycoproteins that were identified with top confidence, the earlier identified 
and experimentally validated Msp1 protein was found (Lebeer et al., 2012b). Moreover, 24 of 
the identified glycoproteins could be validated in independent experiments, i.e. confirmation 
of the glycosylation status of proteins in independently performed lectin blots and PAS 
screenings (results not shown, cf. ‘Independent observation’ column in table 1) or by other 
mass spectrometry based approaches. 
We do acknowledge that our approach, i.e. the implementation of strict rules at several steps 
of the screening process, most probably neglects some glycoproteins, rendering some false 
negatives. 
5.3.4   generaL trenDs in protein gLycosyLation
When looking at the list of identified glycoproteins, some major trends can be delineated. For 
instance, we already mentioned the high number of glycolytic enzymes that were found to be 
glycosylated (Table 5.1). The list of glycoproteins was mined for glycoproteins involved in 
similar processes (cf. KEGG database), which were grouped in functional classes. The result 
is depicted in figure 5.3 and table 5.2.
The identified glycoproteins can be organized in eight classes reflecting their functional 
role in L. rhamnosus GG. The largest set of glycoproteins (27%) comprises carbohydrate 
metabolism-related proteins (Fig. 3). The second largest subset of glycoproteins is involved in 
protein synthesis (22%), particularly in amino acid metabolism en translation processes. Other 
apparent trends are the glycosylation of transport- (12%) and stress-related (15%) proteins. 
Smaller classes contain cell division-related glycosylated proteins (10%), redox enzymes 
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(5%), members of the transcription machinery (5%) and an enzyme involved in nucleotide 
metabolism.
`
                                                                   
Figure 5.3 - General trends among glycoproteins identified in L. rhamnosus GG
This pie chart depicts the relative abundance of glycoproteins of each general trend that can be delineated in the 
glycoproteome of L. rhamnosus GG. For a more detailed view on the proteins present in these specific classes, the 
reader is referred to table 5.2. 
5.3.4.1   carboHyDrate metaboLism
A striking 27% of the identified glycoproteins (11/41) can be linked to the metabolism of 
carbohydrates. Within this group, the largest portion of hits originates from glycosylated 
glycolytic enzymes (17%). Moreover, most of them were classified as high and even top 
confidence glycoproteins according to our glycosylation scoring. An additional set of 
glycosylated targets (10%) are involved in the general carbohydrate metabolism. This high 
number of glycosylated carbohydrate metabolizing enzymes might point towards a feedback 
loop in glycoprotein production and general sugar metabolism. Intuitively, the presence of 
such a level of ‘self’ regulation would make sense. Whether this hypothesis is indeed correct 
and if this trend can be validated in other species too, remains to be investigated.
Intriguingly, for some glycolytic enzymes (GapA, Eno and Pgk) an extra moonlighting 
function has been reported previously. Next to their glycolytic activity these enzymes also 
play role in binding to the extracellular environment (Castaldo et al., 2009; Granato et al., 
1999; Henderson, 2014; Kinoshita et al., 2008a; Kinoshita et al., 2008b; Sanchez et al., 
2009a). These proteins have potentially also a moonlighting role in L. rhamnosus GG as 
many observations were made in closely related lactobacilli (Castaldo et al., 2009; Granato 
et al., 1999; Kinoshita et al., 2008a; Kinoshita et al., 2008b). This hypothesis is substantiated 
by the occurrence of these glycoproteins in the extracellular fractions of the proteome of L. 
rhamnosus GG in this (Table 5.1) and previous studies (Deepika et al., 2012; Saad et al., 
2009; Sanchez et al., 2009a; Sanchez et al., 2009b).
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Table 5.2 – General trends in the glycoproteome of L. rhamnosus GG
Locus tag Accession n° Annotation Confidence
Carbohydrate: glycolysis (-related enzymes)
LGG_00933 gi|258507928 GapA; glyceraldehyde-3-phosphate dehydrogenase Top
LGG_00934 gi|258507929 Pgk; phospholycerate kinase Top
LGG_00936 gi|258507931 Eno; phosphopyruvate hydratase Top
LGG_01374 gi|258508369 PfkA; 6-phosphofructokinase Putative
LGG_01375 gi|258508370 Pyk; pyruvate kinase High
LGG_02138 gi|258509133 GpmA; phosphoglyceromutase High
LGG_02523 gi|258509518 Ldh; L-lactate dehydrogenase Top
Carbohydrate metabolism: general
LGG_00418 gi|258507413 Tal; transaldolase Putative
LGG_01997 gi|258508992 RmlB; dTDP-glucose 4,6-dehydratase Putative
LGG_02039 gi|258509034 RmlC; dTDP-4-dehydrorhamnose 3,5-epimerase High
LGG_02575 gi|258509570 LacD; tagatose-1,6-diphosphate aldolase Putative
Protein synthesis: amino acid metabolism and translation
LGG_00255 gi|258507220 SerA; 2-hyroxyacid dehydrogenase Putative
LGG_01628 gi|258508623 RpsB; 30S ribosomal protein S2 Putative
LGG_01670 gi|258508665 Fmt; methionyl-tRNA formyltransferase Putative
LGG_01717 gi|258508712 PheT; phenylalanyl-tRNA synthetase subunit beta Putative
LGG_02277 gi|258509272 RplJ; 50S ribosomal protein L10 Putative
LGG_02332 gi|258509327 GltX; glutamyl-tRNA synthetase Putative
LGG_02493 gi|258509488 FusA; elongation factor G (EF-G) High
LGG_02472 gi|258509467 RplF; 50S ribosomal protein L6 Putative
LGG_02475 gi|258509470 RplE; 50S ribosomal protein L5 Putative
Stress & chaperones
LGG_01351 gi|258508346 Tig; trigger factor Putative
LGG_01604 gi|258508599 DnaK; molecular chaperone High
LGG_02234 gi|258509229 MutL; DNA mismatch repair protein Putative
LGG_02239 gi|258509234 GroEL; chaperonin GroEL High
LGG_02643 gi|258509638 RecA; recombinase A Putative
LGG_02806 gi|258509801 HtrA; serine protease High
Transport
LGG_00078 gi|258507073 OpuCa; glycine/betaine/L-proline ABC transporter ATP-binding 
protein
High
LGG_00951 gi|258507946 MalE; sugar ABC transporter substrate-biding protein Putative
LGG_01181 gi|258508176 AtpA; F0F1 ATP synthase subunit alpha Top
LGG_02009 gi|258509004 GlnQ; amino acid ABC transporter ATP-biding protein Putative
LGG_02419 gi|258509414 MtsA; manganase ABC transporter substrate-binding protein Putative
Cell division related proteins
LGG_00031 gi|258507026 Msp2 (p40); surface antigen High
LGG_00257 gi|258507252 MurE; UDP-N-acetylmuramoylanalyl-D-glutamate--2,6-
diaminopimelate ligase
Putative
LGG_00324 gi|258507319 Msp1 (p75); cell wall-associated glycoside hydrolase (NLP/P60) Top
LGG_02016 gi|258509011 Surface antigen NLP/P60 High
Redox
LGG_00634 gi|258507629 Dyp-type peroxidase family protein Putative
LGG_02424 gi|258509419 YmjC; NAD-dependent epimerase/dehydratase Putative
Transcription
LGG_01615 gi|258508610 NusA; transcription elongation factor Putative
LGG_02498 gi|258509493 RpoB; DNA-directed RNA polymerase subunit beta Putative
Nucleotide metabolism
LGG_01474 gi|258508469 NrdE; ribonucleotide-diphosphate reductase subunit alpha Putative
Other 
LGG_01900 gi|258508895 Hypothetical protein Putative
Locus tag: gene identifier of the glycoprotein. Accession number: gi identifier of the glycoprotein. Annotation: 
annotation as in current genome release of GenBank (NC_013198.1). Confidence: level of certainty with which the 
glycoprotein was identified (cf. Table 5.1).
124
sy
st
em
at
ic
 e
xp
lo
ra
tio
n 
of
  t
he
 g
ly
co
pr
ot
eo
m
e 
of
 a
 b
en
efi
ci
al
 g
ut
 is
ol
at
e
5.3.4.2   protein syntHesis: amino aciD metaboLism anD transLation
Proteins involved in protein metabolism, more in particular in amino acid metabolism and 
translation processes, are largely represented among the glycosylated proteins identified 
(22%, Fig. 5.3). We could identify four glycosylated ribosomal proteins, as well as enzymes 
involved in the regulation of methionine, phenylalanine and glutamate metabolism (putative 
glycoproteins). The last protein in this class is the elongation factor G or FusA protein. 
Glycosylation of this elongation factor was already reported earlier in the model organism for 
bacterial glycosylation C. jejuni (Young et al., 2002) and in Helicobater pylori (Champasa 
et al., 2013). It is intriguing that members of the largest bacterial multienzyme complex, 
the ribosome, are glycosylated, since glycosylation of members of protein complexes has 
previously been observed or suggested for several other complexes (Tytgat & Lebeer, 2014). 
5.3.4.3   stress-reLateD proteins anD cHaperones
Glycosylation of chaperones was already reported in several bacteria: L. plantarum WCFS1 
(Fredriksen et al., 2013), B. fragilis (Fletcher et al., 2009), H. pylori (Champasa et al., 2013) 
and Francisella tularensis (Balonova et al., 2010). Our analysis resulted in the identification 
of no less than six glycosylated proteins that have a chaperone or stress response-related 
activity (Table 5.2). Glycosylation of the DnaK chaperone confirms the earlier reports in L. 
plantarum WCFS1 (Fredriksen et al., 2013), H. pylori (Champasa et al., 2013)  and F. tularensis 
(Balonova et al., 2010). Another chaperonin, GroEL, was also found to be glycosylated in F. 
tularensis (Balonova et al., 2010) and H. pylori (Champasa et al., 2013) . Taken together, this 
might point towards a specific role or importance of the glycosylation of chaperones. It is 
conceivable that glycosylation of these proteins enhances their stability. Nonetheless, further 
confirmation of this emerging trend is needed with functional data in different bacteria. 
RecA, encoding a recombinase important for DNA repair processes, was also found to be 
glycosylated in L. rhamnosus GG. The protein was isolated from the CWCM fraction and 
in view of this function, it can be envisaged that it is associated to the cytosolic fraction of 
the membrane. Our result corroborates a report from 2004 on the glycosylation of the RecA 
recombinase of H. pylori, which was one of the first reports on the occurrence of intracellular 
glycoproteins (Fischer & Haas, 2004). We nevertheless want to stress that leakiness of the 
fractions is a factor that needs to be taken into account and further validation is required. 
5.3.4.4   transporters
12% (5/41) of the retrieved glycoproteins are transporters or transport-related proteins (Fig. 
5.3 and table 5.2). Glycosylation of ABC transporters and their related proteins seems thus to 
be a general trend among our results. Two of the five glycosylated transporters are moreover 
linked to the transport of amino acids. This is in agreement with the reports on the glycosylation 
of membrane-associated transporters in C. jejuni (Scott et al., 2011) and ABC transporters in 
N. gonorrhoea (Vik et al., 2009) and H. pylori (Champasa et al., 2013). Moreover, some 
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of the glycosylated transporters reported in these species are also linked to the amino acid 
metabolism of the cells.  
5.3.4.5   ceLL Division-reLateD proteins
A common trend in lactobacilli, which are known to glycosylate proteins, is the glycosylation 
of cell wall hydrolases like the Msp1 glycoprotein of L. rhamnosus GG (Lebeer et al., 2012b) 
and related autolysins and cell wall hydrolases in L. plantarum WCFS1 (Fredriksen et al., 
2012; Rolain et al., 2013), L. lactis (Huard et al., 2003) and L. buchneri (Anzengruber et 
al., 2013). In this work, the glycosylation of the cell wall hydrolase and probiotic effector 
Msp1 was further independently confirmed. Furthermore we report on the glycosylation of the 
closely related probiotic effector Msp2 surface antigen (p40) and LGG_02016, both identified 
with high confidence. Our group proved earlier that the rather extensive glycosylation of 
Msp1 improves its stability, but might hamper its activity compared to the closely related 
Msp2 protein (Lebeer et al., 2012b; Yan et al., 2007). 
5.3.4.6   reDox-reLateD proteins anD otHer cLasses
Glycosylation of redox-related proteins has been proven already for a number of species, 
including C. jejuni (Ding et al., 2009; Scott et al., 2009; Young et al., 2002), N. gonorrhoea 
(Vik et al., 2009), H. pylori (Champasa et al., 2013) and F. tularensis (Balonova et al., 2010). 
Here we report on the glycosylation of two cytosolic redox-related proteins in L. rhamnosus 
GG (Table 5.2). 
Smaller classes of glycosylated proteins in L. rhamnosus GG include transcription- (2 
glycoproteins) and nucleotide metabolism-related proteins (1). One protein could not be 
attributed to a specific class (LGG_01900), as the role of this protein is currently unknown. 
5.3.5   Confirmation of GAPDH glycosylation underlines the efficacy of the 
workflow
The LGG_00933 encoded glyceraldehyde 3-phosphate dehydrogenase (GAPDH), GapA, is a 
well-conserved glycolytic enzyme, catalyzing the conversion of glyceraldehyde 3-phosphate 
to D-glycerate 1,3-phosphate. Apart from this canonical function, several moonlighting roles 
have been attributed to this enzyme, especially in eukaryotes (Henderson, 2014; Henderson 
& Martin, 2014). In Prokarya, and more in particular in two L. plantarum strains, this protein 
has been implicated in binding of the bacterium to mucin, human blood antigens and the 
intestinal epithelial cell line Caco-2 (Kinoshita et al., 2008a; Kinoshita et al., 2008b; Ramiah 
et al., 2008). These findings might be valid in L. rhamnosus GG too, as L. plantarum bacteria 
are close relatives and earlier papers also report on the presence of GapA in the extracellular 
fractions of the L. rhamnosus GG proteome (surface and secretome) (Deepika et al., 2012; 
Sanchez et al., 2009a; Sanchez et al., 2009b). Nevertheless, further research is necessary to 
validate this hypothesis. 
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Our results reflect the ubiquitous presence of GapA, as this protein was identified in all four 
proteome fractions for both repetitions of the experiment, illustrating the robustness of the 
workflow (Table 5.1). These findings also corroborate earlier reports on the extracellular 
presence of GapA (Deepika et al., 2012; Saad et al., 2009; Sanchez et al., 2009a; Sanchez et 
al., 2009b), which further substantiates the moonlighting data (Henderson, 2014; Kinoshita et 
al., 2008a; Kinoshita et al., 2008b; Ramiah et al., 2008). 
The GapA enzyme was subsequently purified from all four proteome fractions to confirm its 
glycosylation status as a validation of the used approach. Gel filtration chromatography resulted 
in GAPDH enriched samples for each of the four different fractions. This is exemplified for 
the cytosolic GAPDH enrichment depicted in figure 5.4: the Sypro® stained gel and GapA 
antibody blot show no other bands than the one of the LGG_00933 protein. Furthermore, this 
protein reacts strongly with the PAS stain. The GapA purified from the other three fractions 
generated similar results (results not shown). 
Figure 5.4 - The LGG_00933 protein, GapA, is glycosylated
Glyceraldehyde 3-phosphate dehydrogenase (GapA) was isolated from all four fractions of the L. rhamnosus GG 
proteome. Here the results for the cytosol are depicted. The first panel shows the positive reaction of the protein with 
the GapA antibody. The protein stained (Sypro® stain) gel fragment shows the abundant presence of the enriched 
protein on 1D SDS-PAGE after successful purification of the protein from the proteome. Glycosylation of the GapA 
protein in the cytosolic fraction can be inferred from the strong positive signal of the protein with the Pro-Q® Emerald 
488 dye, which is the commercial version of the Periodic acid Schiff base stain method for glycans. Glycosylation was 
also proven for GapA enriched from the other fractions of the proteome of L. rhamnosus GG (results not shown). 
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Taken together, this independent analysis of purified GapA demonstrates the robustness and 
efficacy of the proposed workflow, as the glycosylation of this protein could be confirmed in 
all four fractions of the L. rhamnosus GG proteome. This is, to our knowledge, the first report 
on the glycosylation of this enzyme.
5.4 Discussion
Here we provide new insights in the glycoprotein repertoire of bacteria by implementing 
a robust and widely applicable workflow to screen glycoproteins (Fig. 5.1). This study 
complements our earlier work on the mapping of glycosyltransferases and their potential role 
(Sanchez-Rodriguez et al., 2014). The methodology makes use of well-established proteomic 
tools such as 2D electrophoresis and mass spectrometry and combines these techniques with 
glycoprotein identification assays, like the PAS glycostain method and lectin probing. More in 
particular the PAS glycostain was used as a general screening method, whilst the lectin probing 
was implemented as lectins bind selectively to sugar monomers in specific configurations. 
Here, the mannose specific lectin GNA was used, as prior work indicated that mannose is 
present in surface glycans of L. rhamnosus GG (Lebeer et al., 2012b; Lebeer et al., 2009), but 
the choice of the lectin will depend on the species/strains.
The vigorous assessment of the data resulted in the identification of 40 new glycoproteins in 
the microbiota isolate L. rhamnosus GG (Table 5.1). The glycosylation of these proteins was 
experimentally shown by two independent methods (PAS staining and lectin blotting), but 
should be confirmed by other complementary methods such as thorough MS analysis of the 
purified proteins and their attached glycans. Moreover, the way the workflow was conceived 
also made it possible to acquire data on the localization of these glycoproteins. While most 
glycoproteins were identified in the CWCM fraction, this particular way of breaking down the 
proteome in different fractions also allowed to confirm the presence of several glycosylated 
proteins in the cytosol (Fig. 5.2). This latter finding corroborates some scarce earlier reports 
(Fischer & Haas, 2004; Fredriksen et al., 2012), but is -to our knowledge- one of the first 
reports on the general occurrence of glycosylated proteins in the cytosol of bacteria. The 
fractionation process was found to be quite robust, since repetition of the experiment showed 
similar results (Table 1) and confirmed earlier reports on protein localization in L. rhamnosus 
GG (Deepika et al., 2012; Sanchez et al., 2009a; Sanchez et al., 2009b). For instance, 
transport-related glycoproteins were indeed identified from the CWCM fraction, while proteins 
implicated in translation and transcription processes are predominantly found intracellularly. 
A peculiar finding was the presence of some glycolytic enzymes, i.e. GapA, Eno and Pgk in 
the extracellular fractions of the proteome. However this result is in accordance with earlier 
localization studies (Deepika et al., 2012; Saad et al., 2009; Sanchez et al., 2009a; Sanchez 
et al., 2009b) and corroborates their moonlighting role (Henderson & Martin, 2014). Protein 
glycosylation might be a regulator of these proteins, i.e. it could act as a switch between their 
canonical and moonlighting role in the cell. Further research will shed light on the plausibility 
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of these hypotheses, but the observation of the glycosylation of these moonlighting proteins 
is intriguing. 
The earlier experimentally validated glycosylated Msp1 protein of L. rhamnosus GG was 
found, as expected, among the top confidence hits of the analysis (Lebeer et al., 2012b). The 
glycosylation of similar cell wall hydrolases was already reported in closely related species, like 
L. plantarum WCFS1 (Fredriksen et al., 2012; Rolain et al., 2013), L. buchneri (Anzengruber 
et al., 2013), L. lactis (Huard et al., 2003) and Streptococcus faecium (Kawamura & Shockman, 
1983). In this work we also report on the glycosylation of two closely related enzymes of Msp1, 
namely Msp2 and LGG_02016 (Table 5.1). Taken all these reports together, this might point 
towards a general trend, at least in lactobacilli. Glycosylation might be used by lactobacilli 
to fine-tune the functionality of these potentially autolytic enzymes related to cell division. 
This hypothesis is supported by the finding that L. plantarum WCFS1 utilizes glycosylation 
of the Msp1 homologue, Acm2, as a negative modulator of its enzymatic activity (Rolain et 
al., 2013). Another potential explanation is the usage of glycosylation as a switch between the 
canonical role of these enzymes (i.e. cell division) and a potential moonlighting role. These 
hypotheses can be valid for Msp1 (and Msp2). In addition to their bacterial role as cell wall 
hydrolases (Claes et al., 2012), Msp1 and Msp2 are also reported to modulate the survival of 
intestinal epithelial cells after secretion and are thus probiotic effectors of L. rhamnosus GG 
(Yan et al., 2011; Yan et al., 2007). In this respect, it was reported earlier that Msp1 is less 
active than its close Msp2 homologue, which was long thought to be non-glycosylated (Lebeer 
et al., 2012b; Yan et al., 2007). However, in this study, we used a more sensitive approach 
that resulted in the unambiguous identification of Msp2 glycosylation in independent samples. 
Probably, the glycan modifying Msp2 is much smaller than the one present on Msp1 causing 
a large molecular weight shift (ca. 75 kDa on SDS-PAGE vs. 48 kDa theoretically predicted) 
(Lebeer et al., 2012b), explaining the previous unsuccessful attempts to identify Msp2 as 
glycoprotein, but this needs to be further investigated by sophisticated glycan MS methods. 
Here we identified Msp2 as a glycoprotein in both repetitions of the experiment (one time with 
a significant glycosylation score, cf. table 1) and in an independent GNA-screening (results 
not shown). Further research is necessary to confirm if glycosylation of cell wall hydrolases 
is really a general trend in lactobacilli or even in bacteria in general and to delineate the 
functional importance of their glycosylation. 
Another trend that could be inferred from the results was the high number of 
glycosylated enzymes of the carbohydrate metabolism, mostly glycolytic enzymes 
(7/11) (Table 5.2). Their glycosylation needs to be further substantiated by independent 
glycan assays, as it is possible that our observations result from the fact that these 
enzymes bind thier substrate, i.e. sugars. Neverthless, we envisage that loosely bound 
sugars will have been removed during the various washing steps of the protocol. 
Among them is the glyceraldehyde 3-phosphate dehydrogenase, GapA (LGG_00933), which 
we further purified to confirm its glycosylation. This enzyme is, albeit its intracellular 
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glycolytic role, present in all four fractions of the glycoproteome (Table 5.1) and was found 
to be glycosylated in all four protein fractions (Fig. 5.4). The ubiquitous presence of this 
enzyme, even in the extracellular fractions of the proteome, corroborates earlier reports on its 
moonlighting role (Henderson, 2014; Kinoshita et al., 2008a; Kinoshita et al., 2008b; Ramiah 
et al., 2008). Another interesting glycosylated enzyme is the L-lactate dehydrogenase encoded 
by LGG_02523. Albeit the presence of other homologues of this enzyme in the L. rhamnosus 
GG genome, this seems to be –at least under the tested conditions– the only glycosylated one. 
Earlier research showed that this class of enzymes is regulated by different mechanisms in 
lactic acid bacteria (Feldman-Salit et al., 2013). Whether glycosylation can be added to this 
list, remains to be further substantiated. 
Our results correlate well with earlier studies of bacterial glycoproteomes, with respect to the 
nature of the glycosylated proteins we report. For instance, screenings in C. jejuni (Ding et 
al., 2009; Scott et al., 2009; Young et al., 2002), B. fragilis (Fletcher et al., 2011), H. pylori 
(Champasa et al., 2013) and N. gonorrhoea (Vik et al., 2009) resulted in the identification of 
several transport-related proteins as glycoproteins, which corroborates our analysis in which 
12% of the identified glycoproteins belong to this class in L. rhamnosus GG (Fig 5.3 & 
Table 5.2). Also the glycosylation of chaperones, like DnaK, is substantiated by results of 
L. plantarum WCFS1 (Fredriksen et al., 2013), H. pylori (Champasa et al., 2013) and F. 
tularensis (Balonova et al., 2010). Glycosylation of proteins involved in redox processes also 
seems to be a general trend, as this now has been reported in four distinct bacteria ((Balonova 
et al., 2010; Ding et al., 2009; Scott et al., 2009; Vik et al., 2009; Young et al., 2002) & 
Table 5.2). Apart from our report of their glycosylation in L. rhamnosus GG, similar findings 
emerged from glycoproteome screenings of C. jejuni (Ding et al., 2009; Scott et al., 2009; 
Young et al., 2002), F. tularensis (Balonova et al., 2010), H. pylori (Champasa et al., 2013) 
and N. gonorrhoea (Vik et al., 2009). Future analyses of glycoproteomes of a wider diversity 
of bacterial species will unveil if these trends can be further generalized for bacteria or a 
subset of species. 
It is intriguing that members of the largest bacterial multienzyme complex, the ribosome, seem 
to be glycosylated. Maybe this glycosylation plays a role in the regulation of the ribosome 
assembly and the timing of translation. Further research is needed to further substantiate the 
glycosylation of these proteins and to shed light on the potential role of their glycan modifications. 
The identified glycoproteins are interesting targets to study in more detail for their 
immunogenic and host-interaction potential, especially for the hits in the extracellular sections 
of the proteome. Very peculiar targets to study further are the moonlighting proteins, like the 
glycolytic enzymes GapA, Pgk and Eno. Especially as their predicted/proven moonlighting 
role is related to host interaction, i.e. mucin binding, binding to epithelial cells, etc. (Castaldo 
et al., 2009; Granato et al., 1999; Henderson, 2014; Kinoshita et al., 2008a; Kinoshita et al., 
2008b; Sanchez et al., 2009a).
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5.5 concLusions
In this work, a new workflow is presented to map the glycoproteome of a bacterium in a 
way that provides information on the cellular localization of the glycosylated targets. We 
were able to identify 41 glycoproteins, which are important for the cellular physiology. Most 
glycoproteins were recovered from the cell wall/membrane fraction, but we also confirm the 
presence of glycoproteins in the cytosol. Moreover, our research generated some new insights 
in the role glycosylation can play in enzyme regulation. This analysis provided a list of targets 
that might play an important role in the interactions between the well-documented microbiota 
isolate and model probiotic strain L. rhamnosus GG on the one side and the human gut on the 
other side.
5.6 suppLementary information
PAS/lectin reactive spots identified with LC MS/MS for each fraction (SP, CWCM, CWA and 
Cyt) for each repetition of the experiment. Available on request.
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abstract
Pili are important proteinaceous cell wall appendages with a well-documented role in adhesion. 
While pili from Gram-positive bacteria are modified posttranslationally by sortase-specific 
cleavage reactions and intramolecular peptide bonds, we here report on a new posttranslational 
modification by glycosylation of pili and its role in the immunological signaling of these pili. 
Molecular techniques were combined with nanoscale mechanical and immunological 
approaches to assess the glycosylation status of the SpaCBA pili of the model probiotic and 
beneficial microbiota isolate L. rhamnosus GG. Single-molecule force spectroscopy using 
AFM tips functionalized with different lectins showed the presence of mannose and fucose 
residues on live piliated L. rhamnosus GG cells but not on isogenic mutants lacking pili. 
Western blots probed with mannose-specific lectins and glycostained gels of purified pili 
corroborated these findings. 
Intriguingly, the pili also interact with the immune lectin receptor DC-SIGN present on 
human dendritic cells (DCs). DC-SIGN typically binds fucose and mannose residues on 
microorganisms. This interaction was further studied using both purified pili and bacterial 
cells (including a non-piliated mutant) and both cell lines that express recombinant DC-SIGN 
and monocyte-derived DCs from different donors. The pili glycans were shown to be important 
for the physical and immunological interactions of L. rhamnosus GG with DCs, in a manner 
that could be blocked with anti-DC-SIGN agents.
significance 
This first report on the glycosylation of heterotrimeric pili in bacteria opens avenues to study 
pili glycosylation in other piliated bacteria. Our work corroborates the role of pili as crucial 
interaction partners in host-microbe interactions. Their glycosylation can infer an extra level 
of specificity to these interactions as we show in this work by evidencing the importance of 
pili glycans in immune interactions. These findings substantiate the few reports on the role of 
bacterial protein glycosylation and spur the research on the functional role of glycosylated pili. 
As these findings were gathered for the microbiota isolate and model probiotic L. rhamnosus 
GG, they are of importance in the further elucidation of the fine details of host-microbe/
microbiota interactions.
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6.1 introDuction
Host-microbe interactions are crucial to life: the microorganisms of the human microbiota 
are vital for our wellbeing. Currently, several big data projects, like the Human Microbiome 
Project (HMP) and the enterotypes study, are mapping this microbial diversity (Arumugam et 
al., 2011; The Human Microbiome Project Consortium, 2012). Concurrently, it is important 
to delineate the key molecules underlying this host-microbial symbiosis. An example of such 
crucial molecules, which also came out of the enterotype study, is the pili. These cell wall 
appendages are pivotal in microorganism colonization of the host epithelium, thus increasing 
their residence time (Arumugam et al., 2011; Krogfelt, 1991). The Arumugam study reported 
on the importance of these pili in Escherichia coli adhesion (Arumugam et al., 2011), but also 
other important microbiota members are piliated, like several Firmicutes (e.g. Lactobacillus 
sp. (Kankainen et al., 2009) and Streptococcus sp. (Brittan & Nobbs, 2015)) and Actinobacteria 
(e.g. Bifidobacterium sp. (Turroni et al., 2014) and Corynebacterium sp. (Rogers et al., 2011; 
Ton-That & Schneewind, 2003)) (Arumugam et al., 2011; Soriani & Telford, 2010; The 
Human Microbiome Project Consortium, 2012). 
In view of the important role of these cell wall appendages, the understanding of their structure 
and its relation to their functional role is key to fully grasp the complexity of host-microbe 
interactions. The structure of Gram-positive pili is significantly different from Gram-negative 
species. Gram-positive pili are covalent structures assembled from multiple protein subunits 
(Kline et al., 2010; Mandlik et al., 2008; Proft & Baker, 2009). Regularly they are composed 
out of three subunits: a pilus backbone, a tip adhesin and a pilin decorating the pilus shaft 
(Mandlik et al., 2008; Proft & Baker, 2009). These subunits are posttranslationally linked by 
sortase-specific cleavage reactions and intramolecular peptide bonds. A housekeeping sortase 
then covalently binds the assembled pilus to the peptidoglycan backbone after recognition of 
an LPXTG motif (Hendrickx et al., 2011; Kang et al., 2007). Here we report on a new form of 
posttranslational modification of complex Gram-positive pili by glycosylation. 
The beneficial microbiota isolate and model probiotic strain L. rhamnosus GG is an example 
of a bacterium producing such sortase-dependent heterotrimeric pili (Douillard et al., 2014; 
Segers & Lebeer, 2014). Immuno-EM images show that these bacterial cells are covered with 
10 to 50 appendages of 1 mm in length (Kankainen et al., 2009). L. rhamnosus GG has two pili 
gene clusters in its genome, encoding two distinct pili appendages, the spaFED and spaCBA 
pili gene clusters (Kankainen et al., 2009). It is thought that only one of these gene clusters 
is actually expressed in standard laboratory conditions (Douillard et al., 2013; Reunanen et 
al., 2012). Structural studies showed that SpaA forms the pilus backbone and SpaC is the 
large tip adhesin. SpaB functions as a stop polymerization signal of the heterotrimeric pili 
and is mainly found at the pilus anchoring point, although some leaky expression across the 
pilus shaft is observed (Reunanen et al., 2012). These SpaCBA pili are important adhesive 
molecules: they are identified as the key modulators of the colonization and persistence of L. 
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rhamnosus GG in mucosa-associated niches (Douillard et al., 2013; Kankainen et al., 2009; 
Lebeer et al., 2012a; von Ossowski et al., 2010). From an immunological perspective, their 
role is less unambiguous: the pili have been shown to interact with macrophages (Vargas 
Garcia et al., 2015), seem to impact TLR-2 signaling (Douillard et al., 2013; von Ossowski et 
al., 2013) and modulate several pro- and anti-inflammatory cytokines (Lebeer et al., 2012a; 
Vargas Garcia et al., 2015; von Ossowski et al., 2013). It is currently hypothesized that the 
pili do not play an immunogenic role as such, but rather facilitate immunogenic effects of 
other surface structures by promoting close contact with host immune cells (Lebeer et al., 
2012a; Segers & Lebeer, 2014; Vargas Garcia et al., 2015). Indeed, earlier Single-Molecule 
Force Spectroscopy (SMFS) studies have shown the unique properties of the SpaCBA pili to 
control the adhesion of L. rhamnosus GG via a zipper-like mechanism in which (the broad 
specificity of) the tip adhesin SpaC plays a key role (Tripathi et al., 2013; Tripathi et al., 
2012b). The location of SpaC on the tip facilitates the initial contact of L. rhamnosus GG 
with host cells, after which SpaC molecules dispersed along the pilus shaft establish the more 
intimate contact (Tripathi et al., 2013). These SMFS studies also provided some first, although 
indirect, indications on the potential glycosylation of the SpaCBA pili of L. rhamnosus GG in 
the sense that sheared pili were shown to strongly cluster together. These strong interactions 
were thought to be lectin-glycan bonds between SpaC pilins (Tripathi et al., 2012b), although 
no experimental evidence was yet provided. 
In this work, we report on the glycosylation of the SpaCBA pili of L. rhamnosus GG and on the 
functional importance of its glycosylation. More in particular we established that the glycans 
present on these pili are key for the interaction between L. rhamnosus GG and dendritic cells 
via the immune lectin receptor DC-SIGN, which specifically recognizes fucose- and mannose- 
binding lectins. A unique multidisciplinary approach was used to describe the glycosylation 
of these pili combining nanomechanical, molecular, glycobiological and immunological 
techniques. This enabled us to present one of the few functional reports on the role of bacterial 
protein glycosylation and on the interaction of bacterial glycoproteins with immune receptors.
6.2 materiaL anD metHoDs
6.2.1   bacteriaL strains anD cuLture conDitions
L. rhamnosus GG was grown at 37°C in MRS medium (Difco) in non-shaking conditions. For 
some experiments the cells, dissolved in PBS, were heat killed by incubating them 15 minutes 
in a water bath at 60°C. 
6.2.2   Data analysis
All data analyses were performed using GraphPad Prism® 6. Significant differences between two 
values were calculated using paired t-tests and the significance level was set at p <0,05. 
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6.2.3   singLe-moLecuLe force spectroscopy
Single-molecule force spectroscopy (SMFS) experiments were performed on live L. rhamnosus 
GG bacteria using the general procedure described previously (Francius et al., 2009; Francius 
et al., 2008; Lebeer et al., 2009). Two lectins were used, i.e. the fucose-specific Aleuria 
aurantia lectin (AAL, Vector Laboratories) and the Hippeastrum hybrid agglutinin (HHA) 
to detect mannose residues (kindly provided by Prof. Els Van Damme, UGhent). Wild type 
L. rhamnosus GG (ATCC 53103) and a pili-deficient ΔspaCBA::TcR mutant (CMPG5357) 
(Lebeer et al., 2012a) were analyzed, following single centrifugation at 4000 g for 2 min. 
AFM tips were functionalized with lectins using ~6 nm long PEG-benzaldehyde linkers (Ebner 
et al., 2007). Cantilevers were first washed with chloroform and ethanol, placed in an UV-
ozone cleaner for 15 min, and immersed overnight in 5.6 M ethanolamine hydrochloride (in 
DMSO) to generate amino groups on the tip surface. The cantilevers then reacted with PEG 
linkers carrying benzaldehyde groups on their free-tangling end for 2 hours, were afterwards 
rinsed with chloroform and immersed further in 1% citric acid solution for 10 min. After 
rinsing with Milli-Q water, the cantilevers were covered with 200 mL PBS solution containing 
0.2 mg/mL lectins, to which 2 mL of a 1 M NaCNBH3 solution was added. After 50 min 
of incubation, 5 μL of a 1 M ethanolamine hydrochloride solution (pH 9.5) was added to 
block unreacted aldehyde groups (10 min). Finally, the cantilevers were washed with PBS 
and stored in the same buffer with added 1% sodium azide (NaN3), until use (within 7 days). 
SMFS measurements were performed at 25°C in PBS buffer (pH 7.4) supplemented with 1 mM 
CaCl2 and 1 mM MgCl2 using a Nanoscope VIII Multimode AFM (Bruker Corporation) and 
oxide sharpened microfabricated Si3N4 cantilevers (Microlevers, Veeco Metrology Group). 
The spring constants of the cantilevers were typically in the range of 0.02–0.04 N/m, as 
determined by the thermal noise method (Hutter & Bechhoefer, 1993). Cells were filtered 
and immobilized onto 1.2 mm diameter isopore polycarbonate membrane (Millipore). The 
membrane filter was then gently rinsed 3 times with PBS, carefully cut into ~1x1 cm2 square 
and attached to a steel sample puck using a double-sided adhesive and mounted onto the 
AFM liquid cell. Unmodified cantilevers were first used to image and localize individual 
L. rhamnosus GG cells. The unmodified cantilevers were then replaced with the lectin-
functionalized tip. Force mapping was performed by collecting a 32x32 array of force-distance 
curves on a 300–500 nm2 localized area of the cell and the two-dimensional adhesion maps 
were reconstructed using the custom analysis described previously (Sullan et al., 2014). All 
force curves were recorded at ~100 ms contact time, with a maximum applied force of 250 pN 
and 2000 nm/s approach and retraction speeds, unless specified otherwise.
6.2.4   purification of tHe spacba piLi of L. rhamnosus gg
L. rhamnosus GG cells (approx. 1011 CFU/mL) were grown in an industrial whey permeate 
based medium (Laakso et al., 2011) and were a kind gift of Dr. Tuomas Salojarvi and Dr. 
Ross Crittenden (Valio Oy Finland). Cells were concentrated by microfiltration, resulting 
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in reatining of the pili (unpublished observation). This concentrate was centrifuged for 30 
minutes at 20 000 g in an Avanti J-26 XPI high-performance centrifuge (Beckman Coulter), 
which resulted in the shearing of the pili (Tripathi et al., 2012b). The supernatant (i.e. Pili 
Raw Material or PRM) was lyophilised (Heto FD 2.5, Heto Lab Equipment) and the residue 
dissolved in 1/25 of its original volume of PBS. The resulting solution was filtered twice, 
first through a 0.45 µm Millex GS syringe-driven filter (Millipore) and then using a 0.22 µm 
Millex HA syringe-driven filter (Millipore). 3 mL aliquots of the filtrate were run through a 
120 mL Superdex 200 gel-filtration column (GE Healthcare) on a FASTA system (Pharmacia) 
using PBS as the eluent at a speed of 1 mL/min. Previous experiments had shown that the pili 
elute in the first protein peak. Based on this result, twenty-four 1 mL fractions of the eluate 
were collected per run in a 96 deepwell plate. The registration of the absorbance at 280 nm 
was used to identify the fractions with a high pili content. 
Two pools were made: Pool A, containing the six fractions of each run nearest to the top of 
the absorbance peak, and Pool B, containing the six fractions of each run following those of 
Pool A (cf. additional figure). Thus resulting in pure pili samples, with pool A having a higher 
molecular weight and purity (21 µg/mL) compared to pool B samples (9 µg/mL). Both pools 
were desalted by changing the buffer from PBS to 50 mM (NH4)2CO3/NH4HCO3 buffer, pH 
8.0 using ZebaTM Spin desalting columns, 40K MWCO (Pierce Biotechnology). The resulting 
solutions were lyophilised (Heto FD 2.5) and the residues dissolved in 1/25 of their original 
volume of PBS and stored at -20 oC. The purity of the pili preparations was assessed by 
Coomassie blue staining, dot blot and probing of the blotted samples with a specific SpaC 
monoclonal antibody (kind gift of MicroDish BV and Podiceps BV) (results not shown). The 
purified pili samples (PRM, B and A) were aliquoted in small amounts, stored at -20°C and 
thawed prior to use. 
6.2.5   purification of tHe L. rhamnosus gg msp1 protein
Native Msp1 was purified as described earlier (Lebeer et al., 2012b) using a combination of 
cationic exchange and ConA lectin affinity chromatography. Briefly, L. rhamnosus GG was 
grown for 24 h in AOAC medium. The supernatant of the culture (after centrifugation at 6 
000 g for 20 min) was loaded on a SP Sepharose HighPerformance column (GE Healthcare), 
equilibrated with 60 mM lactate buffer (pH 4.0). The column was eluted using lactate buffer 
containing a NaCl gradient (100-1000 mM). The presence of Msp1 was verified using SDS-
PAGE and the positive fractions were spin concentrated with Vivaspin filters with a MW cut 
off of 10 000 kDa (Sartorius Stedim biotech Gmbh). Msp1 was further purified from these 
positive fractions using a Hi-trap ConA 4B prepacked column (GE Healthcare). 
6.2.6   isoLation of ceLL waLL-associateD proteins
Cell wall-associated proteins were isolated from wild type L. rhamnosus GG, the ΔspaCBA::TcR 
mutant lacking pili (CMPG5357) and the ΔwelE::TcR mutant (CMPG5351) (Lebeer et al., 2009) 
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on which the SpaCBA pili are overexposed due to the absence of the thick exopolysaccharides 
layer surrounding the cells. Kankainen and co-workers (Kankainen et al., 2009) used this 
approach earlier to confirm the presence of SpaCBA pili on L. rhamnosus GG cells. Here we 
followed the same protocol to isolate the cell wall-associated proteins. The obtained fractions 
were then separated on NuPAGE® Novex® 3-8% Tris-Acetate gels (Life Technologies), which 
are specifically designed to separate high molecular weight proteins. Western blotted samples 
were probed with Msp1 antibody (kind gift of Dr. Ingemar von Ossowski, UHelsinki), SpaC 
antiserum, the mannose-specific lectin HHA (kind gift of Prof. Els Van Damme, UGhent) and 
the fucose-specific lectin AAL (Vector Laboratories) (cf. below). This assay was repeated in 
triplicate.
6.2.7   perioDic aciD scHiff gLycostain 
Purified pili fractions were separated by SDS-PAGE on commercial NuPAGE® Novex® 
3-8%  Tris-Acetate gels (Life technologies). Glycostaining was performed using the commercial 
Periodic Acid Schiff base stain Pro-Q® Emerald 488 (Molecular Probes®) following the 
manufacturer’s guidelines. Poststaining of the PAS stained gel with Sypro® Ruby stain (Molecular 
Probes®) enabled visualization of the protein content of the sample. The gels were scanned using 
a Typhoon 9400 laser scanner (GE Healthcare). Purified Msp1 was used as a positive control. 
The pili samples were also separated on Acrylamide Bis-Acrylamide gels (Amresco). The protein 
content of these samples was visualized using Sypro® stain and Silver stain (SilverQuestTM, 
Life Technologies). Glycosylation of the samples was tested using the Pro-Q® Emerald 488 
kit. Sypro® and PAS stained gels were scanned with a Typhoon 9400 laser scanner. All assays 
were performed at least in triplicate for all purified pili fractions to verify the data. 
6.2.8   Lectin anD antiboDy probing of western bLots
Purified pili samples and cell wall-associated proteins were separated by SDS-PAGE on 
Acrylamide Bis-Acrylamide gels (Amresco) and commercial NuPAGE® Novex® 3-8% Tris-
Acetate gels. These gels were electroblotted to PVDF membranes (Life technologies) as 
previously described (Lebeer et al., 2012b) and using the here mentioned tweaks. The blots 
were blocked with 0.5% polyvinylalcohol (PVA, Sigma-Aldrich®) to reduce background noise 
(Thompson et al., 2011), dissolved in TBST (20 mM Tris-HCl, 500 mM NaCl, 0.1% Tween 
20, pH 7,5) supplemented with 1 mM CaCl2 and 1 mM MgCl2 as cofactors for the lectins. All 
washing steps were performed using this TBST buffer with CaCl2 and MgCl2. The blots were 
probed with a plethora of eight digoxigenin-labeled lectins, such as the mannose-specific 
Galanthus nivalis agglutinin (GNA) and HHA (kindly provided by Prof. Els J.M. Van Damme, 
UGhent), as described in (Tytgat et al., 2014). 
Both types of gels (Tris-Acetate gels and Acrylamide Bis-Acrylamide gels) were Western 
blotted and probed with SpaC antiserum to visualize their pili content as described by 
Kankainen et al. (Kankainen et al., 2009). Each purified pili fraction was tested as described 
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at least in triplicate. 
6.2.9   Enzyme-linked lectin assay  
Purified pili (5 mg/mL, sample A) were dissolved in 50 mM sodium carbonate buffer (pH 9.6) 
and coated overnight onto ELISA plates (X50 Immunolon 4HBX plates, Thermo Scientific) 
at 4°C. For the lectin probing using the mannose-specific lectin HHA, mannan was used as 
a positive control (5 mg/mL). In the case of the fucose-specific lectin AAL, Lewis X was 
coated as a positive control (5 mg/mL) (kind gift of Prof. T. Geijtenbeek, AMC, UvA). Wells 
only containing 50 mM sodium carbonate buffer were used as negative controls for the assay.
The next day the wells were washed trice with PBS, preceding the blockage of the wells with 
0.5% PVA dissolved in TBS (Thompson et al., 2011) for 2-3h at 37°C. The wells were then 
washed three times with PBS prior to the addition of the digoxigenin-labeled lectins dissolved 
in TBS + 0.5% PVA (1h, 37°C). Unbound lectins were removed by washing the wells three 
times with PBST (PBS + 0.1% Tween 20). Then the secondary antibody, anti-digoxigenin 
(Roche) (Tytgat et al., 2014) was added to the cells for 1 hour at 37°C. Prior to development, 
the wells were washed three times with PBST. 4-nitrophenyl phosphate disodium salt (1mg/
mL, Sigma-Aldrich®) dissolved in substrate buffer (carbonate bicarbonate buffer, pH 9.6) was 
added to each well. Color was allowed to develop for 15-30 min at room temperature and the 
absorbance was measured at 405 nm. 
6.2.10    Dc-sign-fc eLisa
High-binding flat-bottom 96-well ELISA plates were coated overnight with 50 mL of 50 mg/
mL ligand dissolved in 0.2 M coating buffer at room temperature. Mannan (1 mg/mL, Sigma-
Aldrich®) was coated as a positive control, whilst plain coating buffer served as negative 
control. After two washes with TSM (20 mM TrisHCl, 150 mM NaCl, 1 mM CaCl2, 2 mM 
MgCl2) the wells were blocked with 1% BSA (Sigma-Aldrich
®) for 30 minutes at 37°C. DC-
SIGN-Fc fragments were 15 minutes preincubated with blocking agents in TSM: the D1 DC-
SIGN specific antibody (20 mg/mL) and calcium chelator EGTA (10 mM). After two more 
washes with TSM, the plate was incubated with 50 L of DC-SIGN-Fc fragments (with block) 
for 2 hours at room temperature on a shaking platform. The wells were washed four times with 
TSM with 0.1% Tween 20 (TSMT), prior to the addition of goat anti-human Fc-PO (Sigma-
Aldrich®) dissolved in TSMT (30 minutes). After six washes with TSMT, the ELISA could be 
developed using a 10 mL substrate solution of 0.1M NaAc, 100 mL TMB and 1 mL H2O2. 15 
minutes later this reaction was stopped by the addition of 50 mL H2SO4. Experimental read-
out was performed at OD450.
6.2.11    interaction between piLi-coateD beaDs, bacteria anD raji(Dc-sign) ceLL Lines
Beads were coated as described by Geijtenbeek and co-workers (Geijtenbeek et al., 1999). 
In short, streptavidin was covalently coupled to fluorescent beads (TransFluoSpheres, 
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1 μm, Alexa 488/Alexa647) and further coated by subsequent incubation with 
biotinylated Swine-anti-rabbit-antibody (20 mg/mL, 2h 37°C, Sigma-Aldrich®), SpaC 
antiserum (5 mg/mL, overnight 4°C) and purified pili (sample B, overnight 4°C). 
Bacteria were labeled with FITC (Sigma-Aldrich®) by mixing 50 mL of 1 mg/mL FITC (Sigma) 
in DMSO with 500 mL 2x108 bacteria in PBS, incubated for 1 hour at RT and washed extensively. 
Raji and Raji-DC-SIGN cells (Geijtenbeek et al., 2000a) were cultured in 
RPMI (Gibco) supplemented with 10% FCS, 2500 U/mL penicillin, 2500 
μg/mL streptomycin, 100 mM L-Glutamine and passaged twice a week. 
5x104 moDCs, Raji or Raji-DC-SIGN cells were preincubated for 30 min at 37°C with 
TSA (TSM supplemented with 0.5% Albumin), DC-SIGN specific antibody D1 (20 mg/
mL), Lewis X (20 mg/mL) or EGTA (5 mM, Sigma-Aldrich®), respectively. Next, cells 
were incubated for 1 hour with FITC-labeled bacteria at MOI 20, washed extensively, 
fixed in 4% vol/vol PFA, and analyzed on FACSCantoTM II (BD Biosciences). 
With the fluorescent beads, 5x104 moDCs, Raji or Raji-DC-SIGN cells were preincubated for 
30 min at 37°C with TSA, DC-SIGN specific antibody D1 (20 mg/mL), Lewis X (20 mg/mL), 
or EGTA (5 mM), respectively. Next, cells were incubated for 30 minutes with 3 mL beads, 
washed extensively, fixed in 4% PFA, and analyzed on FACSCantoTM II (BD, Biosciences).
6.3 resuLts
6.3.1 afm singLe-moLecuLe measurements inDicate tHat tHe L. rhamnosus gg spacba piLi are  
 gLycosyLateD witH fucose anD mannose
SMFS (Dupres et al., 2005; Hinterdorfer & Dufrene, 2006) was previously used to assess the 
nanomechanical properties of the SpaCBA pili of L. rhamnosus GG (Tripathi et al., 2013). 
Here a similar approach was followed to assess the glycosylation status of these pili on living 
L. rhamnosus GG cells using AFM tips functionalized with mannose- and fucose-specific 
lectins. These lectins were chosen based on earlier knowledge on often occurring sugars in 
microbiota members, in view of the abundance of mannose and fucose in the gut mucus, like 
the sugars present on Msp1 (Lebeer et al., 2012b) and Bacteroides fragilis (Coyne et al., 2005; 
Fletcher et al., 2009).
Fig. 6.1 shows the adhesion and rupture length histograms of the interaction of wild type L. 
rhamnosus GG cells and the ΔspaCBA::TcR mutant (CMPG5357) lacking the SpaCBA pili 
(Lebeer et al., 2012a) with the two lectin probes. On wild type cells, a substantial fraction of 
the force curves exhibited adhesion forces for the two lectin probes, suggesting the detection 
of sugar residues. Close examination of the curves revealed two adhesive behaviors. A large 
fraction of the adhesive curves featured single adhesion peaks with moderate forces, mostly 
in the 50–200 pN range (lower curve in the insets in Fig. 6.1B, 6.1D). In view of earlier 
work (Francius et al., 2008), we ascribe these events to specific lectin-sugar interactions. In 
addition, a significant fraction of the curves (from 10% to 40% depending on the cell and on 
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the probe) showed much larger adhesion forces, in the range of 500–1500 pN, and extended 
rupture lengths (500–2000 nm) (upper curve in the insets in Fig. 6.1B, 6.1D). Consistent with 
earlier work (Sullan et al., 2014; Tripathi et al., 2013), these force peaks showed linear shapes 
and constant force steps indicating that the L. rhamnosus GG pilus behaves as a nanospring, 
probably undergoing structural changes when subjected to high forces. This finding strongly 
suggests that the two lectin probes specifically bind to the L. rhamnosus GG SpaCBA pili, 
indicating that they are likely to be glycosylated with fucose and mannose residues. Potentially, 
also glucose could be present on the SpaCBA pili, as the ConA lectin also can specifically 
interact with these residues. Supporting these observations, pili-less cells (ΔspaCBA::TcR 
mutant, CMPG5357) showed no significant binding events (Fig. 6.1E) and a complete lack of 
nanospring profiles (Fig. 6.1F).
Figure 6.1 – Probing of fucose and mannose residues on L. rhamnosus GG pili using AFM
Fig. 6.1A and C depict the adhesion forces and Fig. 6.1B, D the rupture length histograms (n=1024) obtained in buffer, 
from the interaction between L. rhamnosus GG wild type and fucose- and mannose-binding lectin probes (AAL and 
HHA resp.). In Fig. 6.1E,F the force data for the interaction of a pili-deficient ΔspaCBA::TcR mutant (CMPG5357) with 
the two lectin probes are displayed. Insets show representative retraction force curves. 
6.3.2   gLycostaining anD Lectin probing confirms gLycosyLation of purifieD spacba piLi witH  
 mannose anD fucose resiDues
SpaCBA pili were purified from wild type L. rhamnosus GG cells to investigate their 
glycosylation status. Purification resulted in three fractions of pili of different purity, namely 
the Pili Raw Material (PRM), sample B (concentration of 9 μg/mL) and a pure sample of 21 
μg/mL (A). Glycosylation of all these purified pili fractions was assessed using the Periodic 
Acid Schiff glycostain (PAS), of which the results are depicted in figures 6.2 and 6.3. All 
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purified pili fractions (fraction A, Fig. 6.2, and PRM and B fraction on Fig. 6.3), show a 
signal in the high molecular weight range (i.e. >200 kDa) of the gels, which is typically the 
region where SpaCBA pili can be found after SDS-PAGE (Kankainen et al., 2009). A SpaC 
antiserum probed Western blot corroborates that the SpaCBA pili are the cause of the PAS 
signal (Fig. 6.2 and 6.3). As a control of the efficacy of this method, purified Msp1 was also 
subjected to the same procedure resulting in the typical 75 kDa band (cf. previous results 
(Lebeer et al., 2012b)) and a higher glycostained band (complex or oligomer of Msp1). As 
shown in figure 6.2 and 6.3, the Msp1 protein is completely absent in sample B and A, whilst 
the glycoprotein is only present in very low abundance in the PRM fraction (cf. absence of 
bands at 75 kDa, Lebeer et al., 2012b). These results rule out any interference of Msp1 with 
the pili glycosylation signal. Protein content was visualized using Sypro® and silver stain (Fig. 
6.2 and 6.3).
Figure 6.2 – Glycostaining of purified SpaCBA pili 
Application of the PAS glycostain to the purified pili sample (pool A) show the presence of glycoproteins in the high 
molecular weight area (> 200 kDa) of the SDS-PAGE separated samples. Purified Msp1 was used as a positive control, 
whilst probing of the Western blotted samples with SpaC antiserum showed that the PAS signal could be attributed 
to the SpaCBA pili as both show a similar pattern. Protein content is visualized using Sypro® staining. (LK = Precision 
Plus ProteinTM KaleidoscopeTM Standard, Bio-Rad)
All purified pili fractions were probed with a range of lectins with different specificities (Man, 
Fuc, GlcNAc, Gal, Glc, GalNAc), as described by Tytgat et al. (Tytgat et al., 2014). The results 
of the probing of the PRM and B fraction with the mannose-specific lectins GNA and HHA is 
depicted in figure 6.3. The lectins with other specificities, except for the fucose-specific lectin 
AAL, did not show any binding in the high-molecular weight area of the Western blotted 
samples (results not shown). All blots and gels were performed at least in triplicate to confirm 
the validity of the results.
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Figure 6.3 – Probing with mannose-specific lectins confirms SpaCBA pili mannosylation
Purified pili fractions (PRM and pili pool B) were subjected to PAS staining, confirming their glycosylation in the 
high molecular weight area. Both Sypro® and Silver stain were used to show the protein content of these purified 
samples (first two lanes). The absence of bands at 75 kDa on PAS and lectin blots rules out the interference of this 
glycoprotein in the PAS signal (cf. sample B), whilst probing with SpaC antiserum confirmed the correspondence of 
the glycosylation signals to the presence of pili. Similarly, Western blots were also probed with the mannose-specific 
lectins HHA and GNA, further corroborating SpaCBA mannosylation.(LK = Precision Plus ProteinTM KaleidoscopeTM 
Standard, Bio-Rad)
The glycosylation of the pili with mannose and fucose residues was further substantiated with 
Enzyme-linked lectin assays (ELLA). In these assays the purified pili fraction A was probed 
with the mannose-specific lectin HHA (Fig. 6.4, left panel) and the fucose-specific lectin 
AAL (Fig. 6.4, right panel). Both lectins were shown to bind significantly to the purified pili, 
confirming the SMFS results that also indicated modification of the pili with mannose and 
fucose residues.
Figure 6.4 - Enzyme-linked lectin assays corroborate the presence of mannose- and fucose-residues on 
purified SpaCBA pili
Purified pili significantly interact with the mannose specific lectin HHA (left panel) and fucose specific lectin AAL 
(right panel). Coating buffer was used as a negative control, whilst known ligands of both lectins, mannan and Lewis 
X respectively, served as a positive control. As a read-out absorbance was measured at 405 nm.
6.3.3   sampLing of ceLL waLL-associateD proteins of L. rhamnosus gg mutants confirms in vivo 
piLi gLycosyLation
To corroborate the SMFS results and glycan-probing assays performed on purified pili 
further, cell wall-associated proteins were isolated form L. rhamnosus GG cells as described 
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earlier (Kankainen et al., 2009). Cell wall-associated proteins were isolated from wild type L. 
rhamnosus GG, the pilus deficient ΔspaCBA::TcR mutant (CMPG5357) and the ΔwelE::TcR 
mutant (CMPG5351), which lacks the protective, thick exopolysaccharides layer, resulting in 
an overexposure of the SpaCBA pili (Lebeer et al., 2009). 
The results are depicted in figure 6.5 and show that indeed the pili are absent in the ΔspaCBA::TcR 
mutant (SpaC antiserum blot), causing also an absence of fucose- and mannose-specific lectin 
binding to cell wall-associated proteins of this strain (lectin probing with AAL and HHA 
resp.). Both wild type L. rhamnosus GG and ΔwelE::TcR cell wall-associated proteins do bind 
to these lectins. These results corroborate our earlier findings further on the presence of fucose 
and mannose on the SpaCBA pili of L. rhamnosus GG further. Interference of Msp1 signals in 
the high molecular weight area were ruled out by probing with Msp1 antibody. The presence 
of Msp1 and other glycoproteins can account for residual signals on the lectin blots for the 
ΔspaCBA::TcR mutant. 
Figure 6.5 – SpaCBA pili are glycosylated on L. rhamnosus GG cells
Cell wall-associated proteins of L. rhamnosus GG wild type (WT), the pilus-deficient ΔspaCBA::TcR mutant (CMPG5357, 
SpaC) and the pili-overexpressing ΔwelE::TcR mutant (CMPG5351, WelE) were isolated to probe their reactivity with 
mannose- and fucose-specific lectins (HHA and AAL resp.). The positive pattern resulting from lectin probing of wild 
type and ΔwelE::TcR cells could be linked to the presence of SpaCBA pili by a SpaC antiserum probed Western blot as 
both (most) lectin and SpaC signals are absent for the non-piliated L. rhamnosus GG strain samples. Interference of 
the Msp1 glycoprotein was ruled out by a Western blot probed with Msp1 antibody. (LK = Precision Plus ProteinTM 
KaleidoscopeTM Standard, Bio-Rad)
6.3.4   purifieD spacba piLi interact witH Dc-sign-fc fragments
Both the SMFS and lectin probing experiments showed that SpaCBA pili of L. rhamnosus GG are 
modified with mannose and fucose residues. These results indicate that these pili are potential 
ligands for the immune lectin receptor DC-SIGN, which can detect a variety of microorganisms. 
This lectin receptor found on human dendritic cells (DCs) specifically recognizes fucose and 
mannose residues (Geijtenbeek et al., 2000b). Here, we used recombinantly produced DC-
si
x.
147
SIGN to test this hypothesis. These DC-SIGN Fc fragments consist of the extracellular portion 
of DC-SIGN (aa 64–404) fused at the C terminus to the human IgG1 Fc domain (Geijtenbeek 
et al., 2002).
Figure 6.6 – DC-SIGN-Fc fragments interact specifically with SpaCBA pili 
An ELISA with DC-SIGN-Fc fragments results in specific binding to SpaCBA pili. Coating buffer was used as a negative 
control and mannan as positive control (not shown). Binding was quantified by measuring the absorbance at 450 
nm. The interaction of the SpaCBA pili with the DC-SIGN-Fc fragments could be blocked with the DC-SIGN specific 
antibody D1, mannan (M, a ligand of DC-SIGN) and the Ca2+ chelator EGTA.
Figure 6.6 shows the results of an ELISA-binding assay performed with purified pili (sample 
B) and recombinant DC-SIGN-Fc fragments (results of triplicate repetition are shown). 
There is indeed a significant interaction between the purified pili and the purified DC-SIGN 
receptor. Moreover, this interaction can be significantly blocked with a specific antibody 
directed against DC-SIGN, D1 (Geijtenbeek et al., 2000b). The calcium ion-chelating agent 
EGTA (ethylene glycol tetra acetic acid) also blocked the binding of the pili to DC-SIGN. 
This latter finding further corroborates the sugar-lectin nature of the interaction between the 
pili and DC-SIGN, as Ca2+ is an important cofactor enabling DC-SIGN binding (Geijtenbeek 
et al., 2000b). Mannan (1 μg/mL) was included as a positive control and showed a very strong 
interaction (OD450 = 0.9 ± 0.1) with the DC-SIGN-Fc fragments (result not shown). Compared 
to mannan, the interaction of the SpaCBA pili with the lectin receptor is more subtle (OD450 = 
0.2 ± 0.03), but nonetheless significant. The occurrence of the fucose and mannose residues 
on the pili in a more complex context (conformation, configuration…) could explain the fact 
that their interaction is lower compared to that of a pure ligand, like mannan.
6.3.5   Dc-sign expressing ceLL Lines binD botH purifieD spacba piLi anD piLiateD ceLLs
To test the interaction between the SpaCBA pili and DC-SIGN in a more physiological context, 
purified pili were coincubated with the recombinant DC-SIGN expressing cell line (Raji-DC-
SIGN) (van Gisbergen et al., 2005). To allow the quantitative flow cytometric assessment of 
this interaction, the purified pili were coupled to fluorescent beads (Geijtenbeek et al., 1999).
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Figure 6.7 - Pili-beads interact with the Raji-DC-SIGN cell line
Purified pili were conjugated to fluorescent beads enabling the assessment of their interaction to Raji cells transfected 
with the DC-SIGN receptor with flow cytometry. Pili-beads could not interact with untransfected Raji cells, but did 
show a strong interaction with the Raji-DC-SIGN cells. Binding of these beads to DC-SIGN could moreover be blocked 
with the D1 antibody, the Lewis X ligand and the chelating agent EGTA. Binding to Raji and Raji-DC-SIGN cells is 
shown relative to pili-bead Raji-DC-SIGN binding. 
In figure 6.7 the binding between these pili-conjugated beads and the Raji-DC-SIGN cell 
line is shown relative to the interaction between bead-binding to untransfected Raji cells. In 
absolute values, a striking 60% of the pili-beads effectively bound the Raji-DC-SIGN cells. 
Using the DC-SIGN specific antibody D1, the interaction could be lowered to the background 
level, illustrating the specificity of the interaction between the pili and the DC-SIGN receptor. 
Similarly to the DC-SIGN-Fc ELISA results, EGTA also reduced the number of binding 
events significantly. Further corroborating the interaction between the glycosylated pili and 
the lectin receptor, is the blockage of the pili-bead interaction with the fucosylated DC-SIGN 
ligand Lewis X (LeX) (van Die et al., 2003). 
Next, we aimed to check if the pili still function as DC-SIGN ligands when present in the more 
complex context of bacterial cells. Fluorescent wild type L. rhamnosus GG and ΔwelE::TcR 
CMPG5351 mutant piliated cells were tested (FITC-labeled). Non-piliated ΔspaCBA::TcR 
CMPG5357 cells were used as a negative control.
The results depicted in figure 6.8 were obtained using heat killed cells, as independent 
experiments demonstrated no difference in binding efficacy compared to live cells (results 
not shown). The interaction between FITC-labeled bacterial cells and the cell lines was 
investigated using flow cytometry (Geijtenbeek et al., 2003). Wild type L. rhamnosus GG cells 
significantly interacted with the Raji-DC-SIGN cells when compared to their interaction with 
untransfected Raji cells. The non-piliated ΔspaCBA::TcR (CMPG5357) mutant however shows 
no specific interaction with the Raji-DC-SIGN cell line, as this interaction was not susceptible 
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to blocking by DC-SIGN blocking agents and did not significantly differ from binding to 
untransfected Raji cells. The ΔwelE::TcR (CMPG5351) mutant, having more accessible pili, 
interacted even stronger with the DC-SIGN Raji cell line than wild type L. rhamnosus GG. 
When looking at the interference of specific blocking agents with the binding of the bacteria 
and the cell line, the same trends can be observed for the wild type and ΔwelE::TcR mutant 
bacteria. The results for the ΔwelE::TcR mutant seem to be a magnification of the wild type 
results. For both strains DC-SIGN recognition can be blocked almost to background level 
with the anti-DC-SIGN antibody D1 and Lewis X. Less blocking can be seen when the EGTA 
chelating agent is applied. 
Figure 6.8 – Piliated strains can interact with DC-SIGN expressing cell lines
Wild type L. rhamnosus GG and ΔwelE::TcR cells could interact with the Raji-DC-SIGN cell line, whilst the non-piliated 
ΔspaCBA::TcR only showed aspecific binding to Raji cells. The interaction of piliated L. rhamnosus GG cells can be 
reduced and even prevented using DC-SIGN binding agents, like D1 and Lewis X, and the ion-chelator EGTA. All 
values represent the relative binding to Raji-DC-SIGN cells relative to the binding of wild type L. rhamnosus GG to 
untransfected Raji cells.
Taken together, these results suggest that the glycosylated pili are important ligands for the 
DC-SIGN C-type lectin receptor. A higher exposure and accessibility of the SpaCBA pili 
strongly increases (i.e. nearly doubles) the interaction between L. rhamnosus GG cells and the 
Raji-DC-SIGN cell line. 
6.3.6   gLycosyLateD spacba piLi meDiate tHe interaction between L. rhamnosus gg anD  
 monocyte-DeriveD Dcs
To challenge the interaction between the glycans of the SpaCBA pili of L. rhamnosus GG 
and DC-SIGN in in vivo mimicking conditions, adhesion of both pili-beads and live cells to 
monocyte-derived DCs (moDCs) was tested. Our goal was to analyze whether the interaction 
of the glycosylated SpaCBA pili is of importance in a more complex physiological context.
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Figure 6.9 – Purified pili bind monocyte-derived dendritic cells via DC-SIGN
Beads coated with purified pili could specifically interact with moDCs via DC-SIGN as the interaction could be 
inhibited by the addition of the D1 anti DC-SIGN antibody, the DC-SIGN ligand Lewis X and the Calcium chelator 
EGTA. Interference of the Mannose Receptor could be ruled out as an antibody directed against this receptor could 
not block binding of the pili to moDCs. Usage of the DC-SIGN antibody D1 was validated using an IgG1 antibody 
isotype, which was unable to interfere with DC-SIGN binding of the pili. Binding values are calculated relative to the 
binding of pili-beads to moDCs.
The same fluorescent pili-bead adhesion assay was performed as described earlier for the 
interaction with the Raji-DC-SIGN cells. moDCs of three independent donors were tested. 
The results clearly show a significant interaction between the pili-beads and the moDCs 
(Figure 6.9). Moreover this interaction could be blocked with the anti-DC-SIGN antibody 
D1, EGTA and Lewis X. In this assay we also included an isotype of the D1 antibody (IgG1), 
to illustrate that the DC-SIGN specific domains of the D1 antibody are responsible for the 
blocking effect. Inclusion of an antibody directed against the lectin Mannose Receptor (MR) 
further underpinned the specificity of the pili-DC-SIGN interaction. This also ruled out the 
involvement of the MR in the interaction between the pili and DCs as the MR antibody could 
not significantly diminish the interaction between the pili and the moDCs. 
Finally, the role of glycosylated SpaCBA pili in the interaction between FITC-labeled live 
bacteria and moDCs was investigated. The complex context of these interactions makes 
these experiments quite challenging, resulting in milder interactions compared to the above 
described model systems (i.e. pili-beads, Raji-SIGN cell line, DC-SIGN Fc ELISA).
Nevertheless, the experiments reflect similar trends compared to the earlier assays, showing 
an interaction between the bacteria and the moDCs, which can be blocked with DC-SIGN 
ligands and blocking agents. In the upper panel of Fig. 6.10 a representative experiment 
is shown (two technical repeats in one moDC donor), equivalent results were obtained in 
independent repetitions of the experiment. A similar trend in binding could be perceived for 
wild type L. rhamnosus GG and ΔwelE::TcR cells. The interaction between these cells and the 
moDCs could be blocked with D1, LeX and to a minor extend also with EGTA. Also in this 
case, the increased accessibility (overexposure) of the pili on the ΔwelE::TcR cells results in a 
magnification of the trends perceived for wild type cells (results not shown). In the lower panel 
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of figure 6.10, the interaction percentages are depicted for the ΔwelE::TcR cells, illustrating 
the specific blockage of moDC interaction in the presence of anti-DC-SIGN molecules. For 
instance, the D1 DC-SIGN antibody could reduce the binding of ΔwelE::TcR cells to moDCs 
with almost 30% (Fig. 6.10, lower panel). Incubation of moDCs with the negative control, 
i.e. ΔspaCBA::TcR cells, did not result in a specific interaction, as interaction levels could not 
be blocked. There is however significant aspecific interaction between the moDCs and these 
non-piliated cells, probably caused by the interaction of other cell wall molecules with other 
moDCs receptors or by aspecific agglutination of the bacteria to the moDCs.
Figure 6.10 – L. rhamnosus GG interaction with DCs is based on recognition of SpaCBA glycans by the DC-
SIGN lectin receptor
Fig. 6.10 upper panel - Both piliated L. rhamnosus GG strains (i.e. wild type and ΔwelE::TcR) interact with moDCs. 
This interaction depends on the glycosylated pili on the one hand and the DC-SIGN lectin receptor of moDCs on the 
other hand. This latter fact is illustrated by the reduction of this interaction with the DC-SIGN binding blocking agents 
D1, EGTA and Lewis X. Pili-deficient L. rhamnosus GG bacteria (ΔspaCBA::TcR) could only interact aspecifically with 
the moDCs, as this interaction did not alter under the influence of anti-DC-SIGN agents. Binding of strains to moDCs 
is shown relative to the binding of wild type L. rhamnosus GG to moDCs without blocking agents. Fig. 6.10 lower 
panel – FACS plots of the interaction between ΔwelE::TcR cells and moDCs show that agents interfering with DC-
SIGN binding actively reduce the interaction between the piliated bacteria and the moDCs. The effect is the most 
dramatic with the D1 antibody, which reduced moDC binding with almost 30%. On the x-axis: binding percentage of 
FITC-labeled bacteria to moDCs as measured in the FL1 channel of the FACs. On the y-axis: forward scatter.
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6.4 Discussion
Pili are crucial molecules in host-microbe interactions (Arumugam et al., 2011). A good 
understanding of their structure is thus key to fully grasp the molecular basis of these specific 
interactions. Here we report on a second posttranslational modification of these sortase-
dependent covalent structures in Gram-positive bacteria, namely their glycosylation. We 
illustrated via a unique multidisciplinary approach the modification of the heterotrimeric 
SpaCBA pili of the microbiota isolate and model probiotic L. rhamnosus GG. A combination 
of nanomechanical, glycobiological and immunological tools resulted in the proof of the 
modification of these pili with mannose and fucose residues. To strengthen this finding, 
assays with purified pili were complemented with experiments using bacterial cells. Doing so, 
we could rule out interference of the purification process (e.g. contamination) and evaluate 
the importance of the glycosylation of the SpaCBA pili in the presence of other cell wall 
molecules. A similar gradual build-up of assay-complexity was used in the assessment of the 
importance of pili glycosylation for the interaction with moDCs. Moreover, the inclusion of 
solid controls and blocking agents in our assays strengthen the power of our multidisciplinary 
approach. 
The application of SMFS to probe bacterial cell surfaces for glycans was used earlier to detect 
the cell wall polysaccharides of L. rhamnosus GG (Francius et al., 2009; Lebeer et al., 2009) 
and we here show that this is also a useful tool to detect glycosylation of pili appendages. 
Earlier we reported on the peculiar nanospring properties of the SpaCBA pili when probed 
with an AFM tip functionalized with SpaC antiserum (Tripathi et al., 2013). In this work we 
detect the same nanospring behavior when probing the pili with lectin-functionalized tips. The 
fact that similar nanospring behavior was observed with the lectins as with the SpaC specific 
antiserum can be an indication that the SpaC pilins are the pilins carrying the sugar residues, 
but further research is still needed to substantiate this hypothesis. Peculiarly, sheared pili tend 
to aggregate in bundles, the formation of which may be potentially ascribed to lectin-sugar 
interactions of SpaC pilins (Tripathi et al., 2012b). It was suggested that these SpaC pilins 
harbor a von Willebrand factor domain with weak homology to a fucose-binding lectin domain 
(Kankainen et al., 2009). Our report on the presence of fucose residues on the SpaCBA pili 
underpins the plausibility of the hypotheses described by the studies of Kankainen et al. 
(Kankainen et al., 2009) and Tripathi et al. (Tripathi et al., 2012b), but further research is 
needed to proof their validity.
The fact that the SpaC pilin harbors a fucose-binding lectin-like domain, can also support 
an alternative explanation for our results. It can be the case that this fucose-binding motif 
strongly binds fucose, thus rendering a positive fucose signal in our assays. This hypothesis is 
currently being further investigated by growing both piliated and non-piliated L. rhamnosus 
GG cells in media complemented with fucose. As a read-out, Immuno-EM gold labeling of the 
fucose structures and SpaA structural pilin is used (P. Rasinkangas, F. Douillard, Prof. W.M. 
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de Vos, UHelsinki). Furthermore, we will investigate the phenotype of a peculiar mutant of L. 
rhamnosus GG that lacks the genes of the fucose metabolism, but is still piliated. The results 
of these assays will clarify the plausibility of this alternative hypothesis.
We here present not only the first report on the glycosylation of complex heterotrimeric 
pili in bacteria, but also present important clues on the importance of its glycosylation 
for the establishment of specific interactions of L. rhamnosus GG with important immune 
cells, namely dendritic cells. On the latter cells, the DC-SIGN lectin receptor specifically 
recognizes fucose- and mannose-MAMPs (Microbe-Associated Molecular Patterns) on 
microorganisms. A significant interaction between the DCs and purified SpaCBA pili could 
be illustrated via several assays (DC-SIGN-Fc ELISA, binding to Raji-SIGN cell line and 
moDCs). All results could be confirmed on whole L. rhamnosus GG and ΔwelE::TcR mutant 
cells on which the SpaCBA pili are overexposed due to the lack of the thick protective 
exopolysaccharides layer (Lebeer et al., 2009). Non-piliated ΔspaCBA::TcR cells were used 
as a negative control and could indeed not interact with the moDCs in a DC-SIGN dependent 
manner. Moreover the interaction between both purified pili and piliated L. rhamnosus GG 
cells, and moDCs could be blocked with a DC-SIGN specific antibody, the Lewis X ligand 
of DC-SIGN and the calcium chelator EGTA, further illustrating the specific glycan-lectin 
nature of this interaction. Furthermore, we could rule out the involvement of the MR in the 
interaction between moDCs and L. rhamnosus GG. These results make this one of the few 
reports on the involvement of bacterial glycoproteins in immune interactions. Strikingly, DC-
SIGN signaling depends on the presented MAMPs: fucosylated and mannosylated bacterial 
molecules elicit distinct immune responses (Gringhuis et al., 2009). It will be intriguing to 
elucidate the downstream DC-SIGN signaling provoked by binding of the SpaCBA pili, which 
are both fucosylated and mannosylated. Ongoing experiments include moDC maturation assays 
and cytokine assays, the latter probing for changes in IL-6, IL-10 and IL-12 mRNA levels. 
Earlier research established that the DC-SIGN receptor recognizes HIV and is involved in the 
virus transmission (Geijtenbeek et al., 2000a; Geijtenbeek et al., 2002). As both HIV and L. 
rhamnosus GG (pili) bind DC-SIGN, the potential of L. rhamnosus GG cells or purified pili to 
block transmission of HIV by dendritic cells is interesting to pursue.
Taken together we report on the glycosylation of the heterotrimeric adhesive pili of the 
microbiota isolate L. rhamnosus GG. Furthermore, we could show the importance of the 
fucosylation and mannosylation of the SpaCBA pili for the interaction of L. rhamnosus GG with 
the DC-SIGN lectin receptor of human DCs. This work provides new insights in the piliation 
of bacteria and wants to encourage the study of the potential impact of pili glycosylation in 
other important piliated microbiota members and bacteria in general. It will be intriguing 
to see if piliated pathogens, like Streptococcus pyogenes and Enterococcus faecalis, show 
a similar glycosylation and whether their glycosylation plays a role in immune signaling. 
Especially the latter pathogen and its close relative E. faecium, both expressing pili that show 
a striking homology (30-40%) to the SpaCBA pili of L. rhamnosus GG (Kankainen et al., 
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2009), are interesting targets to study via a similar approach. This homology to pathogenic 
pili holds promise for the application of glycosylated pili of GRAS species as adjuvants or 
therapeutic molecules since glycosylation of bacterial molecules has been implicated in the 
enhancement of the biochemical properties and binding specificities of their substrates.
6.5 aDDitionaL figure
This Coomassie Brilliant Blue stained gel (Acrylamide Bis-Acrylamide gel) shows the protein 
content of sample A (the purest purified pili sample) and B, which contains less pili material. These 
two samples result from the pooling of fractions during the purification process (cf. 6.2.4). 
Additional figure – Pooled fractions of purified pili result in samples A and B 
The six fractions with the highest absorbance were pooled to generate sample A, whilst the next six fractions, 
still containing pure pili, were pooled generating sample B. Both samples were separated on an Acrylamide Bis-
Acrylamide gel, which was stained with Coomassie Brilliant Blue stain to visualize the protein content. 
si
x.
155
seven.
general discussion
so, what did we learn?
seven.
general discussion
so, what did we learn?
158
ge
ne
ra
l d
is
cu
ss
io
n
7.1 tHe protein gLycosyLation potentiaL of L. rhamnosus gg
The scope of this PhD work was to unravel if, how and why L. rhamnosus GG glycosylates 
proteins. The discovery of the glycosylation of the cell wall hydrolase and probiotic effector 
Msp1 set off this study (Lebeer et al., 2012b). Glycoproteins and glycoconjugates in general 
are key molecules in bacteria-host interactions (Tytgat & Lebeer, 2014). The elucidation of 
their occurrence in L. rhamnosus GG paves the way for glycoengineering applications and a 
better knowledge of the molecules underlying microbiota- and probiotica-host interactions.
7.1.1   is msp1 aLone?
7.1.1.1   Glycoproteome screening
We could determine that Msp1 is not alone: L. rhamnosus GG produces a glycoproteome that 
is vaster and even comprises glycosylated proteins in the cytosol. We were able to identify 
40 new potentially glycosylated proteins (cf. chapter 5), next to the confirmation of the 
glycosylation status of Msp1. Several interesting proteins were found to be glycosylated, of 
which most are involved in the carbohydrate metabolism. Other hits are proteins involved in 
protein metabolism, transporters and stress-related proteins (chapter 5). Homologues of several 
of these proteins were also found to be glycosylated in other species, which corroborates our 
results. Nevertheless, independent biochemical confirmation of their glycosylation status is 
needed. 
Screening for glycoproteins was performed using 2D electrophoresis as this has already been 
proven to be a potent proteomics tool, but we combined it with PAS glycostain and lectin 
affinity screening. Glycosylated hits were challenged vigorously and attributed a glycosylation 
score to illustrate the level of confidence of their identification. Also, several strict rules 
were applied during the analysis to minimize the number of false positive hits. Even so, an 
independent assessment is still needed to unambiguously confirm the glycosylation status 
of these proteins. A good complementary approach to our 2D gel-based workflow would be 
a gel-free screening for glycosylated proteins. This would not only lead to the confirmation 
of the glycosylated proteins here identified, but would also enable the identification of extra 
glycoproteins which are not accessible by 2D analysis, like proteins present in very low 
abundance and poorly soluble proteins. 
A gel-free approach relies on the enrichment of glycosylated peptides prior to their identification 
by LC MS/MS (Pan et al., 2011). Two methods are commonly applied to enrich glycopeptides: 
covalent linkage of glycopeptides to a hydrazine column after which the peptides are 
enzymatically or chemically released (Ding et al., 2009) and the second method using ion-
paired zwitterionic HILIC (Hydrophilic Interaction Liquid Chromatography), but the latter 
has up till now only been applied for the enrichment of N-glycosylated proteins (Parker et al., 
2011). After enrichment, the peptides are then digested using proteolytic enzymes, preparing 
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them for MS identification. Gel-free approaches are extremely challenging, as these methods 
have not yet been optimized for O-glycosylated bacterial proteins. Moreover this approach 
would require the isolation of the proteins from their various cellular locations, as we showed 
that glycoproteins are present in all cellular localizations. It is widely known that isolation of 
membrane-linked proteins is extremely hard. Even the purification of the Msp1 protein from 
the secreted protein fraction was not without bottlenecks, making the gel-free confirmation 
of glycosylated targets a hard endeavor. Extra technological advances are necessary to enable 
the application of this approach to a wide variety of bacteria. A more direct approach is 
the purification of glycosylated proteins using dedicated chromatographic techniques, as we 
did in chapter 5 for the GAPDH glycoprotein. Specific purification of proteins relies on the 
availability of specific antibodies or techniques, like the blue sepharose column used for 
the enrichment of GAPDH (chapter 5). Such tools are not readily available for all identified 
targets. 
Enrichment of glycopeptides furthermore could enable the elucidation of the sugar monomeric 
composition of the attached glycan. Tandem mass spectrometry techniques result in the further 
breakdown of glycopeptides, rendering specific patterns. The second MS step namely results 
in the fragmentation of the glycan, resulting in several peaks, which are separated by a mass 
difference specific for a sugar monomer. The molecular weight of a fucose is for instance 
147 Da. Linkage of these mass difference patterns to the known molecular weight of sugar 
monomers, enables the reconstruction of the glycan attached to a specific glycopeptide (Schiel, 
2012). This technique requires a high purity and concentration of the protein sample. Moreover 
it is crucial that the glycan structure is not affected during the purification process. Combined 
with the challenging nature of glycopeptide enrichment, these glycomics experiments are 
hard and require the expertise of specialists in the field, like the group of Prof. Wuhrer (VU 
Amsterdam).
7.1.1.2   spacba piLi gLycosyLation
In a dedicated analysis, the glycosylation status of the heterotrimeric SpaCBA pili was 
investigated (chapter 6), in close collaboration with the group of Prof. de Vos (UHelsinki 
& Wageningen University). These pili complexes are too large to visualize on 2D gels, 
explaining why we did not identify them in our glycoproteome screening. Moreover, these 
structures shear off easily, albeit their covalent linkage to the thick peptidoglycan layer. In 
this context, we previously found that high-speed centrifugation of L. rhamnosus GG (8000 g) 
already can result in a loss of piliation (Tripathi et al., 2012b), thus explaining the absence of 
pili after sample preparation. Here we used a unique multidisciplinary approach, which relies 
on biochemical, nanomechanical (group of Prof. Dufrêne, UCL) and immunological (Prof. 
Geijtenbeek, AMC) techniques to show the modification of the SpaCBA pili of L. rhamnosus 
GG with mannose and fucose residues (chapter 6). This conclusion was based on all the results 
of the sampling of both purified pili and piliated strains of L. rhamnosus GG with a large array 
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of techniques. We believe that this first report on the glycosylation of complex pili in bacteria 
will boost the study of other piliated species.
Nevertheless, definite mass spectrometric evidence is lacking. During a research stay in the 
group of Prof. Wuhrer (Analytical Chemistry group, VU Amsterdam), with whom we earlier 
worked together on the Msp1 glycosylation (Lebeer et al., 2012b), an attempt was made to 
check the glycans present on the pili. Unfortunately, the complexity of the pili hampered 
these attempts. Moreover, the low concentration in which bacterial pili can be purified is 
below the detection limit of the equipment commonly used for glycan and glycopeptide mass 
spectrometry. A further optimization of the pili purification process is needed to improve 
the yield of this process. An attempt to do so was made in the context of the PhD project of 
Marijke Segers, starting from 10 L L. rhamnosus GG cultures. Unfortunately we were unable 
to optimize this protocol during the time frame of her PhD, and up till now this did not result 
in a significant amount of purified pili. Another way in which the glycosylation status of the 
pili could be confirmed is their recombinant expression in a non-glycosylating host together 
with the GTs that are likely to modify these pili. This then should result in the heterologous 
production of glycosylated SpaCBA pili, similarly to the experiments performed by Wacker 
et al. (Wacker et al., 2002). However, we were not yet able to identify the candidate GTs that 
may be involved in pili modification (see also chapter 3). Another complementary method 
is the application of deglycosylating chemicals on purified protein samples. These assays 
were performed earlier to substantiate the glycosylation of Msp1 and rely on the usage of 
trifluoromethane sulfonic acid (Lebeer et al., 2012b). This is a harsh method and often also 
results in protein degradation. But this technique is likely to be improved, at the moment the 
potential of special metal complexes to hydrolyze O-glycosidic linkages are being investigated 
(personal communication). 
Thus, albeit the high number of assays suggesting SpaCBA pili glycosylation, the evidence is 
mostly indirect. At the moment we thus cannot completely rule out that the glycosylation signal 
can originate from the strong binding of fucose by the SpaC pilin. This pilin harbors a fucose 
lectin-like domain (Kankainen et al., 2009), which would be an alternative explanation for 
the fucose-specific reactions we observe. Currently, we are trying to rule out this hypothesis 
via assays in which L. rhamnosus GG is grown in the presence of fucose, followed by the 
evaluation of the presence of a fucose-signal. 
7.1.1.3   wHat about msp1?
Although we were able to elucidate that Msp1 is a glycoprotein, identify a glycosylation site, 
get some information on the attached glycan and establish the importance of its glycosylation 
for the stability of the protein (Lebeer et al., 2012b), still many open questions remained. 
During this PhD were able to show that the earlier discovered TVETPSSA glycosylation site 
(Lebeer et al., 2012b), is not the only glycosylated stretch in this protein. An msp1 mutant 
complemented with a vector carrying the Msp1 protein with a point mutation in the serines 
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of the glycosylation motif (CMPG10805) still was glycosylated (unpublished results, cf. 
addendum).  
The quest for the GTs targeting Msp1, and now also of its homologues Msp1 and LGG_02016 
is also still on. An important step in this search will be the experimental validation of the 
protein GTs identified by the in silico method (chapter 3) and the assays described further to 
confirm their GT activity and substrate specificity (cf. addendum). 
This experimental validation, by both knockout mutagenesis and enzymatic analyses of 
recombinantly expressed and purified GTs is not straightforward (see below). We hypothesized 
that the glycosylation process of Msp1 is likely to involve a membrane step. Still we first 
focused on the construction of various knockout mutants in predicted cytosolic GTs (cf. 
addendum). This, because we realize that enzymatic assays with recombinantly expressed 
membrane-bound GTs, especially in multienzyme complexes, will be highly challenging. The 
L. rhamnosus GG GT knockout mutants that already could be constructed (cf. addendum) 
were screened for shifts in molecular weight of Msp1 (which is the major protein present in 
the supernatant). Unfortunately, none of these assays resulted in a clear difference in Msp1 
glycosylation (cf. addendum). This can most likely be partially contributed to GT redundancy. 
Furthermore, various GT knockout mutants could not be constructed up till now, presumably 
because of their essential functions in L. rhamnosus GG. Therefore the search for the GTs 
targeting Msp1 is still open. 
7.1.2   How Does L. rhamnosus gg gLycosyLates its proteins?
7.1.2.1   The quest for glycosyltransferases
The observation that Msp1 is glycosylated immediately gave rise to the question on how L. 
rhamnosus GG can glycosylate proteins. This question became even more pertinent now, since 
we detected several other glycoproteins in L. rhamnosus GG. A good way to investigate the 
glycosylation mechanism used by a bacterium to modify its substrates is to look at the GTs. 
As mentioned before, these are the key enzymes of glycosylation events. GTs are involved in 
the biosynthesis and attachment of glycans to other molecules, thus determining the glycome 
(chapter 2, (Lairson et al., 2008; Tytgat & Lebeer, 2014)). However, the factors determining 
the substrate specificity of these enzymes remain enigmatic, while the promiscuity (i.e. 
targeting of multiple substrates) of GTs hampers their substrate identification further (Tytgat 
& Lebeer, 2014; Weerapana & Imperiali, 2006). In many bacteria, the annotation of these 
enzymes is flakey: in L. rhamnosus GG there was for example even a GT attributed to the 
biosynthesis of LPS (LGG_00999) in the annotation (Kankainen et al., 2009). This does not 
make any sense for a Gram-positive bacterium and probably resulted from an amplification of 
annotation errors based on strong conservation. 
We therefore designed a method that could identify genes potentially encoding GTs in bacterial 
species, without relying on annotation-related input. The in silico method relies on all currently 
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available information on bacterial GTs and was tested by application both to the genomes of L. 
rhamnosus GG and C. jejuni, the latter being a model organism of prokaryotic glycosylation. 
In a second step we then looked at the functional network of the selected genes to get clues 
on their substrate specificity. This workflow enabled us to identify 48 GTs, of which 8 were 
never identified as such earlier in L. rhamnosus GG (chapter 3). Linking these genes to their 
potential substrate resulted in the prediction of the cluster that may be responsible for the 
biosynthesis of the glucose-rich polysaccharides of L. rhamnosus GG, namely the LGG_00278-
LGG_00283 region (Francius et al., 2008). Together with technician Tine Verhoeven, who 
is an expert in the production of L. rhamnosus GG double homologous knockout mutants, 
several attempts were made to construct knockout mutants in this region. These attempts were 
so far –unfortunately– unsuccessful (cf. addendum). This may suggest that these glucose-rich 
polysaccharides and/or GTs perform an essential function in L. rhamnosus GG.
Furthermore, we could identify new GTs (17/44) in the well-studied bacterium C. jejuni, of 
which several might be involved in flaggellin glycosylation (chapter 3). This is interesting 
because the large region responsible for flagellin production and modification is known for 
quite some time now, but up till now the GTs responsible for its glycosylation were not 
identified (Nothaft & Szymanski, 2010). This is of special interest as the flagella of C. jejuni 
are important virulence factors. These results make this method an ideal tool to boost research 
on the glycosylation potential of ‘new’ species and to reassess species of which the glycome 
is already (partially) known (cf. C. jejuni results).
The list of genes potentially encoding GTs in L. rhamnosus GG combined with the information on 
their likely substrates provides a valuable list of targets for further experimental confirmation. 
This list does not render information on the precise biochemical mechanism of the GTs, but 
provides clues on the molecule classes that they might target. We attempted to underpin this 
with experimental evidence by knocking out GT encoding genes, which should then result 
in a shift in the molecular weight of its substrate resulting from the loss of glycosylation. 
Several GT knockout mutants were already constructed, with a focus on the ones predicted to 
target proteins (cf. addendum for a complete list), but none showed a clear (glyco)proteomic 
phenotype (results not shown). Probably this is partially due to the fact that GTs are often 
redundant and promiscuous, meaning that the role of a knocked out GT can be taken over by 
another one (chapter 2, (Tytgat & Lebeer, 2014)). The production of double and triple mutants 
might bypass this feature of GTs, but their construction seems to be even more challenging 
than the production of a single knockout mutant. 
To merely confirm the actual GT activity of a GT, are enzymatic approaches. As GTs require 
sugars activated by a nucleoside phosphate (chapter 2), GT activity can be measured following 
the release of nucleoside phosphates using a phosphatase (Wu et al., 2011). Another strategy 
that was conceived in collaboration with Baptiste Leroy and Prof. Ruddy Wattiez (UMons) is 
to recombinantly express the GTs and purify them. The purified GTs could then be mixed with 
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crude bacterial extracts as a source of substrates and UDP, GDP or CMP activated sugars as 
substrates. This enables the stepwise fractionation and isolation of proteins with GT activity, 
which then can be identified by MS. The resulting list of GTs could then be compared to the 
predicted list of GTs, thus confirming their GT activity. Moreover, recombinantly expressed, 
thus non-glycosylated, substrates could be added to the GTs instead of the crude bacterial 
extracts to specifically mine for GTs targeting this particular substrate. This assay holds great 
promise, but its development is not without its challenges, as it will be difficult to maintain the 
enzymatic activity of the GTs along the fractionation procedure. Moreover, the recombinant 
expression of membrane-linked GTs will not be straightforward. However, the fact that we 
could identify several glycoproteins in the cytosol renders this a potentially valuable approach 
to study cytosolic GTs. Nevertheless, another important caveat is that enzymatic assays do not 
necessarily represent the cellular outcome. 
Taken all these factors together, the experimental validation of GTs remains challenging. The 
experimental bottlenecks also explain why we were unable to pinpoint (a) GT(s) as the one(s) 
targeting Msp1, the SpaCBA pili and the other glycoproteins we identified in L. rhamnosus 
GG up till now. 
7.1.2.2   mecHanistic HypotHeses
What we do know from the work on Msp1, is that the protein is O-glycosylated (Lebeer et al., 
2012b). It is therefore very likely that the other identified glycoproteins of L. rhamnosus GG are 
also O-glycosylated. N-glycosylation seems to be a phenomenon exclusive to Gram-negative 
species (chapter 2, (Tytgat & Lebeer, 2014)), making it all the more likely that L. rhamnosus 
GG only harbors a protein O-glycosylation machinery. This hypothesis nevertheless needs 
further substantiation with experimental evidence, similarly as to the assays we performed for 
Msp1 in collaboration with Prof. Wuhrer (VU Amsterdam).
It is yet hard to give a conclusive answer on the question if L. rhamnosus GG uses a sequential 
or en bloc mechanism to glycosylate its proteins (chapter 2). Previous research has shown 
that the long, galactose-rich EPS are built in an en bloc manner. The EPS gene cluster namely 
harbors a priming GT, GTs to synthesize the glycan further and a polymerase to link all 
glycans together to form the final EPS structure (Lebeer et al., 2009). Potentially, L. rhamnosus 
GG uses a similar mechanism to target its proteins, as previously shown for e.g. the fucose-
containing glycoproteins of B. fragilis (Fletcher et al., 2009). 
On the other hand, a sequential glycosylation mechanism is also not unconceivable. Our 
in silico analysis showed that many GTs (20/48) of L. rhamnosus GG are not clustered in 
genomic regions, but are rather scattered throughout the genome as isolated genes flanked 
by transposable elements, suggesting their acquisition by horizontal gene transfer. And even 
if the GTs occur in clusters, these are generally smaller (mean size of 3 GTs) compared to 
the clusters occurring in C. jejuni (2-5 GTs) (chapter 3, (Sanchez-Rodriguez et al., 2014)). 
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These findings would corroborate the presence of sequential mechanisms. Which of the two 
mechanisms or if L. rhamnosus GG utilizes both to produce glycosylated proteins remains to 
be determined. 
7.1.2.3   export of gLycosyLateD proteins
In Streptococcus species, it was evidenced that glycosylated proteins are transported by 
an alternative Sec system, namely the SecA2 mechanism (as nicely reviewed in (Feltcher 
& Braunstein, 2012)). This accessory SecA2 mechanism harbors both proteins involved in 
glycosylation and transport of glycosylated substrates. Genome mining performed by François 
Douillard and Prof. Willem M. de Vos (UHelsinki & Wageningen University) resulted in 
the identification of a homologue of SecA2 in L. rhamnosus GG, which was called SecX 
(LGG_01063). Strikingly, this homologue only contains the specificity domain and not the 
motor domain that normally also is present in Sec proteins. So we are currently investigating 
if this SecX accessory transport system is actually functional in L. rhamnosus GG and if it is 
involved in the export of glycosylated proteins. We were able to construct a double homologous 
knockout mutant of the secX gene, which is currently being investigated. Based on their strong 
homology to the accessory GTs of the Streptococcus system, the involvement of the yohH-
yohJ encoded GTs in this system is evaluated. L. rhamnosus GG harbors three homologues 
of these GT genes (LGG_00348-349, LGG_1586-87 and LGG_02284-85). Knockout mutants 
of the latter GT clusters were already successfully constructed (cf. addendum), but despite 
numerous efforts the knockout of the first homologous enzymes (LGG_00348-349) did not 
succeed up till now. The GT nature of these genes is further corroborated by their prediction as 
being GTs in our in silico analysis (chapter 3) and the fact that homologues of these enzymes 
are responsible for the Msp1 homologue Acm2 of L. plantarum WCFS1 (Lee et al., 2014). 
Potentially, these GTs are thus involved in the glycosylation of glycosylated proteins like 
Msp1. Nevertheless, the involvement of other GTs cannot be ruled out at the moment and also 
other GTs should be considered. 
Currently we are in the process of assessing the phenotype and (glyco)proteome of these secX 
and yohH-yohJ mutants to validate their actual involvement in glycoprotein secretion in L. 
rhamnosus GG. Furthermore, we are constructing double and triple mutants targeting these 
genes of interest, to rule out redundancy and promiscuity of GTs and secretion systems. But 
most importantly, it remains to be elucidated if SecX is functional at all.  
7.1.3   wHy Does L. rhamnosus gg botHer to gLycosyLate its proteins?
Glycosylation is an energy-costly process for a bacterium, so there must be an evolutionary 
benefit for the bacterium. Glycosylation in general appears to be key in bacterial host 
interactions (Kay et al., 2010). In pathogenic bacteria, in which protein glycosylation is already 
better studied, virulent proteins are often glycosylated. Strategies include the glycosylation 
of immunogenic molecules to remain stealth from the environment and host immune system 
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or in contrast to enhance the interaction with the immune system. But probably the best-
documented function of protein glycosylation is the modulation of the biochemical properties 
of the targeted substrate. Glycosylation can enhance for instance activity of proteins and 
protect them against degradation by proteases (Tytgat & Lebeer, 2014). 
The enormous diversity of glycans that can be produced by bacteria enlarges the glycan-
repertoire immensely (Marino et al., 2010), enabling bacteria to establish very specific 
interactions with the environment. Often these glycans are even species-specific, functioning 
as a kind of ‘barcode’, for instance by interacting with specific immune lectins (Tytgat & 
Lebeer, 2014). Nevertheless, this specific barcoding function has not yet been widely 
documented for bacterial glycoproteins. For example, a role for N-glycosylated proteins and 
distinct lipooligosaccharides glycoforms in C. jejuni in interactions with the immune lectin 
MGL was documented (van Sorge et al., 2009), as well as binding of a mycobacterial cell wall 
glycoprotein SodC to Langerin (Kim et al., 2015).
In bacteria, the role of glycans in the interaction with the environment and host has mainly 
been studied in a dedicated way, i.e. by unraveling the role of a specific glycosylated protein 
for the interaction with a specific partner (cf. chapter 2 and (Tytgat & Lebeer, 2014)). The 
Consortium for Functional Glycomics (www.functionalglycomics.org) provides a platform 
where glycomics tools are bundled and can be consulted free of charge. Their services 
encompass glycan arrays, glycan profiling and gene microarrays. Up till now, most provided 
assays are dedicated to the study of eukaryotic glycosylation, but can sometimes be exploited 
to study the interaction of bacterial glycoproteins with mammalian tissues. It can be expected, 
with the current booming interest in bacterial glycoconjugates, that these services will be 
further expanded to enable functional high throughput screenings of prokaryotes too. The 
work of Hsu and co-workers is an example of a lectin microarray used to fingerprint the 
glycosylation of E. coli (Hsu et al., 2006).
7.1.3.1   tHe spacba piLi interact witH tHe immune Lectin receptor Dc-sign
In this PhD work, we discovered that the adhesive SpaCBA pili of L. rhamnosus GG are 
glycosylated (chapter 6). The fact that these heterotrimeric pili are modified with mannose 
and fucose moieties, made us wonder if they could interact with the immune lectin receptor 
DC-SIGN. This receptor present on human DCs specifically recognizes mannose and fucose 
residues. An initial ELISA test confirmed our hypothesis. Further tests relying both on the use 
of purified pili and (non-)piliated L. rhamnosus GG bacteria, and both on cell lines expressing 
DC-SIGN and monocyte-derived DCs were carried out during a research stay in the group of 
Prof. Geijtenbeek (AMC, UvA Amsterdam). These assays confirmed that the glycosylated 
SpaCBA pili are key for the interaction between L. rhamnosus GG and DCs (chapter 6). It will 
be intriguing to investigate if this is also true for other glycosylated proteins of L. rhamnosus 
GG, like Msp1. 
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The downstream effect of this interaction is currently being further investigated. Preliminary 
results show that the pili influence the maturation of moDCs and potentially also affect cytokine 
expression (results not shown). Further corroboration of these results is needed to show that 
the L. rhamnosus GG-moDC interaction is of functional importance. This would make this 
one of the few reports on the role of glycans in the establishment of specific immunogenic 
interactions between bacteria and their host (manuscript in preparation). 
7.1.3.2   gLycosyLation of ceLL waLL HyDroLases
In this work, we showed that the close homologues of Msp1, namely Msp2 and LGG_02016, 
are also glycosylated (chapter 5). Previous work showed that the glycosylation of Msp1 
infers a larger stability to the protein compared to its close homologue Msp2, which was 
long thought to be unglycosylated (Lebeer et al., 2012b). In this work we showed in several 
independent assays that Msp2 is indeed glycosylated, but probably to a more minor extend 
than Msp1, explaining its late discovery (chapter 5). The modulation of the stability of Msp1 
is a first functional clue why L. rhamnosus GG would glycosylate its proteins. This finding 
is in accordance to the role protein glycosylation plays in C. jejuni, where glycosylation 
protects the proteins against degradation by gut proteases (Alemka et al., 2013). This is 
further corroborated by findings in other gut bacteria, like B. fragilis (Fletcher et al., 2009), 
L. plantarum WCFS1 (Fredriksen et al., 2012) and E. coli 2787 (Charbonneau et al., 2007).
The fact that several homologues of these cell wall hydrolases are glycosylated in other 
closely related species raises the question if the glycosylation of these cell wall hydrolases 
is a common trait in lactobacilli. Research on the glycosylation of the Acm2 autolysin of 
L. plantarum WCFS1 showed that glycosylation acts as a negative regulator of its enzyme 
function (Fredriksen et al., 2012; Rolain et al., 2013). In view of the potentially ‘dangerous’ 
autolytic function of these enzymes it would make sense for the bacteria to fine-tune their 
activity by glycosylation. Indeed, earlier work showed that Msp2 is more active than its 
(heavier) glycosylated Msp1 homologue (Lebeer et al., 2012b). If this is indeed the case and 
if this is a feature shared by all lactobacilli or even by more distantly related species remains 
to be further substantiated. 
A third plausible explanation for the glycosylation of Msp1 and Msp2 is the fact that 
glycosylation might be used by bacteria as a switch between the canonical role of an enzyme 
and its moonlighting function. Apart from being cell wall hydrolases, Msp1 and Msp2 are 
probiotic effectors that can modulate the survival of intestinal epithelial cells (Yan et al., 
2007). It is conceivable, that in parallel to the well-known phosphorylation cycles used by 
organisms to switch between activity states, glycosylation is here used as a control mechanism 
between their enzymatic activities. This is corroborated by the finding of more glycosylated 
moonlighting proteins in our screening of the L. rhamnosus GG glycoproteome (chapter 5).  
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7.2 tecHnoLogicaL impact on bacteriaL gLycobioLogy
As illustrated, the field of bacterial glycobiology is challenging to study. The posttranslational 
and thus non-template driven character of these modifications inflicts several experimental 
difficulties (chapter 2, (Tytgat & Lebeer, 2014)). In the course of this PhD work we tackled 
some of these challenges by proposing new workflows and enhancing some existing protocols. 
7.2.1   systematic approacHes to investigate tHe gLycosyLation potentiaL of bacteria
The field of bacterial protein glycomics is still rather young and glycoproteins have been 
identified only in a limited amount of species (chapter 2, (Tytgat & Lebeer, 2014)). To study 
the glycosylation potential of the model probiotic and microbiota isolate L. rhamnosus GG 
we relied on two systematic approaches: a first one to predict genes encoding GTs and a 
second one to screen the proteome for glycoproteins. In both cases we designed a new, robust 
workflow that can easily be applied (with some minor adaptations) to study new species.
7.2.1.1   annotation of gLycosyLtransferases anD tHeir substrate cLasses
The annotation of GTs in bacteria is often unreliable. This information is mostly inferred 
from data and gene annotations in other species, which leads to the accumulation of erroneous 
annotations across species (chapter 2, (Tytgat & Lebeer, 2014)). Thanks to a stimulating 
collaboration with the bio-informaticians of the group of Prof. K. Marchal (KU Leuven & 
UGhent) combined with our biological input on bacterial (protein) glycosylation, we were 
able to propose a new method to circumvent further propagation of errors. This sequenced-
based method relies on all experimental validated data available about GTs, which is mostly 
bundled in the CAZy database and was further manually extended with all available literature 
on peculiar GTs and glycosylation mechanisms in bacteria (chapter 2 and 3). This workflow 
enables one to screen a bacterial genome for all genes potentially encoding GTs in a robust 
way. 
Finding a link between a GT and its substrate has been proven to be extremely hard. There are 
currently no motifs described that link the two. The promiscuity of GTs moreover hampers the 
identification of substrate motifs (chapter 2, (Tytgat & Lebeer, 2014)). Currently, the ‘best’ 
way to identify the specificity of a GT was by extrapolation of information from clustered 
auxiliary enzymes and its potential substrate. But as seen in L. rhamnosus GG (chapter 3, 
(Sanchez-Rodriguez et al., 2014)) GTs can also occur isolated in the genome, rendering this 
approach not useful. To improve this, we start from the local neighborhood of a predicted 
GT. The STRING database, gathering all known information on protein-protein interactions 
(Szklarczyk et al., 2011), was mined to find functional partners of the identified GTs. This 
results in the drawing up of consensus networks, which enable the linkage of GTs to their 
potential target molecules. The more information (e.g. microarrays, RNA seq, proteomics) 
present in STRING, the better the output of the analysis. For instance, we were able to infer 
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more substrate relations for the better-studied C. jejuni (30/44) than for L. rhamnosus GG 
(20/48) (chapter 3, (Sanchez-Rodriguez et al., 2014). Taken together, our analysis flow 
improves the attribution of plausible GT substrates largely, especially for isolated GTs. 
Moreover, the current analysis was performed using all current information on bacterial GTs. 
As this field is still rather young and rapidly expanding, it will be of interest to redo the 
analysis in a couple of years. This will most probably result in better-substantiated predictions 
and might lead to the identification of extra GTs. Also the linkage of the predicted GTs to 
their substrate largely relies on the amount of data present in the STRING database. This is 
an important factor as illustrated for C. jejuni, in which more GTs could be linked to their 
potential substrate compared to L. rhamnosus GG. Initially, when we conceived the study, 
there was no data present in the STRING database for L. rhamnosus GG. Microarray data en 
other large interaction datasets were included upon our request by other groups, illustrating 
that the current information in the STRING database on L. rhamnosus GG is still limited. In 
a few years, based on the extra information on the interactome that will be generated by then, 
the substrate-relation inference step of our analysis could be largely improved. This might 
lead to better predictions of substrate specificities of the GTs, like the prediction of GTs 
potentially targeting Msp1 and other known glycoproteins of L. rhamnosus GG. 
7.2.1.2   Mapping of bacterial glycoproteomes 
The study of the glycoproteome of L. rhamnosus GG also led to the design of a broadly applicable 
workflow. To infer data on the localization of glycoproteins, a protocol was conceived that 
enables the separation of cytosolic, cell wall-associated, cell wall/membrane and supernatant 
proteins, resulting in a unique extra layer of information. Glycosylated proteins were then 
identified using a combination of both Periodic Acid Schiff base glycostain and lectin probing 
applied to the 2D separated glycoproteome fractions. Robustness of the workflow can be 
ensured by the performance of an independent repeat of the experiment, independent lectin 
probing experiments and the inference of a set of strict rules to select glycan-positive spots. 
MS identification then leads to a list of potentially glycosylated proteins in a species. This 
workflow can be easily applied to other species. The main caveat is to carefully select the 
lectin used for probing of the fractionated glycoproteomes, as this is likely to be species-
specific (chapter 5).
As mentioned before, we strongly recommend the combination of this workflow with gel-free 
approaches. This would not only serve as an extra confirmation of the identified targets, but 
can also increase the number of identified glycoproteins, as insoluble or very large proteins 
are hard to detect in the here-proposed workflow. Moreover, the glycosylation of the here-
identified hits, especially the putative ones, needs to be further experimentally substantiated. 
Purification and assessment of their glycosylation status using MS techniques are only few of 
the techniques that can be used to do so (see earlier).   
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7.2.2   caveats wHen performing Lectin probing
Already for several decades, lectin probing of Western blotted proteins is used by many 
researchers to detect glycosylated proteins (chapter 2, (Tytgat & Lebeer, 2014)). Also in 
this PhD work, lectin probing was one of the key experiments to identify and confirm the 
glycosylation of proteins. In this context we have a long-standing collaboration with lectin 
expert Prof. Els Van Damme (UGhent). She provided us with an array of lectins with different 
specificities, which were applied in several lectin screenings. Lectin probing proved to be 
extremely valuable both in dedicated approaches (cf. chapter 6 on pili glycosylation) and 
general open screening approaches (chapter 5). Albeit this technique has been universally 
used to detect glycoproteins, our experimental endeavors resulted in two important updates 
that can improve the reliability and resolution of lectin probing. 
A first fact is that lectin probed blots often show a lot of background noise, meaning that the 
blot itself tends to color too. Generally, Western blots are blocked using a BSA solution or a 
solution of milk powder. Albeit this does not infer any problems for antibody-based detection 
of proteins, it does hamper the detection of glycoproteins. Both substances contain or are 
contaminated with glycosylated proteins, resulting in a high background signal when probing 
blots with lectin probes. We therefore, based on results of the group of Thompson et al. who 
reported this for ELISAs, recommend the use of the chemical polyvinylalcohol (PVA) instead 
of BSA or milk powder to reduce background noise (chapter 4, 5, 6, (Thompson et al., 2011)). 
Most lectins used for glycan detection are linked to a biotin-molecule, enabling their detection 
with streptavidin. This resulted in L. rhamnosus GG in a recurring strong reactive band of 125 
kDa with when screened with a plethora of lectins. However, this protein could not be purified 
using a lectin-affinity column. Ultimately, identification revealed that this band resulted from 
a pyruvate carboxylase, which are known to bind endogenous biotin. Probing of a Western 
blot with only a secondary streptavidin antibody, revealed the presence of more biotin-binding 
proteins, causing false positive results. We therefore recommend the glycobiology community 
to either include such a streptavidin-probed control blot or to shift to a digoxigenin-based 
detection system. This finding is not only valid for lectin probing, but for all biotin-streptavidin 
based probing systems (chapter 4, (Tytgat et al., 2014)). Especially for open screening 
approaches using lectins, as we performed in chapter 5, it is of high importance to take these 
potential false positives into account. 
7.2.3   muLtiDiscipLinarity is key in gLycobioLogy
The challenging nature of bacterial glycobiology often demands a multidisciplinary approach. 
In this work collaborations were sought with specialists in glycan (Prof. Wuhrer, VUA) 
and protein mass spectrometry (Prof. Wattiez and B. Leroy, UMons), bioinformatics (Prof. 
Marchal, UGhent), pili (Prof. de Vos, UHelsinki & Wageningen University and F. Douillard), 
immunology (Prof. Geijtenbeek, AMC UvA), lectin (Prof. Van Damme, UGhent)… We 
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strongly believe that the gathering of scientists with different backgrounds is essential to 
push new findings in this challenging field (chapter 2, (Tytgat & Lebeer, 2014)). These 
multidisciplinary collaborations were key in this PhD work and several research stays in other 
groups (e.g. 3 months in the lab of Prof. Geijtenbeek, AMC UvA and 2 short stays in the group 
of Prof. de Vos, UHelsinki) were crucial to obtain the here-presented results
A quite unique approach presented in this work, is the collaboration with the AFM-specialists 
of the group of Prof. Dufrêne (UCL). Previously, our lab has worked closely together with this 
group on the elucidation of the nanomechnical properties of the SpaCBA pili of L. rhamnosus 
GG (Francius et al., 2008; Lebeer et al., 2009; Sullan et al., 2014; Tripathi et al., 2013; Tripathi 
et al., 2012a; Tripathi et al., 2012b). The results were intriguing, as they could show that the 
pili act as a nanospring and support the adhesion of L. rhamnosus GG to its environment 
in a zipper-like manner. In chapter 6, we propose a new method to screen for glycosylated 
surface structures on bacteria, by probing live cells with AFM-tips modified with lectins. This 
led to the identification of fucose and mannose residues present on the SpaCBA pili of L. 
rhamnosus GG and provides a novel method to also screen other (piliated) bacteria for surface 
glycosylation (chapter 6). As shown before, cell wall polysaccharides can be detected in a 
similar method (Francius et al., 2009; Francius et al., 2008; Lebeer et al., 2009). We believe 
that single-molecule force spectroscopy combined with lectins provides a powerful method to 
screen surface glycosylation on intact bacterial cells. 
7.3 new insigHts in bacteriaL gLycobioLogy
The results of this PhD also generated some new insights and hypotheses potentially relevant 
for a wider range of species or even to the broader field of bacterial glycobiology. These new 
ideas mainly resulted from the two systematic assays we performed (chapter 3 and 5). It will 
be interesting to see if these results and hypotheses can be further substantiated in the next 
coming years. 
7.3.1   gLycosyLation as a reguLator of muLtienzyme compLexes
As mentioned earlier, research on the functional importance of protein glycosylation in 
particular has been lagging behind (Tytgat & Lebeer, 2014). Results from both our systematic 
analyses (chapter 3 and 5) now indicated that glycosylation of proteins might play a more 
important role than currently is appreciated. Both analyses showed that protein glycosylation 
may be involved in the regulation of multienzyme complexes. 
In the course of the unraveling of the substrate of potential GTs, we found indications that 
some GTs are promiscuous and can be linked both to peptidoglycan biosynthesis and protein 
glycosylation. The proteins they target are moreover members of the cell division machinery 
(chapter 3). Results from our glycoproteome screening corroborated these findings, with the 
identification of three cell wall hydrolases as being glycosylated and the potential glycosylation 
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of the MurE PG biosynthesis enzyme (chapter 5). This hypothesis was underpinned further by 
similar reports on the glycosylation of members of the cell division machinery in B. fragilis 
(Fletcher et al., 2009) and L. plantarum WCFS1 (Fredriksen et al., 2013). 
The glycoproteome screening of L. rhamnosus GG furthermore resulted in the identification 
of several proteins related to protein synthesis (chapter 5). More in particular, structural 30S 
and 50S ribosomal proteins were shown to be glycosylated, together with the elongation factor 
FusA. Of the latter, the glycosylation status was also evidenced in C. jejuni (Young et al., 
2002). The ribosome represents another crucial multienzyme complex of the bacterial cell. 
Taken together this might indicate that bacteria use protein glycosylation as an extra level of 
regulation of their crucial multienzyme complexes. The timing, assembly and stability of both 
the cell division and translation machinery is essential for the wellbeing of the cell, making 
their tight regulation key. 
The experimental substantiation of the potential role of glycosylation as an extra regulation 
level of multienzyme complexes is however challenging. Purification of (membrane-associated) 
multienzyme complexes is cumbersome. For instance, some of them are only present in an 
assembled manner during specific moments during cell growth. 
7.3.2   reguLation of enzymatic activity by gLycosyLation
A striking finding of the glycoproteome screening is the glycosylation of several moonlighting 
enzymes. Three moonlighting enzymes of the glycolysis (GapA, Eno and Pgk) were found 
to be glycosylated (chapter 5). Earlier we also discussed the potential implications of the 
glycosylation of the multifunctional cell wall hydrolases Msp1 and Msp2 (chapter 5). A possible 
explanation is that the cells might use glycosylation of these enzymes as a switch between 
their canonical role and their moonlighting function. The canonical role of all these enzymes 
is mostly situated in the cytosol or linked to the cell wall. Maybe the attachment of a glycan 
targets them for secretion, relocating them to the extracellular side of the bacterium, where 
they can exert their moonlighting role in the adhesion and modulation of the environment. 
Another peculiar finding of chapter 5, is the high number of glycosylated carbohydrate-
enzymes. A high number of enzymes involved in the glycolysis were identified as glycoproteins 
with high confidence. It is likely that their glycosylation functions as a kind of self-regulation 
mechanism. For instance, a top hit was the glycosylation of the L-lactate dehydrogenase 
encoded by LGG_02523 (chapter 5). This corroborates the observation that lactobacilli tend 
to regulate the activity of L-lactate dehydrogenases by different mechanisms (Feldman-Salit 
et al., 2013). Our results suggest that glycosylation can be added to this list. 
7.4 generaL concLusions
In conclusion we give a short overview of the most important findings of this PhD work. 
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• Design of a robust workflow that combines sequential and network-based computational 
predictions to unveil insights in the glycosylation potential of a bacterium. This unique 
method enables the identification of GT-encoding genes and moreover links them to their 
potential substrate molecules.  
• Optimization of experimental techniques necessary to study glycoproteins.
• Design of a robust workflow to screen the functionally fractionated proteome of a bacterium 
for glycoproteins. 
• Discovery of the glycosylation of the complex heterotrimeric SpaCBA pili of L. rhamnosus 
GG. 
• Proof that the glycosylation of these pili is important for the interaction with the host 
immune system, making this one of the few detailed reports on the immunological 
importance of glycosylated structures. 
• Generation of important new insights and hypotheses on protein glycosylation in bacteria 
and especially on the potential functional roles of glycosylation of proteins. 
In general we believe that our results have enhanced the knowledge on glycoproteins as 
important molecules underlying the specific interactions between probiotics and microbiota 
members and their host. Moreover, our work has supported the bacterial glycobiology field 
in general, both by the design of new techniques and the proposition of important new 
hypotheses. However, the experimental validation of the here-proposed hypotheses promises 
to be challenging.  
7.5 Lessons for gLycobioLogy
• Beware of false positive results: revise methods carefully to avoid them. It is advisable 
to include the appropriate controls to check for false positive and negative results. In the 
case of lectin blotting, the digoxigenin detection method is preferable over the biotin-
streptavidin method.
• Multidisciplinarity is key. The non-template driven character of glycobiology demands 
the joining of investigative forces from a variety of disciplines. As illustrated in this 
work, the acquisition of results relies on the collaboration with mass spectrometrists, bio-
informaticians, immunologists and many other experts. 
• Glycosylation might play a role in the regulation of multienzyme complexes. Tight 
regulation of the assembly and activity of these complexes is crucial for the well being of 
the cell. We hypothesize on the role of protein glycosylation in the regulation of the cell 
division machinery and ribosome.
• Glycosylation might regulate the switch between the canonical and moonlighting function 
se
ve
n.
173
of a protein. This hypothesis is corroborated by the glycosylation of several proteins with a 
reported moonlighting role such as the GAPDH enzyme which is both a glycolytic enzyme 
and is implicated to bind to molecules in the environment. 
• Heterotrimeric pili structures can be glycosylated. Up till now only simple, monomeric pili 
have been reported to be glycosylated. Our results open new avenues in the study of the 
glycosylation of piliated species. Moreover, this pili glycosylation can be crucial for the 
establishment of specific immune reactions. 
7.6 perspectives
Many fundamental mechanical questions concerning bacterial protein glycosylation remain 
unanswered. However, the importance of glycoproteins and of glycoconjugates in general 
in host-bacteria interactions becomes more and more apparent (Kay et al., 2010; Tytgat & 
Lebeer, 2014). Research on bacterial glycoproteins is a hot topic as the protein glycosylation 
potential of more and more species is studied. The past decades, most research focused on 
glycoproteins in pathogens, in view of their role in virulence, but nowadays more and more 
reports on the occurrence of glycoproteins in beneficial commensal bacteria are emerging. 
However, research on the functional importance of glycoproteins, and of glycoconjugates 
in general, is still lagging behind. The role of these glycosylated structures is likely to be 
even more important than currently appreciated, cf. the potential role of glycosylation in the 
regulation of multienzyme complexes. It can be envisaged that these gaps in knowledge will 
be gradually filled the next coming years, especially when taken into account that the field 
of bacterial protein glycosylation emerged only a few decades ago. The current knowledge 
only scratches the surface of what there is to know on the occurrence and function of bacterial 
glycoproteins. The future of bacterial glycobiology is promising and it will be fascinating to 
see which species are able to produce these structures and what their evolutionary motif is to 
do so.
As mentioned, glycosylation of proteins is of importance for the modulation of the biochemical 
properties of their substrates and to establish specific interactions with the environment. These 
features can be exploited by the attachment of glycans to specific molecules thus increasing 
their stability or activity and their interaction potential. Glycoengineering of molecules holds 
great promises for the production of therapeutics and bioactive molecules with enhanced 
properties (Werner et al., 2007). The basis for this glycoengineering field was formed by a key 
publication by Wacker and co-workers, showing the heterologous production of a glycoprotein 
of C. jejuni by transfer of the glycosylation machinery into E. coli (Wacker et al., 2002). This 
technology is already widely employed for the production of medical therapeutics in bacteria 
(Elliott et al., 2003; Farahmand et al., 2011; Iwashkiw et al., 2012a; Lindhout et al., 2011; 
Lizak et al., 2011a; Saxon & Bertozzi, 2001). Bacteria are the ideal production system for 
glycosylated agents, as they can be grown easily, production is cheaper, they can be genetically 
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modified and the process can be accelerated compared to production in eukaryotes (Pandhal & 
Wright, 2010). Currently, much research is done on the production of glycoengineered human 
therapeutics in bacteria, like insulin (Jain et al., 2003). Also the production of vaccines both 
for humans (Glycovaxyn, Switzerland) as for animals (Group of Prof. Szymanski, Canada) is 
being pursued (Ihssen et al., 2010). 
Most glycoengineering assays are based on the transfer of the glycosylation machinery of a 
pathogen and its target to E. coli, in which the glycan is further tailored to generate the therapeutic 
molecule of interest. But in the future it would be even more interesting to investigate the 
potential of new bacterial expression system for the production of glycosylated therapeutics 
that would also enable the in situ delivery of the agent. In terms of dosage and protection against 
degradation of the molecules during their passage through the harsh environments of the GIT, 
the in situ production of these molecules would be a large improvement. Lactic acid bacteria 
are envisaged to be ideal drug delivery vehicles (Wells & Mercenier, 2008). Combining these 
two improvements in disease treatment, i.e. the in situ delivery of glycosylated molecules, 
would revolutionize the way in which diseases are treated, by controlling the location of 
release and the efficacy of the therapeutic molecule. 
Our work on the elucidation of the glycosylation potential of the original microbiota isolate 
and probiotic L. rhamnosus GG can aid in this revolution. The GRAS (Generally Regarded 
As Safe) status of this probiotic together with the fact that this bacterium can produce 
glycoproteins makes this an ideal candidate to further investigate. Moreover, in contrast to 
E. coli, L. rhamnosus GG does not produce endotoxins. Taken together, L. rhamnosus GG 
can very well be the probiotic of the future, delivering glycosylated therapeutic molecules or 
vaccines in situ in a safe and controllable way. Moreover, the fact that two probiotic effectors 
of L. rhamnosus GG were found to be glycosylated (i.e. Msp1 and the SpaCBA pili) also open 
avenues for the usage of these isolated glycoproteins as therapeutic molecules. The potential 
of glycoproteins of L. rhamnosus GG as safe new generation vaccine adjuvantia is currently 
being investigated. 
Moreover, the results of this work further improve the knowledge on the molecules 
underlying probiotic- and microbiota-host interactions. The insights of this work can enhance 
an underpinned use of probiotics further. The bacterial glycan barcode of probiotics and 
microbiota is hypothesized to be a crucial part of the interactome with the environment and 
host. Furthermore, better insights on the key molecules present on probiotics can further 
substantiate the fundamental knowledge needed to support functional food and probiotic 
claims, as is now required by EFSA.
Another potential application of a better knowledge of bacterial glycobiology is the 
exploitation of enzymes to synthesize glycans in vitro. This organic synthesis of glycans holds 
many challenges such as the lack of control of the sterochemistry, low yield and difficulty to 
scale-up the process (Nicolaou & Mitchell, 2001). Chemical biologists try to tackle this by 
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purifying glycosyltransferases and other glycan-modifying enzymes in order to synthesize 
glycans in vitro. The benefits of using enzymes are wide-spread: the high catalytic activity, 
lack of side-reactions, mild reaction conditions and high region and stereoselectivity (Faijes & 
Planas, 2007). Especially bacterial GTs hold great promise, as they can be more easily cloned, 
overexpressed and purified compared to their eukaryotic counterparts (Merritt et al., 2013; 
Mutanda et al., 2014). Moreover, bacterial GTs are better accessible to engineering strategies 
to for instance enhance their substrate tolerance (Kiessling & Splain, 2010). These strategies 
are very promising, but are only starting to emerge as knowledge on bacterial glycosylation is 
growing. A benchmarking work was the report on the in vitro reconstruction of the pathway to 
synthesize the branched N-linked heptasaccharide of C. jejuni (Glover et al., 2005a). For the 
first time the biosynthesis of a bacterial glycan was completely reconstructed in vitro using 
purified enzymes. At the moment several groups are investigating this potential of bacterial 
GTs to perform one-pot synthesis of bacterial glycans (personal communication).
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aDDenDum: List of mutants
List of mutants constructed together with technician Tine Verhoeven in the framework of this 
PhD. All described mutants are double homologous recombinant knockout mutants, in which 
an antibiotic resistance cassette replaced the gene of interest. 
gt mutants
Eleven mutants were produced in the framework of the results of our in silico screening for 
genes encoding GTs (chapter 3). Numerous attempts were made to produce mutants at least 
in all GTs predicted to target proteins, unfortunately, some of the targeted GTs seemed to be 
essential. This was the case for the predicted GTs encoded by LGG_00794, LGG_01487 and 
LGG_001283. Some mutants were already produced whilst the GT in silico screening was still 
in progress and later proved to be false positive hits of the analysis, which were discarded in 
the final optimized format of the workflow (LGG_01399 and LGG_02693).
Strain Genotype Target locus Fenotype
CMPG10800 ΔgtrB::TcR LGG_01069 None observed
CMPG10802 ΔyohH-yohJ::TcR LGG_01586-87 None observed
CMPG10803 Δhly::TcR LGG_01399 False positive GT
CMPG10804 ΔxylB::TcR LGG_02693 False positive GT
CMPG10806 ΔLGG_00825-26::TcR LGG_00825-26 None observed
CMPG10808 ΔarbX-arbY::TcR LGG_00998-999 None observed
CMPG10809 Δpbp2A::TcR LGG_01783 None observed
CMPG10811 ΔwelI::TcR LGG_02047 Less EPS compared to WT (chapter 3)
CMPG10815 ΔLGG_01147::TcR LGG_01147 None observed
CMPG10817 ΔyohH-yohJ::TcR LGG_02284-85 None observed
msp1 mutants
To investigate whether the identified glycosylation site in Msp1, namely TVETPSSA, was 
the only modified amino acid stretch in this protein, two new mutants were constructed. The 
existing msp1 single homologous recombinant mutant (CMPG10200) was complemented with 
plasmids carrying the msp1 gene in which the serines of the glycosylation motif were deleted 
via a point mutation (CMPG10805) and another one in which a large stretch rich in serines 
and alanines was deleted around the TVETPSSA region of Msp1 (CMPG10807). Both mutants 
still produced glycosylated Msp1 protein when stained with PAS glycostain and probing with 
lectins (results not shown). 
secx mutants
To investigate whether L. rhamnosus GG harbors a special system to secrete glycosylated 
proteins, we constructed several mutants that can help us to elucidate the existence and 
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functionality of such system.
Strain Genotype Target locus Fenotype
CMPG10810 Δabc::TcR LGG_02580-81 Analysis ongoing
CMPG10816 ΔsecX::TcR LGG_01063 Analysis ongoing
CMPG10818 ΔsecX::EryRΩabc::TcR LGG_01063 and LGG_002580-81 Analysis ongoing
CMPG10819 ΔsecX::TcRΩmsp1::EryR LGG_01063 and LGG_00324 Analysis ongoing
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